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Summary
It is widely accepted that insufficient insulin-stimulated activation of muscle glyco-
gen synthesis is one of the major components of non-insulin-dependent (type 2)
diabetes mellitus. Glycogen synthase, a key enzyme in glycogen synthesis, is ex-
tensively regulated, both allosterically (by glucose-6-phosphate, ATP, and other lig-
ands) and covalently (by phosphorylation). Although glycogen synthase has been
a topic of intense study for more than 50 years, its kinetic characterization has been
confounded by its large number of phosphorylation states. Questions remain re-
garding the function of glycogen synthase regulation and the relative importance
of allosteric and covalent modification in fulfilling this function. The regulation
of glycogen synthase and glycogen phosphorylase, the enzyme that catalyses the
degradation of glycogen chains, are reciprocal in many respects.
In the present research, using mathematical modelling, we aim to establish the
function of the allosteric and covalent regulation of glycogen synthase and glyco-
gen phosphorylase in muscle and, in the case of glycogen synthase, the relative im-
portance of these two mechanisms in performing this function. In order to realize
these aims it is essential that a detailed kinetic model of glycogen metabolism is
constructed.
We begin with a thorough review of the kinetics and regulation of glycogen syn-
thase in which we propose that both allosteric and covalent modification of glycogen
synthase can be described by a Monod-Wyman-Changeux model in terms of appar-
ent changes to L0, the equilibrium constant between the T and R conformers. We
then proceed to develop a rate equation according to the proposed Monod-Wyman-
Changeux model and determine values for its kinetic parameters from published
experimental data using non-linear least-squares regression. We show that the ap-
plication of the Monod-Wyman-Changeux model to glycogen synthase kinetics also
has important implications for the rate equations of enzymes that catalyse the phos-
phorylation and dephosphorylation of glycogen synthase. We formalize these impli-
ii
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cations for a generic protein that follows Monod-Wyman-Changeux-type conforma-
tional change and then also show how the findings apply to glycogen synthase. Tak-
ing into account the kinetic model of glycogen synthase and how it also influences
the covalent regulation of the enzyme, we proceed to construct a detailed mathemat-
ical model of glycogen synthesis that includes the glycogen synthase phosphoryla-
tion cascade. A variation of this model in which glycogen synthase phosphorylation
is described with a single parameter is also provided. We reuse an existing model of
muscle glycogenolysis and also combine these models in an overall model of glyco-
gen metabolism. Finally, we employ the theoretical frameworks of metabolic control
analysis, supply-demand analysis, and co-response analysis to investigate the func-
tion of glycogen synthase and glycogen phosphorylase regulation. We show that
the function of glycogen synthase regulation is not flux control, as assumed in the
textbook view, but rather the maintenance of glucose-6-phosphate within a narrow
range far from equilibrium. Similarly, we show that regulation of glycogen phos-
phorylase functions to minimize variation in cellular energy charge in the face of
highly variable energy demand. We conclude with an appeal for a renewed interest
in the enzyme kinetics of muscle glycogen metabolism.
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Opsomming
Daar word wyd aanvaar dat onvoldoende insulien-gestimuleerde aktivering van
spierglikogeensintese een van die hoofkomponente van insulien-onafhanklike (tipe
2) diabetes mellitus is. Glikogeensintase, ’n sleutelensiem in glikogeensintese is
onderworpe aan breedvoerige regulering, beide allosteries (deur glukose-6-fosfaat,
ATP, en ander ligande) en kovalent (deur fosforilering). Alhoewel glikogeensintase
reeds vir meer as 50 jaar deeglik bestudeer word, word die kinetiese karakteris-
ering daarvan bemoeilik deur die groot aantal fosforilasiestate waarin die ensiem
voorkom. Daar is steeds vrae betreffende die funksie van die regulering van gliko-
geensintase en die relatiewe bydrae van allosteriese en kovalente regulering in die
vervulling van hierdie funksie. Die regulering van glikogeensintase en glikogeen-
fosforilase, die ensiem wat die afbraak van glikogeenkettings kataliseer, is in baie
opsigte resiprook.
In hierdie studie beoog ons om met die hulp van wiskundige modellering vas
te stel watter funksie die regulering van glikogeensintase en glikogeenfosforilase
vervul en, in die geval van glikogeensintase, wat die relatiewe belang is van alloster-
iese en kovalente regulering in die vervulling van hierdie funksie. Om hierdie oog-
merke te verwesentlik is dit nodig dat ’n kinetiese model van glikogeenmetabolisme
ontwikkel word.
Ons begin met ’n omvattende oorsig van die kinetika en regulering van gliko-
geensintase waarin ons voorstel dat beide die allosteriese en kovalente regulering
van glikogeensintase beskryf kan word met die Monod-Wyman-Changeux model
in terme van oe¨nskynlike veranderings aan L0, die ekwilibriumkonstante tussen
die T en R konformasies. Ons gaan dan voort om ’n snelheidsvergelyking te ont-
wikkel volgens die voorgestelde Monod-Wyman-Changuex-model en bepaal ook
die waardes van hierdie vergelyking se parameters vanaf gepubliseerde eksperi-
mentele data deur middel van nie-lineeˆre kleinste-vierkantsregressie. Ons wys dat
die toepassing van die Monod-Wyman-Changuex-model op glikogeensintase-kinetika
iv
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belangrike gevolge het vir die snelheidsvergelykings van die ensieme wat die fosfo-
rilering en defosforilering van glikogeensintase kataliseer. Ons formaliseer hierdie
gevolge vir ’n generiese Monod-Wyman-Changeux-tipe proteı¨en en wys dan ook
hoe die bevindings op glikogeensintase van toepassing is. Met inagneming van die
kinetiese model vir glikogeensintase en hoe dit die kovalente regulering van die
ensiem beı¨nvloed, gaan ons voort om ’n gedetaileerde wiskundige model van gliko-
geensintese, wat ook die glikogeensintase-fosforileringskaskade insluit, te ontwik-
kel. ’n Variasie op hierdie model waarin die fosforilering van glikogeensintase deur
’n enkele parameter beskryf word, word ook voorsien. Ons herbruik ’n bestaande
model van spierglikogenolise en kombineer ook hierdie modelle in ’n oorkoepelende
model van glikogeenmetabolisme. Uiteindelik span ons die teoretiese raamwerke
van metaboliese kontrole-analise, vraag-aanbod-analise, en ko-responsanalise in om
die funksie van die regulering van glikogeensintase en glikogeenfosforilase te on-
dersoek. Ons wys dat die funksie van die regulering van glikogeensintase nie fluk-
siekontrole, soos algemeen in handboeke aangeneem word, is nie, maar liewer dat
dit glukose-6-fosfaat handhaaf binne ’n noue band ver vanaf ekwilibrium. Insge-
lyks wys ons dat die regulering van glikogeenfosforilase funksioneer om variasie
in selluleˆre energielading te beperk ten spyte van hoogs wisselende vlakke van
energie-aanvraag. Ons sluit af met ’n pleidooi vir hernieude belangstelling in die
ensiemkinetika van glikogeenmetabolisme in die spier.
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Chapter 1
Introduction
Glycogen, a branched polymer of glucose, is used by numerous organisms as a glu-
cose store when glucose is abundant or as a source of glucose under conditions of
metabolic depletion [1]. The structure of glycogen has been optimized to store a
large amount of glucose that is readily available without affecting cellular osmo-
larity [2]. In mammals, skeletal muscle is the major site of glucose disposal [3, 4],
storing significantly more glycogen than the liver [5]. Although skeletal muscle in-
sulin resistance is not a sufficient causative agent in non-insulin-dependent (type 2)
diabetes mellitus, it is considered a primary defect in this disease [6]. Jensen et al.
[7] suggest that, in muscle with a high glycogen content, insulin resistance is not
necessarily manifested as decreased glucose uptake, but rather as impaired mus-
cle glycogen synthase (GS) activity. GS, the enzyme that incorporates glucose from
UDP-glucose (UDPG) into glycogen, is extensively regulated by both allosteric and
covalent modification. Glucose-6-phosphate (G6P), acting as an activator, and ATP,
acting as an inhibitor, as well as many other ligands, compete for an allosteric site on
GS. In addition, GS is phosphorylated at nine serine residues, resulting in marked
inhibition.
The extensive regulation of GS activity, and its relatively low activity, has led
to the view that it is the “rate-limiting” enzyme of glycogen synthesis [8]. Accord-
ingly, phosphorylation and activation by G6P are traditionally considered mecha-
nisms that control the flux of glycogen synthesis. This view has been called into
question by several in vivo NMR studies, as reviewed by Shulman et al. [8], in which
it was found that, in general, there is no correlation between the glycogen synthetic
flux and the degree of GS phosphorylation, as measured by the fractional velocity.
Instead, the glycogen synthetic flux was found to be proportional to the glucose im-
1
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port activity. These findings led Shulman et al. [8] to suggest that the regulation of
GS activity is not involved in controlling the flux of glycogen synthesis, but rather
serves to maintain G6P homeostasis [9]. In this view phosphorylation functions to
maintain the sensitivity of GS to its feedforward activator, G6P.
The theoretical framework of metabolic control analysis (MCA) [10, 11] has been
applied to the model proposed by Shulman et al. [8] in a number of studies [9, 12, 13],
confirming that the glycogen synthetic flux is controlled by glucose uptake, and
suggesting a role for phosphorylation in the coordinate activation of glucose trans-
porter 4 (GLUT4) and GS by insulin as a mechanism of G6P homeostasis. Other
metabolic control analytic (MCA) studies, however, found that control of the glyco-
gen synthetic flux is shared almost equally between the glucose uptake and glycogen
synthesis activities [14]. Recently, Roach et al. [1] argued for a more neutral view in
which both glucose uptake and GS potentially control the flux, depending on cellu-
lar conditions.
The notion that the regulation of GS activity by phosphorylation can be a mech-
anism that maintains metabolite homeostasis [9] is in good agreement with the find-
ings of Hofmeyr & Cornish-Bowden [15] that allosteric regulation in feedback in-
hibition loops does not function to control the flux through the regulated enzyme,
but rather to maintain the concentration of the regulatory metabolite within a nar-
row range far from equilibrium. If a similar function is assumed for feedforward
loops, as in the activation of GS by G6P, the allosteric and covalent regulation of
GS activity would appear to be involved in the homeostatic maintenance of G6P.
However, Hofmeyr et al. [16] argue that, unlike the situation in feedback inhibition,
the type of activation—whether by increasing the kcat or decreasing Km of the regu-
lated enzyme—has important consequences for the effectiveness of the mechanism
in maintaining the concentration of the regulatory metabolite homeostatically, pre-
dicting that an increase in kcat is to be expected rather than a decrease in Km.
The presence of allosteric and covalent regulation of GS activity, and the fact that
various stimuli such as insulin signalling make use of both these mechanisms to af-
fect GS activity, raise questions regarding the relative importance of these two mech-
anisms in the regulation of GS activity. Recent studies using mutant mice in which
glycogen synthase kinase 3 (GSK3), a kinase that phosphorylates GS at various sites,
was rendered constitutively active [17] or in which GS was rendered insensitive to
activation by G6P [18] suggest that, in response to insulin, the activation of GS is
predominantly mediated through allosteric and not covalent regulation.
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At present no detailed kinetic treatment exists that is able to account for both
the allosteric and covalent regulation of GS. The development of such a model is
severely complicated by the numerous phosphorylation states in which the enzyme
can exist. It is thus no surprise that GS phosphorylation is almost always discussed
in terms of a two-state model, as the reciprocal of glycogen phosphorylase (GP)
phosphorylation.
Similar questions arise when glycogen degradation is considered. In many re-
spects, the regulation of GP, the enzyme that catalyses the phosphorolysis of non-
reducing glucose residues from glycogen chains to produce glucose-1-phosphate
(G1P), is reciprocal to that of GS. Phosphorylation inhibits GS, but activates GP. G6P
activates GS but inhibits GP. GP is furthermore activated by AMP and inhibited by
ATP. Using a mathematical model of glycogenolysis, Lambeth & Kushmerick [19]
found that the glycogen degradation flux is controlled by the demand for ATP. This
finding raises questions regarding the function, if not flux control, of the covalent
and allosteric regulation of GP.
In this dissertation, using mathematical modelling, we aim to establish 1) the
function of the allosteric and covalent regulation of GS and GP in muscle and 2) in
the case of GS, the relative importance of these two mechanisms in performing this
function. In order to realize these aims it is essential that a detailed kinetic model of
glycogen metabolism, with emphasis on the kinetics of GS, is constructed.
We begin with a comprehensive review of the allosteric and covalent regulation
of GS and suggest that the kinetics of GS is indicative of the classic Monod-Wyman-
Changeux (MWC) model. In Chapter 3 we develop a rate equation for GS based
on the kinetics as reviewed in Chapter 2, and obtain kinetic parameter values for
this equation using non-linear regression of published experimental data. In Chap-
ter 4 we show that the kinetic model identified as providing the best description of
GS kinetics has important implications for the kinetics of any enzymes that cova-
lently modify GS and other proteins that exhibit MWC-type conformational change.
Taking these implications into account, we proceed to construct various detailed
mathematical models of glycogen metabolism (Chapter 5). The model of Lambeth &
Kushmerick [19] is incorporated as a description of glycogen degradation. Finally,
in Chapter 6, we make use of analytical frameworks such as MCA and co-response
analysis to investigate the regulatory design of glycogen synthesis and breakdown.
We also discuss several aspects that must be taken into consideration in the con-
struction of an overall model of glycogen synthesis and degradation. We conclude
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in Chapter 7 with a general discussion of our main findings and suggest directions
for future research.
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Chapter 2
Allosteric and covalent regulation of
glycogen synthase activity1
2.1 Introduction
In this chapter we provide a comprehensive review of the kinetics and regulation
of glycogen synthase (GS). We discuss both the earlier kinetic studies and the more
recent site-directed mutagenesis and crystal structure studies and show how the re-
sults from these studies can form the basis of a unifying view of the covalent and
allosteric regulation of GS that largely overcomes the combinatorial explosion re-
sulting from the numerous phosphorylation states of the enzyme. We begin with
a detailed general discussion of the kinetics, structure, and regulation of GS. We
then proceed to formulate these aspects in terms of a phenomenological kinetic rate
equation for the purpose of discussing the effects of covalent and allosteric regula-
tion on the kinetic properties of GS. Finally, we propose a variation on the classic
Monod-Wyman-Changeux (MWC) model that succinctly accounts for all the appar-
ent modifications to GS kinetic properties.
This review is not intended as a comprehensive survey of glycogen metabolism
in general, but specifically concerns the regulation of mammalian skeletal muscle
GS from a kinetic perspective. For a comprehensive general review of developments
in glycogen metabolism research over the last decade, the reader is referred to the
recent publication by Roach et al. [1]. The present review follows what could be
considered a “bottom-up” approach, as we avoid discussing higher level regulatory
phenomena such as insulin signalling, but rather focus on the mechanisms under-
1An abridged version of this chapter has been published in FEBS Journal [20].
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pinning GS regulation. For a discussion of the effects of exercise, adrenaline and
insulin stimulation on GS, the reader is referred to the recent “top-down” review by
Jensen & Lai [5]. Where no mammalian muscle data were available we also consid-
ered, with due care, results from research conducted on other mammalian tissues,
other eukaryotes, or even prokaryotes. Unless stated otherwise, or where the context
indicates otherwise, “GS” refers to the muscle enzyme.
2.2 Glycogen synthase and its kinetics
Reaction and thermodynamics
Glycogen chains are readily elongated by glycogen phosphorylase (GP) operating
in the reverse direction using glucose-1-phosphate (G1P) as substrate. However,
Leloir and co-workers showed—first in liver [21] and then in muscle [22]—that the
physiologically relevant synthetic pathway uses UDP-glucose (UDPG) as substrate,
leading to the discovery of GS. GS catalyses the bi-bi reaction in which the glucosyl
(Glc) moiety from UDPG is incorporated into a glycogen molecule comprising n
glucose residues by means of an α(1 → 4) glycosidic bond to produce UDP and
a glycogen molecule comprising n + 1 glucose residues [22, 23] according to the
equation
UDPG+Glcn 
 UDP+Glcn+1 (2.1)
GS requires an oligosaccharide primer as a glucose acceptor and is therefore not
capable of de novo glycogen synthesis. Glucose, maltose, and other short oligosaccha-
rides are either unsuitable or only weak primers [22, 24]. Instead, de novo glycogen
synthesis is initialized in two phases by the homodimer glycogenin (EC 2.4.1.186).
In the first phase, a tyrosyl residue of one subunit (Tyr194 in rabbit muscle) [25, 26] is
glycosylated in an intersubunit reaction by its partner [27, 28]. In the second phase,
a further seven glucosyl residues are added successively in an intrasubunit reac-
tion [26], producing a suitable primer for GS. Like GS, glycogenin uses UDPG as
substrate, but has an additional divalent cation (Mn2+ or Mg2+) requirement [29].
GS is initially complexed with glycogenin and it is believed that this association is
necessary for proper initiation of glycogen synthesis [30]. Branches are initiated by
branching enzyme (EC 2.4.1.18), which cleaves α(1→ 4) bonds to reintroduce them
as α(1→ 6) bonds [31], thus creating new chains that can serve as primers for elon-
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gation by GS. On average, each glycogen chain branches twice and is 12–14 glucose
residues long [2]. The terminal glucosyl residues of glycogen chains are referred to
as non-reducing ends.
The equilibrium constant of the GS reaction is expressed as
Keq =
[UDP]eq[Glcn+1]eq
[UDPG]eq[Glcn]eq
(2.2)
While Glcn and Glcn+1 typically denote entire glycogen molecules, it is really only
the non-reducing ends of a glycogen molecule that can partake in the elongation
reaction. We may thus define [Glcn] and [Glcn+1] as the total concentrations of all
non-reducing ends that can serve as substrates and products. The majority of non-
reducing ends can, however, serve as both substrates and products. For sufficiently
large glycogen molecules, the difference between the equilibrium values of [Glcn]
and [Glcn+1] therefore becomes negligible, so that Eq. 2.2 simplifies to
Keq =
[UDP]eq
[UDPG]eq
(2.3)
Kornfeld & Brown [32] reported the formation of 0.0018 µmoles UDPG from
7 µmoles UDP in the presence of GS and 5 mg glycogen (pH 7.5, 30◦C), from which
a Keq of 3900 can be calculated using Eq. 2.3. Assuming that all α(1→ 4) glycosidic
bonds in the glycogen molecule are equivalent, an assumption supported by Gold-
berg et al. [33], the Keq can also be calculated from the free energy changes of the
component half-reactions. Gold [34] estimated a value of 400 at pH 7.0 and 25◦C. A
value of 230 (pH 7.0, 25◦C) is estimated for the reaction with maltopentaose as glu-
cose acceptor using the group contribution method developed by Jankowski et al.
[35] as implemented by the online service eQuilibrator [36]. Adjusted for pH (7.15)
and ionic strength (0.2 mM), this value increases to about 1000. Kashiwaya et al. [37]
report a much lower value of 37.7 (corrected for physiological pH and Mg2+ in rat
heart).
The difference of more than two orders of magnitude in reported Keq values is
a testament to the dependence of this value on experimental conditions. The value
increases both with ionic strength and pH [36]. The temperature dependence of the
Keq is not clear. The large value calculated from the results of Kornfeld & Brown
[32] can probably be ascribed both to the high pH and to difficulties in accurately
measuring the reactant concentrations. In comparison, the equilibrium ratio of ADP
to ADP-glucose for the E. coli enzyme has been reported as ranging from 55.5 to 151
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as the pH ranges from 5.27 to 6.82 at 37◦C [38]. Considering the similarity of the
ADP-glucose and UDPG phosphoester bonds and the muscle pH of 6.8–7.15 [39],
the physiologically relevant Keq for GS in muscle is probably in the order of 102.
Regardless of the precise value, it is clear that the reaction will not operate in the
reverse direction under physiological conditions.
Kinetic mechanism
The determination of the GS kinetic mechanism is complicated by glycogen’s dual
function as both substrate and product. In addition to the usual substrate binding
terms, initial velocity equations are required to include product binding terms for
glycogen [40]. Moreover, if the glycogen concentration is varied, it will always vary
in both its capacity as substrate and product [34]. As a result, the interpretation of
Lineweaver-Burk and other reciprocal plots, in which each substrate is varied while
keeping the other constant, changes significantly. For instance, Brown & Larner [41]
suggested a ping-pong mechanism on the basis of parallel Lineweaver-Burk plots,
whereas due to the presence of glycogen it can be shown that a ping-pong mecha-
nism should in fact result in intersecting plots [40]. Others [24, 42] have obtained
reciprocal plots indicative of either rapid equilibrium random or ordered sequential
mechanisms, while Plesner et al. [40] would accept only the rapid equilibrium ran-
dom mechanism. In order to overcome the pitfalls associated with reciprocal plots,
Gold [34] studied the mechanism of the rabbit muscle enzyme by determining the
equilibrium isotope exchange rates between UDPG and glycogen, and UDPG and
UDP. Gold [34] concluded that the mechanism is rapid equilibrium random, but con-
ceded that it cannot be distinguished from a rapid equilibrium ordered mechanism
with dead-end binary complexes by any of the methods he employed. Although
the majority of research seems to favour the random order mechanism, an ordered
sequential mechanism cannot be ruled out at this point.
The rapid equilibrium random bi-bi mechanism is seemingly incompatible with
the observation [34, 43, 44] that glycogen forms stable complexes (lasting 3 min on
average) with glycogen synthase [34]. However, the kinetic mechanism only de-
scribes the rapid exchange of individual non-reducing ends and does not preclude
additional interaction of the glycogen molecule as a whole with GS. Considering the
lifetime of the glycogen-GS complex and the kinetic mechanism, Gold [34] makes the
conservative estimate that up to 550 chains are visited by GS. It has also been sug-
gested that GS is able to add several glucosyl residues successively to the same chain
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of a glycogen molecule, i.e., that elongation is processive [34, 45, 46]. The number of
successively added residues is known as the action pattern. Action patterns of 1.4–1.7
[45] and 9 (estimated by [34] from [46]) have been reported. These action patterns
are however incompatible with a rapid equilibrium random mechanism, which pre-
dicts that exactly one glucose residue is successively incorporated in the same chain
(distributive elongation) [34]. Parodi et al. [46] observed higher action patterns for
liver GS as the molecular weight of glycogen increased. They ascribed the increase
to the possibility that GS penetrates glycogen molecules of higher molecular weight
and thus loses mobility, increasing the likelihood that the same chain will be glycosy-
lated repetitively. More recently, Baskaran et al. [47] found that yeast GS exhibited a
distributive pattern of catalysis with maltooctaose as glucose acceptor. If similar be-
haviour is exhibited by the muscle enzyme, deviation from distributive elongation is
then not necessarily linked to a change in the kinetic mechanism, but rather the result
of limited access to chains. At any rate, if glycogen saturation is assumed—a reason-
able assumption given the tight association of GS with glycogen—the kinetic mech-
anism is of little import to initial velocity kinetic treatments, as all the bi-substrate
mechanisms suggested simplify to the simple uni-reactant case in which only UDPG
is considered a substrate [42].
Tertiary and quaternary structure
Glycogen synthases are members of the GT-B superfamily of glycosyltransferases
[48]. The tertiary structure of members of this family, which also includes GP, is
characterized by a duo of N-terminal and C-terminal Rossmann fold domains sep-
arated by an interdomain cleft that houses the active site. The C-terminus typically
folds back onto the N-terminal Rossmann fold domain so that the two domains are
linked by a two-stranded hinge [49]. Significant rotation around this narrow hinge
is possible and GT-B members differ widely with regard to the size of the interdo-
main cleft. Glycogen synthases have a particularly deep fissure between the N- en
C-domains [50] and it has been suggested that an interdomain closure is required
to bring glycogen (binding along the N-domain) and the nucleotide sugar (bind-
ing to the C-domain) together for catalysis [49]. Glycogen synthases can be further
classified into the ADP-glucose-utilizing non-regulated GT-3 family—including the
bacterial and archaeal enzymes—and the UDPG-utilizing regulated GT-5 family—
including the mammalian and yeast enzymes [49]. The most significant structural
differences between the GT-3 (comprising ∼50 kDa protomers) and GT-5 (compris-
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ing ∼80 kDa protomers) families are the presence of two N-terminal inserts (β2–β5
and β7–α10), and a C-terminal insert (β11–α17) of which the most prominent sec-
ondary structures is a coiled-coil formed by helices α15 and α16 in GT-5 members.
Another unique feature of eukaryotic GS is the presence of a conserved arginine-
rich cluster (Arg580/581/583/587/589/592 in yeast) on the regulatory R helix (helix
α22), believed to be involved in allosteric and covalent regulation.
The only available GS crystal structures are those of the bacteria Agrobacterium
tumefaciens (AtGS) [49] and E. coli (EcGS) [50], the archaeon Pyrococcus abyssi (PaGS)
[52], and only recently the yeast—and first eukaryote—S. cerevisiae (ScGS) [51]. The
oligomerization of the known structures range from monomeric to tetrameric and
the secondary structures involved in intersubunit interactions differ widely. AtGS
was solved as an asymmetric dimer [49] in which a 10-residue C-domain insert (407–
416) facilitates the primary intersubunit contacts [52]. PaGS, the smallest known GS,
lacks the AtGS dimerization insert, but terminates in an 11-residue hydrophobic tail
(427–437) not present in bacteria [52]. The C-terminal hydrophobic tail (folded back
onto the N-domain) associates with a hydrophobic pocket (53–55, 105–115, 141–142)
on the N-domain of a neighbouring subunit, resulting in a trimeric quaternary struc-
ture with a three-fold symmetry in which the three N-domains are tightly associated.
ScGS contains both the AtGS dimerization insert and the PaGS hydrophobic tail in-
volved in trimerization, but neither sequence is conserved and they appear not to
be involved in oligomerization [51]. Instead, ScGS [51, 53] is a two-fold symmetric
dimer of a two-fold symmetric dimer pair, in which the subunits can be numbered
(following Baskaran et al. [51]) from A to D (Fig. 2.1). The intersubunit contacts in
the A/D (and B/C) interface involve the reciprocal association of helix α16 (located
in the eukaryote-specific C-terminal insert) of one subunit with the region between
helix α2 and sheet β4 (located in the first of the unique N-terminal inserts) of the
partner subunit. In the interface between dimer pairs (AD/BC), the main contacts
comprise a reciprocal association of helix α15 from one subunit to the region between
α15 and β10, so that the α15/16 helix pairs of subunits A and C associate, and those
of subunits B and D associate. The A/B and C/D interfaces house the allosteric sites,
whereas the A/D and B/C interfaces house the active sites. Intriguingly, in AtGS
and the activated form of ScGS the movement of the N-domains are unrestricted;
whereas in PaGS the N-domains are involved in the trimerization permitting only
C-domain movement. It appears that GS oligomerization evolved independently in
bacteria, archaea, and eukaryotes.
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Figure 2.1: Cartoon of the tetrameric structure of yeast GS. Due to the high overall similarity
between mammalian and yeast GS, it is expected that the mammalian muscle GS assumes
a similar quaternary structure and undergoes a comparable conformational transition upon
activation. In the basal state (a, b) closure of the interdomain cleft that houses the active site
is impeded by interaction across the A/D and B/C interfaces of α15/16 and α2. In the active
state (c, d), which is induced by glucose-6-phosphate, interaction across the A/C and B/D
interfaces is established and the impediment on interdomain closure is abrogated. Adapted
from [51].
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The oligomerization state of the muscle GS isozyme (∼84 kDa) has been reported
by various workers as dimeric [54, 55], trimeric [41, 54, 56], or tetrameric [44, 54, 57–
61]. It is unlikely that the dimeric forms reflect the in vivo state, as they were either
shown to contain a proteolytic fragment [54] or were obtained at very low concen-
trations, with the authors [55] suggesting the formation of a tetramer at higher in
vivo concentrations. Horcajada et al. [52] point out that in many of these earlier in-
vestigations the oligomerization state was determined based on the sedimentation
coefficient, a measure which assumes a strictly globular protein shape. Based on
the presence in muscle GS of an insert analogous to the PaGS hydrophobic tail, and
on the findings of Brown & Larner [41] using sedimentation equilibrium ultracen-
trifugation, a technique not influenced by the protein shape, Horcajada et al. [52]
favour a trimeric state for muscle GS. Other workers [59], however, also using sedi-
mentation equilibrium ultracentrifugation, observed results indicative of a tetramer.
The structure of eukaryotic GS is highly conserved, with only the phosphorylation
sites and loops between conserved secondary structures differing [51]. Consider-
ing this high degree of conservation, and, in particular, the presence in muscle GS
of the secondary structures corresponding to the yeast α15–16 helices, the quater-
nary structure of muscle GS is probably, as for the yeast enzyme, tetrameric. It has,
however, been reported that glycogen, the degree of phosphorylation [62], glucose-
6-phosphate (G6P), and ATP [55] influence the degree of GS oligomerization; higher
or lower degrees of oligomerization can therefore not be ruled out.
Regulatory arginine cluster
Following the assumption that the allosteric and covalent regulation of eukaryotic
GS is brought about by the interaction of the negatively charged phosphorylated
residues and G6P with basic amino acid residues, Pederson et al. [63] identified sev-
eral arginine and lysine residues that are conserved in eukaryotes. They proceeded
to generate 23 yeast GS mutants in which these residues were systematically re-
placed with alanine residues, with up to three mutations per mutant enzyme. Two
of the mutants, R579A/R580A/R582A (human muscle numbering used for compar-
ison; initial methionine included) and R586A/R588A/R591A, were completely in-
sensitive to activation by G6P, while still exhibiting significant activity in the absence
of G6P. Upon phosphorylation the Vmax for GS of mutant R579A/R580A/R582A,
which was already very low, did not decrease much further, whereas GS of the mu-
tant R586A/R588A/R591A, which displayed normal activity in the dephosphory-
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Human muscle GS SRRQRIIQRNRTERL 592
Rabbit muscle GS SRRQRIIQRNRTERL 592
Human liver GS SRRQRIIQRNRTERL 592
Yeast GSY1 TRRQRINQRNRTERL 593
Yeast GSY2 TRRQRINQRNRTERL 593
Figure 2.2: Sequence alignment of the regulatory arginine cluster from mammalian and
yeast glycogen synthases. The arginine residues (blue) are conserved across eukaryotes.
Sequences were obtained from the NCBI RefSeq database [65].
lated state, was significantly inactivated. Hanashiro & Roach [64], working with
the rabbit muscle enzyme, obtained essentially the same overall results, with the
important difference that in their work the R579A/R580A/R582A mutant’s activity
was decreased four-fold upon phosphorylation, whereas the R586A/R588A/R591A
mutant was unaffected. The six arginine residues in these mutants constitute what
is now referred to as the regulatory arginine cluster and are located on the R helix
(Fig. 2.2).
Noting that the mutations introduced by Hanashiro & Roach [64] not only abol-
ished G6P sensitivity, but also altered the enzyme’s activity in the absence of G6P,
Bouskila et al. [18], also working with the muscle enzyme, mutated the six arginine
residues singly or in pairs and found that the single point mutations R582A and
R586A had no effect on GS activity, but were sufficient to abrogate G6P sensitivity.
Both mutants were, however, still activated by dephosphorylation. These findings
suggest that Arg582 and Arg586 mediate regulation by G6P, a view that is supported
by the crystal structure data of the yeast enzyme, which position these residues in the
G6P binding pocket [51]. Baskaran et al. [51] found that the R579A/R580A double
mutant exhibited activity comparable to the wildtype enzyme, but was significantly
inhibited by phosphorylation. In contrast, the R588A/R591A double mutant was
significantly inactivated compared to the wildtype, but could be activated to wild-
type levels by addition of G6P. Note the differences between the yeast triple mu-
tant R579A/R580A/R582A and double mutant R579A/R580A. The basal activity of
the triple mutant is much lower than that of the double mutant; the triple mutant
is also unresponsive to phosphorylation, whereas the double mutant is further in-
hibited. Similar disagreement is observed between the R586A/R588A/R591A and
R588A/R591A mutants in yeast. In both cases the yeast double mutants appear to be
in closer agreement with the muscle triple mutants from Hanashiro & Roach [64]. To
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Table 2.1: Response of arginine cluster mutants to G6P and phosphorylation compared to
wildtype GS [18, 51, 64]. Amino acids are numbered according to the muscle enzyme [18].
aInactivation occurs to a lesser extent than in wildtype. bDephosphorylation activates the
enzyme. cOnly slight additional inactivation is observed.
Enzyme Inactivated by
mutation
Inactivated by
phosphorylation
Reactivated by G6P
wildtype N/A Yes Yes
R579A, R580A No Yesa Yes
R582A, R586A No Yesb No
R588A, R591A Yes Noc Yes
our knowledge the R579A/R580A and R588A/R591A double mutants have not been
investigated for muscle. Considering the sequence similarity between the yeast and
muscle enzymes, however, we speculate that the individual functions of the six argi-
nine residues are similar in yeast and muscle. In summary (Table 2.1), Baskaran et al.
[51] suggest that Arg579 and Arg580 interact with phosphorylated serine residues,
thereby stabilizing an inactive conformation; whereas Arg582 and Arg586 interact
with the phosphate group of G6P, thereby stabilizing an active conformation. Fi-
nally, Arg588 and Arg591 stabilize the dephosphorylated, non-activated enzyme;
phosphorylation or replacement by alanine residues neutralize the charge of these
residues, leading to inactivation.
Kinetics
As noted earlier, UDPG and UDP are believed to bind in the interdomain cleft to
the C-terminal Rossmann fold. As Rossmann fold domains are associated with nu-
cleoside binding capability [66], the enzyme-ligand interaction probably mostly in-
volves the UDP moiety. In agreement with this position, UDP has been found to be a
competitive inhibitor with regard to UDPG. There is no reason to believe that either
UDPG or UDP binds to additional sites on the GS subunit. In the majority of kinetic
studies UDPG exhibits hyperbolic saturation curves [24, 40–42, 58, 67–70], with only
a few accounts [69, 71–73] reporting deviations from Michaelian kinetics, mostly in
the form of negative cooperativity [74]. Sølling [42] argues that the observed nega-
tive cooperativity is an artefact that disappears if appropriate measures are taken to
minimize UDP product inhibition. In support of the argument of Sølling [42], Roach
et al. [72] observed that hyperbolic kinetics is restored in the presence of G6P. In at
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least one account, G6P has been shown to counter UDP inhibition [75].
The formation of tight enzyme-glycogen complexes [34, 43] indicates that, apart
from the N-domain binding site in the catalytic cleft, glycogen likely interacts with
GS at several additional sites. Dı´az et al. [76] identified a non-catalytic glycogen
binding site on the surface of the N-domain of PaGS. Four glucose moieties of mal-
tohexaose were found to bind at this site by curling around Tyr174. Mutation of
Tyr174 to alanine decreased the acceptor affinity and specific activity with glycogen
as substrate, but had no effect on specific activity with maltohexaose as acceptor.
In cosedimentation experiments, the native enzyme was found in the pellet frac-
tion, whereas the mutant (which still had an intact catalytic glycogen binding site)
was located in the supernatant, suggesting that the non-catalytic site has a much
higher affinity for glycogen than the catalytic site. Dı´az et al. [76] continued to iden-
tify Tyr239 as the human muscle GS counterpart to Tyr174. Mutation of Tyr239 and
the nearby Tyr242 decreased both the affinity for glycogen and the specific activity,
whereas specific activities were essentially unchanged with maltohexaose as accep-
tor. Baskaran et al. [47] identified four maltodextran binding sites, in addition to the
catalytic site, on ScGS. One of these sites (site 1) corresponds roughly to the site iden-
tified for PaGS, but involves unique eukaryotic structures and interestingly does not
include the residue corresponding to Tyr174. The remaining three sites are located
on the C-domain, with site 4 located in the catalytic cleft near the catalytic glyco-
gen binding site. For all four sites, mutation of key residues decreased the Vmax and
affinity for glycogen. Only mutation of site 4 affected the activity with maltooctaose
as acceptor, leading the authors to suggest that this site is involved in positioning
the acceptor in the catalytic site.
The enhanced glycogen affinity brought about by the non-catalytic glycogen bind-
ing sites essentially dictates that glycogen binding occurs in a positively cooperative
fashion. As these additional sites have little or no effect on the affinity for oligosac-
charides such as maltohexaose, this cooperativity is not expected to be the result
of any conformational change, but rather an increase in the apparent concentration
of chains (from the same glycogen molecule) in the vicinity of unoccupied sites on
the same and, possibly, neighbouring subunits. It is therefore surprising that kinetic
studies report non-cooperative glycogen binding [24, 40, 41] or even negative co-
operativity [74]. We speculate that this apparent contradiction could be resolved if
complex formation, which likely proceeds by positive cooperative binding, positions
the tetramer such that only a single catalytic site is accessible to a glycogen chain. In
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such a situation, glycogen binding can be considered infinitely negatively coopera-
tive. Infinitely negative cooperativity is kinetically equivalent to Michaelian kinetics.
Deviation from this strict infinite negative cooperativity—such as if rotation of the
enzyme allows an additional catalytic site to become available, albeit with a reduced
affinity for glycogen—would be observed as classic negative cooperativity.
Before we discuss the effects of modifiers on GS activity, a brief note on nomencla-
ture is warranted. Following Cornish-Bowden [77], we use the term specific to refer
to any modification that results in an altered substrate affinity; and the term catalytic
to refer to modification that results in an altered maximal velocity. We adopt these
terms because the more familiar terms (competitive and non-competitive) do not apply
to the case of enzyme activation. The term competitive is still used to indicate that
ligands physically compete for the same site, as opposed to affecting each other’s
binding affinity by another mechanism.
GS is allosterically regulated by G6P, ATP, and several other ligands. G6P is a
potent activator of GS [22] and is generally recognized as the most important al-
losteric modifier of GS. Several workers have reported that G6P activates GS by
increasing the substrate affinity, catalytic rate, or both. We will discuss the na-
ture of G6P activation in detail in Section 2.4. ATP, on the other hand, inhibits GS
[39, 42, 67, 78, 79]. This inhibition is brought about by decreasing the enzyme’s affin-
ity for UDPG [39, 42]. To the best of our knowledge, there is no evidence that ATP
also inhibits GS catalytically, but this possibility cannot be ruled out. Regrettably,
ATP inhibition is often neglected in GS kinetic studies. Kinetic studies that include
both G6P and ATP indicate a competitive binding pattern [42, 67, 78]. However, con-
trary to what is expected for pure competition, it has been noted in a few cases that
G6P saturation is unable to reverse ATP inhibition completely [42, 67]. Two explana-
tions have been offered in this regard. First, G6P and ATP bind to different allosteric
sites, but binding of either ligand significantly decreases the affinity for the other
ligand [67]. Alternatively, both ligands compete for the same allosteric site, but ATP
also competes with UDPG at the catalytic site [42]. In support of the latter explana-
tion, it has been observed that the rat muscle enzyme is able to use ADP-glucose as
a glucose donor at half the rate of UDPG [80], showing that the adenosine moiety is
able to bind to the active site. Moreover, ScGS crystal structure data show that in the
G6P binding pocket only the amino acid residues that bind the phosphate moiety are
ordered, with the remaining residues only assuming an ordered conformation upon
ligand binding [51]. The phosphate moiety is therefore likely a major determinant
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of ligand specificity at the allosteric site. This provides a basis on which G6P and
ATP—though structurally disparate, apart from the phosphate moiety—could both
bind to the same site. Activation and inhibition curves of G6P and ATP have been
found by different workers to be either hyperbolic or sigmoidal. Cooperative G6P
binding has mostly been observed for the phosphorylated enzyme [67, 69, 72, 81],
but the dephosphorylated form has also been found to exhibit mild cooperativity
[42]. ATP cooperativity has been observed for the dephosphorylated enzyme [67].
There is also strong evidence for positive heterotropic cooperativity between G6P
and ATP binding [42, 67, 69]. ATP and ADP are probably equally important GS in-
hibitors [39, 79], but detailed kinetic data for the latter ligand are very limited. AMP
has also been reported as a weak inhibitor of GS at high concentrations [39, 79], but
considering the low AMP concentration in muscle it is unlikely that AMP is a signif-
icant effector of GS in vivo. In the remainder of this review ATP serves as a model
GS inhibitor.
The kinetics of GS is influenced by several additional effectors, many of which
do not clearly exhibit either activation or inhibition. Several G6P analogues such
as galactose-6-phosphate and glucosamine-6-phosphate activate GS, but to a lesser
extent than G6P [22, 78]. Therefore, despite activating GS, these analogues inhibit
activation by G6P. UTP is a competitive inhibitor with respect to UDPG [67] and
possibly G6P [69]. ADP and AMP bind to the allosteric site and inhibit GS in a sim-
ilar way as ATP [42, 79]. Sølling [42] suggests that these nucleotide inhibitors will
all probably bind both to the catalytic site—by virtue of being nucleotides—and to
the allosteric site—by possessing phosphate moieties. Sulphate and inorganic phos-
phate have been reported as either activators [42] or inhibitors [82], depending on
phosphorylation state. Others found inorganic phosphate to be inhibitory regardless
of GS phosphorylation [39, 79].
Mg2+ activates GS, but becomes inhibitory in the absence of inhibitors [42]. Al-
though direct interaction with GS cannot be ruled out, the ambiguous effect of Mg2+
is probably not the result of interaction with GS; instead, Mg2+ forms chelate com-
plexes with the various GS activators and inhibitors, thereby mitigating their effects
[42, 82]. Mg2+ activation is strongest with respect to allosteric site inhibitors such as
ATP [42]. The contention that a phosphate (or anionic) moiety is required for binding
at the allosteric site is supported by this observation, as the effect of Mg2+ is to neu-
tralize the phosphate moiety. Activation by G6P, which also binds to the allosteric
site, is not noticeably influenced by Mg2+ [42, 82], presumably because the associa-
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tion constant of Mg-G6P (Ka = 70 M−1, 30◦C; calculated from [83]) is three orders of
magnitude lower than that of Mg-ATP (Ka = 73× 103 M−1, 30◦C [84]). Activation by
pyrophosphate, which readily complexes with Mg2+, is however completely abol-
ished by Mg2+ [42]. The phosphate moiety is probably less important for binding at
the catalytic site, as UDP inhibition is not markedly influenced by Mg2+ even though
UDP readily complexes with Mg2+ (Ka = 4× 103 M−1) [42]. Based on these observed
effects of Mg2+, we speculate that at high concentrations of Mg2+, ATP inhibition
could shift away from the allosteric site to the catalytic site.
Finally, GS is phosphorylated in vivo at at least nine serine residues [85, 86]. Over-
all, phosphorylation has a potent inhibitory effect, but not all phosphorylation sites
affect the enzyme’s activity. We will discuss the regulation of GS by phosphoryla-
tion in detail in Section 2.3. Briefly, inhibition by phosphorylation is the result of an
altered affinity of GS for its reactants and modifiers and possibly a decrease in the
turnover number (kcat).
Phenomenological rate equation
Up to this point, we have reviewed the general properties and kinetics of GS. We
now proceed to develop a detailed formal treatment of GS kinetics that will serve as
the setting within which we will discuss the allosteric and covalent regulation of GS.
The kinetics of most enzymes is adequately described with only the familiar con-
cepts of maximal velocity and half-saturation concentrations parametrized by the
Vmax and Michaelis constants. In addition to these concepts, a formal treatment of
GS kinetics must also describe cooperativity, and catalytic and specific modification.
To describe these concepts, we will here adopt the Hill formalism as generalized by
Hofmeyr & Cornish-Bowden [87], and Westermark et al. [88]. It is often considered a
weakness of the Hill equation that it does not have a mechanistic interpretation; that
is, it is largely independent of the kinetic mechanism and the mechanism of cooper-
ativity, at least for non-integer values of the Hill coefficient. However, we consider
this a strength when, as for GS, there is little agreement regarding these mechanisms
in the first place. Moreover, while not all the Hill equation’s parameters have mecha-
nistic interpretations, they have clear operational definitions. Nevertheless, it should
be mentioned that the Hill equation is unable to describe heterotropic cooperativity
such as is observed for GS between G6P and ATP. This shortcoming does not alter
the meaning of any parameter, but requires us to consider ATP as constant when
G6P is varied and the other way around.
Stellenbosch University  http://scholar.sun.ac.za
CHAPTER 2. REGULATION OF GLYCOGEN SYNTHASE ACTIVITY 19
Based on the properties and kinetics of GS discussed up to this point, we make
the following simplifying assumptions:
• glycogen is saturating and binds equally well as substrate and product to GS
and is therefore left out
• product inhibition by UDP is significant, but binding at the allosteric site is
negligible
• G6P could be both a catalytic and specific activator
• ATP is only a specific inhibitor
• ATP binds to both the catalytic and allosteric site
• all other effectors are constant and their effects are absorbed in the explicit
parameters
Eq. 2.4 then describes the velocity of the GS reaction as in Eq. 2.1 for a particular
GS phosphorylation state at constant G6P and ATP concentrations [87]:
v =
µcatVmax σ(σ+ pi)h−1
µspec + (σ+ pi)h
×
(
1− Γ
Keq
)
(2.4)
where Vmax = kcat · [E]tot; kcat is the catalytic constant; [E]tot is the total GS concen-
tration; σ = [UDPG]/UDPG0.5; pi = [UDP]/UDP0.5; UDPG0.5 and UDP0.5 are the
UDPG and UDP half-saturation concentrations in the absence of other ligands; h is
the degree of reactant (UDPG and UDP) binding cooperativity; Γ is the mass-action
ratio; Keq is the equilibrium constant; and µcat and µspec describe catalytic and spe-
cific modification. Note that when µcat = 1 and µspec = 1, then Eq. 2.4 simplifies to
the standard reversible Hill equation without modifier effects [87].
From the derivation by Westermark et al. [88] and considering our assumptions,
the expression for µcat is given by
µcat =
1+ γG6P · αG6P · ξhG6PG6P + αATP · ξhATPATP
1+ αG6P · ξhG6PG6P + αATP · ξhATPATP
(2.5)
where ξG6P = [G6P]/G6P0.5; ξATP = [ATP]/ATP0.5; G6P0.5 and ATP0.5 are the G6P
and allosteric site ATP half-saturation concentrations in the absence of other ligands;
γG6P ≥ 1 is the factor by which saturating G6P multiplies kcat (values larger than
unity indicate activation); αG6P ≥ 1 and αATP < 1 are the factors by which saturating
Stellenbosch University  http://scholar.sun.ac.za
CHAPTER 2. REGULATION OF GLYCOGEN SYNTHASE ACTIVITY 20
G6P and ATP divide the reactant half-saturation concentrations; hG6P is the degree
of G6P binding cooperativity; and hATP is the degree of ATP binding cooperativity at
the allosteric site. Although we assume that ATP is not a catalytic inhibitor, it does
reverse catalytic activation by G6P and must therefore appear in µcat. In the absence
of G6P or if ATP is saturating, µcat = 1, thus reflecting our assumption that ATP does
not affect the enzyme’s catalytic capacity. In the absence of ATP, on the other hand,
µcat increases from unity to γG6P as the G6P concentration changes in the range from
zero to saturation. At saturating G6P concentrations, the maximal velocity of GS is
thus multiplied by a factor γG6P.
Specific activation by G6P and ATP at the catalytic and allosteric sites is described
by µspec [87]:
µspec =
(
1+ ξhATP′ATP′
)( 1+ ξhG6PG6P + ξhATPATP
1+ αG6P · ξhG6PG6P + αATP · ξhATPATP
)
(2.6)
where ξATP′ = [ATP]/ATP′0.5; ATP′0.5 is the catalytic site ATP half-saturation con-
centration in the absence of other ligands; and hATP′ is the degree of ATP binding
cooperativity at the catalytic site. If [G6P] G6P0.5, Eq. 2.6 simplifies to
µspec =
1
αG6P
(
1+ ξhATP′ATP′
)
(2.7)
showing that, although G6P completely overcomes ATP inhibition at the allosteric
site, ATP inhibition at the catalytic site would only be abolished for a large value
of αG6P. Saturation by ATP, on the other hand, causes µspec → ∞; that is, reactant
binding is completely inhibited.
The non-mathematically minded may safely ignore these equations, but should
keep the operational definitions of the parameters in mind, as they form the basis
for further discussion.
Measures of activity
The complex allosteric and covalent regulation of GS has led to the adoption of mea-
sures such as activity ratio and fractional velocity to quantify the effects of phospho-
rylation and the enzyme’s sensitivity to G6P. It was initially thought that GS—like
GP—is phosphorylated at only one site and that the phosphorylated form is entirely
dependent on G6P for activity. This led Villar-Palasi & Larner [89] to introduce the
activity ratio as the ratio of enzyme activity in the absence of G6P (representative
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of I form activity) to that at saturating (typically 7.2 or 10 mM) G6P concentrations
(representative of the total enzyme activity):
AR =
vG6P=0
vG6PG6P0.5
=
I
I + D
(2.8)
The activity ratio, which is often alternatively known as the -G6P/+G6P ratio
or expressed as a percentage (%I), can thus be interpreted as the fraction of total
enzyme that is present in the I form. However, as more phosphorylation sites were
discovered, it became clear that—although it provided a good measure of the effect
of phosphorylation on GS kinetics—the activity ratio could no longer be considered
a mole fraction. Guinovart et al. [90] offered an interpretation at the hand of the
Michaelis-Menten equation, assuming that G6P has no catalytic effect and increases
the UDPG affinity to the point of saturation for even the most phosphorylated states:
AR =
v
Vmax
=
σ
1+ σ
(2.9)
where σ = [UDPG]/KUDPG. It is clear from Eq. 2.9 that the activity ratio is inde-
pendent of the affinity of GS for G6P [90]. With Eq. 2.4 we are now in a position to
provide a more general expression for the activity ratio, accounting for both catalytic
and specific activation. Setting [UDP] = 0 and [ATP] = 0, and substituting Eq. 2.4 in
Eq. 2.8, we obtain:
AR =
1+ αG6P · σ
γG6P · αG6P(1+ σ) (2.10)
As in Eq. 2.9 the enzyme’s affinity for G6P does not influence the activity ratio,
however, the degree to which saturating G6P activates GS catalytically (quantified
by γG6P) and specifically (quantified by αG6P) is reflected in this value. In the limit
where αG6P → ∞, i.e., supposing that saturating G6P will also enhance UDPG bind-
ing to the point of saturation, and if γG6P = 1, i.e., G6P results in no catalytic acti-
vation, Eq. 2.10 simplifies to Eq. 2.9. On the other hand, strong catalytic activation
(very large γG6P) will generally result in low activity ratios. In the context of phos-
phorylation, the activity ratio is then a measure of the effect of phosphorylation on
UDPG binding affinity, and specific and catalytic activation by G6P. But it cannot be
determined from the activity ratio alone whether phosphorylation affects the kcat or
G6P0.5. Moreover, Guinovart et al. [90] point out that the activity ratio is only sensi-
tive to changes in phosphorylation if σ ≈ 1, necessitating the use of high, impractical
UDPG concentrations for extensively phosphorylated enzyme states.
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Fractional velocity has been proposed as a more sensitive measure of the effects
of phosphorylation [90]. It is defined as the ratio of enzyme activity in the presence
of low physiological G6P concentrations to that in the presence of saturating G6P:
FVx =
vG6P=x
vG6PG6P0.5
(2.11)
where x is a physiological G6P concentration. Substituting Eq. 2.4 into Eq. 2.11 yields
FVx =
(1+ αG6P · σ)
(
1+γG6P·αG6P·ξhG6PG6P
1+αG6P·ξhG6PG6P
)
γG6P · αG6P
(
1+ξ
hG6P
G6P
1+αG6P·ξhG6PG6P
+ σ
) (2.12)
Since G6P increases the affinity of GS for UDPG, the fractional velocity reflects
changes in the degree of phosphorylation even if UDPG is not near its half-saturation
concentration [90]. Furthermore, it also reflects the effects of phosphorylation on
G6P affinity.
Due to the complex kinetics of GS, even recent studies on the allosteric and cova-
lent regulation of GS often only report the activity ratio or fractional velocity. It is in
principle possible to determine kinetic parameter values from these ratios, provided
they were determined under differing conditions. In the sections to come, however,
we will use the activity ratio and fractional velocity—keeping in mind their inter-
pretations in terms of Eq. 2.4—only to examine trends in parameter values.
2.3 Regulation by phosphorylation
Rosell-Perez et al. [71] showed that GS can be isolated as two kinetically distinct
forms: the active G6P-independent (I) form and the less active G6P-dependent (D)
form. Their work was prompted by the observation that pre-incubation with insulin
or G6P increased the enzyme’s activity in the absence of G6P. This activation was
the first indication of the covalent modification now known to be reversible phos-
phorylation. To date more than 15 phosphorylation sites have been discovered, but
only nine sites have so far been confirmed as in vivo targets [85]. GS was the first
enzyme in which hierarchical multisite phosphorylation was discovered and serves
as a paradigm for this, now recognized as common, phenomenon [86, 91].
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Figure 2.3: In vivo phosphorylation sites in mammalian GS [85, 86, 91–94]. Dashed boxes
indicate phosphorylation clusters. The listed kinases are known to phosphorylate the indi-
cated sites in vitro.
Phosphorylation sites and clusters
GS is phosphorylated in vivo by a variety of kinases at at least nine phosphorylation
sites (Table 2.2). The confirmed in vivo phosphorylation sites are grouped into four
phosphorylation clusters [86, 91] (Fig. 2.3). Phosphorylation sites in a cluster are
equally spaced and are phosphorylated in a hierarchical, sequential manner. Each
cluster has a primary phosphorylation site that must be phosphorylated before se-
quential phosphorylation of the secondary sites can proceed. Phosphorylation of the
primary site by the primary kinase creates the recognition motif for the secondary
kinase at the second site. Phosphorylation of the secondary sites recursively cre-
ates the recognition motif of the secondary kinase as long as free sites remain in the
cluster. Primary and secondary phosphorylation is generally catalysed by different
enzymes; otherwise, since the primary kinase has no requirement for prior phos-
phorylation, the process would not occur sequentially. However, amino acids such
as Glu and Asp mimic the chemistry of phosphate groups and can thus serve as
recognition motifs for secondary kinases, eliminating the need for a primary kinase
[91].
Sites 2 and 2a form a cluster in the N-terminal region (Ser7 to Ser10). Site 2 is
phosphorylated by a number of kinases, including cAMP-dependent protein ki-
nase (PKA), phosphorylase kinase (PhK), calmodulin-dependent protein kinase II
(CaMKII), and AMP-activated protein kinase (AMPK). Casein kinase 1 (CK1), with
a recognition motif of S(P)-X-X-S, catalyses the secondary phosphorylation at site 2a
[100, 106, 107]. Although phosphorylation at site 2 significantly enhances phospho-
rylation at site 2a, the latter can proceed in the absence of phosphorylation at site 2.
Sites 5, 4, 3c, 3b, and 3a form a cluster near the C-terminus. Site 5 is the primary site
and is phosphorylated by casein kinase 2 (CK2). Phosphorylation of site 5 creates
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Table 2.2: In vivo phosphorylation sites in mammalian GS. Amino acids are numbered ac-
cording to the rabbit muscle enzyme.
Residue Name Kinase References
Ser7 2 PKA [95]
PhK [96, 97]
CaMKII [98]
AMPK [99]
Ser10 2a CK1 [100]
Ser656 5 CK2 [101]
Ser652 4 GSK3 [102]
p38 MAPK [94]
DYRK2 [92]
Ser648 3c GSK3 [103]
Ser644 3b GSK3 [103]
p38 MAPK [94]
Ser640 3a GSK3 [103]
PASK [93]
DYRK family [92]
Ser697 1a PKA [104]
Ser710 1b PKA [104]
CaMKII [105]
the glycogen synthase kinase 3 (GSK3) recognition motif S-X-X-X-S(P) and is an ab-
solute prerequisite for secondary phosphorylation by GSK3 [102, 108]. Proceeding
in the N-terminal direction, GSK3 sequentially phosphorylates sites 4, 3c, 3b, and 3a.
Sites 1a (Ser697) and 1b (Ser710) can technically not be considered phosphory-
lation clusters. However, both are located in motifs that resemble the amino acid
sequence surrounding site 2. In particular, both are phosphorylated in vivo by PKA
and are located three residues N-terminal to a serine or threonine residue [86]. Phos-
phorylation of these downstream residues by CK1 has been demonstrated with syn-
thetic peptides, but the in vivo significance of these sites is unknown [86]. As such,
sites 1a and 1b can be considered primary sites of vestigial (or emerging!) clusters
that are in theory capable of hierarchical phosphorylation. Site 1b is also phospho-
rylated by CaMKII [105].
GS dephosphorylation is catalysed by protein phosphatase 1 (PP1), which is tar-
geted to glycogen by several regulatory subunits [5, 31]. It is not known whether
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dephosphorylation follows a sequential pattern. There is some indication that de-
phosphorylation of sites 2 and 2a proceeds sequentially and in the opposite direction
to phosphorylation: a phosphate at site 2a inhibits dephosphorylation of site 2 [109].
At least one case has been reported where a protein phosphorylated sequentially
by CK2 and GSK3 undergoes sequential dephosphorylation in the reverse direction
[110]. However, it is not known whether the GS sites phosphorylated by these en-
zymes are also dephosphorylated sequentially.
Despite the cluster organization of phosphorylation sites, phosphorylation does
not always proceed hierarchically. Members of the dual specificity tyrosine phos-
phorylation regulated protein kinase (DYRK) family [92], PAS kinase (PASK) [93],
and mitogen-activated protein kinase (p38 MAPK) [94] do not require prior phos-
phorylation (their recognition motifs do not include a phosphorylated serine residue)
and are thus able to circumvent hierarchical phosphorylation. DYRK1A, DYRK1B,
DYRK2, and PASK directly phosphorylate site 3a. DYRK2 possibly phosphorylates
site 4 [92], acting as a primary kinase by creating the recognition motif of GSK3 that
would allow secondary phosphorylation by this kinase without prior phosphoryla-
tion by CK2 at site 5. Likewise p38 MAPK phosphorylates sites 4 and 3b. p38 MAPK
also phosphorylates three other sites—Thr713, Thr718, and Ser724—in vitro, but it is
not known whether these sites are phosphorylated in vivo. Thr173 is the “secondary”
site of site 1b.
The obligate sequential phosphorylation of GS by GSK3 begs the question whe-
ther the phosphorylation is processive (several sites are phosphorylated before the
kinases dissociates from its substrate) or distributive (at most one site is phosphory-
lated before the kinase dissociates). Working with synthetic peptides, Fiol et al. [111]
observed intermediate phosphorylation states, suggesting that phosphorylation is
distributive. However, they also noted that some intermediate states accumulated
to a lesser extent than others, indicating that phosphorylation at these sites is also
processive to some degree.
Kinetic effects of phosphorylation
The majority of kinetic studies on GS have been done within the paradigm of the
two-state I/D model of phosphorylation. However, as the exact phosphorylation
state of many of the isolated I or D forms is unknown, kinetic parameters reported
in these studies are highly variable. The difficulty in isolating completely dephos-
phorylated GS is well-known to experimentalists and has led to the adoption of
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bacterial expression systems [107]. It is also unlikely that the D forms isolated by
various workers were phosphorylated to the same extent or at the same sites. More-
over, supraphysiological kinase concentrations were often used, resulting in non-
specific phosphorylation and phosphorylation at sites that would not occur in vivo
[86]. Nevertheless, a comparison of the reported I and D kinetics provides useful
information regarding the general effect of phosphorylation. In this section we will
explore the general effects of phosphorylation—which is believed to be mediated
by the interaction of phosphorylated serine residues with the basic residues in the
arginine cluster—on the kinetic parameters of GS as defined by Eq. 2.4, and the con-
tribution of individual phosphorylation sites towards these effects.
Modification of kinetic parameters
It is not clear whether phosphorylation affects the kcat of GS. Due to the low ac-
tivity of phosphorylated GS, the specific activity is often determined at saturating
G6P. However, by comparing these specific activities, one can only draw conclu-
sions about the effect of phosphorylation on the apparent kcat, which is defined as
kcat,app = kcat · γG6P at saturating G6P. Interestingly, kcat,app appears to be unaffected
by phosphorylation, since phosphorylated and dephosphorylated forms have sim-
ilar maximal activities in the presence of G6P [71, 72, 112, 113]. This could either
be interpreted to mean that phosphorylation does not alter kcat, or that both kcat and
γG6P are altered such that their product remains constant. In cases where the specific
activity has been determined for various phosphorylation states of GS in the absence
of G6P [114, 115], a decline in this value cannot be attributed exclusively to a decline
in kcat, as in the absence of G6P the UDPG concentration (4.4 mM) used in the assays
is not necessarily saturating. Roach et al. [72] observed essentially the same Vmax for
a number of phosphorylation states; assuming similar enzyme concentrations, this
suggests that phosphorylation does not affect the kcat.
As will be discussed in Section 2.3, particular phosphorylation sites target GS
to specific subcellular locations. Phosphorylation at these sites does not affect the
activity of GS per se, but by targeting GS to glycogen-rich pools could increase the
apparent local total GS concentration [E]tot, and thus the maximal velocity.
The most pronounced effect of phosphorylation is a marked decrease in UDPG
affinity, i.e., phosphorylation increases UDPG0.5. Rosell-Perez and co-workers ob-
served a four-fold higher UDPG0.5 in rat muscle [71], a 1.5-fold higher UDPG0.5 in
rabbit muscle [116], and a five-fold higher UDPG0.5 in dog muscle [117] for the D
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form than for the I form. The fold increase was much smaller in all three cases in the
presence of G6P. These and other data have been interpreted to mean that at satu-
rating G6P the apparent UDPG0.5 is independent of phosphorylation state [113]. At
saturating G6P the apparent UDPG0.5 is defined as UDPG0.5,app = UDPG0.5/αG6P.
In order for UDPG0.5,app to remain constant despite phosphorylation, any increase in
UDPG0.5 must be matched by an equal increase in αG6P. Others have only observed
a significant difference in UDPG0.5 for the I and D forms in the presence of high
ATP concentrations (6 mM) [39]. Roach et al. [72] isolated nine samples of GS with
phosphate contents ranging from 0.27 to 3.49 mol per mol subunit. In these samples
UDPG0.5 increased with the phosphate content from 1.3 to 9100 mM. In the pres-
ence of 5 mM G6P it increased from 65 to 160 µM. These high values obtained for the
more phosphorylated forms are probably artefactual, as discussed by the authors,
but the overall trend is nevertheless clear. Similarly, Guinovart et al. [90] recorded an
increase in UDPG0.5 from 1.5 to 200 mM as the number of phosphates per subunit
increased from 0 to 4.3.
It should be noted that, in order to adhere to the thermodynamic constraints of
the Haldane equation, phosphorylation must have equal effects on UDPG0.5 and
UDP0.5. However, it has been noted in a few cases that phosphorylation strengthens
UDP inhibition, i.e. it decreases UDP0.5 [79, 118]. If this is indeed the case, phosphory-
lation should also be expected to have differential effects on the forward and reverse
catalytic constants.
Piras et al. [39, 67] noted that higher G6P concentrations are necessary to reverse
ATP inhibition in the D form than in the I form, and that the D form is much more
strongly inhibited by ATP than the I form. Since they observed no effect of G6P
on UDPG0.5 at pH 6.6, the higher G6P requirements suggest that G6P0.5 increases
with phosphorylation, i.e., the affinity for G6P decreases, while the affinity for ATP
increases. Without parameter fitting it cannot be determined whether the increase
in ATP affinity is the result of decreased ATP′0.5, ATP0.5, or both. Roach et al. [72]
showed that G6P0.5 could increase by roughly three orders of magnitude as the phos-
phate content increased from 0.27 to 3.49 mol per mol subunit. Similarly, Nimmo
et al. [119] observed an increase in G6P0.5 from 0.05 to 10 mM as the number of phos-
phates per subunit increased from 0 to 1.95. Wang & Roach [120] found that com-
plete phosphorylation by GSK3 increased G6P0.5 ten-fold, whereas phosphorylation
by PKA and CK1 increased G6P0.5 100-fold [56].
As discussed earlier, there is evidence that γG6P and αG6P increase with phospho-
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rylation such that the effects of phosphorylation on kcat and UDPG0.5 are cancelled
by saturating G6P. However, although the specific activation of GS by G6P is well-
established, it is much less certain whether G6P also increases the catalytic capacity
(kcat) of GS. However, if kcat · γG6P is indeed independent of the phosphorylation
state and if γG6P > 1, then it is implied that phosphorylation also affects kcat. The
effect of phosphorylation on αATP is not known. However, in analogy to αG6P, we
speculate that αATP approaches unity as phosphorylation increases; that is, ATP will
bring about little further inhibition in GS states that are already substantially inhib-
ited by phosphorylation.
It is generally accepted that UDPG binding is non-cooperative, i.e. h = 1, regard-
less of the phosphorylation state of GS. Hyperbolic kinetics have been reported for
both the I form and D form [24, 41, 67]. Even in cases where negative cooperativity
has been reported, h appears to be unaffected by phosphorylation. Roach et al. [72]
reported an average h value of 0.8 for nine GS samples of varying phosphorylation
degrees. In the presence of G6P, this value increased to unity for all phosphorylation
states, thus restoring hyperbolic kinetics.
Roach et al. [72] reported an increase in sigmoidicity with regard to G6P with
phosphorylation, i.e. hG6P increased with phosphorylation. Hill plots of their data
were, however, not linear. In support of these findings, Piras et al. [67] observed
steeper Hill plots for the D form than the I form. This effect was potentiated in the
presence of ATP. ATP did not seem to affect hG6P in the I form. Similar results were
observed for the D form in bovine heart [69]. Phosphorylation of sites in the N-
terminal region, however, appears to have little effect on hG6P [56]. Plesner et al. [82]
observed sigmoid kinetics with regard to G6P only at low substrate concentrations.
The converse was observed with regard to hATP, i.e. sigmoidicity with respect to
ATP binding decreases with phosphorylation [67]. In the I form, G6P increased hATP,
but in the D form G6P had little effect.
Importance of individual phosphorylation sites
Thus far we have discussed the general effect of phosphorylation on GS kinetics
without considering the importance of specific phosphorylation sites towards the
observed change in kinetic parameters. Much time has been devoted to determine
which phosphorylation sites have the greatest influence on GS kinetics. The rela-
tive importance of a particular site can be assigned by considering the effect that
phosphorylation of the site has on the activity ratio.
Stellenbosch University  http://scholar.sun.ac.za
CHAPTER 2. REGULATION OF GLYCOGEN SYNTHASE ACTIVITY 29
Two methods have been used to determine the activity ratio and, in a few cases,
kinetics for various GS phosphorylation states: phosphorylation with site-specific
kinases, and site-directed mutagenesis. The first method relies on the hierarchical
and sequential nature of GS phosphorylation. By using a primary and secondary
kinase pair a specific phosphorylation cluster can be systematically phosphorylated.
A disadvantage of this method is that the kinases are not all specific for only one
site. PKA, for instance, will phosphorylate sites 2, 1a, and 1b. This particular case
can be overcome by using PhK, which only phosphorylates site 2. A greater limi-
tation of this method is that intermediate secondary phosphorylation states cannot
be obtained. That is, secondary phosphorylation sites are all phosphorylated by the
same kinase and it is thus difficult to prevent phosphorylation of the entire cluster
in order to study intermediate states. Furthermore, regardless of promoting dephos-
phorylation, isolated GS usually still contains low amounts of residual phosphate
[107]. By using site-directed mutagenesis, on the other hand, phosphorylation sites
can be destroyed by replacing the serine residues of interest with alanine residues.
This method too relies on sequential phosphorylation in that phosphorylation of a
cluster cannot proceed past a mutated site. When using this method it must be kept
in mind that kinases such as those from the DYRK family, PASK, and p38 MAPK are
able to circumvent hierarchical phosphorylation and could phosphorylate sites past
the mutated residues.
Studies using site-directed mutagenesis showed that no single phosphorylation
site completely controls GS activity [114]. However, by mutating two phosphory-
lation sites simultaneously, a dramatic increase in activity ratio is usually observed.
This is the case if both mutated sites are in the same cluster, but more so if sites from
different clusters are mutated. The influence of a phosphorylation site must be in-
terpreted both in terms of its intrinsic effect on GS activity and its role in sequential
phosphorylation. Consider for instance site 5: in the first sense this site has virtually
no influence, as it does not affect GS activity, but it is crucial in the latter sense in that
it is a prerequisite for secondary phosphorylation. The experimentally determined
activity ratios of GS phosphorylated at various sites are summarised in Table 2.3.
Brown et al. [56] used PKA and CK1 to systematically phosphorylate the N-
terminal phosphorylation sites. They found that phosphorylation at site 2a (using
only CK1) has a much greater effect on the activity ratio than phosphorylation at
site 2 (using only PKA). Phosphorylation at both sites did not further decrease the
activity ratio significantly. Kinetic analysis of these forms showed a mild increase in
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G6P0.5 for both the forms phosphorylated at sites 2 or 2a, but a significant further in-
crease when both sites were phosphorylated. This increase in G6P0.5 when both sites
are phosphorylated does not correspond to a decrease in activity ratio below what is
already seen for phosphorylation at only site 2a. As these workers used PKA, sites
1a and 1b were likely also phosphorylated. In contrast, more recent findings [106], or
studies using PhK instead of PKA [109], recombinant GS (in an effort to limit resid-
ual phosphorylation) [107], or site-directed mutagenesis [114] indicate that site 2 is
the more important site and that phosphorylation at only site 2a, or phosphorylation
of this site in addition to phosphorylation at site 2, has a less significant effect on the
activity ratio. In the N-terminal region, then, site 2 is probably the most important
site in terms of both its intrinsic effect and its potentiation of phosphorylation at site
2a.
Incorporation of one phosphate per GS subunit by CK1 at site 5 has no effect on
the activity ratio [107]. However, phosphorylation at this site is an absolute prereq-
uisite for phosphorylation of the secondary sites in the rest of the cluster. Subsequent
phosphorylation by GSK3 over 50 minutes resulted in the incorporation of an addi-
tional four phosphates per GS subunit and a marked decrease (from roughly 0.7 to
0.1) in activity ratio. Using site-directed mutagenesis, Wang and Roach [120] showed
that only phosphorylation at sites 3b and 3a have significant effects on the activity
ratio. Kuma et al. [94] reported that phosphorylation at site 3b had no inhibitory ef-
fect, but that subsequent phosphorylation at site 3a decreased GS activity. It appears
then that the sole function of sites 5, 4, 3c, and, to some extent, 3b is to facilitate phos-
phorylation at site 3a, which results in potent inhibition. The existence of kinases,
such as the DYRK family, PASK, and p38 MAPK, that directly phosphorylate site 3a
supports this view. It is also interesting to note that in the C-terminal region only
sites 3a and 3b are conserved between the yeast and mammalian enzymes [121].
As measured by their effect on the activity ratio, sites 1a and 1b do not appear to
be important in terms of inhibition [114].
While complete phosphorylation of the clusters in the N- or C-terminal regions
leads to substantial inactivation of GS, complete inactivation is only attained when
both clusters are phosphorylated fully or at the important sites [107, 114]. The effects
of phosphorylating various sites in combination on GS activity has been the topic
of extensive site-directed mutagenesis studies [114, 115, 122]. These studies have,
however, been complicated by the presence of kinases that circumvent hierarchical
phosphorylation, the existence of which was not known at the time. The experi-
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Table 2.3: Activity ratios (Eq. 2.8) of various GS phosphorylation states. Unless stated oth-
erwise, the G6P concentration, when present, was 7.2 mM. UDPG was present at 4.4 mM.
Lower values indicate greater inhibition. a[G6P] = 10 mM. bSites 1a and 1b possibly phos-
phorylated; average of soluble and pellet fractions.
Phosphorylated sites Activity ratio Reference
none 0.8 [120]
2 0.45a [109]
2+2a 0.17a [109]
5 0.8 [120]
5+4 0.8 [120]
5+4+3c 0.8 [120]
5+4+3c+3b 0.6 [120]
5+4+3c+3b+3a 0.1 [120]
2+5+4+3c+3b 0.166b [114]
2+5+4+3c+3b+3a 0.02b [114]
2a+5+4+3c+3b 0.019b [114]
2a+5+4+3c+3b+3a 0.011b [114]
mentally determined activity ratio values of GS phosphorylated at various sites are
summarised in Table 2.3.
Phosphorylation-dependent translocation
It is becoming increasingly clear that subcellular compartmentalization and translo-
cation are major factors in the regulation of glycogen metabolism [123, 124]. Glyco-
gen and many enzymes associated with it have been shown to be targeted to various
intracellular compartments.
Recent studies suggest a strong link between GS phosphorylation state and sub-
cellular localization. Prats et al. [125], working with rabbit muscle, found that GS
phosphorylated at site 1b was exclusively associated with myofibrillar cross-striations
(sarcomere I-bands). This was observed under both basal and exercise-stimulated
conditions. Under basal conditions, GS phosphorylated at sites 1a or 3a+3b was
found mainly in a perinuclear region and at cross-striations. Under exercise-stimulated
conditions, however, GS phosphorylated at these sites was associated with actinin-
containing spherical structures. No association with these spherical structures was
observed for GS phosphorylated at sites 1b or 2+2a. GS phosphorylated at sites 2+2a
was found in intermyofibrillar clusters, regardless of exercise stimulation. Similar re-
sults were obtained for human muscle [126]. In summary, phosphorylation at site 1b
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Table 2.4: Phosphorylation-dependent intracellular distribution of GS [125, 126]
Phosphorylated sites Basal Exercise-stimulated
2, 3a, 3a+3b, 1a perinuclear region
cross-striations
spherical structures
2+2a intermyofibrillar clusters intermyofibrillar clusters
1b cross-striations cross-striations
exclusively targets GS to the intramyofibrillar cross-striations, whereas phosphory-
lation at site 2+2a targets GS to intermyofibrillar clusters (Table 2.4). Prats et al. [124]
proposes that phosporylation at sites 2+2a, and the subsequent translocation, is the
result of AMPK-dependent sensing of glycogen depletion in the intermyofibrillar
region. Similarly, they argue that, since intramyofibrillar glycogen is preferentially
used during exercise, phosphorylation at site 1b by PKA in response to adrenaline
stimulation targets GS to this compartment to replete glycogen after exercise. Site 1b
has been shown to be phosphorylated by CaMKII, suggesting a role for Ca2+ in GS
translocation. From a kinetic perspective we have seen that phosphorylation at site
1b and, to a lesser extent, site 2a have little effect on GS activity. The above findings,
however, suggest major roles for these two sites in GS translocation, which in turn
regulates GS activity.
Insulin and glycogen content have also been shown to affect the subcellular local-
ization of GS. Brady et al. [127] reported an insulin-induced decrease in cytosolic GS
and ascribed it to G6P-mediated activation of PP1. Similarly, in human muscle cells
insulin treatment results in dephosphorylation at sites 3a and 3b and a concomitant
translocation to a particulate subcellular fraction [128]. The effect is abolished by in-
sulin pre-treatment, possibly because under these conditions glycogen accumulates
and overrides the insulin signal [128]. However, in rhesus monkey muscle, insulin
treatment does not result in GS translocation [129]. Cid et al. [130] found that the
distribution of GS is not affected by phosphorylation, but that deletion of the region
enclosing the regulatory arginine cluster, which is implicated in regulation by G6P
and phosphorylation, affected the nuclear accumulation of GS. There was also an in-
verse correlation between glycogen content and nuclear accumulation. Nielsen et al.
[131] showed that at low glycogen levels GS translocated to a cytoskeleton fraction
from a glycogen-rich membrane fraction. Low glycogen levels were also associated
with smooth immunofluorescent stains at what corresponds to I-bands.
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Function of GS multisite phosphorylation
Compared to GP, which is phosphorylated at only a single site, the multisite phos-
phorylation of GS seems almost excessive. Multisite phosphorylation is, however,
not uncommon. Its prevalence and general function have been reviewed extensively
[91, 132, 133]. Here we will discuss its function as it pertains to GS. As discussed, GS
has both dispersed sites and clusters, and within clusters phosphorylation is hierar-
chical, sequential, and mostly distributive.
Multisite phosphorylation facilitates the integration of signals from the various
endocrine, neural, and metabolic stimuli. As regards GS, signal integration is man-
ifested on the level of both individual phosphorylation sites and clusters. Multiple
kinases phosphorylate the same sites or clusters, and many sites share the same ki-
nase. Site 2 is a substrate for numerous kinases regulated by different signals. Sim-
ilarly, site 3a can be phosphorylated directly by a number of kinases, or via hierar-
chical and sequential phosphorylation by GSK3. Site 1b is likewise phosphorylated
both by PKA and CaMKII. The adrenaline-stimulated cAMP-dependent pathway
and the insulin-stimulated PI3K-dependent pathway—arguably the most prominent
GS phosphorylation pathways—each affects different phosphorylation clusters.
Hierarchical phosphorylation is not a prerequisite for sequential phosphoryla-
tion. Appropriately positioned anionic amino acids are able to mimic phosphory-
lated primary phosphorylation sites and thus allow for sequential secondary phos-
phorylation [91]. However, hierarchical phosphorylation facilitates regulation at
two levels: primary phosphorylation and secondary phosphorylation [86]. As both
are catalysed by different kinases, each kinase can be regulated independently. In
the N-terminal cluster of GS, it is the primary kinases that are regulated; either by
the cAMP-dependent pathway (PKA) or by metabolic signals (AMPK). In the C-
terminal cluster, on the other hand, the secondary kinase, GSK3, is regulated via the
PI3K-dependent pathway. In addition, phosphorylation can also be regulated at the
phosphatase level. Both adrenaline- and insulin-stimulation regulate PP1 activity.
In a random phosphorylation mechanism, the number of phosphorylation states
per subunit increases exponentially with the number of phosphorylation sites. A
protein subunit with n phosphorylation sites can result in up to 2n phosphorylation
states. In sequential phosphorylation, on the other hand, the number of phosphory-
lation states is a linear function (n+ 1) of the number of sites. If one assumes strict se-
quential phosphorylation (and dephosphorylation), the number of distinct GS phos-
phorylation states per subunit amounts to (2 + 1) × (5 + 1) × 2× 2 = 72. Were a
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random mechanism employed, the number of states would amount to 29 = 512. Se-
quential phosphorylation therefore severely limits the number of phosphorylation
states and brings about an orderly transition between different states. This is ben-
eficial if, as in the case of GS, only specific phosphorylation sites (for example, site
3a) elicit a particular effect. Phosphorylation of site 3a can be achieved and reversed
with precision by adjusting the ratio of kinases to phosphatases appropriately in a
sequential mechanism. In a random mechanism, on the other hand, phosphoryla-
tion of a particular site cannot be achieved with precision. However, a number of
kinases circumvents sequential GS phosphorylation, obscuring any benefit it might
entail. The number of states per cluster is therefore also likely significantly more
than 72.
It has been argued (as discussed by Gunawardena [134]) that multisite phospho-
rylation, particularly if it proceeds distributively and sequentially, results in an ultra-
sensitive response to the ratio of kinase to phosphate, so that below a certain thresh-
old the protein in question would be almost completely dephosphorylated, whereas
above the threshold complete phosphorylation is rapidly attained. According to this
view, more phosphorylation sites result in higher sensitivity, approaching switch-
like behaviour. However, it has been demonstrated [134] that, although multiple
phosphorylation creates a sharp threshold, an increase of the kinase to phosphatase
ratio beyond the threshold does not result in switch-like behaviour, i.e., complete
phosphorylation does not ensue rapidly. On the contrary, beyond the threshold,
the response becomes milder as the number of phosphorylation sites increases. It
seems feasible then that a function of the sequential phosphorylation of GS is to
fine-tune the threshold at which the ratio of kinase to phosphatase elicits a response.
This is particularly of interest if one considers that, apart from GS, GSK3 has nu-
merous substrates in various signalling pathways [135]; regulation of GSK3 affects
all these pathways, but by employing multiple phosphorylation to different extents,
each pathway can refine its response to changes in GSK3 levels.
2.4 Regulation by glucose-6-phosphate
In 1959 Leloir et al. [22] were the first to show that G6P activates GS. They contin-
ued to show that G6P, which can appear to be a requirement for catalysis by highly
phosphorylated GS, does not take part in the reaction and presumably binds to an al-
losteric site. This initial work was followed by kinetic studies in a variety of species
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[71, 116, 117, 136, 137], which suggested that GS activation by G6P is a universal
feature in eukaryotes. The regulation of GS by G6P is multifaceted and the initial
assessment of Leloir et al. [22] is no surprise:
“As to the mechanism by which G-6-P increases the activity of the glycogen-
forming enzyme, no clue was obtained.”
To date five mechanisms have been described by which G6P affects GS activity:
it is 1) a substrate precursor, 2) an allosteric GS activator, 3) a GS kinase inhibitor, 4)
a GS phosphatase activator, and 5) it enhances the export of GS from the nucleus.
In this section we will discuss the binding of G6P to GS and the resulting confor-
mational change that leads to activation (both allosteric and covalent) and possibly
translocation of GS.
G6P-induced conformational change
The activation of GS by G6P must ultimately be the result of some conformational
change, but little is known about such a conformational change in the muscle en-
zyme. However, due to the high degree of conservation between the yeast and
muscle enzymes, it is instructive to consider the conformational change induced
in ScGS upon G6P binding as revealed by the crystal structure of this enzyme in
the presence of G6P [51]. In ScGS, G6P binds between the R helix (α22) and helix
α13. The former contains the regulatory arginine cluster and links the crossed-over
C-terminus and the phosphorylation sites to the C-terminal Rossmann fold domain.
Helix α13 (together with α12) forms the main connection between the N- and C-
terminal Rossmann fold domains. The phosphate moiety of G6P binds tightly in
a pocket formed by amino acid residues from both the R helix and α13—including
Arg582 and Arg586, residues that have been shown to be essential for G6P activa-
tion of the yeast [51, 63] and muscle [18, 64] enzymes. This pocket is ordered in the
unbound state, and undergoes little change upon G6P binding. The G6P glucose
moiety, on the other hand, forms hydrogen bonds with His280 and Gln283, which
reorders the region between residues 278 and 284, allowing Asn284 to hydrogen
bond with the corresponding residue of the subunit across the dimer pair two-fold
symmetry (i.e. the A/B or C/D interface). The arginine residues therefore likely act
as anchors of the G6P molecule so that the glucose moiety can bond with His280
and Gln283 [51]. It is tempting to speculate that the phosphate of ATP is similarly
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anchored by Arg582 and Arg586, with the difference that the adenosine moiety sta-
bilizes an inactive conformation.
G6P binding and the subsequent reordering of residues 278–284 bring about sig-
nificant conformational change [51, 53] (Fig. 2.1d). The R helices within the A/B and
C/D dimers are forced apart by 3.4 A˚ and the intersubunit helices (α15 and α16) of
the B/D dimer pairs are translated by 14.2 A˚ away from that of the A/C pair and ro-
tated by 7 ◦. Within subunits, the C-domain is rotated by 8.5 ◦ relative to the intersub-
unit helix pair, and the N-domain is rotated a further 4.5 ◦ relative to the C-domain.
The overall effect of the conformational change is that the association between the
N-domain insert (α2 and the loop between β4 and β5) and C-domain insert (α16),
which locks the subunits in an inactive open conformation, as well as the reciprocal
intersubunit interaction of the loops between β15 and α18 within the A/D and B/C
interfaces are abrogated (Fig. 2.1c). In the G6P-bound form, α16 instead associates
with the loop between β15 and α18 of its partner subunit in the dimer, allowing the
interdomain closure that is required for catalysis.
Comparing the structures of the G6P insensitive mutant R580A/R581A/R583A
(yeast enzyme numbering) to the inactive, but G6P sensitive, mutant R589A/R592A
in the presence of G6P, Baskaran [53] observed a closure of the active site of subunit
B relative to the G6P insensitive mutant over and above of that witnessed in the re-
maining three subunits. This additional closure was the result of G6P binding in the
active site of subunit B. Although generally acting as a GS activator, this observa-
tion suggests that G6P could also compete with GS substrates, presumably UDPG,
for the active site and therefore inhibit GS. Slight inhibition by G6P has been noted
before for the dephosphorylated enzyme [64].
Effect of G6P on GS kinetics
In agreement with the extensive conformational change resulting from G6P binding,
G6P affects the kinetics of GS significantly.
Several workers have observed higher apparent kcat values in the presence of
G6P. Such catalytic activation is described by γG6P > 1. In many cases the extent
to which kcat is affected seems to depend on the degree of phosphorylation. Rosell-
Perez et al. consistently found an increase in the kcat of the phosphorylated D enzyme
from rat [71], rabbit [116], and dog [117], but observed no or little change in the kcat
for the dephosphorylated I form. The effect was independent of Mg2+. Kornfeld
& Brown [32], however, only reported an increase in kcat in the presence of Mg2+.
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Others, working with the I form, reported no change in kcat, but did observe that
contamination with the D form resulted in catalytic activation of GS [42]. Catalytic
activation was also observed for the D form from rat adipose tissue [68], bovine
heart [69], and pig brain [70]. More recently, Lai et al. [138] found that catalytic
activation increases with glycogen content, which in turn correlates with degree of
phosphorylation. However, several workers have found no increase in kcat in the
presence of G6P, regardless of the phosphorylation state. Piras et al. [67] found no
increase in kcat for both the I and D forms of the rat muscle enzyme in response to
G6P. Similarly, Roach et al. [72] observed essentially the same Vmax, and thus kcat, in
the presence and absence of G6P for a range of phosphorylation states of the rabbit
muscle enzyme.
The apparent effect of G6P on UDPG0.5, on the other hand, is well-established
(see for example [72]). Even for the most phosphorylated forms, G6P decreases the
apparent UDPG0.5 dramatically. This potent activation potential is indicative of a
large αG6P value. In most cases where catalytic activation was observed, specific
activation was also observed.
G6P further activates GS by suppressing ATP binding at the allosteric site. This
effect manifests as an apparent increase in ATP0.5. Several secondary effects on kcat
and UDPG0.5 could ensue, depending on the type of inactivation (specific or cat-
alytic) that results from ATP binding. If, for instance, ATP inhibited GS by increasing
the apparent UDPG0.5 (i.e. αG6P < 1), then G6P would enhance substrate binding in
the presence of ATP over and above its own direct activation of GS. Indeed, Piras
et al. [67] argue that this indirect activation of GS has more physiological relevance
than the direct effect of G6P on UDPG0.5, since even the phosphorylated forms are
often saturated with G6P at physiological concentrations, thus obscuring both the
function of phosphorylation and G6P activation. In their view, ATP, which binds
preferentially to the phosphorylated enzyme, restores the necessary G6P sensitivity
in inactive GS. Moreover, G6P increases hATP, especially in the dephosphorylated
enzyme, suggesting that, in addition to competing with ATP, G6P also stabilizes a
conformation with a low affinity for ATP.
Finally, it is generally accepted that high G6P concentrations activate even the
most phosphorylated forms of GS to the same level as the dephosphorylated enzyme
[31, 89, 113]. This, as discussed earlier, is equivalent to stating that both kcat · γG6P
and UDPG0.5/αG6P are constants that are independent of phosphorylation state. Any
effect of phosphorylation on kcat or UDPG0.5 is therefore reversed by G6P.
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G6P-dependent covalent activation
Apart from reversing the effects of phosphorylation on the kinetics of GS, it has been
demonstrated in a few cases that G6P also enhances the reversal of covalent phos-
phorylation itself; either by inhibiting GS kinases, or by activating GS phosphatases.
Phosphorylation by PKA at site 2 potently inactivates GS. It has, however, been
observed that in rabbit skeletal muscle insulin inhibits PKA in a seemingly compet-
itive fashion with regard to cyclic AMP (cAMP) [139]. At least one mechanism by
which insulin inhibits PKA is by increasing the G6P concentration [139]. PKA (or
R2C2) is a tetrameric enzyme consisting of two catalytic (C) subunits, each associ-
ated with a regulatory (R) subunit [140]. The R subunit is a pseudosubstrate that
inhibits the C subunit by blocking its active site. Each R subunit has two binding
sites for cAMP, which binds to it sequentially, leading to the stepwise dissociation of
the R and C subunits and thus activation of PKA. Several PKA substrates are able to
activate PKA in a cAMP-independent fashion [139]. These substrates compete with
the R subunit for the active site. In the absence of cAMP, GS is able to stimulate PKA
to an activity that is roughly 50% of that in the presence of 2 µM cAMP. When G6P
is bound to GS, however, the ability of GS to activate PKA is abolished.
G6P inhibition of phosphorylation appears to be specific to PKA and GS [139].
No other GS kinases are inhibited by G6P, neither is the phosphorylation of other
PKA substrates affected. The possibility that G6P brings about the inhibition by
binding to the C or R subunits of PKA is thus ruled out and the inactivation must
be the result of G6P binding to the allosteric site on GS. Since GS activates PKA by
competing with the R subunit, one would expect that G6P decreases the C subunit’s
affinity for GS. No changes in the Km or Vmax were however found in the presence
or absence of G6P. G6P appears then, by causing a conformational change in GS, to
only hinder its ability to activate PKA and not the kinetics of PKA. This hints at an
activation mechanism other than pure competition of GS with the R subunit. It has
been suggested that the protein substrates of PKA could activate it by interaction
with the R subunit [139].
G6P also inhibits one or more yeast GS kinases [141].
Traut & Lipmann [142] observed that incubation with G6P increased the activity
of lamb muscle GS in the absence of G6P. GS activated in this way retained the ac-
tivation after several days in cold storage. The activation by G6P was reversed by
incubation with ATP. Therefore, apart from allosterically activating GS, it also acti-
vated the enzyme in a, presumably, covalent fashion. Kinase inhibition by G6P, as
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discussed above, does not appear to have contributed significantly to the results ob-
tained by Traut & Lipmann, as their preparations were, judging by the activity ratio,
already extensively phosphorylated. This suggests that G6P also has the potential to
enhance the dephosphorylation of GS. These findings have subsequently been veri-
fied by various other workers. Kato & Bishop [143] showed that G6P enhances the
D to I form conversion of rabbit muscle GS by a protein phosphatase. This effect of
G6P was not observed in the absence of the phosphatase. G6P analogues such as
glucosamine-6-phosphate and galactose-6-phosphate, which also activate GS, had a
similar effect on the dephosphorylation of GS. No effect was seen for the dephospho-
rylation of histone by the same phosphatase in the presence of G6P, suggesting that
the activation of the phosphatase by G6P is mediated by the binding of G6P to GS.
Others have shown that activation of the phosphatase reaction by G6P is inhibited
by inorganic phosphate and sulphate [144], and ATP [145]. ATP was also shown to
inhibit dephosphorylation of GS in human muscle [145].
More recently, Villar-Palasi [146] found that, in rabbit muscle, G6P activates the
D form of GS covalently by promoting dephosphorylation. This effect was observed
for both PP1 and protein phosphatase 2A (PP2A). Except for a slight activation at
low G6P concentrations of GP dephosphorylation by PP1, G6P did not enhance the
dephosphorylation of any other tested PP1 or PP2A substrates. This suggests that
G6P does not directly activate the phosphatases in question, but rather causes a con-
formational change in GS, rendering it a better substrate. G6P activated dephospho-
rylation by PP1 and PP2A to the same degree. The G6P phosphatase activation was
observed by measuring both the change in GS activity ratio and phosphate release.
From both methods a Ka of 0.2 mMwas calculated for phosphatase activation. This
coincided with the Ka for GS activation as determined for the preparation used in
the study, strengthening the argument that the activation is caused by G6P binding
to GS. Intriguingly, the affinity of the phosphatases for GS was not altered by G6P.
The activation appears to rather involve an increase in the Vmax and thus presumably
the catalytic constant kcat. It has been suggested that the GS conformational change
resulting from G6P binding exposes the phosphorylation sites to PP1 [147]. Although
such a view is a useful metaphor, it is not strictly in agreement with the observation
that only the kcat of the phosphatase is affected. Several other sugar phosphates that
are known to activate GS were tested [146]. Those with the highest affinities for GS,
such as fructose-6-phosphate and galactose-6-phosphate, yielded the highest cova-
lent activation, with the former matching G6P, but there appeared to be no direct
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relationship between GS affinity and phosphatase activation [146]. Note that even
though PP2A is not generally considered a major in vivo GS phosphatase, we in-
clude it here to better illustrate that the reported activation of GS dephosphorylation
by G6P is substrate-specific, i.e., independent of the particular phosphatase.
Nucleocytoplasmic shuttling
There is mounting evidence that the subcellular distribution of GS, from both liver
and muscle, is regulated by glucose. In liver, incubation with glucose results in the
translocation of GS from the cytosol to a region near the cell membrane [148, 149].
Similarly, Cid et al. [130] have shown that muscle GS translocates from the nucleus
to the cytosol when incubated with glucose. Under conditions of glycogen and glu-
cose depletion, GS conversely translocates to the nucleus. In addition to mediating
the allosteric and covalent regulation of GS, the arginine cluster also functions as
a nuclear localization sequence. Arginine cluster mutants, in which G6P sensitiv-
ity and presumably nuclear localization are abrogated, exhibited little or no nuclear
accumulation. Systematic mutation of the GS phosphorylation sites indicated that
phosphorylation does not affect nucleocytosolic GS translocation, suggesting that
only G6P stimulates translocation to the cytosol. Moreover, based on the observa-
tion that 6-deoxyglucose does not stimulate translocation to the cytosol, Cid et al.
[130] suggest that it is in fact G6P, and not glucose, that elicits the translocation.
If this is indeed the case, G6P-stimulated translocation of GS to the cytosol would
effectively increase the total GS concentration, [E]tot, in the cytosol.
As G6P stimulates net dephosphorylation of GS, it is expected that it would also
influence the subcytosolic distribution of GS by promoting the dephosphorylation
of sites, such as 2a and 1b, that are associated with targeting GS to various fractions
in the cytosol.
Function of G6P feedforward activation
G6P is a precursor of UDPG, one of the GS substrates. Activation of GS by G6P
therefore constitutes a feedforward activation loop. Hofmeyr & Cornish-Bowden
[15] have previously demonstrated that a similar regulatory mechanism, the feed-
back inhibition loop, does not function to control the flux through the regulated en-
zyme, but rather to maintain the concentration of the regulatory metabolite within a
narrow range. In terms of GS, supposing a function of feedforward activation simi-
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X S Psupply 1 2
Figure 2.4: Minimal feedforward activation mechanism. Metabolite X is a product of the
supply system, a substrate of enzyme 1, and an allosteric activator of enzyme 2. In order for
the feedforward activation of enzyme 2 by X to be effective, enzyme 2 must hold the majority
of flux control within the isolated block that excludes the supply system.
lar to that of feedback inhibition, the function of G6P activation is not to regulate the
flux through GS, but rather to maintain G6P homeostasis. However, Hofmeyr et al.
[16] argue that, unlike the situation in feedback inhibition, the type of activation—
whether by increasing kcat or decreasing Km—has important consequences for the
effectiveness of the mechanism in maintaining the concentration of the regulatory
metabolite homeostatically. We will only briefly consider these consequences here.
See [16] for a thorough mathematical exposition.
Consider the minimal feedforward activation loop portrayed in Fig. 2.4. Enzyme
2, the regulated enzyme, is activated allosterically by metabolite X, the regulatory
metabolite. In order for the feedforward loop to be effective—that is, for activation
of enzyme 2 to have any significant effect on the pathway—enzyme 2 should control
the flux through the isolated subpathway (that part of the pathway that excludes
the supply enzyme). One way in which complete flux control by enzyme 2 can
be achieved is if it is saturated by its immediate substrate, S. However, in such a
scenario any increase in the affinity of enzyme 2 for S resulting from activation by X
is clearly futile, as enzyme 2 is already saturated by S and cannot bind more substrate
in order to operate faster; enzyme 2 has reached its maximal velocity. Alternatively,
if the action of X is to increase the catalytic rate, kcat (and Vmax by extension), of
enzyme 2, the enzyme could operate faster despite being saturated by its substrate.
Hofmeyr et al. [16] thus argue that catalytic activation (increase in kcat) is expected to
be the dominant type of activation in feedforward mechanisms.
In terms of GS, then, it is expected that G6P should be a catalytic—and not neces-
sarily a specific—activator of GS, i.e., γG6P > 1 should hold. This is indeed the case
for the major yeast GS [63]. However, it is much less certain whether this is also the
case for the mammalian muscle enzyme. As discussed, many of the earlier studies
found catalytic activation for the D form and specific activation for the I form. It can
however be argued, that, since the I form already has a high affinity for UDPG, it
is in fact the I form that would benefit most from catalytic activation, whereas the
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D form, with a lower UDPG affinity, would benefit from specific (and catalytic) ac-
tivation. There are two solutions not considered explicitly by Hofmeyr et al. [16] in
which pure specific activation could still result in efficient feedforward activation.
First, GS is a bisubstrate enzyme. In bisubstrate kinetics specific activation (and,
trivially, catalytic activation) with regard to one substrate, say glycogen, manifests
as catalytic activation with regard to the other, say UDPG, with the condition that the
first substrate is not saturating. Therefore, if G6P enhances glycogen binding, which
is likely the case, it would appear to increase the apparent kcat if considered with
respect to UDPG, even if kinetically G6P were only a specific activator. However, it
is not clear to what extent such a situation is relevant physiologically, as GS is likely
saturated by glycogen in vivo. Second, saturation by UDPG is not the only device
by which flux control can be retained by GS; the same outcome would be achieved
if the enzyme preceding GS operated near equilibrium. Since GS need no longer be
saturated by UDPG, a G6P-induced increase in the affinity for UDPG becomes an
effective form of activation.
We must however not only consider the direct effects of G6P on GS. As men-
tioned, G6P also activates GS by reversing inhibition by ATP and phosphorylation.
If either ATP or phosphorylation decreases the apparent kcat, then by reversing this
decrease, G6P would appear to be a catalytic activator even if it exhibits no such
activation in the absence of ATP or phosphorylation. The observation that G6P is a
catalytic activator of the D form probably indicates a reversal of inhibition by phos-
phorylation, but there is no definitive evidence that either ATP or phosphorylation
decreases the apparent kcat. Finally, in what is effectively catalytic activation, G6P
increases the total cytosolic concentration of GS by inducing its translocation from
the nucleus. However, as glycogen depletion is a requirement for nuclear retention
of GS, this mechanism of activation would likely only be relevant during the onset
of glycogen resynthesis after exercise.
The effectiveness of G6P feedforward activation, whether specific or catalytic, ap-
pears to depend strongly on such cellular conditions as the concentrations of UDPG
and ATP, the degree of GS phosphorylation, and glycogen content. In order to un-
derstand the function of GS feedforward regulation by G6P, it must be established
definitively whether G6P is a catalytic or specific activator of GS, to what extent GS
is saturated by its substrate in vivo, and to what extent ATP and phosphorylation
affect the apparent catalytic capacity of GS.
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2.5 A unifying view of covalent and allosteric
regulation
The complex kinetics and regulation of GS, as discussed in the previous two sections,
continue to evade description by a succinct mechanistic model. The sheer number
of phosphorylation states and an incomplete understanding of how GS kinetics is
altered by phosphorylation makes it near impossible to capture the enzyme’s be-
haviour with conventional enzyme kinetic rate equations. In this section we will
argue that, without deriving any form of rate equation yet, the MWC model could
provide an adequate description of the nuances of GS kinetics and regulation—both
allosteric and covalent—as reviewed in this writing.
Let us briefly summarize the interplay between G6P, ATP and phosphorylation.
In many respects the effects of regulation by G6P and phosphorylation are reciprocal
(Fig. 2.5A). G6P binding activates GS (a) in a cooperative fashion (b). It not only re-
verses the inhibitory effects of phosphorylation, but also reverses phosphorylation
itself (c). Phosphorylation, on the other hand, inhibits GS (e). It also inhibits G6P
binding (g), but intriguingly enhances G6P binding cooperativity (h). Conversely,
the effects of ATP and phosphorylation on GS and each other appear to be qualita-
tively identical (Fig. 2.5B). Both inhibit GS (a, e). ATP enhances phosphorylation (c)
and phosphorylation enhances ATP binding (g). In addition, phosphorylation de-
creases ATP binding cooperativity (h). Finally, G6P binding affects ATP binding and
phosphorylation similarly; and ATP binding and phosphorylation affect G6P bind-
ing in similar ways (Fig. 2.5C). G6P and ATP decrease each other’s binding affinity
(c, g), but enhance each other’s binding cooperativity (h, d).
Several trends concerning the interplay between activation and inhibition of GS
emerge. Activators and inhibitors inhibit each other’s binding, but enhance each
other’s binding cooperativity. Inhibitors, on the other hand, enhance each other’s
binding, but each decreases the degree of cooperativity to which the other binds. It
is evident, therefore, that phosphorylation—though covalent—exhibits exactly the
same qualitative behaviour with respect to G6P as ATP—a classic allosteric inhibitor.
We arrived at this picture of GS regulation with the aid of the Hill equation. How-
ever, as we have seen, the Hill equation cannot account for the heterotropic coopera-
tivity that is observed between activators and inhibitors; that is, in the Hill equation
h, the degree of cooperativity, is constant. It has been proposed that a modification
term be incorporated in the Hill equation that would allow h to be a function of
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Figure 2.5: Regulation of GS by G6P, ATP, and phosphorylation (∗). Blue arrows indicate
activation, red arrows indicate inhibition, and dashed lines indicate predicted, but as of yet
unobserved, effects. (A) G6P binding activates GS (a) and is positively cooperative (b). While
phosphorylation inhibits G6P binding (g), it increases the degree of G6P binding coopera-
tivity (h). Phosphorylation inhibits GS (e), but phosphorylation and its effects are reversed
by G6P (c). It is predicted that, in addition to hierarchical phosphorylation, phosphorylation
is also cooperative (f) and that the degree of this cooperativity is increased in the presence
of G6P (d). (B) ATP inhibits GS (a) in a cooperative manner (b). Phosphorylation enhances
ATP binding (g), but decreases the degree of ATP cooperativity (h). ATP is predicted to de-
crease the degree of cooperative phosphorylation (g). (C) G6P inhibits ATP binding (c), but
increases the degree of ATP cooperativity (d). Similarly, ATP inhibits G6P binding (g) and
enhances the degree of G6P cooperativity (h). Note that the arrows in A are isomorphic to the
arrows in C, and that within B the arrows originating from ATP are symmetrical with respect
to the arrows originating from ∗. This indicates that phosphorylation behaves qualitatively
like a classic MWC-type allosteric inhibitor.
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other modifiers [150]. Such a modification term would however soon lapse into an
infinite regress, as it would have to contain binding terms that are themselves raised
to yet another modified Hill coefficient. Another shortcoming of the Hill equation
is that the ability of G6P to completely reactivate GS of any phosphorylation state
can only be described by imposing explicit constraints on the equation parameters.
For instance, kcat and γG6P must be constrained by the relationship kcat · γG6P = C,
where C is a constant.
The MWC model does not suffer these shortcomings and readily explains the
trends observed in GS regulation. Piras et al. [67] offered an explanation of the in-
terplay between G6P, ATP, and phosphorylation using the MWC model. Noting
that phosphorylation enhanced G6P cooperativity, but decreased ATP cooperativity,
they suggested that the covalent modification of GS exerts its effects in exactly the
same way as classic MWC-type allosteric modification does: by altering the equilib-
rium constant L0 between an active R conformation and an inactive T conformation.
In the MWC model cooperativity arises due to the simultaneous or concerted con-
formational change of all subunits of the enzyme. By binding preferentially to a
particular conformation, modifiers shift the equilibrium of all subunits, regardless
of whether they are occupied, towards that conformation and thus enhance subse-
quent modifier binding. However, cooperativity is only observed if the majority of
the enzyme is in the conformation not favoured by the modifier in question. The
results of Piras et al. [67] are then explained if the majority of the dephosphorylated
I form is already in the active form so that G6P binding is only mildly cooperative.
Phosphorylation, which favours the T conformation, would then enhance G6P coop-
erativity. The converse would be true with regard to ATP cooperativity. This model
is depicted in Fig. 2.6.
Sølling [42] also described the kinetics of GS by employing two enzyme confor-
mations and suggested that the MWC model might account for his findings. How-
ever, since he worked with the I form which shows little G6P cooperativity, normal
Michaelian kinetics for each conformation provided an adequate description. Ki-
netic [63] and crystal structure [51] studies of the yeast enzyme lend further support
to a discrete state model such as the MWC model. A three-state model has been
suggested in which the enzyme is normally present in a basal I conformation (not to
be confused with the I form of the I/D nomenclature). Phosphorylation would then
stabilize an inactive T conformation, whereas G6P would stabilize an active R con-
formation. Conformational change, particularly involving the interdomain closure
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Figure 2.6: Monod-Wyman-Changeux-type model of allosteric and covalent GS regulation.
Dephosphorylated GS is predominantly in the R conformation. Activation by G6P shifts the
equilibrium between the two conformations towards R, but inhibition by ATP and phospho-
rylation (∗) shifts the equilibrium towards T. Both allosteric and covalent regulation then
manifests as an apparent change to L0, the equilibrium between T and R. Not all phosphory-
lation sites would contribute equally to a change in L0; phosphorylation at sites that do not
affect GS activity will also not alter L0. No crystal structure of phosphorylated GS is avail-
able and it is thus possible that a second inactive conformation exists. The cartoons used
here are based on the crystal structures of basal and activated yeast GS [51].
of subunits, is a recurring theme in GS from various crystal structure studies.
The complete activation of any GS phosphorylation state by saturating levels of
G6P is readily described by the MWC model. If the affinity of the R conformation
for G6P were such that G6P binding lowers the apparent value of L0 more than
phosphorylation increases it, G6P binding would completely overcome inhibition
by phosphorylation. Note also that in such a scenario saturating G6P would activate
any phosphorylation state, including the dephosphorylated state, to the same level,
which is equivalent to constraining the values of kcat · γG6P and UDPG0.5/αG6P. If
ATP were also able to bind to the catalytic site, then the MWC model would, like
the Hill model, be compatible with the observation that G6P does not completely
overcome ATP inhibition [42, 67].
Not only does the MWC model account for the reversal of the effects of phospho-
rylation by G6P but it also predicts the observed inhibition of phosphorylation itself
as manifested by G6P-induced GS kinase inhibition and activation of PP1. If, as pro-
posed, phosphorylation stabilizes the inactive T conformation, then by extension the
T conformation is more readily phosphorylated. Hence, all modifiers that stabilize
the R conformation will not only activate GS kinetically, but will also promote its co-
valent activation by stabilizing the conformation that is less readily phosphorylated.
Kinase inhibition by G6P has only been observed for PKA; whereas GSK3, PhK, and
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CK1 showed no activation by G6P. The MWC model, however, predicts that only ki-
nases that phosphorylate sites that affect GS activity should be inhibited by G6P and
thus little, if any, inhibition is expected for PhK and CK1, if used alone. Similarly, the
majority of sites phosphorylated by GSK3 have no effect on GS activity and no inhi-
bition by G6P is expected for the phosphorylation of these sites. Inhibition by G6P
is however expected for phosphorylation of site 3a by GSK3, but was not observed
[139]. No explanation can be offered in this regard, except that site 3a might have
already been phosphorylated substantially, given that the phosphorylation state was
not known. Similarly, ATP is predicted to enhance net GS phosphorylation over and
above its contribution as kinase cosubstrate (c in Fig. 2.5B). Embi et al. [151] have
indeed observed stimulation of GSK3 by ATP even after the kinase was already sat-
urated with ATP, suggesting a substrate-specific effect. Inhibition of PP1 by ATP, in
a manner reversible by G6P, is well-established [142, 145, 152–154].
In the majority of kinetic treatments that incorporate modifier effects, it is as-
sumed that specific modification affects binding of substrate-product pairs to the
same extent and that catalytic modification affects forward and reverse rate con-
stants to the same extent. These assumptions are sufficient but not necessary to
satisfy the constraints of the Haldane relationship. Differential modification of the
binding affinities of substrates and products is allowed by the Haldane relationship,
but with the condition that the forward and reverse rate constants are also modified
differentially and to the same extent. Describing differential modification of rate
constants and binding affinity in the Michaelian or Hill models, however, leads to
complicated rate equations; whereas in the MWC model the behaviour can be ac-
counted for without the introduction of additional parameters. This advantage of
the MWC model is, however, not an argument for its applicability to GS kinetics.
A few objections have been levelled against the MWC model as a model for GS
regulation. First, Piras et al. [67] argued that non-cooperative substrate binding is
seemingly incompatible with this model. Non-cooperative substrate binding can,
however, be achieved by making the usual assumption that only the R conformation
is catalytically active, as well as the assumption that the UDPG substrate binds with
equal (or only slightly different) affinities to the R conformation and to the T confor-
mation. These assumptions lead to no, or very mild, substrate binding cooperativity
(comparable to that seen for G6P in the dephosphorylated form) for both the de-
phosphorylated and phosphorylated states, but also impose catalytic activation by
G6P. Modifier binding cooperativity is retained, as modifiers bind with vastly dif-
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ferent affinities to the two conformations. This mechanism is predicted to exhibit
positive substrate cooperativity if the apparent affinity of the two conformations for
UDPG is affected to different extents by a competitive inhibitor. This has indeed
been observed for the bovine heart enzyme, in which UTP elicited positive cooper-
ativity with respect to UDPG binding [69]. These assumptions are also supported
by Sølling [42] who was unable to detect significant conformational change induced
by UDPG or UDP. Non-cooperative substrate binding can also be achieved if it is as-
sumed that glycogen can bind to only one subunit at a time due to steric constraints
and that UDPG can only bind to the subunit that is already bound to glycogen. These
two assumptions are equivalent to assuming infinite negative cooperativity, which is
kinetically indistinguishable from hyperbolic kinetics. This mechanism is, however,
incompatible with random order bi-bi kinetics, the favoured kinetic mechanism for
GS. Although glycogen saturation alters the random bi-bi mechanism to an appar-
ent ordered mechanism, the assumptions here imply a true ordered mechanism that
would affect even the sites not occupied by glycogen.
In a further objection, Plesner et al. [82] argue that G6P cooperativity is an arte-
fact that disappears at high substrate concentrations and they thus reject the MWC
model. Their observation is however in agreement with the model proposed here.
UDPG is expected to bind preferentially to the R conformation (otherwise specific
activation would not be observed). High substrate concentrations would therefore
stabilize the R conformation and so abrogate G6P cooperativity. The disappearance
of G6P cooperativity is thus not an artefact, but a characteristic, of the model.
Some aspects of GS regulation suggest that a MWC model with more than two
conformations might be required. Many earlier GS kinetic studies found that cat-
alytic activation by G6P was restricted to the D form, whereas specific activation
was restricted to the I form. Unless these finding were artefactual, they can only be
accounted for by a MWC model with at least three conformations. In a similar vein,
Piras et al. [39] noted that the specific activation of GS by G6P was pH-dependent,
which could indicate that an additional pH-dependent conformational transition oc-
curs. Some workers [42, 82] have also found that inorganic phosphate and sulphate
are inhibitors of the D form, but activate the I form. This situation could perhaps be
explained with a two-state MWC model if phosphate and sulphate prefer to bind to
the R conformation. In the I form, which is often assayed in the absence of G6P, they
would result in slight activation, whereas in the D form, which is rarely assayed in
the absence of G6P, they would impair G6P activation by competing for the allosteric
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site. However, if phosphate and sulphate are true inhibitors of the D form, that is,
not only with respect to G6P, additional conformations would be required to explain
the behaviour. Based on crystal structure data, a three-state MWC type model has
indeed been proposed for yeast GS [51], but no rigorous kinetic studies have yet
confirmed this proposal. Until a two-state MWC model is shown to be inadequate,
however, little is gained by considering additional conformational states.
The MWC model proposed here, in which phosphorylation increases L0, makes
a few predictions that have, to our knowledge, not been tested experimentally. First,
it predicts that phosphorylation is cooperative (see f in Fig. 2.5A). That is, phospho-
rylation of, say, site 2 on one subunit must enhance phosphorylation of site 2 on
the next subunit. And more generally, phosphorylation of any site that increases L0
should enhance subsequent phosphorylation of any other phosphorylation site—on
the same or other subunits of the oligomeric enzyme—that also increases L0. In sim-
pler terms, if phosphorylation at two different sites, whether on the same or different
subunits, both stabilize the T conformation, then phosphorylation of one site should
enhance phosphorylation at the other site. Similarly, dephosphorylation should also
proceed cooperatively. Not all phosphorylation sites affect the activity, and thus
L0, of GS. Phosphorylation sites like 1a, 1b, and 5–3c have little if any effect on GS
activity and thus no cooperative phosphorylation of these sites is expected. Hierar-
chical sequential phosphorylation is not equivalent to cooperative phosphorylation;
however, in a MWC model, these two mechanisms could be difficult to tell apart in
phosphorylation assays. Suppose for instance that phosphorylation at both sites 2
and 2a stabilizes the T conformation. Phosphorylation of site 2a would then be en-
hanced by prior phosphorylation at site 2 by virtue of the recognition motif of CK1
containing a phosphorylated serine residue, but also because phosphorylation at site
2 stabilizes the same conformation that is favoured by phosphorylation at site 2a. It
has been noted that phosphorylation of sites 2 and 2a is synergistic [106]: prior phos-
phorylation at site 2 greatly enhances, but is not a requirement for, phosphorylation
at site 2a. If regulation of GS is indeed adequately described by a MWC-type model,
this enhanced phosphorylation at site 2a cannot purely be the result of hierarchical
sequential phosphorylation.
Second, it is predicted that G6P would enhance the degree of cooperative phos-
phorylation by stabilizing the conformation not favoured by phosphorylation (d in
Fig. 2.5A). ATP, on the other hand, will decrease the degree of cooperativity of phos-
phorylation (d in Fig. 2.5B), despite the fact that it enhances phosphorylation itself
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(c in Fig. 2.5B).
The kinetics and regulation of GS seem to be adequately described by a MWC
model in which phosphorylation acts like a classic allosteric modifier. The sequen-
tial or Koshland-Ne´methy-Filmer (KNF) model [155] is, however, expected to pro-
vide an equally adequate description. However, an equation derived from the as-
sumptions of the KNF model for a tetramer in a tetrahedral arrangement with prod-
uct inhibition and two allosteric modifiers would be too complicated to be useful.
Moreover, in the KNF model it is not immediately clear which parameters would
be influenced by phosphorylation. The MWC-type model proposed here is almost
certainly a gross over-simplification of the true regulation of GS, but is nevertheless
a useful working model.
2.6 Conclusion
In this chapter we discussed the general kinetic properties of GS and how these prop-
erties are affected by allosteric and covalent regulation. The covalent regulation of
GS is particularly elaborate, allowing the enzyme to be sensitive to multiple regu-
latory signals. However, only a few of the phosphorylation sites have direct effects
on the enzyme’s activity. The majority appear to rather fulfil auxiliary roles such as
targeting the enzyme to appropriate sub-cellular compartments or to facilitate the
phosphorylation of those sites that do directly affect activity. In this regard the sites
phosphorylated by GSK3 are of particular interest, as this kinase can be considered
a hub in signal transduction, regulating several downstream processes. We postu-
late that the multiple GSK3 sites on GS function to calibrate the response of GS to
changes in the activity of GSK3. The allosteric regulation of GS also appears to be
multifaceted. Not only is the enzyme’s activity directly influenced by its allosteric
modifiers, its sub-cellular and nucleocytoplasmic distribution is also affected. More-
over, the allosteric and covalent regulation of GS is tightly intertwined. It is clear
that no discussion of the covalent regulation of GS is complete without mention of
its effect on G6P activation, and no treatment of its allosteric regulation is complete
without also considering its effect on phosphorylation. Part of the function of either
regulatory mechanism, it seems, is to regulate the other.
There is no a priori reason why covalent and allosteric modification of an enzyme
should be considered to be qualitatively different. In fact, both kinds of interaction
are, as it were, allosteric; in either case the enzyme’s activity is affected by modifiers
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binding (whether covalently, or through ionic or hydrophobic interactions) to a site
other than the catalytic site. Notwithstanding, earlier studies on GS kinetics were
usually entirely devoted to either the I or D form, with little attempt to sketch an inte-
grated view. In an effort to remedy this situation, we here proposed a unifying view
of GS regulation in which covalent modification is considered to be qualitatively
identical to classic allosteric modification as per the MWC model. This is indeed the
standard depiction of the regulation of GS in textbooks: phosphorylation favours an
inactive T conformation, whereas G6P favours the active R conformation. However,
to our knowledge, this model has never been applied in a kinetic treatment of GS
and its implications for the function of the extensive phosphorylation of GS has not
been considered. Our own endeavours in this regard is the theme of the next chap-
ter. A major advantage of this model is that it eliminates the need to determine the
kinetic parameters for GS in all its possible phosphorylation states, leaving only the
requirement to establish the relationship between a particular phosphorylation state
and L the equilibrium constant between the T and R conformers in the absence of
ligands.
We have discussed the function of G6P as a feedforward activator of GS and sug-
gested that this feedforward mechanism plays a role in G6P homeostasis in that it
increases the response of the flux local to the glycogen synthesis pathway to G6P.
One reason for this elevated response is the fact that G6P binds cooperatively to
GS. In the unifying model of GS regulation that we here propose, both ATP (h in
Fig. 2.5C) and phosphorylation (h in Fig. 2.5A) increase the degree of G6P binding
cooperativity and are thus expected to enhance the response of the glycogen synthe-
sis pathway to G6P. If the feedforward loop is indeed a mechanism of G6P homeo-
stasis, then physiological concentrations of ATP, as demonstrated by Piras et al. [67],
and phosphorylation should be expected to enhance G6P homeostasis.
The model we propose here has interesting implications regarding the relative
importance of allosteric and covalent regulation. Using knock-in mice in which GS
was desensitized to G6P, Bouskila et al. [18] recently reported that allosteric, and
not covalent, regulation is the major mechanism by which insulin activates glycogen
synthesis. From Fig. 2.5A it is clear that if GS is desensitized to activation by G6P,
i.e., if arrow (a) is removed, several functions of phosphorylation also disappear (h,
g), leading to a possible underestimation of the importance of phosphorylation. In
particular, only the direct effect of phosphorylation on the activity of GS would be
observed, but its role in increasing the sensitivity of GS towards G6P would be ne-
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glected. Similarly, if one were to remove the phosphorylation sites on GS, the func-
tion of G6P to inhibit phosphorylation is obscured. It is our opinion that mathemat-
ical modelling and metabolic control analysis (MCA) [10, 11] could provide insights
into the relative contributions of allosteric and covalent regulation towards the ac-
tivation of GS, if indeed these contributions can be considered in isolation. It could
also provide valuable insights regarding the regulatory design of muscle glycogen
metabolism and its involvement in the onset of insulin resistance. One of the cen-
tral aims of MCA is to relate properties of individual enzymes to global pathway
responses. It is therefore essential to obtain a quantitative grasp of the precise effects
of regulation on the kinetics of GS, a grasp that can only be obtained by returning
to enzyme kinetics. We thus echo the call by Jensen & Lai [5] for a detailed quanti-
tative investigation of the effects of allosteric and covalent regulation on the kinetic
properties of GS.
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Chapter 3
Development of a glycogen synthase
rate equation
3.1 Introduction
In the previous chapter, borrowing the terminology of the Hill model, we discussed
the kinetics and regulation of glycogen synthase (GS) in detail. The Hill model is in-
dependent of the kinetic mechanism and mechanism of cooperativity of the enzyme
it describes and its parameters have clear operation meanings. We argued that the ef-
fects of allosteric and covalent regulation of GS on its kinetic parameters, as defined
by the Hill model, are consistent with an Monod-Wyman-Changeux (MWC)-type
model in which not only allosteric modification, but also covalent modification, al-
ters the equilibrium constant, L0, between the classic T and R conformations. In this
chapter we set out to develop a rate equation for GS based on such a MWC-type
model. Considering only the interconversion between GS phosphorylation states, a
general form of the rate equation is provided. Several specific forms are then pro-
posed for the rate equation, based on the observed GS kinetics. Parameter optimiza-
tion is used to determine which forms provide the best description of experimental
kinetic data. Finally, we investigate the relationship between L0 and the fractional
velocity and show how L0 can be determined from the fractional velocity.
3.2 Phosphorylation states
The total number of distinct phosphorylation states, s, for a protein subunit with n
phosphorylation sites grouped together in the same phosphorylation cluster that are
53
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phosphorylated randomly is given by the function
s = 2n (3.1)
In the case of strict sequential phosphorylation and dephosphorylation, the number
of states is given by
s = n + 1 (3.2)
Since several independent phosphorylation clusters, some randomly phosphory-
lated and some sequentially phosphorylated, can be present on a subunit, the total
number of states is the product of states in each cluster
s =∏
i
si (3.3)
where i denotes a particular phosphorylation cluster.
Let C22a, C543abc, C1a, and C1b designate the four phosphorylation clusters of GS
(subscripts indicate the phosphorylation sites in each cluster). According to Eq. 3.3,
and assuming random phosphorylation for the sites in each cluster, the number of
phosphorylation states for a single GS subunit is
s = sC22a · sC543abc · sC1a · sC1b (3.4)
= 22 · 25 · 2 · 2 (3.5)
= 29 (3.6)
= 512 (3.7)
Assuming strict sequential phosphorylation and dephosphorylation, on the other
hand, the number of phosphorylation states per GS subunit is
s = sC22a · sC543abc · sC1a · sC1b (3.8)
= (2+ 1)(5+ 1)(1+ 1)(1+ 1) (3.9)
= 72 (3.10)
As discussed earlier, the majority of evidence suggests, however, that GS is a
tetramer. The number of states for a random mechanism and sequential mechanism
is then respectively 5124 and 724. But if it is assumed, as in the MWC-model, that
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the four subunits are equivalent and that enzyme forms to which the same number
and type of ligand (and thus also covalent bonds) are bound are kinetically equiv-
alent, the number of kinetically distinct states decreases dramatically. Granted this
assumption, the number of kinetically distinct states for an enzyme with m sub-
units and n phosphorylation sites grouped in the same cluster and phosphorylated
randomly (assuming phosphorylation at all sites affect the kinetics) is given by the
function
s = (m + 1)n (3.11)
In the case of sequential phosphorylation, on the other hand, the number of states
is given by the formula for the (n+ 1)th element of the r-topic numbers (the numbers
in the (r + 1)th diagonal of Pascal’s Triangle) with r = m:
s =
(n + 1)(m)
m!
(3.12)
where (n + 1)(m) is the rising factorial. Setting m = 1, Eqs. 3.11 and 3.12 simplify
to Eqs. 3.1 and 3.2 as expected. As before, if multiple phosphorylation clusters can
exist per subunit, the number of states is given by the product of the states for each
cluster (Eq. 3.3).
Assuming a random phosphorylation mechanism, the number of kinetically dis-
tinct states in which tetrameric GS (m = 4) can exist is
s = sC22a · sC543abc · sC1a · sC1b (3.13)
= (4+ 1)2 · (4+ 1)5 · (4+ 1) · (4+ 1) (3.14)
= 59 (3.15)
= 1953125 (3.16)
and for a sequential mechanism
s = sC22a · sC543abc · sC1a · sC1b (3.17)
=
3× 4× 5× 6
4!
· 6× 7× 8× 9
4!
· 2× 3× 4× 5
4!
· 2× 3× 4× 5
4!
(3.18)
= 15× 126× 5× 5 (3.19)
= 47250 (3.20)
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Figure 3.1: Interconversion between 18 GS phosphorylation states. Phosphorylation within
each phosphorylation cluster is assumed to proceed strictly sequentially. Phosphorylation
of sites 1a and 1b is neglected.
Finally, if sites 1a and 1b, which do not significantly affect GS activity, are ne-
glected the numbers of GS states for a random and sequential mechanism decrease
to 57 and 1890 respectively. Still, regardless of whether a random or sequential
phosphorylation mechanism is considered, it is by no means feasible to develop a
single MWC-type equation that will incorporate all the phosphorylation states of
tetrameric GS. Neither is it feasible to model the interconversion between these states
with the appropriate kinase and phosphatase reactions. In the present treatment of
GS kinetics, we have therefore decided on the following simplifying assumptions:
1) both phosphorylation and dephosphorylation of all the phosphorylation clusters
proceed strictly sequentially, 2) phosphorylation at each site is all-or-nothing, that is,
if for instance site 2 is phosphorylated, it is simultaneously phosphorylated on all
four subunits. The same holds for dephosphorylation. 3) Sites 1a and 1b are ne-
glected, because phosphorylation at these sites does not result in kinetically distinct
phosphorylation states. Although sites 5, 4, 3c, and 3b also have little effect on GS
kinetics, they are included, because they are required for phosphorylation at site 3a.
Given these assumptions, GS is modelled as existing in only (2+ 1)(5+ 1) = 18
states . Even though these 18 states are the result of simplifying assumptions, they
represent a subset of the total number of possible states and are therefore real phos-
phorylation states in which GS can exist. Indeed many of these states have been the
subject in site-directed mutagenesis and sequential phosphorylation studies. Kinetic
data, albeit limited, are therefore available for some of these states. Moreover, kinetic
data for the interconversion between some of these states are also available.
With 18 phosphorylation states it is feasible to explicitly model the interconver-
sion between the states with separate kinase and phosphatase reactions (Fig. 3.1).
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Unlike for the allosteric modification of GS, there will therefore be no explicit terms
for covalent modification in the GS rate equation. As we have chosen to represent
each phosphorylation state as a separate species, the general form of the GS rate
equation is the sum of the rates of all the GS states:
v =∑
i
vi (3.21)
where i is a particular phosphorylation state. In the next section, several models
of allosterism and cooperativity are considered in order to arrive at an appropriate
expression for vi.
3.3 Kinetic models
Based on the detailed review of GS kinetics in the previous chapter, the following
assumptions are made:
• GS is a tetrameric enzyme
• reagents bind according to a random order bi-bi mechanism, but due to glyco-
gen saturation the mechanism simplifies to a uni-reactant mechanism
• glycogen binding is non-cooperative or, equivalently, infinitely negatively co-
operative
• UDP-glucose (UDPG) binding is non-cooperative in the absence of inhibitors
• glucose-6-phosphate (G6P) is an allosteric activator that binds cooperatively to
the phosphorylated enzyme
• G6P activation could be catalytic or specific, or both catalytic and specific
• ATP is an allosteric inhibitor that binds cooperatively to the dephosphorylated
enzyme
• ATP is a specific inhibitor, but the inhibition could also have a catalytic com-
ponent
• ATP and G6P compete for the same allosteric site, but the possibility that they
bind to different sites cannot be ruled out
• ATP possibly competes with UDPG at the active site
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Hill model
We have stated previously that the Hill model does not describe the kinetics of GS
adequately. Here we will show more concretely why this is indeed the case. Adapt-
ing the Hill-type equation proposed earlier (Eq. 2.4) to also allow for the possibility
that ATP could be a catalytic inhibitor, to reflect which parameters depend on the
phosphorylation state, and setting h = 1, an expression for vi can be written as
vi = kcati · [E]toti · µcati ×
σi
µspeci + σi + pii
×
(
1− Γ
Keq
)
(3.22)
where
µcati =
1+ γG6Pi · αG6Pi · ξhG6PiG6Pi + γATPi · αATPi · ξ
hATPi
ATPi
1+ αG6Pi · ξhG6PiG6Pi + αATPi · ξ
hATPi
ATPi
(3.23)
and
µspeci =
(
1+ ξ
hATP′ i
ATP′ i
) 1+ ξhG6PiG6Pi + ξhATPiATPi
1+ αG6Pi · ξhG6PiG6Pi + αATPi · ξ
hATPi
ATPi
 (3.24)
where kcat is the catalytic constant; [E]tot is the total GS concentration; σ =
[UDPG]
UDPG0.5
;
pi = [UDP]UDP0.5 ; ξG6P =
[G6P]
G6P0.5
; ξATP =
[ATP]
ATP0.5
; ξATP′ =
[ATP]
ATP′0.5 ; UDPG0.5, UDP0.5, G6P0.5,
ATP0.5, and ATP′0.5 are the UDPG, UDP, G6P, allosteric site ATP, and catalytic site
ATP half-saturation concentrations in the absence of other ligands; γG6P > 1 is the
degree of G6P catalytic activation; γATP < 1 is the degree of ATP catalytic inhibition;
αG6P > 1 and αATP < 1 are reactant-modifier interaction factors; hG6P is the degree of
G6P binding cooperativity; hATP and hATP′ are the degrees of ATP binding coopera-
tivity at the allosteric and catalytic sites, respectively; Γ = [UDP]
[UDPG] is the mass-action
ratio; and Keq is the equilibrium constant. Parameters that depend on the phospho-
rylation state are indicated with the subscript i. Note that [E]toti is not a parameter,
but a variable species concentration.
In order to describe the kinetics of all 18 GS phosphorylation states a total of 253
parameters are required (14 phosphorylation-dependent parameters per state plus
one phosphorylation-independent parameter). Obtaining values for this multitude
of parameters from the limited kinetic data that are available is, however, not feasi-
ble.
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The number of parameters can be slightly reduced by considering that, in the
absence of ATP, saturating G6P appears to completely overcome the effect of phos-
phorylation on kcat and UDPG0.5, i.e., the apparent kcat and UDPG0.5 at saturating
G6P have constant values that are independent of the phosphorylation state i:
kcatapp = γG6Pi · kcati (3.25)
and
UDPG0.5app = UDPG0.5i/αG6Pi (3.26)
Rewriting these equations to have γG6Pi and αG6Pi on the left hand side and sub-
stituting in Eq. 3.22 results in an equation with two more phosphorylation-indepen-
dent parameters and two fewer parameters per state, decreasing the number of pa-
rameters to 219. Introducing similar constraints for ATP, which is harder to justify,
further decreases the number of parameters to 185. However, even considering this
reduced number of parameters, we have not been able to find a rich enough experi-
mental data set in the literature that would allow fitting these parameters.
A more serious impediment to the application of the Hill model to GS kinetics,
regardless of whether a rich enough experimental data set can be obtained, is its
inability to account for variations in the degree of cooperativity (heterotropic coop-
erativity). It is well-established that G6P increases the degree of cooperativity with
which ATP binds to GS, and the other way around. In an attempt to remedy this
shortcoming, it has been proposed [150] that the Hill coefficient for a particular lig-
and be expressed as a function of the heterotropic ligand that alters it (assuming a
hyperbolic relationship):
happ = h
(
1+ βξ
1+ ξ
)
(3.27)
where ξ = x/x0.5; x and x0.5 are the heterotropic ligand concentration and half-
saturation concentration; and β is the factor by which h is multiplied at saturating x.
Given that both G6P and ATP bind cooperatively to GS, one would, however, expect
a sigmoidal relationship, but a sigmoidal relationship would result in the mutually
recursive expression of hG6Papp in terms of hATPapp:
hG6Papp = hG6P
(
1+ βξhATPapp
1+ ξhATPapp
)
(3.28)
Stellenbosch University  http://scholar.sun.ac.za
CHAPTER 3. DEVELOPMENT OF A GLYCOGEN SYNTHASE RATE EQUATION 60
where
hATPapp = hATP
(
1+ βξhG6Papp
1+ ξhG6Papp
)
(3.29)
These forms would be even more complicated if they also reflected the competi-
tion between ATP and G6P. Unless it can be shown that the dependence of the Hill
coefficient for each ligand on the concentration of the other ligand is hyperbolic, we
would not consider this approach to be workable, especially since two additional
parameters, possibly depending on the phosphorylation state, would have to be in-
troduced.
Monod-Wyman-Changeux model
The MWC model is probably the best-known model of cooperativity and allosterism.
In the MWC model all n subunits of an enzyme are simultaneously in either the T or
R conformation. The conversion of all subunits from one to the other conformation
is thus concerted. The equilibrium ratio of the concentration of unliganded enzyme
in the T conformation to that in the R conformation is given by L0, the allosteric
constant. Any ligand that preferentially binds to a particular conformation will by
necessity shift the equilibrium between the liganded T and R conformations in the
direction of the preferred conformation and thus appear to alter L0. The subsequent
binding of another ligand of the same or different type will therefore be enhanced,
as the proportion of enzyme in this conformation is increased, thus giving rise to
homotropic cooperativity. The subsequent binding of a different ligand that prefers
the opposite conformation would, on the other hand, be hindered. There is, how-
ever, a greater potential for the second ligand to alter the equilibrium in favour of
the opposite conformation, thus giving rise to heterotropic cooperativity.
Another attractive feature of the MWC model is that it describes cooperativity
on a per ligand basis, even allowing complete non-cooperative binding for some
ligands while others still bind cooperatively. There is no single parameter, as in the
Hill model, that describes cooperativity. Instead the degree of cooperativity depends
on L0, the allosteric constant, n, the number of subunits, and on the relative affinities
of the two conformations for a particular ligand. Consider the simple irreversible
MWC equation for an enzyme with an allosteric modifier:
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v =
Vmaxtnσt (1+ σt)
n−1 L0
(
1+ ξt
1+ ξr
)n
+Vmaxrnσr (1+ σr)
n−1
(1+ σt)
n L0
(
1+ ξt
1+ ξr
)n
+ (1+ σr)
n
(3.30)
where t and r denote enzyme in the T and R conformations; σ = s/Ks; ξ = x/Kx; s
and x are the substrate and modifier concentrations; Ks and Kx are intrinsic dissocia-
tion constants; and L0 is the allosteric constant. Both conformations are catalytically
active and substrate is allowed to bind to either the T or R conformation. Setting
n = 1 results in
v =
VmaxtσtL0
(
1+ ξt
1+ ξr
)
+Vmaxrσr
(1+ σt) L0
(
1+ ξt
1+ ξr
)
+ (1+ σr)
(3.31)
thereby abolishing cooperativity with respect to all ligands, regardless of the values
of L0 or the relative affinities of the two conformations for any particular ligand.
Similarly, setting L0 = 0, or letting L0 → ∞ results in
v =
Vmaxnσ (1+ σ)
n−1
(1+ σ)n
(3.32)
=
Vmaxnσ
1+ σ
(3.33)
thereby abolishing all cooperativity and modifier effects. Cooperativity is observed
for all other values of L0, with the maximum degree of cooperativity with respect to
a particular ligand occurring when L0 =
√
(Kt/Kr)n. Alternatively, setting σ = σr =
σt, i.e., assuming that substrate binds equally well to the T and R conformations,
results in
v =
VmaxtnσL0
(
1+ ξt
1+ ξr
)n
+Vmaxrnσ
(1+ σ) L0
(
1+ ξt
1+ ξr
)n
+ (1+ σ)
(3.34)
In this form of the equation substrate binds non-cooperatively while cooperativity
with respect to the allosteric modifier remains unaffected. The situation is slightly
more complicated when ligands compete for the same site. Supposing that the mod-
ifier binds to the catalytic site, instead of the allosteric site, alters Eq. 3.34 to
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v =
Vmaxtnσ (1+ σ+ ξt)
n−1 L0 +Vmaxrnσ (1+ σ+ ξr)
n−1
(1+ σ+ ξt)
n L0 + (1+ σ+ ξr)
n (3.35)
showing that substrate binds cooperatively, but only in the presence of modifier.
Appreciation for the per-ligand description of cooperativity in the MWC model
is often lost due to the assumption, which is practically always made, that substrate
only binds to the R conformation (σt = 0), essentially forcing the condition σt 6= σr,
so that substrate binding is always cooperative. Indeed, the supposed inability of the
MWC model to describe non-cooperative substrate binding has been put forward as
an argument against its applicability to GS kinetics [67].
As for the Hill model, an expression for vi according to the MWC model could
be formulated by considering each of the 18 phosphorylation states of GS to be de-
scribed by a different set of parameter values. This would mean that each phos-
phorylation state is in equilibrium between a T and R conformation, but that T and
R conformations in different states are not necessarily kinetically identical. There
would thus be 18 possibly unique T conformations and R conformations. But we
here run into the same problems as with the Hill model: a separate set of parameter
values, with the exception of n and Keq, will have to be obtained for each phos-
phorylation state. A simple solution entails treating all T conformations and all R
conformations, regardless of phosphorylation states, as identical, but allowing each
phosphorylation state to have a different value for L0. In other words, a single T and
R conformation is shared by all the phosphorylation states, but for each state the
equilibrium T/R ratio will be potentially different. This simplification decreases the
number of parameters significantly, as only L0 and the concentration of the enzyme
in a particular state will vary with phosphorylation. All other parameters have the
same values, regardless of phosphorylation state.
Not only does the number of parameters decrease, but by treating covalent mod-
ification as equivalent to classic MWC-type allosteric modification, i.e., as an appar-
ent change to the value of L0 (albeit explicit in the case of covalent modification)
it becomes possible to describe the experimentally observed changes in cooperativ-
ity with respect to G6P and ATP resulting from phosphorylation. In particular, if
phosphorylation increases the apparent value of L0, it will increase cooperativity
with respect to G6P by virtue of decreasing the concentration of the conformation
preferred by G6P. Conversely, phosphorylation will decrease the degree of cooper-
ativity with respect to ATP binding. Admittedly, these phenomena would also be
observed without assuming that all T conformations and all R conformations are
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identical, but not making this assumption runs contrary to the central assumption
of the MWC model that ligands do not affect the kinetics of any conformation, but
rather affect the apparent equilibrium concentrations of conformations.
We will now proceed to investigate particular forms of the MWC equation, but let
us first consider a generic form from which more specific forms can be obtained. The
reversible uni-substrate MWC equation for an enzyme with n subunits, an arbitrary
number of active site competitive inhibitors, allosteric sites, and ligands competing
per allosteric site is given by [156, 157]:
v =
Vmaxtnσt
(
1+ σt + pit +∑
j
ξtj
)n−1
L0∏
k
(
1+∑
l
ξtkl
)n
+
Vmaxrnσr
(
1+ σr + pir +∑
j
ξrj
)n−1
∏
k
(
1+∑
l
ξrkl
)n
(
1+ σt + pit +∑
j
ξtj
)n
L0∏
k
(
1+∑
l
ξtkl
)n
+(
1+ σr + pir +∑
j
ξrj
)n
∏
k
(
1+∑
l
ξtkl
)n
×
(
1− Γ
Keq
)
(3.36)
where t and r indicate parameters pertaining to the T and R conformations; j indi-
cates a particular non-reactant catalytic site ligand; k indicates a particular allosteric
site; l indicates a particular ligand that binds to allosteric site k; σ = s/Ks; pi = p/Kp;
ξ = x/Kx; s, p, and x are substrate, product and modifier concentrations; Ks, Kp, and
Kx are intrinsic dissociation constants; L0 is the equilibrium ratio of unliganded en-
zyme in the T conformation to unliganded enzyme in the R conformation; Γ = p/s
is the mass-action ratio; and Keq is the equilibrium constant.
We considered several specific forms of Eq. 3.36 in order to obtain the most ap-
propriate expression for vi. In each case the enzyme was assumed to be a tetramer,
i.e. n = 4. Furthermore, although we do not consider GS to be irreversible, we were
unable to find an appropriate data set in which UDP is varied; we therefore only con-
sidered irreversible forms of Eq. 3.36. When applying Eq. 3.36 to the case of GS, the
observation that saturating G6P concentrations do not completely reverse inhibition
by ATP can be described in two ways. In the first description it is assumed that G6P
and ATP compete for the same allosteric site, but that ATP also binds to the catalytic
site in competition with the substrate UDPG, yielding the equation (DepCom):
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vi =
Vmaxtnσt
(
1+ σt + ξATP′ t
)n−1
L0i
(
1+ ξG6Pt + ξATPt
1+ ξG6Pr + ξATPr
)n
+
Vmaxrnσr
(
1+ σr + ξATP′ r
)n−1
(
1+ σt + ξATP′ t
)n
L0i
(
1+ ξG6Pt + ξATPt
1+ ξG6Pr + ξATPr
)n
+(
1+ σr + ξATP′ r
)n
(3.37)
The MWC equation is often simplified by adopting the assumption that substrate
is unable to bind to the T conformation, i.e., σt = 0. However, as discussed above,
this assumption only allows for strong cooperativity with respect to substrate bind-
ing, whereas in the case of GS only mild or no cooperativity is observed for UDPG
binding. Alternatively, if it is assumed that only the R conformation exhibits any
catalytic activity, i.e., Vmaxt = 0, a much simpler form, but one which allows for mild
or no substrate cooperativity, is obtained (terms that disappear as a result of this and
subsequent assumptions are shown in gray, DepComR):
vi =
Vmaxtnσt
(
1+ σt + ξATP′ t
)n−1
L0i
(
1+ ξG6Pt + ξATPt
1+ ξG6Pr + ξATPr
)n
+
Vmaxrnσr
(
1+ σr + ξATP′ r
)n−1
(
1+ σt + ξATP′ t
)n
L0i
(
1+ ξG6Pt + ξATPt
1+ ξG6Pr + ξATPr
)n
+(
1+ σr + ξATP′ r
)n
(3.38)
For the case in which ATP does not bind to the catalytic site, but still competes
with G6P for the allosteric site (setting ξATP′ r = 0 and ξATP′ t = 0) Eq. 3.37 simplifies
to (Dep)
vi =
Vmaxtnσt
(
1+ σt+ ξATP′ t
)n−1
L0i
(
1+ ξG6Pt + ξATPt
1+ ξG6Pr + ξATPr
)n
+
Vmaxrnσr
(
1+ σr + ξATP′ r
)n−1
(
1+ σt + ξATP′ t
)n
L0i
(
1+ ξG6Pt + ξATPt
1+ ξG6Pr + ξATPr
)n
+(
1+ σr + ξATP′ r
)n
(3.39)
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and, further, if Vmaxt = 0 (DepR):
vi =
Vmaxtnσt
(
1+ σt + ξATP′ t
)n−1
L0i
(
1+ ξG6Pt + ξATPt
1+ ξG6Pr + ξATPr
)n
+
Vmaxrnσr
(
1+ σr + ξATP′ r
)n−1
(
1+ σt + ξATP′ t
)n
L0i
(
1+ ξG6Pt + ξATPt
1+ ξG6Pr + ξATPr
)n
+(
1+ σr + ξATP′ r
)n
(3.40)
We also considered the case in which UDPG binds equally well to the T and R
conformations in the absence of other ligands, i.e. σ = σr = σt, resulting in the
equation (DepComNoSpec):
vi =
Vmaxtnσ
(
1+ σ+ ξATP′ t
)n−1
L0i
(
1+ ξG6Pt + ξATPt
1+ ξG6Pr + ξATPr
)n
+
Vmaxrnσ
(
1+ σ+ ξATP′ r
)n−1
(
1+ σ+ ξATP′ t
)n
L0i
(
1+ ξG6Pt + ξATPt
1+ ξG6Pr + ξATPr
)n
+(
1+ σ+ ξATP′ r
)n
(3.41)
or if only the R conformation is active (DepComNoSpecR):
vi =
Vmaxtnσ
(
1+ σ+ ξATP′ t
)n−1
L0i
(
1+ ξG6Pt + ξATPt
1+ ξG6Pr + ξATPr
)n
+
Vmaxrnσ
(
1+ σ+ ξATP′ r
)n−1
(
1+ σ+ ξATP′ t
)n
L0i
(
1+ ξG6Pt + ξATPt
1+ ξG6Pr + ξATPr
)n
+(
1+ σ+ ξATP′ r
)n
(3.42)
In the second description, incomplete reversal of inhibition by ATP in the pres-
ence of saturating G6P is obtained by assuming that G6P and ATP do not in fact bind
to same allosteric site, obviating the need to allow for ATP binding at the catalytic
site (Independent):
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Table 3.1: Summary of different MWC-type equations and assumptions considered as can-
didate GS rate equations.
Equation Independent
allosteric ligand
binding
ATP catalytic
site inhibition
σr = σt Active T
state
Dep X
DepR
DepCom X X
DepComR X
DepComNoSpec X X X
DepComNoSpecR X X
Independent X X
IndependentR X
vi =
Vmaxtnσt
(
1+ σt
)n−1
L0i
(
1+ ξG6Pt
1+ ξG6Pr
)n (1+ ξATPt
1+ ξATPr
)n
+
Vmaxrnσr
(
1+ σr
)n−1
(
1+ σt
)n
L0i
(
1+ ξG6Pt
1+ ξG6Pr
)n (1+ ξATPt
1+ ξATPr
)n
+
(
1+ σr
)n (3.43)
Further assuming, as before, that only the R conformation is active yields (Indepen-
dentR):
vi =
Vmaxtnσt
(
1+ σt
)n−1
L0i
(
1+ ξG6Pt
1+ ξG6Pr
)n (1+ ξATPt
1+ ξATPr
)n
+
Vmaxrnσr
(
1+ σr
)n−1
(
1+ σt
)n
L0i
(
1+ ξG6Pt
1+ ξG6Pr
)n (1+ ξATPt
1+ ξATPr
)n
+
(
1+ σr
)n (3.44)
To simplify reference to the eight cases considered above, we adopt the terminol-
ogy summarized in Table 3.1.
3.4 Parameter optimization
Experimental data
In order to use Eq. 3.21 in parameter optimization, it is necessary to have knowledge
of all the phosphorylation states and the concentrations at which they were present
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in the assay used to obtain the experimental results. We have not been able to obtain
an experimental data set from the literature in which both the exact phosphoryla-
tion states were known and in which the assay was repeated for all the conditions
that would allow parameter optimization for any of the kinetic models proposed.
However, we have been able to show that, for any of the MWC-type kinetic models,
Eq. 3.21 can be rewritten as a single term, as opposed to a sum, that takes on the
form of vi, as defined for the particular kinetic model, but with L0, which replaces
L0i, as a function of the concentrations of the GS phosphorylation states and the L0i
values for all the states (see Appendix A.1). In this form, if L0 is treated as a param-
eter, it is not necessary to know in which phosphorylation states GS is present or
at what concentrations. The only remaining requirement is that experimental data
must be available for both extensively dephosphorylated and extensively phospho-
rylated enzymes states. In order to obtain values for the parameters of Eqs. 3.37 to
3.44, the enzyme must also be assayed for a range of UDPG, G6P, and ATP concen-
trations.
Exploiting the sequential and hierarchical phosphorylation of GS, various states
of the C543 [107, 120] and C22a [106] clusters have been assayed. However, as these
studies did not have a complete kinetic characterization of GS kinetics as goal, the
states were assayed at a single UDPG concentration and at only two G6P concen-
trations. Inhibition by ATP was also not considered. On the other hand, others like
Sølling [42] assayed GS in the presence of several allosteric modifiers at various con-
centrations, but only considered a particular phosphorylation state.
The kinetic characterization of rat muscle GS by Piras et al. [39, 67] provides, to
our knowledge, the only experimental data set in which GS was assayed at varying
substrate, product, activator, and inhibitor concentrations for both the dephospho-
rylated (I form) and phosphorylated (D form) enzyme. Parameters for the various
candidate definitions of vi were therefore fitted to this data set. Note that the exact
composition of the two enzyme forms in terms of phosphorylation state is unknown,
but, judging by the ratio of activity in the absence and presence of 10 mM G6P, the I
form (0.75–1) was essentially dephosphorylated, whereas the D form (0.05–0.15) was
extensively phosphorylated.
There are a few shortcomings in using this data set. First, the enzyme concentra-
tions used in the assays are unknown; it is thus not possible to obtain values for kcat.
Second, the dependence of activity on the concentration of UDPG at different ATP
concentrations for the two phosphorylation states are represented as Lineweaver-
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Burk plots. Using data linearized according to this transformation in parameter
optimization increases the error in parameter values. To minimize this error and
also to avoid forcing hyperbolic kinetics on UDPG binding, we chose to reverse this
linearization, but in so doing ran the risk of enlarging any error introduced during
the digitization of the data. Third, the exact x coordinates of many data points are
unknown, so that error is introduced in both the x and y coordinates during digiti-
zation. Fourth, Piras et al. [39] considered the D form to be contaminated with 10%
of the I form and therefore applied a correction to the D form data. Their conclusion
was probably based on the misconception that the D form is entirely dependent on
G6P; they therefore ascribed any observed activity in the absence of G6P to contami-
nation with I form. We have not attempted to reverse this correction, but expect that
it will only affect the value of L0. Since no L0 value fitted to the data of Piras et al. [67]
corresponds to a known phosphorylation state, error in this value is not a concern.
Data points were extracted from the graphs in [67] with the program Engauge Dig-
itizer (http://digitizer.sourceforge.net). High-resolution PNG images of the graphs
were obtained from a PDF version of the paper. These images were imported into
Engauge individually and zoomed to an appropriate size. The coordinates for each
data point were set manually at what was judged to be the centre of the associated
symbol. Where values were clearly given in the text, digitized x coordinates were
adjusted accordingly.
Methods
Algorithm and weighting
The Levenberg-Marquardt algorithm [158] was used to minimize the sum of squared
residuals S:
S =
n
∑
i=1
r2i (3.45)
where r2i = (vi − vˆi)2, with v the observed rate and vˆ the rate calculated from the
rate equation.
We found this algorithm to be considerably faster than global optimization al-
gorithms such as simulated annealing (SciPy, http://www.scipy.org) or particle swarm
[159], but it is less likely to find the global minimum. To increase the likelihood of
obtaining a global minimum, we seeded each optimization with random initial pa-
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rameter values for 1000 repetitions. This method does, however, not guarantee that
a global minimum is found. To avoid the assignment of negative parameter values,
all parameters were constrained to be positive (> 1× 10−25).
Separate Vmax values were fitted for the four data sets, as the concentrations of I
and D form are unknown and unlikely to be equal. Moreover, it is not clear whether
the same enzyme concentration was used in assays in which UDPG or G6P was
varied, even for the same enzyme form. Separate values were also fitted for L0 for
enzyme in the I and D forms.
Each residual should ideally be weighted by the standard deviation of the ob-
served rate so that data points with greater error contribute less towards S. As no
information is available regarding the error in the data sets of Piras et al. [67], we
considered two weighting strategies: scaled residuals and half-scaled residuals. In the
first the residuals are normalized by the calculated rate vˆ before squaring:
r2i =
(
vi − vˆi
vˆi
)2
(3.46)
In the second the residuals are essentially weighted by the square root of the calcu-
lated rate and then squared:
r2i =
(vi − vˆi)2
vˆi
(3.47)
The appropriate weighting strategy was chosen, as discussed later, by inspection of
residuals plots.
Statistics
The coefficient of determination, R2, the adjusted coefficient of determination, R¯2,
and the F-statistic were used to identify the best-fit equation. R¯2 is a variant of R2
that is adjusted for the number of observations and parameters:
R¯2 = 1− (1− R2) n− 1
n− p− 1 (3.48)
The F-statistic was calculated according to the formula
F =
(
Sspec − Sgen
pgen − pspec
)(
n− pgen
Sgen
)
(3.49)
where S is the sum of squared residuals; n is the number of observations; p is the
number of parameters; and gen and spec distinguish between the more generic and
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the more specific rate equation. The critical F-value with degrees of freedom pgen −
pspec and n − pgen for p = 0.01 was obtained from a table. The null hypothesis
was that the more generic equation does not provide a significantly better fit than
the more specific equation. The null hypothesis was rejected if the F-statistic was
greater than the critical F-value. In cases where the null hypothesis was rejected or
R¯2 had a lower value for the more generic equation, the more specific equation was
considered the best-fit equation.
Software
The optimization was carried out using a combination of Python programming lan-
guage modules: NumPy (http://numpy.scipy.org) and SciPy for numeric procedures;
LMfit-py (http://newville.github.com/lmfit-py), a wrapper around the SciPy im-
plementation of the Levenberg-Marquardt algorithm with added support for con-
straints; and matplotlib (http://matplotlib.org) for visualization. IPython [160] was
used as an interactive shell for Python. IPython’s built-in support for parallel com-
puting was used to speed up optimizations.
To ease the optimization procedure, we developed an extensible optimization
framework as a Python module that interfaces with the above modules. This frame-
work will be discussed in detail elsewhere. Briefly, the framework was developed to
be independent of the format of experimental data, optimization algorithm, weight-
ing strategy, calculation of the predicted rate (whether using an equation or a simu-
lation environment like PySCeS), and output format. In each case a sensible default
is provided, but custom implementations can easily be substituted.
Results
In all cases, regardless of the weighting strategy employed, and despite some equa-
tions providing fits with high R2 values, the parameter error estimates of the rate
equations in which both the T and R conformations were allowed to exhibit catalytic
activity were very large or no error estimates could be calculated due to some pa-
rameters violating the constraint, > 1× 10−25. Only those rate equations that limit
activity to the R conformation (DepComR, DepR DepComNoSpecR, IndependentR)
were therefore considered.
In the case where no weighting strategy was applied, DepComR had the highest
R2 value (Table 3.2), but did not provide a significantly better fit than DepCom-
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Table 3.2: Optimized kinetic parameters obtained using no weighting strategy
DepComR DepR DepComNoSpecR IndependentR
Parameter value error value error value error value error
R2 0.9477 – 0.90894 – 0.94763 – 0.93728 –
R¯2 0.93918 – 0.89652 – 0.9398 – 0.92872 –
KUDPGr 0.98 0.29 2.82 1.14 1.07 0.13 0.84 0.13
KUDPGt 1.06 0.13 2.05 0.59 – – 1.46 0.22
KG6Pr 7.12 · 10−2 2.19 · 10−2 0.14 5.08 · 10−2 7.95 · 10−2 2.23 · 10−2 0.17 2.72 · 10−2
KG6Pt 0.23 0.11 0.16 6.8 · 10−2 0.23 8.1 · 10−2 0.6 0.12
KATPr 4.92 2.47 7.33 5.04 5.72 2.8 26.2 16.67
KATPt 2.28 1.17 2.13 0.94 2.59 0.96 3.21 0.82
K′ATPr 25.42 11.89 – – 29.12 15.13 – –
K′ATPt 6.44 2.69 – – 6.69 1.78 – –
LI0 0.45 0.16 0.24 0.12 0.38 0.12 0.69 0.24
LD0 13.21 6.98 1.64 · 106 6.03 · 1011 10.21 4.29 7.61 3.33
VI;G6Pr 0.65 0.14 1.61 0.61 0.69 6.62 · 10−2 0.58 6.17 · 10−2
VD;G6Pr 0.54 9.09 · 10−2 8.73 · 105 3.21 · 1011 0.59 9.01 · 10−2 0.44 4.79 · 10−2
VI;UDPGr 0.52 0.13 0.86 0.27 0.54 5.23 · 10−2 0.43 2.9 · 10−2
VD;UDPGr 0.35 5.18 · 10−2 8.11 · 105 2.99 · 1011 0.38 5.28 · 10−2 0.28 1.97 · 10−2
NoSpecR, which had the highest R¯2 value. DepComR was significantly better than
DepR. DepComNoSpecR could not be compared to DepR using the F-test, as DepR
is not a simplified form of DepComNoSpecR, but DepR had a much lower R¯2. Like-
wise, Independent could not be compared with the F-test to any of the equations
in which G6P competes with ATP, because they represent different simplifications
of the same generic equation. Nevertheless, based on the R¯2 value, Independent,
though better than DepR, provides a worse fit than either DepComR and DepCom-
NoSpecR.
Similar results were consistently found for scaled (Table 3.3) and half-scaled (Table
3.4). In all cases DepComR provided the best fit, but was not significantly better
than DepComNoSpecR. DepR provided the worst fit and in all cases no error esti-
mates could be calculated. Independent provided the second worst fit. These results
led us to choose DepComNoSpecR as the simplest model to provide an adequate
description of the experimental data (Fig. 3.2).
To identify the weighting strategy that minimizes the effects of experimental er-
ror on the fitted parameters and any error introduced during the digitization of data,
especially those resulting from inverting the Lineweaver-Burk plots, graphs of the
weighted residuals against the calculated rate were plotted (Fig. 3.3). Although the
availability of more data points would aid the interpretation, several trends can be
observed. For the data depicting the dependence of I form activity on UDPG and
ATP, the variance in both unscaled and half-scaled appears to increase with the calcu-
lated rate. These weighting strategies therefore neglect data points with small calcu-
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Table 3.3: Optimized kinetic parameters obtained using a scaled weighting strategy
DepComR DepR DepComNoSpecR IndependentR
Parameter value error value error value error value error
R2 0.93702 – 0.8944 – 0.93694 – 0.915 –
R¯2 0.92676 – 0.88 – 0.92752 – 0.90341 –
KUDPGr 1.07 0.39 0.92 – 1 0.19 0.78 0.19
KUDPGt 1.02 0.22 1.69 – – – 1.6 0.29
KG6Pr 6.62 · 10−2 1.94 · 10−2 0.12 – 6.41 · 10−2 1.88 · 10−2 0.22 2.88 · 10−2
KG6Pt 0.19 7.38 · 10−2 1.83 · 10−7 – 0.18 5.79 · 10−2 1.07 0.14
KATPr 3.17 1.31 5.01 – 3.05 1.26 23.53 10.03
KATPt 1.57 0.7 7.5 · 10−7 – 1.48 0.56 2.01 0.59
K′ATPr 30.65 27.06 – – 30.17 25.71 – –
K′ATPt 6.97 2.79 – – 7.13 2.27 – –
LI0 0.31 0.12 1 · 10−25 – 0.31 0.12 0.21 0.14
LD0 8.28 3.35 2.13 · 10−24 – 8.29 3.46 4.58 3.04
VI;G6Pr 0.7 0.2 0.58 – 0.67 9.38 · 10−2 0.52 8.39 · 10−2
VD;G6Pr 0.59 0.15 0.45 – 0.57 0.1 0.39 6.49 · 10−2
VI;UDPGr 0.46 0.15 0.33 – 0.44 5.64 · 10−2 0.33 4.59 · 10−2
VD;UDPGr 0.51 0.13 0.39 – 0.49 8.93 · 10−2 0.33 5.29 · 10−2
Table 3.4: Optimized kinetic parameters obtained using a half-scaled weighting strategy
DepComR DepR DepComNoSpecR IndependentR
Parameter value error value error value error value error
R2 0.96278 – 0.92523 – 0.96274 – 0.94666 –
R¯2 0.95672 – 0.91503 – 0.95718 – 0.93938 –
KUDPGr 0.74 0.2 0.69 – 0.77 9.71 · 10−2 0.6 0.1
KUDPGt 0.77 9.71 · 10−2 1.38 – – – 1.25 0.18
KG6Pr 7.14 · 10−2 1.65 · 10−2 8.83 · 10−2 – 7.38 · 10−2 1.63 · 10−2 0.2 2.48 · 10−2
KG6Pt 0.24 8.45 · 10−2 1.52 · 10−7 – 0.25 6.19 · 10−2 0.93 0.13
KATPr 4.68 1.72 3.42 – 4.91 1.75 24 10.86
KATPt 2.18 0.86 5.47 · 10−7 – 2.3 0.66 2.42 0.54
K′ATPr 20.95 9 – – 21.63 9.31 – –
K′ATPt 5.38 1.74 – – 5.31 1.05 – –
LI0 0.36 0.11 1 · 10−25 – 0.34 9.42 · 10−2 0.5 0.23
LD0 13.16 5.11 2.74 · 10−24 – 12.28 4.13 9.63 4.61
VI;G6Pr 0.53 9.64 · 10−2 0.46 – 0.54 4.92 · 10−2 0.45 4.75 · 10−2
VD;G6Pr 0.43 6.37 · 10−2 0.34 – 0.44 5.11 · 10−2 0.34 3.63 · 10−2
VI;UDPGr 0.45 9.77 · 10−2 0.33 – 0.46 4.04 · 10−2 0.35 2.58 · 10−2
VD;UDPGr 0.36 4.78 · 10−2 0.28 – 0.36 3.76 · 10−2 0.27 2.22 · 10−2
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Figure 3.2: Comparison of experimental data points [67] to the rates calculated from the best-
fit equations (DepComNoSpecR in all cases) for the unscaled, scaled, and half-scaled weighting
strategies.
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Figure 3.3: Weighted residual plots with respect to the calculated rate vˆ. UDPG and ATP are
varied in the first two rows, whereas G6P and ATP are varied in the last two rows. Shaded
areas indicate trends in residual distribution.
lated values, whereas the scaled strategy gives a more even weight to all data points,
regardless of the calculated rate. For the D form no clear trend can be observed, but
the residuals appear to be more randomly distributed for the scaled strategy. For the
data depicting the dependence of D form activity on G6P and ATP, unscaled is biased
towards the mid-range residuals, whereas scaled is biased towards the low-range
residuals. For half-scaled the weighting is more even, but high-range residuals are
still neglected. For the D form, unscaled is biased towards the high-range residuals,
scaled is biased towards the low-range residuals, and half-scaled slightly neglects the
high-range residuals. Based on these results, we chose scaled for the data depicting
the dependence of I and D form activity on UDPG and ATP, and half-scaled for the
data depicting the dependence of I and D form activity on G6P and ATP.
We next repeated the parameter optimization, but with the appropriate weight-
ing strategies applied. The optimized parameters are listed in Table 3.5. Again, only
the rate equations in which only the R conformation is active provided useful fits.
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Table 3.5: Optimized kinetic parameters obtained using a scaled weighting strategy for data
obtained by varying UDPG and a half-scaled strategy for data obtained by varying G6P
DepComR DepR DepComNoSpecR IndependentR
Parameter value error value error value error value error
R2 0.97008 – 0.94123 – 0.97008 – 0.94864 –
R¯2 0.96521 – 0.93321 – 0.96561 – 0.94163 –
KUDPGr 0.72 0.16 0.76 – 0.72 9.14 · 10−2 0.7 0.12
KUDPGt 0.72 9.52 · 10−2 1.63 – – – 1.63 0.18
KG6Pr 6.75 · 10−2 1.49 · 10−2 0.1 – 6.76 · 10−2 1.44 · 10−2 0.19 2.73 · 10−2
KG6Pt 0.29 9.34 · 10−2 2.15 · 10−7 – 0.29 7.18 · 10−2 1.09 0.19
KATPr 4.93 1.59 4.51 – 4.94 1.49 13.09 5.36
KATPt 2.33 0.89 6.2 · 10−7 – 2.33 0.59 1 0.5
K′ATPr 15.9 6.08 – – 15.92 6.04 – –
K′ATPt 3.93 1.13 – – 3.93 0.7 – –
LI0 0.3 9.74 · 10−2 1 · 10−25 – 0.3 9.35 · 10−2 6.28 · 10−2 8.07 · 10−2
LD0 15.5 6.53 3.36 · 10−24 – 15.45 6.16 1.74 2.27
VI;G6Pr 0.52 8.16 · 10−2 0.49 – 0.52 4.67 · 10−2 0.47 5.3 · 10−2
VD;G6Pr 0.41 5.86 · 10−2 0.34 – 0.41 4.26 · 10−2 0.35 4.05 · 10−2
VI;UDPGr 0.41 8.14 · 10−2 0.32 – 0.41 3.88 · 10−2 0.32 2.72 · 10−2
VD;UDPGr 0.36 4.75 · 10−2 0.32 – 0.36 3.56 · 10−2 0.3 3.09 · 10−2
DepComR and DepComNoSpecR provided equally good fits, followed by Indepen-
dentR and DepR, for which no errors could be estimated. Being the more simple
model, DepComNoSpecR had a smaller R¯2 value than DepComR. Its estimated er-
rors were also smaller than that of DepComR. These results indicate that, of the
tested equations, DepComNoSpecR best describes the experimental data obtained
by Piras et al. [67].
Discussion
Piras et al. [67] found that ATP inhibition of GS is formally of the competitive type,
but that reversal of this inhibition by G6P does not affect the Km for UDPG, indicat-
ing that ATP binds to an allosteric site. They also found that the reversal of inhibition
by G6P is not complete and therefore argue that ATP and G6P possibly bind to differ-
ent allosteric sites. Sølling [42] also found that G6P is unable to completely reverse
ATP inhibition and suggested that, in addition to competing with G6P for the same
allosteric site, ATP also competes with UDPG for the catalytic site. To determine
which of these scenarios provided the best description of GS kinetics, we considered
several forms of the MWC equation. In one set of equations, G6P and ATP binding
was considered dependent, i.e., binding to the same allosteric site. Within this group
we further distinguished between forms in which a.) ATP does not bind to the cat-
alytic site (Dep), and b.) ATP does bind to the catalytic site (DepCom). In the other
set, ATP and G6P were considered to bind to separate allosteric sites (Independent).
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Figure 3.4: Comparison of experimental data points [67] to the rates calculated from the
best-fit equation (DepComNoSpecR) for the mixed weighting strategy
The fitted values of σr and σt were very similar for DepCom, we therefore also con-
sidered a form in which it was assumed that σr = σt (DepComNoSpec). Finally, from
these four rate equations a further four were obtained by assuming in each case that
only the R conformation is catalytically active.
Several weighting strategies were employed in an effort to minimize the con-
tribution of outliers. Based on graphs in which the scaled residuals were plotted
against the calculated rate, we chose the scaled strategy for data in which UDPG and
ATP were varied, and the half-scaled strategy for data in which G6P and ATP were
varied.
Of the tested equations, DepR provided the worst fit, indicating that mere com-
petition for the same allosteric site by G6P and ATP is not sufficient to describe the
kinetics of GS. This finding is in agreement with both Piras et al. [67] and Sølling
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[42], who found that G6P does not completely reverse ATP inhibition as is assumed
in DepR. IndependentR provided the second worst fit, ruling out the suggestion by
Piras et al. [67] that ATP and G6P bind to different allosteric sites. Finally, DepComR
and DepComNoSpecR provided equally good fits and equivalent parameter values.
Having one less parameter than DepComR, DepComNoSpecR is the simplest equa-
tion that provides a good description of GS kinetics. Our data therefore indicate that
the kinetics of GS is best described by a rate equation in which ATP competes with
G6P for the allosteric site but also with UDPG for the catalytic site. In all cases, the
rate equations in which both the T and R conformations were catalytically active re-
sulted in either very large errors in the fitted parameters or in negative parameter
values.
The application of DepComNoSpecR to GS kinetics implies that G6P is not in it-
self a specific activator of GS, i.e., it does not affect the enzyme’s affinity for UDPG,
but merely reverses specific inhibition by ATP. This finding, although in good agree-
ment with the analysis of Piras et al. [67], differs from the conventional view that
G6P is a specific activator even in the absence of ATP. These contradictory findings
are explained by recalling that Piras et al. [67] worked at pH 6.6. When working
at pH 7.8 their findings essentially agreed with the conventional view. Given the
physiological muscle pH range (6.6–7.1), it must be stressed that our findings and
those of Piras et al. [67] only apply to one end of the spectrum. Most other studies
(see for example [42, 79, 90]) have worked at higher pH concentrations, often ex-
ceeding the physiological limit. Since inhibition of GS by ATP is known to increase
as the pH decreases [67], working at a high pH has the advantage of minimizing
ATP inhibition in experimental set-ups. A more complete description of GS kinetics
would also have to consider the effect of pH, possibly by including an additional
pH-dependent conformational change. Note, however, that the lack of specific ac-
tivation by G6P does not mean that G6P results in no activation in the absence of
ATP, it merely implies that all activation in the absence of ATP must be the result of
catalytic activation, i.e., an apparent increase in the rate constant.
3.5 Estimation of L0 for each phosphorylation state
Fractional velocity is frequently reported in the GS literature as an indication of the
phosphorylation state of GS or its sensitivity towards G6P. In Chapter 2 we provided
an expression for the fractional velocity according to the Hill model (Eq. 2.12) to pro-
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vide insight into the relationship between the fractional velocity and kinetics param-
eters. We can now provide an expression according to Eq. 3.42 (DepComNoSpecR).
In the absence of ATP Eq. 3.42 simplifies to
vi =
Vmaxrnσ(1+ σ)n−1
(1+ σ)nL0i
(
1+ ξG6Pt
1+ ξG6Pr
)n
+ (1+ σ)n
(3.50)
= Vmaxrnσ(1+ σ)−1
[
L0i
(
1+ ξG6Pt
1+ ξG6Pr
)n
+ 1
]−1
(3.51)
The fractional velocity is thus expressed as follows
FVx =
vi,G6P=x
vi,G6PKG6Pt,r
=
Vmaxrnσ(1+ σ)−1
[
L0i
(
1+ ξG6Pt
1+ ξG6Pr
)n
+ 1
]−1
Vmaxrnσ(1+ σ)−1
[
L0i
(
ξG6Pt
ξG6Pr
)n
+ 1
]−1
=
L0i
(
KG6Pr
KG6Pt
)n
+ 1
L0i
(
1+ ξG6Pt
1+ ξG6Pr
)n
+ 1
(3.52)
showing that it is independent of the UDPG concentration and affinity. Setting x = 0,
the activity ratio is also obtained:
AR = FV0 (3.53)
=
L0i
(
KG6Pr
KG6Pt
)n
+ 1
L0i + 1
(3.54)
Since (KG6Pr/KG6Pt)n ' 0.003, the activity ratio is an approximation of 1/(L0i + 1)
or Ri/(Ti + Ri), the fraction of enzyme in state i present in the R conformation in the
absence of ligands. This result is particularly interesting, as the initial definition of
the activity ratio was indeed that of a mole fraction, namely the fraction of enzyme
in the I form: I/(D + I).
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More importantly, by rewriting Eq. 3.52, L0i can be expressed in terms of frac-
tional velocity, so that L0i can be calculated for any phosphorylation state of GS for
which the fractional velocity (or activity ratio) is known:
L0i =
1− FV
FV
(
1+ ξG6Pt
1+ ξG6Pr
)n
−
(
KG6Pr
KG6Pt
)n (3.55)
The fractional velocity or activity ratio is only available for a few of the 18 phospho-
rylation states considered here. Following the principles explained below, however,
we were able to calculate all 18 L0i values. The left-hand side of Fig. 3.5 depicts an
MWC-type enzyme that is phosphorylated in random order at two phosphoryla-
tion sites denoted 1 and 2. Phosphorylation is assumed to alter the apparent T/R
equilibrium in a manner analogous to any classic allosteric modifier. It is further
assumed that in all phosphorylation events all the subunits are phosphorylated si-
multaneously at the site in question. For the unliganded dephosphorylated form the
equilibrium between the T and R conformations is then given by L0. For the un-
liganded form phosphorylated at site 1, the corresponding equilibrium is given by
L01, and so on. K is the equilibrium constant of phosphorylation for a particular form
as denoted by the subscripts. However, since the overall equilibrium constant must
be the same regardless of whether a particular site is phosphorylated before or after
the T/R transition occurs, it is clear that not all the equilibria can be independent.
In particular, if L01 differs from L0 by a factor α1 as in the right-hand side of Fig. 3.5,
then since K1rL01 = L0K1t must hold, K1t = α1K1r must also hold. If we further
define L02 = α2L0, then since K1rL012 = L02K1t, it can be shown that L012 = α1α2L0.
It thus follows that if L0, L01 and L02 are available L012 can be calculated. The same
result is readily but tediously obtained for more elaborate phosphorylation schemes.
The general rule is that if a value of L0 is available for each phosphorylation state in
a sequentially phosphorylated cluster, then values can be calculated for states that
result from combinations of phosphorylation in different clusters.
L0 could be calculated from the activity ratio for 12 of the 18 phosphorylation
states (Table 3.6). As not all the activity ratios were calculated at the same saturating
G6P concentration, we used an adapted form of Eq. 3.55 that explicitly contains the
saturating G6P concentration:
L0 =
1− FV0
FV0 −
(
KG6PrKG6Pr + [G6P]satKG6Pr
KG6PrKG6Pr + [G6P]satKG6Pt
)n (3.56)
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T12
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Figure 3.5: Kinetic model of a MWC-type enzyme phosphorylated at independent phospho-
rylation sites. All-or-none phosphorylation is assumed so that all subunits of a particular
form are in the same phosphorylation state. Phoshorylation is assumed to alter the apparent
equilibrium between the T and R conformations.
Table 3.6: Activity ratios for various phosphorylation states obtained from literature data
and the corresponding values of L0 calculated using Eq. 3.56. A few L0 values calculated
according to the expressions in Table 3.8 are included here for comparison.
L0i L0i
(from activity (from component
Phosphorylated sites [G6P]sat (mM) Activity ratio Ref. ratio) L0i values)
none 7.2 0.8 [120] 0.25 –
2 10 0.45 [109] 1.23 –
2–2a 10 0.17 [109] 4.98 –
5 7.2 0.8 [120] 0.25 –
5–4 7.2 0.8 [120] 0.25 –
5–3c 7.2 0.8 [120] 0.25 –
5–3b 7.2 0.6 [120] 0.67 –
5–3a 7.2 0.1 [120] 9.31 –
2; 5–3b 7.2 0.17 [114] 5.13 3.29
2; 5–3a 7.2 2 · 10−2 [114] 58.96 45.68
2–2a; 5–3b 7.2 1.9 · 10−2 [114] 62.79 13.29
2–2a; 5–3a 7.2 1.1 · 10−2 [114] 129.74 184.69
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Table 3.7: Factors from which all values of L0 can be calculated according to the expressions
in Table 3.8
Factor Value
α2 4.9
α2a 4.04
α5 1
α4 1
α3c 1
α3b 2.67
α3a 13.89
Table 3.8: Calculated L0 values for all 18 GS phosphorylation states
Phosphorylation state Expression L0i
dephosphorylated L0 0.25
2 α2L0 1.23
2–2a α2α2aL0 4.98
5 α5L0 0.25
2;5 α2α5L0 1.23
2–2a;5 α2α2aα5L0 4.98
5–4; α5α4L0 0.25
2;5–4 α2α5α4L0 1.23
2–2a;5–4 α2α2aα5α4L0 4.98
5–3c α5 . . . α3cL0 0.25
2;5–3c α2α5 . . . α3cL0 1.23
2–2a;5–3c α2α2aα5 . . . α3cL0 4.98
5–3b α5 . . . α3bL0 0.67
2;5–3b α2α5 . . . α3bL0 3.29
2–2a;5–3b α2α2aα5 . . . α3bL0 13.29
5–3a α5 . . . α3aL0 9.31
2;5–3a α2α5 . . . α3aL0 45.68
2–2a;5–3a α2α2aα5 . . . α3aL0 184.69
The factors (denoted by α) by which each phosphorylation site apparently alters
L0, calculated from the values in Table 3.6, are listed in Table 3.7. The remaining six
L0 values were calculated from the expressions in Table 3.8. For four states (2; 5–3b,
2; 5–3a, 2–2a; 5-3b, and 2–2a; 5-3a) the value of L0 could be calculated both directly
from the activity ratio and according to the expressions in Table 3.8, allowing us
to validate this method of calculation and, by implication, the assumption that GS
kinetics is described by a MWC-type model in which phosphorylation alters the
apparent L0. In all four cases the values obtained from the two methods were of the
same order of magnitude (Table 3.6).
Stellenbosch University  http://scholar.sun.ac.za
CHAPTER 3. DEVELOPMENT OF A GLYCOGEN SYNTHASE RATE EQUATION 82
3.6 Fractional velocity as a function of
phosphorylation degree
Guinovart et al. [90] determined the fractional velocities for GS in a range of phos-
phorylation states (Fig. 3.6). They calculated the GS fractional velocity as the ratio
of the activity in the presence of a low non-saturating G6P concentration to that in
the presence of 10 mM G6P. The UDPG concentration for both activities was held
constant at 0.2 mM. Using our 18-state model of GS, we attempted to reproduce the
findings of Guinovart et al. [90].
The degree of phosphorylation (or average number of phosphates per subunit) is
defined as
Pdeg =∑
i
pi
[GSi]
[GS]tot
(3.57)
where pi is the number of phosphorylated sites of GS in phosphorylation state i. The
degree of phosphorylation is not a parameter, but a variable and cannot be manipu-
lated directly. We therefore used a stochastic method to obtain sets of GS state con-
centrations that span the entire range (0 to 7) of possible degrees of phosphorylation.
For each set the fractional velocity was calculated for the appropriate non-saturating
G6P concentrations. The fractional velocities were then plotted against degree of
phosphorylation (Fig. 3.6).
Good agreement was found between our model prediction and the experimental
data obtained by Guinovart et al. [90]. However, a few discrepancies warrant dis-
cussion. First, full inactivation occurs at a much lower degree of phosphorylation
in the experimental data of Guinovart et al. [90] than in the simulated data. This
most likely reflects the fact that phosphorylation of GS is not strictly sequential in all
phosphorylation clusters. In particular, it has been reported that sites 3a and possi-
bly 3b can be phosphorylated by members of the dual specificity tyrosine phospho-
rylation regulated protein kinase (DYRK) kinase family without the requirement of
prior phosphorylation at sites 5, 4 and 3c [92]. As phosphorylation at these sites re-
sults in potent inhibition, a decrease in the fractional velocity is expected to occur at
lower degrees of phosphorylation than predicted if strict sequential phosphorylation
is assumed. Second, the predicted fractional velocities are somewhat higher than the
experimental values. This could be explained by the fact that our simulated values
do not allow for the possibility of product inhibition or other phenomena that could
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Figure 3.6: Relationship between fractional velocity and degree of phosphorylation as ob-
tained from Guinovart et al. [90] (left) and reproduced from our optimized parameters and
calculated L0i values (right). The non-saturating G6P concentrations were: 0 mM ( ),
0.1 mM ( ), 0.25 mM ( ), and 0.5 mM ( ). The saturating G6P concentration was
10 mM in all cases. UDPG was present at 0.2 mM.
have affected the experimental values. In addition, the fact that no UDPG binding
terms are present in Eq. 3.52 could result in the simulated values being higher.
In the next chapter we consider the implications that the GS rate equation devel-
oped in this chapter has for the interaction of allosteric and covalent modification.
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Chapter 4
Interaction of allosteric and covalent
enzyme modification
4.1 Introduction
We have argued that the observed effects of phosphorylation on glycogen synthase
(GS) kinetics is qualitatively the same as would be expected if GS were a Monod-
Wyman-Changeux (MWC)-type enzyme in which phosphorylation, in addition to
allosteric modification, resulted in a shift in the apparent equilibrium between en-
zyme in the T and R conformations. We then proceeded to show that a rate equation
based on such a MWC-type model does indeed provide a good description of the
experimental data published by Piras et al. [67]. In this chapter we will show that
this model has far-reaching implications, affecting not only the GS rate equation, but
also the rate equations of enzymes that catalyse the covalent modification of GS. The
significance of these implications are demonstrated by analysing a minimal feed-
forward activation system in which the regulated enzyme is inhibited by covalent
modification. Finally, the findings are applied to GS and glycogen synthesis.
A central principle employed throughout this chapter is that the free energy
change, and thus Keq, for the conversion of one substance to another is constant
regardless of which other states served as intermediates. Consider, for example,
the conversion of protein A to protein B as in the left hand side of Fig. 4.1. The
overall equilibrium constant Keq for the conversion of A to B remains unaffected
whether the conversion took place via intermediate I or intermediate I′, so that
Keq = Keq1 · K′eq2 = K′eq1 · Keq2. It follows that
K′eq1
Keq1
=
K′eq2
Keq2
= α, where α is a constant,
so that the left hand side of Fig. 4.1 can also be shown as in the right hand side. In
84
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A
I′
I
B
Keq2 K′eq2
Keq1
K′eq1
Keq
A
I′
I
B
Keq2 αKeq2
Keq1
αKeq1
Keq≡
Figure 4.1: Reaction scheme of conversion of protein A to protein B via intermediates I and
I′. The Keq is constant and independent of whether I or I′ served as intermediate. The left
hand scheme is therefore equivalent to the right hand scheme.
what follows, where applicable, we will immediately write equilibrium constants in
terms of factors as in the right hand side of Fig. 4.1.
4.2 Interaction of allosteric and covalent modification
In Chapter 3 we have seen that if phosphorylation is considered to alter L0 by a factor
α, then by necessity the equilibrium constant of phosphorylation of the T conforma-
tion differs from the equilibrium constant of phosphorylation of the R conformation
by the same factor α. We will now investigate this matter further. In contrast to the
earlier treatment, however, we will not assume all-or-none modification.
Conformational change alters the apparent equilibrium constant of
covalent modification
Consider a monomeric enzyme in equilibrium between a T and R conformation that
undergoes covalent modification at a single site:
R R′
T T′
Keq
αKeq
L0 αL0
(4.1)
where R and T represent the classic “relaxed” and “taut” conformations of the MWC
model, prime (′) denotes the enzyme form that is covalently modified, Keq is the
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equilibrium constant of covalent modification, and α is the factor by which covalent
modification alters L0. The concentration of the group that is transferred to the en-
zyme is considered constant and thus omitted. The apparent equilibrium constant
of covalent modification is therefore defined as:
Keq,app =
[T′] + [R′]
[T] + [R]
=
[R′](αL0 + 1)
[R](L0 + 1)
= Keq
(
αL0 + 1
L0 + 1
)
(4.2)
If α < 1, then Keq,app < Keq, otherwise if α > 1, then Keq,app > Keq. If co-
valent modification has no effect whatsoever on the apparent L0, i.e., α = 1, then
Keq,app = Keq. For any given covalent modification state, α has a fixed value, but L0
can potentially undergo an apparent alteration by additional modification, whether
covalent or allosteric. As the apparent value of L0 decreases, Keq,app approaches Keq.
If L0 is very large, on the other hand, Keq,app approaches αKeq. Note, however, that
the equilibrium constants for the reactions R→ R′ and T→ T′, Keq and αKeq, remain
constant; it is only their relative contribution towards the Keq of the apparent reaction
E→ E′ (where E and E′ are the total unmodified and modified proteins) that changes
with L0.
Adding an allosteric modification layer to Eq. 4.1 yields:
R
T
R′
T′
RX
TX
R′X
T′X
L0 αL0
βL0
αβL0
Keq
αKeq
Keq
αKeq
ξ
βξ
ξ
βξ
(4.3)
where X denotes an allosteric modifier with concentration x; ξ = x/Kx; Kx is the
modifier dissociation constant; and β is the factor by which L0 is apparently altered
upon modifier binding. The expression for Keq,app now reads
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Keq,app =
[T′] + [R′] + [R′X] + [T′X]
[T] + [R] + [RX] + [TX]
= Keq
(
αL0(1+ βξ) + 1+ ξ
L0(1+ βξ) + 1+ ξ
)
(4.4)
In the absence of allosteric modifier, Eq. 4.4 simplifies to Eq. 4.2, but at saturating
modifier concentrations it is transformed to
Keq,app = Keq
(
αβL0 + 1
βL0 + 1
)
(4.5)
= Keq
(
αL0 + 1β
L0 + 1β
)
(4.6)
showing that if X binds preferentially to the T conformation (β > 1) it increases the
apparent value of L0 and thus displaces Keq,app towards αKeq. If, however, X prefers
to bind to the R conformation (β < 1), then Keq,app approaches Keq as x increases.
Note that X need not be an allosteric modifier; any ligand that prefers binding to
either the T or R conformation (β 6= 1) will affect Keq,app. In fact, any process what-
soever (including additional covalent modification) that has an apparent effect on L0
will also affect Keq,app.
Covalent modification is positively cooperative
Similar results are obtained for a dimeric enzyme. Figure 4.2 depicts the kinetic
model of a dimeric MWC-type enzyme with a single covalent modification site per
subunit. The statistical factors 2 and 12 must be included to show that, for instance, R
′
can be formed by modifying any of the two sites of R, or by eliminating modification
from any of the two sites of R′′. The same is true with regard to T′.
The expression for the overall apparent equilibrium constant is
K2eq,app =
[T′′] + [R′′]
[T] + [R]
= K2eq
(
α2L0 + 1
L0 + 1
)
Keq,app = Keq
√
α2L0 + 1
L0 + 1
(4.7)
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R R′ R′′
T T′ T′′
2Keq 12Keq
2αKeq 12 αKeq
L0 αL0 α2L0
Figure 4.2: Reaction scheme for the covalent modification of a dimeric Monod-Wyman-
Changeux-type enzyme. Each covalent modification (indicated by ′) alters the equilibrium
between the T and R conformations by a factor α. See text for details.
Keq,app thus varies with L0 and α in a manner qualitatively the same as for the
monomeric enzyme.
Considering only the first covalent modification the apparent equilibrium con-
stant is given by
2Keq1,app =
[T′] + [R′]
[T] + [R]
= 2Keq
(
αL0 + 1
L0 + 1
)
Keq1,app = Keq
(
αL0 + 1
L0 + 1
)
(4.8)
and for the second modification by
1
2
Keq2,app =
[T′′] + [R′′]
[T′] + [R′]
=
1
2
Keq
(
α2L0 + 1
αL + 1
)
Keq2,app = Keq
(
α2L0 + 1
αL0 + 1
)
(4.9)
It can be shown that Keq2,app > Keq1,app for all α ∈ (0,∞), α 6= 1 and L0 ∈ (0,∞):
∆Keq,app = Keq2,app − Keq1,app (4.10)
= Keq
L0(1− α)2
(1+ αL0)(1+ L0)
> 0 (4.11)
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It follows that the second modification proceeds more readily than the first, i.e.,
covalent modification is positively cooperative. If α = 1 (if covalent modification has
no apparent effect on L0), then Keq2,app = Keq1,app and no cooperativity is observed.
R
T
R′
T′
R′′
T′′
RX
TX
R′X
T′X
R′′X
T′′X
RX2
TX2
R′X2
T′X2
R′′X2
T′′X2
L0 αL0 α2L0
2Keq
2αKeq
1
2Keq
1
2 αKeq
βL0 αβL0 α
2βL0
2Keq
2αKeq
1
2Keq
1
2 αKeq
β2L0 αβ
2L0 α2β2L0
2Keq
2αKeq
1
2Keq
1
2 αKeq
2ξ
1
2 ξ
2βξ
1
2 βξ
2ξ
1
2 ξ
2βξ
1
2 βξ
2ξ
1
2 ξ
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Figure 4.3: Reaction scheme for the covalent and allosteric modification of a dimeric Monod-
Wyman-Changeux-type enzyme. Each covalent modification (indicated by ′) alters the equi-
librium between the T and R conformations by a factor α, whereas binding of the allosteric
modifier X alters the T and R equilibrium by a factor β. See text for details.
Adding an allosteric site, Fig. 4.2 is extended to Fig. 4.3. The overall apparent
equilibrium constant then becomes
Keq,app = Keq
√
α2L0(1+ βξ)2 + (1+ ξ)2
L0(1+ βξ)2 + (1+ ξ)2
(4.12)
or
Keq,app = Keq
√
α2β2L0 + 1
β2L0 + 1
(4.13)
if the modifier is saturating. The Keq,app for the first covalent modification is
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2Keq1,app =
[T′] + [R′] + [T′X] + [R′X] + [T′X2] + [R′X2]
[T] + [R] + [TX] + [RX] + [TX2] + [RX2]
= 2Keq
(
αL0(1+ βξ)2 + (1+ ξ)2
L0(1+ βξ)2 + (1+ ξ)2
)
Keq1,app = Keq
(
αL0(1+ βξ)2 + (1+ ξ)2
L0(1+ βξ)2 + (1+ ξ)2
)
(4.14)
and
1
2
Keq2,app =
[T′′] + [R′′] + [T′′X] + [R′′X] + [T′′X2] + [R′′X2]
[T′] + [R′] + [T′X] + [R′X] + [T′X2] + [R′X2]
=
1
2
Keq
(
α2L0(1+ βξ)2 + (1+ ξ)2
αL0(1+ βξ)2 + (1+ ξ)2
)
Keq2,app = Keq
(
α2L0(1+ βξ)2 + (1+ ξ)2
αL0(1+ βξ)2 + (1+ ξ)2
)
(4.15)
for the second covalent modification. The difference between Keq2,app and Keq1,app
is, given the same constraints as earlier, also positive:
∆Keq,app = Keq
L0(1+ βξ)2(1− α)2
[(1+ ξ)2 + αL0(1+ βξ)2] [(1+ ξ)2 + L0(1+ βξ)2]
> 0 (4.16)
Cooperativity with respect to covalent modification is therefore observed regardless
of the concentration of allosteric modifier. However, the allosteric modifier and its
preference for the T or R conformation does affect the degree of cooperativity with
respect to covalent modification. This effect can be investigated by considering the
difference between ∆Keq,app in the presence of allosteric modifier and ∆Keq,app in
the absence of modifier. To simplify the calculation we assume allosteric modifier, if
present, is saturating:
∆Kξ→∞eq,app − ∆Kξ=0eq,app = Keq β
2L0(1− α)2
(1+ αβ2L0)(1+ β2L0)
− Keq L0(1− α)
2
(1+ αL0)(1+ L0)
= −Keq (α− 1)
2(β2 − 1)(αβ2L20 − 1)
(1+ L0)(1+ αL0)(1+ β2L0)(1+ αβ2L0)
(4.17)
For positive values of Eq. 4.17, binding of the allosteric modifier leads to an in-
crease in the degree of cooperativity with respect to covalent modification. Con-
versely, a decrease in degree of cooperativity is seen for solutions where Eq. 4.17 is
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negative. Finally, where Eq. 4.17 is zero, the allosteric modifier has no effect on the
degree of cooperativity. There are five cases to consider.
1. If the allosteric modifier is an inhibitor (β > 1) and covalent modification is
inhibitory (α > 1) or only mildly activating (αβ2 > 1), then the allosteric modi-
fier will decrease the cooperativity with respect to covalent modification for all
L0 >
√
1
αβ2
and increase the cooperativity for all L0 <
√
1
αβ2
where
√
1
αβ2
< 1
(Fig. 4.4A).
2. If the allosteric modifier is an activator (β < 1) and covalent modification is
also activating (α < 1) or only mildly inhibitory (αβ2 < 1), then the allosteric
modifier will decrease the cooperativity with respect to covalent modification
for all L0 <
√
1
αβ2
and increase the cooperativity for all L0 >
√
1
αβ2
where√
1
αβ2
> 1 (Fig. 4.4B).
3. If the allosteric modifier is an activator (β < 1) and covalent modification is
strongly inhibitory (α > 1, αβ2 > 1), then the allosteric modifier will increase
the cooperativity with respect to covalent modification for all L0 >
√
1
αβ2
and
decrease the cooperativity for all L0 <
√
1
αβ2
where
√
1
αβ2
< 1 (Fig. 4.4C).
4. If the allosteric modifier is an inhibitor (β > 1) and covalent modification is
strongly activating (α < 1, αβ2 < 1), then the allosteric modifier will increase
the cooperativity with respect to covalent modification for all L0 <
√
1
αβ2
and
decrease the cooperativity for all L0 >
√
1
αβ2
where
√
1
αβ2
> 1 (Fig. 4.4D).
5. In the trivial case where only the R conformation can be phosphorylated (α =
0), the allosteric modifier will increase cooperativity with respect to covalent
modification for all values of L0 if it is an inhibitor (β > 1) or decrease it if it
is an activator (β < 1). The converse is true if only the T conformation can be
phosphorylated.
In all five cases β can be replaced with 1+βξ1+ξ to evaluate the effect of non-saturating
allosteric modifier on the degree of cooperativity with respect to covalent modifica-
tion.
Although it depends on the exact values of α, β and L0 whether the allosteric
modifier increases or decreases the degree of cooperativity with respect to covalent
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0 1 ∞
√
1
αβ2
L0
(α > 1, β > 1) or (α < 1, β > 1, αβ2 > 1)
A
0 1 ∞
√
1
αβ2
L0
(α < 1, β < 1) or (α > 1, β < 1, αβ2 < 1)
B
0 1 ∞
√
1
αβ2
L0
α > 1, β < 1, αβ2 > 1
C
0 1 ∞
√
1
αβ2
L0
α < 1, β > 1, αβ2 < 1
D
Figure 4.4: Influence of saturating allosteric modifier on the degree of cooperativity with
respect to covalent modification. Depending on the value of L0, the allosteric modifier will
either have no effect ( ) on the cooperativity of covalent modification, increase it ( ), or
decrease it ( ).
modification, the following general conclusions can be drawn. If covalent and al-
losteric modification both prefer the same conformation, then if the enzyme is al-
ready predominantly present in that conformation, the degree of cooperativity with
respect to covalent modification is decreased in the presence of allosteric modifier. If,
however, covalent and allosteric modification prefer opposite conformations, then if
the enzyme is already predominantly present in the conformation preferred by co-
valent modification and given that covalent modification is the stronger effect, the
degree of cooperativity with respect to covalent modification is increased in the pres-
ence of allosteric modifier. The same overall conclusions can be drawn for enzymes
with more than two subunits.
Half-saturation and half-alteration
Further extending the kinetic model in Fig. 4.3 to an arbitrary number of subunits,
n, the overall equilibrium constant becomes
Keq,app = Keq n
√
αnL0(1+ βξ)n + (1+ ξ)n
L0(1+ βξ)n + (1+ ξ)n
(4.18)
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The extent γx to which a particular allosteric modifier concentration x alters the
overall Keq,app relative to the alteration seen with saturating allosteric modifier can
be defined as follows:
γx =
Keq,app − Kξ=0eq,app
Kξ→∞eq,app − Kξ=0eq,app
(4.19)
γx ranges from 0 to 1 as x increases from zero to saturation. Setting γx = 12 and
ξ = ξ 1
2
, an expression can be obtained for the dimensionless concentration, ξ 1
2
, at
which half the maximal alteration to Keq,app is observed.
γx =
1
2
Keq,app − Kξ=0eq,app
Kξ→∞eq,app − Kξ=0eq,app
=
1
2
Keq,app =
1
2
(
Kξ→∞eq,app + K
ξ=0
eq,app
)
(4.20)
Keq n
√√√√αnL0(1+ βξ 12 )n + (1+ ξ 12 )n
L0(1+ βξ 1
2
)n + (1+ ξ 1
2
)n
=
1
2
Keq
(
n
√
αnL0βn + 1
L0βn + 1
− n
√
αnL0 + 1
L0 + 1
)
(4.21)
ξ 1
2
=
L0 + 1
L0β+ 1
(assuming n = 1) (4.22)
Unfortunately, an analytical solution does not exist for arbitrary values of n. The
half-saturation concentration is similarly defined as [161]:
L0 =
ξ 1
2
− 1
1− βξ 1
2
(
1+ ξ 1
2
1+ βξ 1
2
)n−1
(4.23)
ξ 1
2
=
L0 + 1
L0β+ 1
(assuming n = 1) (4.24)
Again, a general analytical solution does not exist. Nevertheless, we see that for
a monomeric enzyme the allosteric modifier half-saturation concentration for the
covalently unmodified enzyme is equal to the concentration that results in half-
maximal alteration of the apparent equilibrium constant for covalent modification.
All that can be said for oligomeric enzymes (n > 1) is that both the half-saturation
and half-alteration concentrations are between Kx and Kx/β and not necessarily
equal.
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4.3 Rate equations for covalent modification
In the previous section we have shown that the equilibrium constant for the covalent
modification of an MWC-type protein, in which covalent modification brings about
a shift in the equilibrium between the unliganded T and R conformations, undergoes
an apparent change as a result of allosteric and covalent modification of the protein.
Covalent modification of such a protein would typically be catalysed by an enzyme.
It would therefore be of interest to derive a rate equation for such a reaction. The
Haldane relationship
Keq =
VfKp
VrKs
(4.25)
requires that any change in the equilibrium constant (left hand side of Eq. 4.25) must
be accompanied by compensating changes in the kinetic parameters on the right
hand side of Eq. 4.25. Here we will derive rate equations for the forward and reverse
covalent modification reactions. A critical step in the derivation of a rate equation is
the expression of all enzyme forms in terms of only intrinsic equilibrium constants,
the free enzyme concentration, and unbound ligand concentrations. This step can
only be performed if it is assumed that all species are in equilibrium. This assump-
tion, however, cannot be made if the interconversion between enzyme forms is itself
enzyme-catalysed. Note that the assumption is valid if one is interested in equilib-
rium conditions as in the previous sections where an expression for the apparent
equilibrium constant was sought. In order to derive a rate equation, then, one is
forced to derive a separate equation for each covalent enzyme state and to subse-
quently describe the interconversion between states with additional rate equations.
The overall rate is then the sum of the rates of the constituent enzyme states. In the
previous chapter we were concerned with finding an expression for such a sum of
rates. Here our focus turns to the interconversion between covalent enzyme states.
The interconversion between the two covalent states of a monomeric protein with a
single covalent modification site and one allosteric site will be used as an example
(Fig. 4.5). Since the forward and reverse interconversions are usually catalysed by
different enzymes, two rate equations are required to describe the interconversion.
Forward covalent modification
Assuming that the forward covalent modification reaction is a bi-substrate coupled
reaction with a random binding order that is catalysed by enzyme A, the kinetic
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E E′
A
B
Figure 4.5: Forward and reverse covalent modification of a monomeric Monod-Wyman-
Changeux-type enzyme by enzymes A and B. This scheme is obtained by collapsing all the
conformations of a particular state in Eq. 4.3 into a single entity, so that, for instance, E
collectively represents R, T, RX, and TX.
model is given in Fig. 4.6. During catalysis, unmodified protein E is converted to
modified protein E′ by the transfer of the group (′) from the co-substrate, C′, to the
co-product, C. Covalent modification alters the T/R equilibrium, L0, by a factor α.
A modifier X binds to the allosteric site of both covalent states of protein E, so that
each covalent state exists in four forms (the T and R conformations and the two corre-
sponding liganded forms). Binding of modifier X alters L0 by a factor β. In addition,
binding of protein E to enzyme A alters L0 by a factor γ, or stated otherwise, the
affinity of enzyme A for the R conformation differs from that for the T conformation
by a factor γ. The parameters kf and kr are the forward and reverse rate constants of
covalent modification. See Fig. 4.6 for additional parameter definitions.
The overall equilibrium constant for the conversion of ARC′ to AT′C is constant
and independent of whether AR′C or ATC′ serves as an intermediate. Similarly,
the equilibrium constant for the conversion of ARXC′ to AT′XC is independent of
whether AR′XC or ATXC′ serves as intermediate. It follows that the forward rate
constants for covalent modification of the complexes ATC′ and ATXC′ must be mul-
tiplied by α. Alternatively, the reverse rate constants must be multiplied by 1α . These
thermodynamic requirements can, of course, also be satisfied by combined changes
in the forward and reverse constants. In what follows, however, we will only con-
sider changes to the forward rate constants as shown in Fig. 4.6.
The total concentration of A can be expressed as
[A]tot = [A] + [AE] + [AC′] + [AEC′] + [AEC] + [AE′] + [AC] + [AE′C] + [AE′C′]
(4.26)
where
[AE] = [AR] + [AT] + [ARX] + [ATX] (4.27)
[AEC] = [ARC] + [ATC] + [ARXC] + [ATXC] (4.28)
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A
AR
AT
ARX
ATX
AE
ARC
ATC
ARXC
ATXC
AEC
R
T
RX
TX
E
AC′
ARC′
ATC′
ARXC′
ATXC′
AEC′
A
AR′
AT′
AR′X
AT′X
AE′
AR′C′
AT′C′
AR′XC′
AT′XC′
AE′C′
R′
T′
R′X
T′X
E′
AC
AR′C
AT′C
AR′XC
AT′XC
AE′C
σr
σt
pir
pit
σr
σt
pir
pit
γL0
βγL0
ξ
βξ
αγL0
αβγL0
ξ
βξ
γL0
βγL0
ξ
βξ
αγL0
αβγL0
ξ
βξ
L0
βL0
ξ
βξ
αL0
αβL0
ξ
βξ
γL0
γβL0
ξ
βξ
αγL0
αβγL0
ξ
βξ
σ2
σ2
pi2
pi2
pi2 σ2
kf
kr
αkf
kr
kf
kr
αkf
kr
Figure 4.6: Kinetic model for the forward covalent modification (E+C′  E′+C) of protein
E by enzyme A. Reactants are assumed to bind in random order. The formation of two dead-
end complexes, AEC and AE′C′, is allowed. The forward and reverse catalytic constants are
denoted by kf and kr; σr = rKs1
; σt =
tγ
Ks1
; pir = r
′
Kp1
; pit =
t′γ
Kp1
; t and r are the concentrations
of the T and R conformations of free protein E; σ2 = c
′
Ks2
; pi2 = cKp2
; and K denotes intrinsic
substrate (s) and product (p) dissociation constants for the substrate/product pair (1) and for
the co-substrate/co-product pair (2). The factors α, β, and γ quantify the apparent changes
to L0 as a result of covalent modification, allosteric modification, and binding to enzyme A.
The four non-covalent forms in which any covalent state can exist can be represented as a
single form that is able to complex with A (dashed boxes).
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[AEC′] = [ARC′] + [ATC′] + [ARXC′] + [ATXC′] (4.29)
[AE′C] = [AR′C] + [AT′C] + [AR′XC] + [AT′XC] (4.30)
[AE′] = [AR′] + [AT′] + [AR′X] + [AT′X] (4.31)
[AE′C′] = [AR′C′] + [AT′C′] + [AR′XC′] + [AT′XC′] (4.32)
or in terms of intrinsic equilibria:
[A]tot = [A] (1+ σr [(1+ ξ) + γL0(1+ βξ)] + pir [(1+ ξ) + αγL0(1+ βξ)])
(
1+ σ2 + pi′2
)
(4.33)
The total concentration of unbound protein E is given by
e = [R] + [T] + [RX] + [TX] (4.34)
= [R] [(1+ ξ) + L0(1+ βξ)] (4.35)
and the total concentration of unbound protein E’ is given by
e′ = [R′] + [T′] + [R′X] + [T′X] (4.36)
= [R′] [(1+ ξ) + αL0(1+ βξ)] (4.37)
It thus follows that, [R] =
e
(1+ ξ) + L0(1+ βξ)
and [R′] = e
′
(1+ ξ) + αL0(1+ βξ)
,
so that
σr =
σ1
(1+ ξ) + L0(1+ βξ)
(4.38)
and
pir =
pi1
(1+ ξ) + αL0(1+ βξ)
(4.39)
where σ1 = eKs1
and pi1 = e
′
Kp1
. Substituting Eqs. 4.38 and 4.39 into Eq. 4.33 gives
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[A]tot = [R]
(
1+ σ1
[
(1+ ξ) + γL0(1+ βξ)
(1+ ξ) + L0(1+ βξ)
]
+ pi1
[
(1+ ξ) + αγL0(1+ βξ)
(1+ ξ) + αL0(1+ βξ)
])
(1+ σ2 + pi2)
(4.40)
The rate of covalent modification is described by
vA =
kf[ARC′] + kf[ARXC′] + αkf[ATC′] + αkf[ATXC′]
− (kr[AR′C] + kr[AR′XC] + kr[AT′C] + kr[AT′XC]) (4.41)
=
[A]tot
[
kf[ARC′] + kf[ARXC′] + αkf[ATC′] + αkf[ATXC′]
− (kr[AR′C] + kr[AR′XC] + kr[AT′C] + kr[AT′XC])
]
[A]tot
(4.42)
=
Vfσ1
[
(1+ ξ) + αγL0(1+ βξ)
(1+ ξ) + L0(1+ βξ)
]
σ2 −Vrpi1
[
(1+ ξ) + αγL0(1+ βξ)
(1+ ξ) + αL0(1+ βξ)
]
pi2(
1+ σ1
[
(1+ ξ) + γL0(1+ βξ)
(1+ ξ) + L0(1+ βξ)
]
+ pi1
[
(1+ ξ) + αγL0(1+ βξ)
(1+ ξ) + αL0(1+ βξ)
])
(1+ σ2 + pi2)
(4.43)
where Vf = kf[A]tot and Vr = kr[A]tot. Equation 4.43 can be written in the form of the
classic bi-substrate random order rate equation:
vA =
Vf,appσ1,appσ2 −Vrpi1,apppi2(
1+ σ1,app + pi1,app
)
(1+ σ2 + pi2)
(4.44)
with Vf,app = Vf
[
(1+ ξ) + αγL0(1+ βξ)
(1+ ξ) + γL0(1+ βξ)
]
, σ1,app = σ1
[
(1+ ξ) + γL0(1+ βξ)
(1+ ξ) + L0(1+ βξ)
]
,
and pi1,app = pi1
[
(1+ ξ) + αγL0(1+ βξ)
(1+ ξ) + αL0(1+ βξ)
]
. Note that, since we have considered
kr to be unaltered by covalent modification, there are no terms that modify Vr.
Setting vA = 0 in Eq. 4.44, an expression for the equilibrium constant is obtained:
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Vf,appσ1,appσ2 −Vrpi1,apppi2(
1+ σ1,app + pi1,app
)
(1+ σ2 + pi2)
= 0
Vf,appσ1,appσ2 = Vrpi1,apppi2
ceq · e′eq
c′eq · eeq
=
Vf,appKp1,appKp2
VrKs1,appKs2
Keq,app =
Vf,appKp1,appKp2
VrKs1,appKs2
Keq,app =
VfKp1Kp2
VrKs1Ks2
[
(1+ ξ) + αL0(1+ βξ)
(1+ ξ) + L0(1+ βξ)
]
Keq,app = Keq
[
(1+ ξ) + αL0(1+ βξ)
(1+ ξ) + L0(1+ βξ)
]
(4.45)
The expression of Keq,app in Eq. 4.45 is, as expected, identical to the expression in
Eq. 4.4. Writing Eq. 4.44 in terms of Keq,app yields
vA =
Vf,appσ1,appσ2
(
1− e
′ · c/(e · c′)
Keq,app
)
(
1+ σ1,app + pi1,app
)
(1+ σ2 + pi2)
(4.46)
or, in expanded form:
vA =
Vfσ1
[
(1+ ξ) + αγL0(1+ βξ)
(1+ ξ) + L0(1+ βξ)
]
σ2
1− e′ · c/(e · c′)
Keq
[
(1+ ξ) + αL0(1+ βξ)
(1+ ξ) + L0(1+ βξ)
]

(
1+ σ1
[
(1+ ξ) + γL0(1+ βξ)
(1+ ξ) + L0(1+ βξ)
]
+ pi1
[
(1+ ξ) + αγL0(1+ βξ)
(1+ ξ) + αL0(1+ βξ)
])
(1+ σ2 + pi2)
(4.47)
If we now suppose that covalent modification does not bring about any confor-
mational change to protein E, i.e., that α = 1, then a factor
[
(1+ ξ) + γL0(1+ βξ)
(1+ ξ) + L0(1+ βξ)
]
can be cancelled from the numerator and denominator of Eq. 4.47, resulting in the
rate equation for the classic bi-substrate random order mechanism. Therefore, even
if enzyme A binds the T and R conformations with different affinities (γ 6= 1), no
kinetic parameters are modified. On the other hand, if we suppose that enzyme A
binds the T and R conformations with equal affinity (γ = 1), then σ1,app = σ1 and
pi1,app = pi1, showing that only the maximal forward carrying capacity, Vf, under-
goes apparent modification:
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vA =
φVfσ1σ2
(
1− e
′ · c/(e · c′)
φKeq
)
(1+ σ1 + pi1) (1+ σ2 + pi2)
(4.48)
where φ =
[
(1+ ξ) + αL0(1+ βξ)
(1+ ξ) + L0(1+ βξ)
]
.
Any change in the apparent Michaelis constants in response to allosteric modi-
fication of the substrate and product is solely the result of the differential affinities
of the enzyme for the two substrate and product conformations and is not directly
linked to the fact that covalent modification alters the value of L0. Changes to the
forward maximal rate is, however, solely the result of the fact that covalent modifi-
cation alters L0. In what follows, we will assume that enzyme A has an equal affinity
for both conformations of its substrate and product, so that allosteric modification
can only affect the forward maximal rate as in Eq. 4.48.
Note that modification is absent from the reverse maximal rate as a result of an
assumption; equations can also be derived in which only Vr is apparently modi-
fied, or in which both Vf and Vr are modified. The important point is that catalytic
modification, whether in the forward or reverse directions, is the result of covalent
modification changing the value of L0, and is independent of whether enzyme A
has different affinities for the T and R conformations. Note also that the values of
α and β are specific to protein E, and must have the same values in the rate equa-
tions for forward and reverse covalent modification. The value of γ, on the other
hand, is specific to the enzyme that catalyses the modification; it should generally
differ for forward and reverse covalent modification and even for different enzymes
catalysing covalent modification in the same direction.
Reverse covalent modification
Assuming that the reverse covalent modification reaction is a uni-bi reaction with a
random binding order catalysed by enzyme B, the kinetic model is given in Fig. 4.7.
G is the group released upon reversing the covalent modification. Following a simi-
lar method as in the derivation of the forward reaction rate equation, the rate for the
reverse covalent modification reaction can be shown to be described by
vB =
φ−1Vfσ′
(
1− e · g/e
′
φ−1Keq
)
σ+ (1+ pi2) (1+ pi1)
(4.49)
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Figure 4.7: Kinetic model for the reverse covalent modification (E′  E+G) of protein E by
enzyme A. Reactants are assumed to bind in random order. The formation of non-productive
ternary complexes is ignored. The forward and reverse catalytic constants are denoted by kf
and kr; σr = r
′
Ks ; σt =
t′γ
Ks ; pir =
r
Kp1
; pit =
t′γ
Kp1
; t and r are the concentrations of the T and R
conformations of free protein E; pi2 =
g
Kp2
; and K denotes intrinsic substrate (s) and product
(p) dissociation constants. The factors α, β, and γ quantify the apparent changes to L0 as a
result of covalent modification, allosteric modification, and binding to enzyme A. The four
non-covalent forms in which any covalent state can exist can be represented as a single form
that is able to complex with A (dashed boxes).
where Vf = kf[B]tot, σ =
e′
Ks
, and pi1 =
e
Kp1
. See legend of Fig. 4.7 for additional
parameter definitions.
Generalization to n subunits
The kinetic model becomes significantly more complicated for proteins with more
than one subunit. Since an additional covalent modification site is gained with each
additional subunit, the number of forward and reverse covalent modification reac-
tions equals the number of subunits. The covalent modification of a protein with
n subunits therefore requires n forward and n reverse rate equations. Moreover,
protein states that are the reagents in one reaction act as competitors in other reac-
tions. Finally, the number of allosteric sites also increases and thus the number of
non-covalent states.
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In what follows we will derive the general forms of the n forward and reverse rate
equations required to describe the covalent modification of a protein with n subunits.
We will not attempt a detailed derivation, but, with the aid of simplifying principles,
instead broadly describe how the rate equations were obtained. We begin with the
derivation of the forward rate equations, and then also provide the equations for the
reverse reactions.
As was shown in the derivation for the forward reaction with a monomeric pro-
tein, it is not necessary to explicitly consider all the non-covalent forms of a par-
ticular covalent state. For instance, binding of R, T, RX, and TX may be described
collectively as the binding of E, so that the binding constant is really an apparent con-
stant of which the value depends on the allosteric and covalent modification state of
the protein.
We thus only have to consider the n + 1 covalent modification states in which
protein E can exist:
E′(0), E′(1), . . . , E′(n) (4.50)
where ′(i) indicates the number of covalently modified subunits of the particular
state. All the states in Eq. 4.50 can exist in free form and in complexes with A. The
concentration of free E′(i) is expressed by
e′(i) = r′(i)
[
(1+ ξ)n + αiL0(1+ βξ)n
]
(4.51)
where r′(i) is the concentration of state E′(i) that is present in the R conformation, and
hence
r′(i) = e
′(i)
(1+ ξ)n + αiL0(1+ βξ)n
(4.52)
A particular state E′(i) can complex with A as either a substrate or a product. E′(i)
has (n − i) unmodified subunits and and i modified subunits. As a substrate, the
concentration of E′(i) is then effectively multiplied by (n− i), whereas in its capacity
as product the concentration of E′(i) is effectively multiplied by i. It is thus clear that
E′(0) can only function as a substrate (its concentration as product is multiplied by
zero), whereas E′(n) can only function as a product (its concentration as substrate is
multiplied by zero). All other states function as both substrates and products.
The concentration of E′(i) complexed as a substrate with A is expressed by
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[AE′(i)]s =
n
∑
j
[AR′(i)Xj]s +
n
∑
j
[AT′(i)Xj]s (4.53)
= [AR′(i)]s(1+ ξ)n + [AR′(i)]sαiγL0(1+ βξ)n (4.54)
= [AR′(i)]s
[
(1+ ξ)n + αiγL0(1+ βξ)n
]
(4.55)
= [A](n− i)r
′(i)
Ks1
[
(1+ ξ)n + αiγL0(1+ βξ)n
]
(4.56)
= [A](n− i) e
′(i)
Ks1
[
(1+ ξ)n + αiγL0(1+ βξ)n
(1+ ξ)n + αiL0(1+ βξ)n
]
(4.57)
= [A](n− i)σ(i)1
[
(1+ ξ)n + αiγL0(1+ βξ)n
(1+ ξ)n + αiL0(1+ βξ)n
]
(4.58)
= [A](n− i)σ(i)1,app (4.59)
where σ(i)1,app = σ
(i)
1
[
(1+ ξ)n + αiγL0(1+ βξ)n
(1+ ξ)n + αiL0(1+ βξ)n
]
. Similarly, the concentration of E′(i)
complexed as a product with A is expressed by
[AE′(i)]p = [A](i)pi
(i)
1,app (4.60)
where pi(i)1,app = pi
(i)
1
[
(1+ ξ)n + αiγL0(1+ βξ)n
(1+ ξ)n + αiL0(1+ βξ)n
]
.
In the absence of co-substrate and co-product, the total concentration of enzyme
A is given by
[A]tot = [A] +
n
∑
j=1
[AE′(j−1)]s +
n
∑
j=1
[AE′(j)]p (4.61)
= [A]
(
1+
n
∑
j=1
(n− j + 1)σ′(j−1)1,app +
n
∑
j=1
jpi′(j)1,app
)
(4.62)
If the co-substrate and co-product, which bind independently of protein E, are also
taken into account, Eq. 4.61 becomes
[A]tot = [A]
(
1+
n
∑
j=1
(n− j + 1)σ′(j−1)1,app +
n
∑
j=1
jpi′(j)1,app
)
(1+ σ2 + pi2) (4.63)
The rate of the ith reaction, E′(i−1) +C′  E′(i) +C, where i ∈ [1, n], is described
by
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vAi = kf
n
∑
j
[AR′(i−1)XjC′] + αkf
n
∑
j
[AT′(i−1)XjC′]− kr[AE′(i)C]
= kf
n
∑
j
[AR′(i−1)Xj]sσ2 + αkf
n
∑
j
[AT′(i−1)Xj]sσ2 − kr[AE′(i)]ppi2
= kf[AR′(i−1)]s(1+ ξ)nσ2 + αkf[AR′(i−1)]sαi−1γL0(1+ βξ)nσ2 − kr[AE′(i)]ppi2
= kf[AR′(i−1)]s
[
(1+ ξ)n + αiγL0(1+ βξ)n
]
σ2 − kr[AE′(i)]ppi2
= kf[A](n− i + 1)r
′(i−1)
Ks1
[
(1+ ξ)n + αiγL0(1+ βξ)n
]
σ2 − kr[A](i)pi(i)1,apppi2
= kf[A](n− i + 1) e
′(i−1)
Ks1
[
(1+ ξ)n + αiγL0(1+ βξ)n
(1+ ξ)n + αi−1L0(1+ βξ)n
]
σ2 − kr[A](i)pi(i)1,apppi2
= kf[A](n− i + 1)σ′(i−1)1
[
(1+ ξ)n + αiγL0(1+ βξ)n
(1+ ξ)n + αi−1γL0(1+ βξ)n
]
σ2 − kr[A](i)pi(i)1,apppi2
= kf[A](n− i + 1)σ′(i−1)1,app
[
(1+ ξ)n + αiγL0(1+ βξ)n
(1+ ξ)n + αi−1L0(1+ βξ)n
]
σ2 − kr[A](i)pi(i)1,apppi2
= k(i)f,app[A](n− i + 1)σ′(i−1)1,app σ2 − kr[A](i)pi(i)1,apppi2 (4.64)
where k(i)f,app = kf
[
(1+ ξ)n + αiγL0(1+ βξ)n
(1+ ξ)n + αi−1L0(1+ βξ)n
]
. Multiplying the numerator and de-
nominator of Eq. 4.64 with [A]tot yields
vAi =
k(i)f,app[A]tot[A](n− i + 1)σ′(i−1)1,app σ2 − kr[A]tot[A](i)pi(i)1,apppi2
[A]tot
(4.65)
=
k(i)f,app[A]tot(n− i + 1)σ′(i−1)1,app σ2 − kr[A]tot(i)pi(i)1,apppi2(
1+
n
∑
j=1
(n− j + 1)σ′(j−1)1,app +
n
∑
j=1
jpi′(j)1,app
)
(1+ σ2 + pi2)
(4.66)
=
V(i)f,app(n− i + 1)σ′(i−1)1,app σ2 −Vr(i)pi(i)1,apppi2(
1+
n
∑
j=1
(n− j + 1)σ′(j−1)1,app +
n
∑
j=1
jpi′(j)1,app
)
(1+ σ2 + pi2)
(4.67)
(4.68)
which can also be written in terms of the equilibrium constant:
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vAi =
V(i)f,app(n− i + 1)σ′(i−1)1,app σ2
1− e′(i) · c′/(e′(i−1) · c)n− i + 1
i
K(i)eqA,app

(
1+
n
∑
j=1
(n− j + 1)σ′(j−1)1,app +
n
∑
j=1
jpi′(j)1,app
)
(1+ σ2 + pi2)
(4.69)
where V(i)f,app = k
(i)
f,app[A]tot, Vr = kr[A]tot, and K
(i)
eqA,app = KeqA
[
(1+ ξ)n + αiL0(1+ βξ)n
(1+ ξ)n + αi−1L0(1+ βξ)n
]
.
If it is assumed that enzyme A binds the T and R conformations of protein E with
equal affinities, Eq. 4.69 simplifies to
vAi =
Vfφi(n− i + 1)σ′(i−1)1 σ2
1− e′(i) · c′/(e′(i−1) · c)n− i + 1
i
KeqAφi

(
1+
n
∑
j=1
(n− j + 1)σ′(j−1)1 +
n
∑
j=1
jpi′(j)1
)
(1+ σ2 + pi2)
(4.70)
with φi =
[
(1+ ξ)n + αiL0(1+ βξ)n
(1+ ξ)n + αi−1L0(1+ βξ)n
]
.
We will not provide a detailed derivation of the reverse reaction, but simply state
that the rate of the ith reverse reaction, E′(i)  E′(i−1) + G, where i ∈ [1, n], is de-
scribed by
vBi =
V(i)f,appiσ
′(i)
app
1− e′(i−1) · g/e′(i)i
n− i + 1K
(i)
eqB,app

n
∑
j=1
jσ′(j)app + (1+ pi2)
(
1+
n
∑
j=1
jpi′(n−j)1,app
) (4.71)
where K(i)eqB,app = KeqB
[
(1+ ξ)n + αi−1L0(1+ βξ)n
(1+ ξ)n + αiL0(1+ βξ)n
]
. If it assumed that γ = 1, then
Eq. 4.71 becomes
vBi =
Vfφ−1i iσ
′(i)
1− e′(i−1) · g/e′(i)i
n− i + 1KeqBφ
−1
i

n
∑
j=1
jσ′(j) + (1+ pi2)
(
1+
n
∑
j=1
jpi′(n−j)1
) (4.72)
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with φ−1i =
[
(1+ ξ)n + αi−1L0(1+ βξ)n
(1+ ξ)n + αiL0(1+ βξ)n
]
.
Let us briefly consider the expression for φi in more detail. So far we have con-
sidered E simply as a protein that exhibits MWC-type conformational change. E
could, of course, also be an enzyme itself. Each covalent state of E could then
potentially catalyse a particular reaction, and one could derive a rate equation for
each state. The denominator for the rate equation of state E′(i) would be given by
(1+ ξ)n + αiL0(1+ βξ)n. In general, the expression for φi is thus the ratio of the de-
nominators of the rate equations for states E′(i−1) and E′(i), which allows expression
of φi for proteins with arbitrary numbers of ligand binding sites:
φi =
i product state rate denominator
i substrate state rate denominator
(4.73)
4.4 Application to a minimal model of feedforward
activation and covalent inhibition
In order to better illustrate the significance of the interaction between covalent and
classic allosteric modification, we considered the minimal feedforward activation
mechanism in which the regulated enzyme (enzyme 2) is also inhibited by covalent
modification as shown in Fig. 4.8. Binding of modifier X pushes the T/R equilibrium
towards the R conformation, whereas covalent modification pushes the equilibrium
towards T.
The main pathway comprises two enzymatic reactions. Enzyme 1 catalyses the
conversion of metabolite X to S according to classic reversible Michaelis-Menten ki-
netics:
v1 =
V1ξ1
(
1− s/x
Keq1
)
1+ ξ1 + σ1
(4.74)
where ξ1 =
x
K1x
and σ1 =
s
K1s
.
Enzyme 2, catalysing the conversion of S to P, is an irreversible MWC-type en-
zyme that has an allosteric binding site for X, which acts as an activator, and a cova-
lent modification site, of which modification leads to inhibition. Although the MWC
equation was initially developed to describe binding cooperativity in oligomeric en-
zymes, the behaviour we wish to explore here does not depend on cooperativity,
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Figure 4.8: Feedforward activation mechanism in which the regulated enzyme is inhibited
by covalent modification. Pathway precursor and allosteric modifier X activates enzyme 2,
an MWC-type enzyme that is inhibited by covalent modification. Since covalent modifica-
tion favours the T conformations and allosteric modification favours the R conformation,
modifier X promotes net reversal of covalent modification by inhibiting enzyme A, which
catalyses forward covalent modification, and activating enzyme B, which catalyses reverse
covalent modification. The reaction network consists of two modules not connected by mass
flow: the main pathway converting X to P with flux J1, and the pathway that catalyses the
interconversion between covalent states of enzyme 2 with flux J2.
but on the transition between the T and R conformations. To simplify analysis we
therefore choose n = 1. The rate of enzyme 2 is described by the sum of the rates
catalysed by the two enzymatic states (E20 and E21):
v2 =∑
i
v2i (4.75)
=∑
i
ckk2 · e2i · csσ2 · αiL0
(
1+ cxξ2
1+ ξ2
)
+ k2 · e2i · σ2
(1+ csσ2) αiL0
(
1+ cxξ2
1+ ξ2
)
+ (1+ σ2)
(4.76)
where k2 is the forward rate constant for the R conformation; ck is the factor by
which the rate constant for the T conformation differs from that of the R conforma-
tion so that ckk2 is the effective rate constant for the T conformation; e2i is the total
concentration of enzyme 2 in state i; σ2 = s/Kr2s and cs = Kr2s/Kt2s; ξ2 = x/Kr2x
and cx = Kr2x/Kt2x; Kr2s, Kt2s, Kr2x, and Kt2x are the intrinsic dissociation constants
with respect to S and X for the T and R conformations; α is the factor by which co-
valent modification alters L0; L0 is the allosteric constant; and i ∈ [0, 1]. We have
chosen cx < 1 so that modifier X prefers to bind to the R conformation, resulting in
activation by virtue of cs < 1 and/or ck < 1. Covalent modification was chosen as
inhibitory (α > 1).
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The rate equations for the forward modification reaction, catalysing the reaction
E20 +C′  E21 +C, and for the reverse modification reaction, catalysing the reaction
E21  E20 +G, are of the same form as Eqs. 4.70 and 4.72, but with n = 1:
vA =
φ · kA[A]tot · σA1 · σA2
(
1− e21c/(e20c
′)
φKeqA
)
(1+ σA1 + piA1) (1+ σA2 + piA2)
(4.77)
and
vB =
φ−1kB[B]tot · σB
(
1− e20g/e21
φ−1KeqB
)
σB + (1+ piB1) (1+ piB2)
(4.78)
where kA and kB are the forward rate constants for enzymes A and B; σA1 = e20/KAs1;
σA2 = c′/KAs2; piA1 = e21/KAp1; piA2 = c/KAp2; σB = e21/KBs; piB1 = e20/KBp1; and
piB2 = g/KBp2. The expression for φ is given by the denominator of v21 divided by
the denominator of v20:
φ =
(1+ csσ2) αL0
(
1+ cxξ2
1+ ξ2
)
+ (1+ σ2)
(1+ csσ2) L0
(
1+ cxξ2
1+ ξ2
)
+ (1+ σ2)
(4.79)
Note therefore, that all ligands of enzyme 2 are effectively also ligands of enzymes
A and B. We will consider the conditions that facilitate effective regulation of the
flux of this system by feedforward and covalent activation using metabolic control
analysis (MCA).
Metabolic control analysis
MCA [10, 11] is a theoretical framework that quantitatively relates the responses of
steady-state variables such as fluxes or variable metabolite concentrations to a per-
turbation in a system parameter such as the concentration of an enzyme, external
metabolite, or effector. Any such systemic response is a combination of local effects
(changes in the rates of individual enzymatic steps that are directly affected by the
perturbation) and systemic effects (changes in steady-state fluxes or metabolite con-
centrations caused by these rate changes in individual enzymatic steps). Local effects
are quantified by elasticity coefficients and systemic effects by control coefficients.
The elasticity coefficient is defined as
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ε
vi
sj =
∂ ln vi
∂ ln sj
∣∣∣∣∣
sk,sl ,...,pq,pr,...
(4.80)
where vi is the rate of any step i in the system, sj is any particular variable species
or parameter that directly affects the step, sk, sl, . . . are the other variable species
that directly affect the step, and pq, pr, . . . are the parameters of the step. Note that
all variables are set to their steady-state values. Although elasticities are defined in
terms of infinitesimal changes, they may be interpreted operationally as the percent-
age change in the rate of a step resulting from a 1% change in the value of sj. Alter-
natively, the elasticity coefficient is the slope of the graph of ln vi plotted against ln sj
at the steady-state value of sj.
The control coefficient is defined as
Cyvi =
∂ ln y
∂ ln vi
∣∣∣∣
vj,vk,...
(4.81)
where vi is defined as before, vj, vk, . . . are the rates of all other steps in the system,
and y is either a flux, in which case Cyvi is a flux-control coefficient, or a steady-state
metabolite concentration, in which case it is a concentration-control coefficient. The
control coefficient therefore quantifies the percentage change in a system variable
(flux or steady-state concentration) that results from a 1% change in the rate of step i.
The systemic response of a flux or steady-state metabolite concentration y to a
perturbation in any parameter pj is described by the response coefficient
Rypj =
∂ ln y
∂ ln pj
∣∣∣∣∣
pk,pl ,...
(4.82)
where pk, pl, . . . are all other system parameters, and the other symbols are defined
as before. The central statement of MCA is that the response coefficient of a param-
eter pj that affects a single step i can be partitioned as the product of the control
coefficient, quantifying the systemic effect, and the elasticity coefficient, quantifying
the local effect:
Rypj = C
y
viε
vi
pj (4.83)
More generally, if multiple steps are affected by a change in pj, the response coeffi-
cient is given by:
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Rypj =∑
i
Cyviε
vi
pj (4.84)
=∑
i
iRypj (4.85)
where i is an element of the set of all enzymatic steps that are directly affected by
a change in pj, and iR
y
pj = C
y
viε
vi
pj is the partial response coefficient, quantifying the
response of y to a change in pj through step i.
Modular control analysis
If a reaction network comprises two or more modules that are not connected by
mass flow, a distinction can be made between integral or global control coefficients,
describing the global control properties of the modular system, and intramodule
control coefficients, describing the control properties of a given module considered
in isolation [162]. The global control coefficient has the same definition (and is in fact
the same measure) as the control coefficient in Eq. 4.81, but a different symbol, G, is
used to distinguish it from the intramodule control coefficient:
Gyvi =
∂ ln y
∂ ln vi
∣∣∣∣
vj,vk,...
(4.86)
In contrast, the intramodule control coefficient is defined as
Cyvi =
∂ ln y
∂ ln vi
∣∣∣∣
vj,vk,...,yq,yr,...
(4.87)
where yq, yr, . . . are the variables of all other modules. The integral and intramodule
control coefficients have the same operational definition, i.e., it is the percentage
change in a steady-state variable that results from a one percent change in the rate
vi, and differ only in scope.
Control analysis of the modular system in Fig. 4.8
The reaction network in Fig. 4.8 comprises two separate modules that are not con-
nected by mass flow, namely, the main pathway from X through P (flux J1), and the
interconversion between states of enzyme 2 (flux J2). All the control coefficients of
this system, and thus also the response coefficients, can be expressed in terms of
elasticities. In the present analysis, we are particularly interested in the flux-control
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coefficients quantifying the control of flux J1 with respect to the enzymes in the main
and cyclical pathways (see Appendix B.1 for the solution of all control coefficients).
For the sake of clarity and brevity, we express the integral control coefficients in
terms of intramodule control coefficients where possible:
G J1v1 = 1− G J1v2 (4.88)
G J1v2 =
C J1v2
1+ Csv2C
e20
vA
∗εv2e20
(
εvBs − εvAs
) (4.89)
G J1vA = G
J1
v2
∗εv2e20C
e20
vA (4.90)
G J1vB = −G J1vA (4.91)
where
Ce20vA =
[(
εvBe20 − εvBe21 ·
e20
e21
)
−
(
εvAe20 − εvAe21 ·
e20
e21
)]−1
(4.92)
C J1v1 =
εv2s
εv2s − εv1s
(4.93)
C J1v2 =
−εv1s
εv2s − εv1s
(4.94)
Csv2 =
−1
εv2s − εv1s
(4.95)
∗εv2e20 = ε
v2
e20 − εv2e21 ·
e20
e21
(4.96)
While it may seem unusual that εvAs and ε
vB
s are potentially non-zero, it should be
remembered that all ligands of enzyme 2 are also indirect, but real, modifiers of
enzymes A and B (see Eqs. 4.77–4.79).
Conditions for effective feedforward and covalent activation
The conditions that will permit effective activation of flux J1 in response to an in-
crease in concentration x are those that maximize the response coefficient RJ1x . R
J1
x
can be expressed as the sum of partial response coefficients, each of which quantifies
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the response of J1 to X through one of four routes, namely, as substrate of enzyme
1, as feedforward activator of enzyme 2, as indirect inhibitor of A, and as indirect
activator of B:
RJ1x = 1R
J1
x +
2RJ1x + AR
J1
x +
BRJ1x (4.97)
A partial response coefficient iR
Jj
p is maximized when G
Jj
i and ε
i
p are maximized
(in absolute terms). If Jj is the flux of a linear pathway, the maximal value that G
Jj
i
can achieve is unity when enzyme i is in the same module as the flux Jj or any other
value, including negative values, when enzyme i is not in the same module as flux
Jj.
The partial response coefficient with respect to X through enzyme 1 is given by
1RJ1x = G
J1
v1ε
v1
x (4.98)
=
(
1− G J1v2
)
· εv1x (4.99)
and the partial response coefficient with respect to X through enzyme 2 is given by
2RJ1x = G
J1
v2ε
v2
x (4.100)
=
C J1v2
1+ Csv2C
e20
vA
∗εv2e20
(
εvBs − εvAs
) · εv2x (4.101)
It is clear that G J1v1 can only be maximized at the cost of minimizing G
J1
v2 , which would
however also disregard any response elicited by the allosteric regulation of enzyme
2. From a regulatory perspective, this represents an uninteresting scenario. Be-
sides, as we shall see, 1RJ1x is not necessarily maximized when G
J1
v1 is maximized.
We are therefore rather interested in the conditions that will maximize G J1v2 and ε
v2
x .
From Eq. 4.89 it is clear that the maximum value of G J1v2 tends to C
J1
v2 when the term
Csv2C
e20
vA
∗εv2e20
(
εvBs − εvAs
)
, which will always have a positive value, is minimized. This
condition will also cause G J1v1 to approach its minimum, namely, C
J1
v1 . Let us now, for
a moment, suppose that Csv2C
e20
vA
∗εv2e20
(
εvBs − εvAs
)
= 0, so that G J1v2 = C
J1
v2 and G
J1
v1 = C
J1
v1 .
It follows that G J1v2 → 1 and G J1v1 → 0 when
∣∣εv1s ∣∣  ∣∣εv2s ∣∣. This condition is achieved
if enzyme 1 is near equilibrium (εv1s → −∞) or if enzyme 2 is saturated with its
substrate (εv2s = 0). These are of course the extreme cases and combinations of both
strategies will also suffice. Note, however, that when enzyme 1 is near equilibrium,
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|εv1s | ' |εv1x |, so that, despite the vanishingly small value of C J1v1 , 1RJ1x will be approxi-
mately equal to εv2s .
As discussed by Hofmeyr et al. [16], saturation of enzyme 2 with its substrate
has important implications for the efficiency of the feedforward loop. In particular,
saturation with S will not only cause εv2s → 0, which is desirable, but will also affect
εv2x . Consider ε
v2
x at saturating s (see Eq. B.39 in Appendix B.2):
lim
σ→∞ ε
v2
x =
ckcsαiL0cxξ + ξ
ckcsαiL0(1+ cxξ) + (1+ ξ)
− csα
iL0cxξ + ξ
csαiL0(1+ cxξ) + (1+ ξ)
(4.102)
It is clear that if X has no catalytic effect or, put differently, that if the T and R confor-
mations exhibit the same maximal rate (ck=1) then ε
v2
x = 0. However, a difference in
the catalytic rates of the T and R conformation is not sufficient under all conditions
to ensure a non-zero value for εv2x . In particular, if the binding affinities of the T and R
conformations for S differ sufficiently
(
i.e. if cs  1αi L0
)
, then the terms in Eq. 4.102
that contain cs become negligible so that ε
v2
x again becomes zero. Our results there-
fore agree with those of Hofmeyr et al. [16], but with the added qualification that if
the enzyme in question (enzyme 2 in our case) is an MWC-type enzyme saturated
with substrate, then specific activation by X is not only insufficient to maximize εv2x ,
but will in fact let this value, and thus 2RJ1x , approach zero when it is sufficiently
strong
(
i.e. if cs  1αi L0
)
. If enzyme 2 were oligomeric, εv2x would increase with the
number of subunits, but even then a value for εv2x above 4 would be rarely encoun-
tered.
The term Csv2C
e20
vA
∗εv2e20
(
εvBs − εvAs
)
is minimized when either or all of its factors
are minimized. The value of
∣∣Csv2∣∣ is minimized by the same conditions that max-
imise C J12 . As is evident from Eq. 4.100 it is not desirable to minimize either
∗εv2e20 or∣∣Ce20vA ∣∣, which will also minimize the absolute values of G J1vA and G J1vB . Finally, the term(
εvBs − εvAs
)
is minimized when S saturates enzyme 2, or if S binds equally well to the
T and R conformation of enzyme 2 (Appendix B.2), in which case no specific acti-
vation of enzyme 2 by X is observed. Note that in order to ensure a maximal value
for G J1v2 if cs 6= 1, then
∣∣Csv2∣∣ must have a sufficiently small value to compensate for
the large value of
∣∣Ce20vA ∗εv2e20∣∣ that is necessary to maximize the response to X through
covalent regulation.
The expression for ARJ1x is given by
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ARJ1x = G
J1
vAε
vA
x
= G J1v2 · Ce20vA · ∗εv2e20 · εvAx (4.103)
We must therefore consider which conditions maximize the absolute values of the
four factors in Eq. 4.103. We have already considered G J1v2 and saw that its maximum
value, C J1v2 , is increased when
∣∣εv1s ∣∣  ∣∣εv2s ∣∣. However, if this condition is met by
virtue of saturating enzyme 2 with its substrate, then the effect on ∗εv2e20 and ε
vA
x must
also be considered. At saturating S and if cs  1αi L0 the value of
∗εv2e20 approaches
zero (see Appendix B.2). This stems from the fact that all states of enzyme 2 exhibit
identical kinetics when s is saturating; interconversion between these states are then
of no consequence to the activity of enzyme 2. Similarly, if cs  1αi L0 then ε
vA
x = 0 (see
Appendix B.2). This is explained by considering that, given these conditions, both
forms of enzyme 2 are predominantly in the R conformation, so that an increase in
X results in no significant further transition to the R form.∣∣Ce20vA ∣∣ is maximized when its denominator (εvBe20 − εvBe21 · e20e21)− (εvAe20 − εvAe21 · e20e21) is
minimized in absolute terms. If the reactions catalysed by A and B are considered
insensitive to their products and operate far from equilibrium, then εvBe20 = 0 and
εvAe21 = 0, so that C
e20
vA simplifies to (see Appendix B.2):
Ce20vA =
[
−εvBe21 ·
e20
e21
− εvAe20
]−1
(4.104)
=
[(
σB1
1+ σB1
− 1
)
· e20
e21
+
(
σA1
1+ σA1
− 1
)]−1
(4.105)
Thus we see that if both A and B are saturated with their respective substrates,
i.e., if σB1 → ∞ and σB1 → ∞, then Ce20vA → −∞. This condition is equivalent to
what has been termed zero-order ultrasensitivity by Goldbeter & Koshland [163] and
formulated in terms of MCA by Small & Fell [164]. Complete saturation is of course
not necessary and will in reality not necessarily be observed because of the presence
of competitive inhibitors such as the products of A and B.
The value of ARJ1x is therefore maximized if S saturates enzyme 2, but binds
equally well to both the T and R conformations (cs = 1). Alternatively, enzyme 1
should be near equilibrium. Interestingly, as long as X binds with different affinities
to the T and R conformations, the absence of specific activation (cs = 1) and catalytic
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activation (ck = 1) of enzyme 2 by X, will not result in a zero value for ε
vA
x . This re-
sults from the fact that only a conformational change (cx 6= 1) is required for enzyme
A to be sensitive to X. For this sensitivity to be relayed to flux J1, however, some form
of activation is required, preferably catalytic activation. In addition, both A and B
should exhibit reasonable substrate occupation. Since G J1vA = −G J1vB and εvAx = −εvBx
the same conditions that maximize ARJ1x will also maximize BR
J1
x = G
J1
vBε
vB
x .
In summary then, the conditions that maximize RJ1x are those that
• satisfy ∣∣εv2s ∣∣ ∣∣εv1s ∣∣
– i.e., enzyme 1 should be near equilibrium or enzyme 2 should be satu-
rated with substrate, with the condition that if the latter is the case, then
X should be a catalytic rather than specific activator of enzyme 2
• minimize (εvBs − εvAs )
– i.e., enzyme 2 should be saturated with substrate, or X must not be a spe-
cific activator of enzyme 2
• maximize ∗εv2e20
– i.e., the different forms of enzyme 2 must not have identical kinetics. This
condition is automatically met by our initial assumption that covalent
modification alters L0 by a factor of α. However, as we have seen, if X
is a specific activator of enzyme 2 and if enzyme 2 is saturated with sub-
strate, this condition is no longer necessarily met.
• maximize ∣∣Ce20vA ∣∣
– i.e., enzymes A and B must exhibit near zero-order sensitivity towards its
substrate and operate far from equilibrium
We have of course chosen X and S to be catalytic effectors of enzymes A and B.
This choice was, however, mandated by the fact that we chose α 6= 1. We excluded
any specific effects in the interest of simplicity and because they are not mandated
by choosing α 6= 1. We don’t expect the conditions identified here to change signifi-
cantly if these effects were included. We also expect similar conditions to maximize
RJ1x if enzyme 2 were an oligomeric enzyme.
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Feedforward activation and covalent modification contribute
synergistically to the flux response with respect to X
In the previous section we have stated that the contribution of X through each of four
mechanisms (as initial substrate, feedforward activator, inhibitor of A, and activator
of B) towards the flux is quantified by the partial response coefficients as in Eq. 4.97.
If then, for instance, 2RJ1x is larger than AR
J1
x , it can be said that X increases the flux
more through the feedforward loop than by inhibiting A. Although this is certainly
the case, we will here show that the contribution through the feedforward loop or
the contribution through inhibition of enzymes A or B, if quantified in isolation, is
an underestimation of the true contribution that is observed when both mechanisms
are present. Consider the following four variations on the system in Fig. 4.8:
• FF+COV: both the feedforward loop and covalent modification are present
• FF: only the feedforward loop is present
• COV: only covalent modification is present
• NONE: neither the feedback loop nor covalent modification is present
In FF covalent modification is removed, or more precisely, its effect on the kinetics
of enzyme 2 is abolished, by setting α = 1. This has the side-effect that εvAx = 0 and
εvBx = 0, so that Eq. 4.97 simplifies to
RJ1x = 1R
J1
x +
2RJ1x
= C J1v1ε
v1
x + C
J1
v2ε
v2
x (4.106)
Note however that εv2x is also affected since all the states of enzyme 2 now have
identical kinetics, i.e., that of the unmodified state:
εv2x =∑
i
v2i
v2
ε
v2i
x (4.107)
= εv20x ∑
i
v2i
v2
(since αi = 1 for all i) (4.108)
= εv20x (4.109)
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Since covalent modification was chosen as inhibitory and allosteric modification was
chosen as activatory, the value of εv2x decreases when covalent modification is abol-
ished.
Alternatively, in COV the feedforward loop is removed by letting Kr2x and Kt2x
approach infinity or by setting Kr2x = Kt2x. This has the result that ε
v2
x = 0, but
importantly εvAx and ε
vB
x again also become zero. Equation 4.97 then simplifies to
RJ1x = 1R
J1
x
= C J1v1ε
v1
x (4.110)
Finally, in NONE both the feedforward loop and covalent modification are re-
moved, yielding the same expression for RJ1x as COV (Eq. 4.110).
In summary, the presence of covalent modification not only increases RJ1x by in-
creasing 2RJ1x (through ε
v2
x ), but also results in two additional terms (AR
J1
x and BR
J1
x )
in the expression for RJ1x , leading to a further increase in flux response. However,
the presence of the feedforward loop is a prerequisite for these two additional terms
to be non-zero. We therefore see that the contributions of the feedforward loop and
covalent modification towards the flux response with respect to X cannot be quanti-
fied in isolation; the contribution of both these mechanisms depends on whether the
other is present. This finding is of consequence if one wishes to determine the rela-
tive importance of allosteric and covalent modification. By abolishing one of these
mechanisms by, for instance, mutation, the response through the other is likely to be
underestimated (Fig. 4.9).
4.5 Discussion
The results of the previous two chapters, namely that the kinetics of GS can be de-
scribed by an MWC-type model in which both allosteric and covalent regulation
elicit their effects by altering the apparent equilibrium between an inactive T and
active R conformation, led us to develop a formal treatment of the interaction be-
tween allosteric and covalent regulation. Although the MWC model is the standard
textbook model of GS regulation, we believe its implications have not been fully ap-
preciated, nor has it, to our knowledge, been employed in an actual treatment of
GS kinetics. In this chapter we set out to formalize the implications of interaction
between allosteric and covalent modification in a manner independent of whether
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Figure 4.9: The flux response with respect to X as a function of x for the feedforward system
in Fig. 4.8. The contribution of partial flux responses are stacked to add up to the overall
flux response coefficient (thick black line). In FF+COV the feedforward loop and covalent
modification are present. In FF or COV only the feedforward loop or covalent modification
is present. In NONE neither the feedforward loop nor covalent modification is present. Co-
valent modification alone is not sufficient to elicit a higher flux response than what is seen
when neither mechanism is present. Covalent modification does however increase 2RJ1x (com-
pare FF+COV and FF). The feedforward loop is necessary for any additional flux response
resulting from the inhibition of A and the activation of B by X. Parameters of the system
were chosen by taking the conditions that will maximize RJ1x , as discussed in the text, into
account. Suboptimal parameters were chosen for purposes of illustration: V1 = 50, K1x = 1,
K1s = 10, Keq1 = 10, ck = 0, k2 = 10, cs = 1, Kr2s = 1, cx = 0.1, Kr2x = 0.01, α = 6, L0 = 10,
Keq2 = 10, kF = 2, [A]tot = 5, KAs1 = 0.05, KAs2 = 0.1, KAp1 = 10, KAp2 = 10, KeqF = 10000,
kB = 2, [B]tot = 100, KBs1 = 0.05, KBp1 = 10, KBp2 = 10, KeqB = 10000, x = 10, s = 0, p = 0,
e20 = 1, e21 = 0, c′ = 1, c = 0, g = 0.
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the modification results in activation or inhibition and independent of the type of
covalent modification, e.g., phosphorylation. We showed that when covalent and al-
losteric modification act with opposing effects on an enzyme, covalent modification
will inhibit the binding of allosteric modifiers, and conversely an allosteric modifier
will inhibit covalent modification of the enzyme. In contrast, covalent modifica-
tion will, within a certain range, enhance the binding cooperativity of an allosteric
enzyme; whereas an allosteric modifier will enhance cooperativity with respect to
covalent modification.
The effect of covalent modification on allosteric modification is, to a certain ex-
tent, already contained in the classic MWC equation, where it can be considered as
an explicit change to the value of L0. The effect of allosteric modification on covalent
modification (over and above the apparent change to L0), on the other hand, must
be described in additional rate equations, i.e., the rate equations of forward and re-
verse covalent modification. We derived expressions for the modification terms that
must be included in such rate equations. Two findings in this regard are of note.
First, if covalent modification alters L0, then the forward or reverse rate constants of
the enzyme that catalyses the covalent modification must be multiplied by a mod-
ification term. Second, if the enzyme that catalyses the covalent modification has
different affinities for the two conformations of its substrate, then its Michaelis con-
stants must also be multiplied by modification terms. If, on the other hand, covalent
modification does not alter L0, then all modification terms, including those that mod-
ify the Michaelis constants, disappear. It has been shown in a number of cases that
the ligands of an enzyme affect the Vmax and/or Michaelis constants of kinases or
phosphatases that phosphorylate and dephosphorylate the enzyme (see for instance
[146, 165–168]), but to our knowledge a mechanism that formally explains this phe-
nomenon has not been developed. We derived general rate equations containing
the necessary modification terms for forward and reverse covalent modification of
MWC-type enzymes.
We applied the findings to a minimal feedforward system in which the allosteri-
cally regulated enzyme is also modified covalently. We limited the allosteric effect to
activation and the covalent effect to inhibition in an effort to mimic the mammalian
muscle glycogen synthesis pathway. It is, however, conceivable that similar results
will be obtained for feedback inhibition systems. A plausible system to study in
this regard would be the feedback system in which glucose-6-phosphate (G6P) in-
hibits glycogen phosphorylase (GP), an enzyme activated by phosphorylation. In
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agreement with the earlier findings of Hofmeyr et al. [16], we showed that the flux
response with respect to the feedforward modifier X, as mediated through the feed-
forward loop, is maximized if the regulated enzyme is saturated with its immediate
substrate S, but that under these conditions activation by X will only be effective if
it enhances the catalytic rate, as opposed to the substrate affinity, of the regulated
enzyme. In addition, however, we showed that not only is specific activation in-
sufficient to elicit a flux response with respect to X (due to the fact that the enzyme
is already saturated with its substrate), but also that it is detrimental to such a re-
sponse (due to the fact that sufficiently strong specific activation causes all of the
enzyme to be present in the R conformation, abolishing any further conversion to
the R conformation, and thus activation, by X).
We also studied the conditions that maximize the response of the system flux to
the indirect activation and inhibition of the forward and reverse covalent modifi-
cation reactions by X. Since both these responses are scaled by G J1v2 , the same con-
ditions that maximize the flux control of enzyme 2 (εv2s → 0) are expected to also
maximize these responses. Here it is, in one respect, of little consequence whether X
is a catalytic or specific activator of the regulated enzyme; instead, what is at stake
is whether X brings about a significant increase of enzyme in the R conformation
relative to enzyme in the T conformation. However, since in the MWC model such
conformational change always goes hand in hand with differential ligand affinities,
it is of consequence whether substrate binding favours the R conformation over the
T conformation, i.e., whether cs < 1. If the regulated enzyme is saturated with
its substrate and if the substrate’s preference for the R conformation is sufficiently
strong, then X will not be able to bring about any further conformational change,
so that the absolute values of G J1vA , G
J1
vB , ε
vA
x , and ε
vB
x are minimized. More generally,
any ligand or covalently bonded group that favours the same conformation as X to
a sufficiently strong degree will minimize the flux response with respect to X. We
emphasize the role of substrate S only because saturation with S is one condition
that will maximize G J1v2 .
Overall, these results indicate that in order to maximize the flux response with
respect to the allosteric modifier in a feedforward activation system in which the
regulated enzyme exhibits MWC kinetics and is potentially inhibited by covalent
modification, it is expected that the allosteric modifier should activate the regulated
enzyme by means of increasing its apparent maximal catalytic rate and not by means
of increasing its affinity for its immediate substrate. In fact, the presence of specific
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activation, which implies conformational change upon substrate binding, will de-
crease the flux response with respect to the allosteric modifier. Incidentally, these
conditions are in good agreement with the GS kinetic parameters determined in the
previous chapter. The optimized GS kinetic parameters indicate that the feedfor-
ward modifier G6P activates GS by increasing its maximal catalytic rate, but that in
the absence of ATP the substrate UDP-glucose (UDPG) binds with equal affinity to
the T and R conformations.
Covalent inhibition increases the flux response with respect to the allosteric mod-
ifier. This increase is the result of two distinct but related mechanisms. First, the ap-
parent L0 increases with the degree of covalent modification, which in turn increases
the value of εv2x and thus 2R
J1
x , the response elicited as a result of the feedforward loop.
Second, net covalent modification is inhibited by the allosteric modifier, resulting in
a sharper increase in flux, i.e., a larger response coefficient, with respect to changes
in x than is expected if only the feedforward loop were present. We thus see that
feedforward activation and covalent inhibition increase the flux response with re-
spect to X synergistically: covalent inhibition enhances the response elicited by the
feedforward loop, and the feedforward loop is a prerequisite for the response to in-
crease due to covalent inhibition. This situation illustrates that the response with
respect to X elicited by either of these mechanisms quantified in isolation, does not
reflect the response observed when both mechanisms are active.
The present treatment can be considered a combination and extension of the ear-
lier treatments by Small & Fell [164] and Hofmeyr et al. [16]. Small & Fell [164] in-
vestigated the conditions that will maximize the response of steady-state variables in
response to modifiers that affect the enzymes in a monocyclic covalent modification
cycle. Hofmeyr et al. [16], on the other hand, investigated the conditions required for
maximal efficiency of feedforward activation loops in which an allosteric enzyme is
activated by a substrate precursor in the pathway. While Small & Fell [164] were
only concerned with covalent modification and Hofmeyr et al. [16] were only con-
cerned with allosteric modification, our results show that the allosteric modifiers of
an enzyme must also act as modifiers of the enzymes that catalyse its covalent modi-
fication, particularly when the modified enzyme exhibits MWC-type kinetics. Apart
from the addition of allosteric modification, the present treatment differs from that
of Small & Fell [164] in a number of respects. First, the modification terms in the rate
equations for the enzymes catalysing the interconversion of enzyme 2 are not arbi-
trary but are governed by the kinetics of enzyme 2. Second, all ligands of enzyme 2
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are, and must be, considered effectors of the enzymes catalysing the interconversion
of enzyme 2. Third, both covalent states of enzyme 2 are considered active. Fourth,
by implication, all effectors have equal but opposite effects on the forward and re-
verse covalent modification enzymes. We show that, apart from the requirement
for zero-order sensitivity, the same conditions that maximize the response of an en-
zyme to its activator will also maximize the flux response to these ligands through
activation and inhibition of the enzymes in the covalent modification cascade.
It appears that, in the system considered here, the function of both the feedfor-
ward loop and covalent modification is to increase the response of the pathway flux
to metabolite X. If this system were to be included in a larger pathway, one could
consider the flux response coefficient RJ1x as the elasticity of the subsystem rate with
respect to changes in x. Since high elasticities generally indicate low flux control,
we conclude that the regulatory mechanisms in this pathway do not function to
regulate the flux through the pathway, but to maintain the concentration of metab-
olite X within narrow bounds. These findings have implications for the regulation
of glycogen synthesis. GS is often cited as the flux-controlling enzyme of glycogen
synthesis (see for instance [34, 51, 109, 127, 146, 169]). While this is almost certainly
true if one considers glycogen synthesis in isolation, i.e., excluding glucose uptake
and glycolysis, the results of this chapter suggest that in muscle glycogen metabo-
lism as a whole the regulation of GS, whether by allosteric or covalent modification,
functions to maintain intracellular concentrations of G6P within a narrow range and
not to control the flux. Glycogen synthesis is of course much more complicated than
the simple system considered here. First, in addition to activation by G6P, GS is also
inhibited by ATP. Second, GS is inhibited by phosphorylation at multiple sites per
subunit. Third, GS phosphorylation and the influx of glucose into muscle cells are
regulated by endocrine and other stimuli. We are now in a position to construct a
detailed model of glycogen metabolism and to analyse the regulatory design of this
complicated metabolic system.
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Modelling glycogen metabolism in
mammalian skeletal muscle
5.1 Introduction
Up to this point we have considered the kinetics of glycogen synthase (GS) in detail
and developed a rate equation that is able to describe these kinetics as altered by al-
losteric and covalent modification. We considered the theoretical implications of the
developed GS rate equation in a generic minimal model of feedforward activation
that resembles the glycogen synthesis pathway. We are now in a position to inquire
into the regulatory design of skeletal muscle glycogen metabolism using full-scale
detailed kinetic models.
A model of mammalian skeletal muscle glycogen metabolism is by its very na-
ture not expected to resemble quantitatively the skeletal glycogen metabolism of
any mammal in particular. Moreover, skeletal muscle is a heterogeneous tissue that
comprises fibre types that have traditionally been classified as either oxidative fast-
twitch or glycolytic slow-twitch fibres [170]. Four major fibre types are now distin-
guished according to the fibre’s speed of contraction and resistance to fatigue [170].
This classification can be further refined to many additional minor fibre types based
on, amongst other factors, the isoform of myosin expressed in the fibre. By defi-
nition, these fibre types differ widely in terms of metabolism, further complicating
attempts to model muscle metabolism. For the most part, the experimental data used
to construct our models of glycogen metabolism were obtained from published stud-
ies using enzymes purified from rodent muscle extracts. Our model results should
therefore more closely resemble non-oxidative fast-twitch muscle, the predominant
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fibre type in rodent muscle. In addition to the difficulty in confining our models to
a specific species and muscle fibre type, it is also subject to the usual critique lev-
elled against the treatment of metabolic systems as well-stirred reactors in which
metabolites are present at much larger concentrations than enzymes [171]. These
criticisms may be even more relevant when considering the highly structured na-
ture of muscle [171] and the fact that protein kinases and phosphatases are present
at concentrations comparable to their protein substrates. In spite of these difficulties,
we demonstrate (see Chapter 6) that the models presented here provide reasonable
quantitative descriptions of published experimental results.
Perhaps the greatest difficulty encountered when constructing a model is its pa-
rametrization. Parameter values reported in the literature are often of poor quality.
Reasons for this poor quality range from fitting parameters to linear transformations
that inflate error, through erroneously treating sigmoidal kinetics as hyperbolic ki-
netics, to determining bi-substrate parameters at non-saturating concentrations of
the co-substrate. Most important, however, is the fact that enzymes are often as-
sayed not under the conditions prevailing in the cell but at which they operate op-
timally. In a more robust, but time-consuming, approach one would experimentally
determine the kinetics of all model enzymes at conditions prevailing in the cell type
in question [172]. Such a treatment was not within the scope of the current project.
Where necessary, however, we redetermined kinetic parameters from published ex-
perimental data using non-linear regression. However, parametrized models are not
the only models that are useful. The structure and regulatory features of a metabolic
system on its own, informed by how one would model it, provide a framework
within which experimental results can be interpreted.
In a kinetic model the time derivatives of metabolite concentrations are described
in terms of reaction stoichiometry and the rates of reactions that produce or consume
the metabolite in question, together constituting a system of ordinary differential
equations. It is therefore necessary to obtain rate equations for all enzymatic rates,
transport processes, and mass-action reactions. All enzymatic and transport rates
were described with reversible rate equations of the form [173]
v = VfK(s, p, x, . . . )
(
s− p
Keq
)
(5.1)
where Vf is the maximal forward rate; K(s, p, x...) is a positive binding function of
substrates s, products p, and modifiers x; and Keq is the equilibrium constant. This
form does not contain the maximal velocity of the reverse reaction (Vr), which is
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seldom determined experimentally, and ensures thermodynamic consistency by ex-
plicitly including the Keq. An exception in this regard are the rate equations of GS
and glycogen phosphorylase (GP) which were modelled as irreversible reactions.
In what follows, basic knowledge of enzyme kinetics is assumed. Kinetic param-
eters, such as the Michaelis constant, will not be defined for each reaction. The pa-
rameter naming scheme roughly follows the format Pc,E,M, where P is any parameter
further qualified by the subscript c. E and M denote the enzyme or process and me-
tabolite or species to which the parameter pertains. Ki,HK,ADP is then the Michaelis
constant that describes inhibitory binding of ADP to hexokinase (HK). For the sake
of readability, where it is clear from the context, subscripts and commas are omitted.
Unless stated otherwise, identical symbols in different equations do not denote the
same parameters.
Although great care was taken to include all the relevant reactions and the mod-
ifiers that affect these reactions, our main goal was to investigate the regulatory
design of glycogen metabolism. As such we did not include reactions that would
complicate the models unnecessarily without providing more insight in this regard.
In what follows, we first give an overview of glycogen metabolism as a basis
for our choice of included reactions and their rate equations. We consider glycogen
metabolism as a system that comprises several individual metabolic modules, with
an emphasis on glycogen synthesis. Finally, we combine these modules in several
models, of varying scope, of glycogen metabolism, and briefly discuss the software
used in this process.
5.2 Glycogen metabolism
Glucose uptake and GLUT4 trafficking
Glucose is imported into muscle from the interstitial tissue by means of facilitated
transport. Two transmembrane glucose transporters, glucose transporter 1 (GLUT1)
and glucose transporter 4 (GLUT4), are present in muscle [174]. GLUT1, which is
constitutively located in the sarcolemma [175, 176], is present at about 10 to 60% the
levels of GLUT4 [174]. Under basal conditions, however, only about 5% of GLUT4
is located in the sarcolemma or in T-tubules, deep invaginations in the sarcolemma
[177, 178]. It has been suggested that GLUT1 could contribute significantly to basal
glucose uptake, but there is no conclusive evidence for this [174]. The majority
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of GLUT4 is located in intracellular vesicles cycling between as many as 11 dis-
tinct cytosolic pools, involving GLUT4-storage vesicles, endosomes, the trans-Golgi
network, and numerous protein complexes [178]. Insulin stimulation and exercise
result in rapid translocation of cytosolic GLUT4 to the sarcolemma and T-tubules.
Insulin stimulation increases plasma membrane GLUT4 to 40–50% of total GLUT4
[177]. Under these conditions GLUT4 accounts for the majority of glucose uptake
[174]. Insulin regulates GLUT4 trafficking through the insulin-PI3K-Akt axis [179].
In this axis insulin binds to the insulin receptor resulting in the activation of insulin
receptor kinase which phosphorylates insulin receptor substrate proteins. These
recruit PI3-kinase (or PI3K), which converts phosphatidylinositol(4,5)P2 to phos-
phatidyl(3,4,5)P3 (or PIP3). PIP3 indirectly activates protein kinase B (Akt2), which
in turn phosphorylates various substrates leading to the recruitment of GLUT4 to the
plasma membrane. While the molecular mechanism has not been fully elucidated,
it is thought that the net increase in cell surface GLUT4 is the result of increased
exocytosis and not the result of decreased endocytosis [180].
In spite of the complexity of GLUT4 trafficking and the insulin-PI3K-Akt axis,
we modelled insulin stimulation of exocytosis by including a hyperbolic catalytic
activation term in the GLUT4 rate equation (Eq. 5.3).
In terms of glucose transport kinetics GLUT1 is probably the best-studied glu-
cose transporter. Interest in GLUT1 kinetics arose from the observed 10-fold lower
Vmax and Km for entry into a glucose-free cell (zero-trans entry) than the correspond-
ing parameters for exit into a glucose free medium (zero-trans exit) [181]. Moreover,
the Km for entry is higher when determined from equilibrium exchange experiments
(the glucose concentration is varied inside and outside but kept equal; labelled glu-
cose is initially absent on the inside) than from zero-trans experiments or infinite-
trans experiments (internal glucose is saturating while external glucose is varied)
[182]. GLUT1 asymmetry has been challenged by observations that the asymmetry
is reduced or absent when working with ghost cells (erythrocytes of which the cy-
tosol is replaced with medium) or inside-out vesicles, suggesting that asymmetry
results from interaction of cytosolic factors with the intracellular epitopes of GLUT1
[183]. It has indeed been shown that ATP inhibits GLUT1 and brings about asym-
metry [184]. Others [182] have also argued that GLUT1 asymmetry is overestimated
due to experimental difficulties, favouring the position that GLUT1 is intrinsically
symmetric. As a further argument against GLUT1 asymmetry, it has been shown
that the mobile carrier model, one of two models commonly used to describe trans-
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porter kinetics [181], when adapted for asymmetry, is thermodynamically unsound
[185]. This finding does, however, not completely rule out asymmetry, which can
still be accounted for by a fixed site model [185]. Although GLUT1 assymetry has
been observed in human erythrocytes, it has not been observed in rat and rabbit
erythrocytes, nor in rat adipocytes and CHO fibroblasts [182]. In contrast, it is well-
established that GLUT4 glucose transport is symmetric [186].
We modelled the transport of glucose into the muscle cell (Glco 
 Glci) by
GLUT1 and GLUT4 with reversible Michaelis-Menten equations in which symmet-
ric glucose binding was assumed. As discussed, an insulin activation term was in-
cluded in the GLUT4 equation.
vGLUT1 =
kcat[GLUT1]
KGlc
(
[Glco]− [Glci]Keq
)
1+
[Glco]
KGlc
+
[Glci]
KGlc
(5.2)
vGLUT4 =
kcat[GLUT4mem]
KGlc
(
[Glco]− [Glci]Keq
)
1+
[Glco]
KGlc
+
[Glci]
KGlc
×
[Ins]
EC50Ins
1+
[Ins]
EC50Ins
(5.3)
The rate equation for total glucose transport is given by
vGLUT = vGLUT1 + vGLUT4 (5.4)
Since the equilibrium constant for transport of glucose across the sarcolemma
is equal to one, net import of glucose by GLUT1 and GLUT4 is only possible in
the presence of a glucose concentration gradient. This gradient is maintained by
hexokinase which phosphorylates glucose to glucose-6-phosphate (G6P) upon en-
try into the cell. Two isoforms of hexokinase, hexokinase 1 (HK1) and hexokinase 2
(HK2), are present in muscle. HK2 is the predominant form in rat muscle, whereas
in human muscle, based on the percentage contribution to total hexokinase activ-
ity (70–75%), HK1 is the predominant form [187]. The majority of HK1 (95%) and
HK2 (72%) is recovered in a particulate fraction during extraction [187]. It has been
shown that insulin stimulation leads to the translocation of HK2, but not HK1, to
the particulate fraction within 30 minutes of treatment with no apparent increase
in total HK2 protein [188]. Two hours after treatment, an increase in HK2 mRNA
and protein is observed, with an increase in soluble fraction HK2 [189]. No increase
in HK1 protein is observed. As reviewed in [190], HK1 readily associates with the
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mitochondrial membrane protein, porin, possibly explaining its recovery in the par-
ticulate fraction. This association is mediated by a targeting hydrophobic region
near the N-terminal of HK1 that is also present in HK2. It has been postulated that
association with the mitochondrion provides ‘privileged’ access to ATP produced
during oxidative phosphorylation. It has also been shown that the Km for ATP is
lowered and that G6P inhibition is reduced [191]. Whether these are real changes to
hexokinase kinetics or simply the result of an increased apparent ATP concentration
is not known.
It is thought that HK1 and HK2, both monomeric 100 kDa proteins, are the prod-
ucts of gene duplication and fusion of an ancestral gene coding for a 50 kDa protein
[190]. This position is supported by a high degree of amino acid sequence similar-
ity between the N-terminal and C-terminal halves, and between these halves and
50 kDa hexokinases such as hexokinase 4 (often denoted glucokinase). Only the C-
terminal half of HK1 has a functional catalytic site, but the N-terminal half is still
able to bind G6P and ATP [192]. In contrast, catalytic activity is retained in both the
C-terminal and N-terminal halves of HK2 [193, 194]. It has also been shown that
binding of glucose to the N-terminal half increases the affinity for G6P of the C-half,
which is otherwise higher than that of the N-half [195]. When expressed as discrete
proteins, the C-half of HK1 [192] and the C- and N-halves of HK2 [193] are inhibited
by G6P. The extent to which binding of G6P to one domain inhibits the other is not
clear.
In our treatment of HK kinetics we have assumed that any interaction between
the C- and N-terminal domains is already contained in the apparent kinetic param-
eters of bi-substrate rate equations and have therefore not included any explicit
interaction between these domains. Glucose phosphorylation by HK1 and HK2
(Glci +ATP
 G6P+ADP) was modelled with the reversible bi-substrate Michaelis-
Menten equation with random binding order. Since G6P also binds to the adenylate
site and ADP also binds to the sugar site [196], additional competive inhibition terms
for these ligands were included. Translocation to mitochondria and the possible ac-
companying change in kinetics were not considered. The identical rate equations for
HK1 and HK2 are given by
vHK1 =
Vmax
KGlciKATP
(
[Glci][ATP]− [G6P][ADP]Keq
)
(
1+
[Glci]
KGlci
+
[G6P]
KG6P
+
[ADP]
K′ADP
)(
1+
[ATP]
KATP
+
[ADP]
KADP
+
[G6P]
K′G6P
) (5.5)
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Figure 5.1: Glucose uptake pathway. External glucose is transported into the cell by GLUT1
and GLUT4 and then phosphorylated by HK1 and HK2 to produce G6P. Apart from normal
product inhibition, G6P and ADP also compete with ATP and Glci, respectively.
and
vHK2 =
Vmax
KGlciKATP
(
[Glci][ATP]− [G6P][ADP]Keq
)
(
1+
[Glci]
KGlci
+
[G6P]
KG6P
+
[ADP]
K′ADP
)(
1+
[ATP]
KATP
+
[ADP]
KADP
+
[G6P]
K′G6P
) (5.6)
The overall rate of glucose phosphorylation is given by
vHK = vHK1 + vHK2 (5.7)
The glucose uptake module is depicted in Fig. 5.1. From here G6P is either chan-
nelled into glycogen synthesis or glycolysis. G6P can also be considered the product
of glycogen degradation.
Glycogen synthesis
Phosphoglucomutase (PGLM) catalyses the reaction that converts G6P to glucose-1-
phosphate (G1P), exhibiting typical reversible Michaelis-Menten kinetics [197]. The
rate equation for PGLM is given by
vPGLM =
Vmax
KG6P
(
[G6P]− [G1P]
Keq
)
1+
[G6P]
KG6P
+
[G1P]
KG1P
(5.8)
UDPG-pyrophosphorylase (UPP) converts UTP and G1P to UDP-glucose (UDPG)
and pyrophosphate (PPi). Two isoforms, the products of alternative splicing of the
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same gene, are present in muscle [198]. Isoform 1, UDPG-pyrophosphorylase 1
(UPP1), exhibits hyperbolic kinetics towards all substrates, whereas isoform 2, UDPG-
pyrophosphorylase 2 (UPP2), exhibits sigmoidal kinetics with respect to PPi and
possibly G1P. Only UPP1 was included in the model, as detailed kinetic parame-
ters for UPP2 are not available. UPP1 was modelled with the reversible bi-substrate
Michaelis-Menten equation with random reactant binding order:
vUPP =
Vmax
KUTPKG1P
(
[UTP][G1P]− [UDPG][PPi]
Keq
)
(
1+
[UTP]
KUTP
+
[PPi]
KPPi
)(
1+
[UDPG]
KUDPG
+
[G1P]
KG1P
) (5.9)
GS catalyses the incorporation of the glucose moiety from UDPG into an existing
glycogen chain. As discussed in Chapter 2, GS is not capable of de novo glycogen syn-
thesis, but instead relies on glycogenin and branching enzyme to produce glycogen
primers and new branches that can be elongated by GS. The complex regulation of
GS by allosteric and covalent modification is discussed in Chapter 2. A rate equation
that provides a good description of GS kinetics was developed in Chapter 3. Glyco-
genin and branching enzyme were not included in the model. GS was modelled
with Eq. 3.42, repeated here for convenience:
vGS =∑
ij
kcat,r[GS]ijn
[UDPG]
KUDPG
(
1+
[UDPG]
KUDPG
+
[ATP]
K′r,ATP
)n−1
(
1+
[UDPG]
KUDPG
+
[ATP]
K′t,ATP
)n
L0ij

1+
[G6P]
Kt,G6P
+
[ATP]
Kt,ATP
1+
[G6P]
Kr,G6P
+
[ATP]
Kr,ATP

n
+
(
1+
[UDPG]
KUDPG
+
[ATP]
K′r,ATP
)n
(5.10)
where i and j denote the phosphorylation states of the N-terminal and C-terminal
phosphorylation clusters.
Equation 5.10 can be rewritten as (Appendix A.1):
vGS =
kcat,r[GS]n
[UDPG]
KUDPG
(
1+
[UDPG]
KUDPG
+
[ATP]
K′r,ATP
)n−1
(
1+
[UDPG]
KUDPG
+
[ATP]
K′t,ATP
)n
L0,app

1+
[G6P]
Kt,G6P
+
[ATP]
Kt,ATP
1+
[G6P]
Kr,G6P
+
[ATP]
Kr,ATP

n
+
(
1+
[UDPG]
KUDPG
+
[ATP]
K′r,ATP
)n
(5.11)
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where
L0,app =
∑
ij
[GS]ij
∆ij
L0ij
∑
ij
[GS]ij
∆ij
(5.12)
∆ij =
(
1+
[UDPG]
KUDPG
+
[ATP]
K′t,ATP
)n
L0ij

1+
[G6P]
Kt,G6P
+
[ATP]
Kt,ATP
1+
[G6P]
Kr,G6P
+
[ATP]
Kr,ATP

n
+
(
1+
[UDPG]
KUDPG
+
[ATP]
K′r,ATP
)n
(5.13)
Equation 5.12 can also be written as
L0,app =
∑
ij
tij
∑
ij
rij
(5.14)
which shows its resemblance to the original definition of L0:
L0 =
t
r
(5.15)
where t and r are the concentrations of unliganded enzyme in the T and R conforma-
tions. Despite this similarity, in the original definition L0 is independent of ligand
concentrations, whereas L0,app is not.
Note that L0,app is a function of the concentrations of GS in its various phospho-
rylation states and the L0 values for each state ij. Any change in the phosphorylation
state of GS is reflected in the value of L0,app. L0,app assumes its minimum value, L000
when GS is completely dephosphorylated, and its maximum value, L02a3a, when GS
is completely phosphorylated. The phosphorylation and dephosphorylation of GS
may therefore be mimicked by treating L0,app as a parameter, designated L0, of which
the values range between L000 and L02a3a.
In models that did not explicitly include the interconversion between the various
GS phosphorylation states, we therefore used the following rate equation for GS:
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G6P PGLM G1P UPP
UTP PPi
UDPG GS Glcn+1
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Figure 5.2: Glycogen synthesis pathway. PGLM converts G6P to G1P, which is converted
to UDPG by UPP. GS incorporates the glucose moiety from UDPG into an existing glycogen
chain. G6P activates GS by binding to an allosteric site.
vGS =
kcat,r[GS]n
[UDPG]
KUDPG
(
1+
[UDPG]
KUDPG
+
[ATP]
K′r,ATP
)n−1
(
1+
[UDPG]
KUDPG
+
[ATP]
K′t,ATP
)n
L0

1+
[G6P]
Kt,G6P
+
[ATP]
Kt,ATP
1+
[G6P]
Kr,G6P
+
[ATP]
Kr,ATP

n
+
(
1+
[UDPG]
KUDPG
+
[ATP]
K′r,ATP
)n
(5.16)
The glycogen synthesis pathway is depicted in Fig. 5.2.
Glycogen degradation and glycogen phosphorylase
phosphorylation
GP, a dimeric enzyme, catalyses the reaction in which the terminal glucose residue
from a non-reducing end of a glycogen chain is phosphorylated and cleaved from
the chain, releasing it as G1P: Glcn+1 + Pi 
 Glcn + G1P [31, 199]. Under resting
conditions, GP exists primarily in an inactive form GPb which can be converted to
the active form GPa by phosphorylation of Ser14 catalysed by activated phospho-
rylase kinase (PhK) (Fig. 5.4). Dephosphorylation of GPa is catalysed by protein
phosphatase 1 (PP1). Both GP subunits undergo phosphorylation, which allows for
an intermediate phosphorylation state (ab form) to exist. Apart from the covalent
regulation, GP is also regulated by several modifiers at three allosteric binding sites
[31, 199]. The first site, which can be considered the activation site, binds AMP and
ATP which leads to activation. The AMP affinity of this site is much greater than the
ATP affinity. G6P and glucose also bind to this site, but result in potent inhibition
[200]. The second site, often termed the ‘nucleoside site’, also binds AMP and ATP,
but, in contrast to the activation site, this results in inhibition [199, 201]. The AMP
affinity of this site is, however, much lower than the ATP affinity, so that inhibition
by AMP only occurs at supra-physiological concentrations. Finally, GP has a high-
affinity non-catalytic glycogen binding site, which is believed to keep the enzyme
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Glcn+1 GP G1P PGLM G6P
GlcnPi
Figure 5.3: Glycogen degradation pathway. GP cleaves a terminal glucose moiety from a
glycogen chain in a phosphorolysis reaction to produce G1P. G1P is in turn converted to
G6P by PGLM. G6P is an allosteric inhibitor of GP. Note, however, that G6P is not included
as a GP inhibitor in the model by Lambeth & Kushmerick [19].
GPb
PhKP
PP1
GPa
Figure 5.4: GP phosphorylation pathway. Dephosphorylated GPb is phosphorylated at
Ser14 by activated PhK to produce GPa. The corresponding phosphatase reaction which
converts GPa to GPb is catalysed by PP1. Co-substrates and co-products are not shown.
in tight association with glycogen between individual catalytic events [31, 199]. GP
kinetics is most often described in terms of the Monod-Wyman-Changeux (MWC)
model, with the prevailing hypothesis that phosphorylation and activation by al-
losteric modifiers stabilize an active R conformation, whereas dephosphorylation
and inhibition stabilize an inactive T conformation [31, 199]. It has been suggested
that a three-state MWC model provides a significantly better description of GP ki-
netics than the conventional two-state model [201].
We modelled GP with the same Hill-like rate equation used by Lambeth & Kush-
merick [19]:
vGP =
fGPaVmax
Ki,GlyKPi
(
[Pi][Glcres]− [G1P][Glcres]Keq
)
1+
Glcres
KGlyf
+
[Pi]
KPi
+
[Glcres][Pi]
KGlyfKi,Pi
+
[Glcres]
KGlyb
+
[G1P]
KG1P
+
[Glcres][G1P]
KGlybKi,G1P
+
(1− fGPa)Vmax
Ki,GlyfKPi
(
[Pi][Glcres]− [G1P][Glcres]Keq
)
[AMP]h
αKhAMP
1+
[AMP]h
αKhAMP

1+
[Glcres]
Ki,Glyf
+
[Pi]
Ki,Pi
+
[Glcres]
Ki,Glyb
+
[G1P]
Ki,G1P
+
[Glcres][Pi]
Ki,GlyfKPi
+
[Glcres][G1P]
KG1PKi,Glyb
(5.17)
As explained in the supplementary material to [202], the parameter values for the
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AMP activation term in the original model of Lambeth & Kushmerick [19] are incor-
rect. We here use the corrected parameter values for the GPb rate equation as given
in [202]. Alternatively, where indicated, we modelled GP with a three-state MWC
equation of the form:
vGP =
fGPa kcat,r[GP]n
[Pi]
Kr,Pi
(
1+
[Pi]
Kr,Pi
+
[G1P]
Kr,G1P
)n−1
(
1+
[Pi]
Kr,Pi
+
[G1P]
Kr,G1P
)n
+ Lu
(
1+
[Pi]
Ku,Pi
+
[G1P]
Ku,G1P
)n1+
[AMP]
Ku,AMP
+
[G6P]
Ku,G6P
1+
[AMP]
Kr,AMP
+
[G6P]
Kr,G6P

n1+
[ATP]
Ku,ATP
1+
[ATP]
Kr,ATP

n
+
(1− fGPa )kcat,r[GP]n
[Pi]
Kr,Pi
(
1+
[Pi]
Kr,Pi
+
[G1P]
Kr,G1P
)n−1
(
1+
[Pi]
Kr,Pi
+
[G1P]
Kr,G1P
)n
+ Lt
(
1+
[Pi]
Kt,Pi
+
[G1P]
Kt,G1P
)n1+
[AMP]
Kt,AMP
+
[G6P]
Kt,G6P
1+
[AMP]
Kr,AMP
+
[G6P]
Kr,G6P

n1+
[ATP]
Kt,ATP
1+
[ATP]
Kr,ATP

n
(5.18)
The three-state MWC model differs from the classic two-state MWC model only in
that a third conformation (here indicated by U) is present in addition to the con-
ventional T and R conformations. The U conformation may differ from the T and
R conformations in catalytic capacity and ligand affinities. In Eq. 5.18 only the R
conformation is catalytically active. See Appendix C.2 for the development of this
equation. In addition to describing AMP activation, it also includes terms describ-
ing ATP and G6P inhibition. Note that this equation is irreversible and contains no
glycogen binding terms.
GP phosphorylation is described by explicitly altering the fraction of the enzyme
in the phosphorylated and dephosphorylated forms. As such, no GP kinase and
phosphatase reactions were considered.
G1P produced by GP is converted to G6P by PGLM, the same enzyme that catal-
yses the reverse reaction in glycogen synthesis. The overall glycogen degradation
pathway is depicted in Fig. 5.3.
Glycolysis
In glycolysis ATP is produced during the conversion of G6P to lactate according to
the net reaction
G6P+ 2 Pi + 3 ADP
 2 lactate+ 2 H2O+ 3 ATP (5.19)
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Figure 5.5: Glycolysis pathway as defined by Lambeth & Kushmerick [19]. G6P is converted
to two molecules of lactate with an accompanying net production of ATP. An ATPase reac-
tion is included as an ATP demand.
We will not here provide a detailed discussion of muscle glycolysis. We used an
implementation of the model of muscle glycolysis by Lambeth & Kushmerick [19].
The glycolysis pathway, as in [19], is depicted in Fig. 5.5.
Where indicated, we used an abbreviated form of the glycolysis pathway which
only includes the phosphoglucose isomerase (PGI) reaction and a quasi zero-order
fructose-6-phosphate (F6P) sink reaction representing the remainder of the glycoly-
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G6P PGI F6P sink
Figure 5.6: Abbreviated glycolysis pathway. Only the PGI reaction from Lambeth & Kush-
merick [19] is included. The remainder of the glycolysis pathway is modelled with a quasi
zero-order sink reaction.
sis pathway. The sink reaction was modelled with an irreversible Michaelis-Menten
equation (Eq. 5.20).
vsink =
Vmax[F6P]
[F6P] + KF6P
(5.20)
Although phosphofructokinase (PFK) is the immediate consumer of F6P, the kinetics
of the sink reaction is really determined by the ATPase (or myosin) reaction, which
controls the flux local to the sink block. The kinetic parameters of the sink reaction
were therefore based on the values for the ATPase reaction. The abbreviated glycol-
ysis pathway is shown in Fig. 5.6.
Cyclic AMP-dependent signalling cascade and related reactions
Upon stimulation of a membrane G-coupled receptor protein by catecholamines
such as adrenaline, its α-subunit is activated and released [203]. The activated α-
subunit in turn activates the enzyme adenylyl cyclase which catalyses the conversion
of ATP to cyclic AMP (cAMP). Two molecules of cAMP bind each regulatory sub-
unit of the R2C2 cAMP-dependent protein kinase (PKA) holoenzyme leading to the
stepwise dissociation and activation of the two catalytic subunits. Several protein
substrates of PKA can induce the dissociation of catalytic and regulatory subunits
by competing with the regulatory subunit [139]. PKA inhibitor associates with the
free catalytic subunit to inhibit it. A summary of the cAMP-dependent activation of
PKA is depicted in Fig. 5.7.
The stepwise activation of PKA in response to cAMP and the sequestration of
the free catalytic subunit of PKA by the PKA inhibitor protein can be considered as
effectively changing the PKA concentration. Since these processes add degrees of
freedom to the model parameter space, but affect only a single variable of interest,
we instead modelled this variable, the concentration of PKA, as a fixed value that
can be varied explicitly.
PKA phosphorylates and activates both PhK and protein phosphatase inhibitor 1
(I1). Activated I1 binds to PP1 and inhibits it. Activated PhK is dephosphorylated
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Figure 5.7: Cyclic AMP-dependent activation of PKA. The PKA holoenzyme (R2C2) dissoci-
ates in a stepwise manner in response to cAMP, which binds to the regulatory R subunits, to
release the catalytic subunit C (here designated PKA). PKA is inhibited by the PKA inhibitor
protein (PKI).
and inactivated by PP1, whereas activated I1 is dephosphorylated by protein phos-
phatase 2A (PP2A).
Activation and deactivation of PhK were modelled with random order bi-substrate
and uni-bi Michaelis-Menten equations. As a simplifying assumption, product bind-
ing was considered negligible:
vPKA,PhK =
kcat[C]
KPhKKATP
(
[PhK][ATP]− [PhKP][ADP]
Keq
)
(
1+
[PhK]
KPhK
)(
1+
[ATP]
KATP
) (5.21)
and
vPP1,PhKP =
kcat[PP1]
KPhKP
(
[PhKP]− [PhK][Pi]
Keq
)
(
1+
[PhKP]
KPhKP
) (5.22)
Activation and deactivation of I1 were modelled with similar equations as for
PhK, but with PP2A as the phosphatase:
vPKA,I1 =
kcat[PKA]
KI1KATP
(
[I1][ATP]− [I1P][ADP]
Keq
)
(
1+
[I1]
KI1
)(
1+
[ATP]
KATP
) (5.23)
and
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vPP2A,I1P =
kcat[PP1]
KI1P
(
[I1P]− [I1][Pi]
Keq
)
(
1+
[I1P]
KI1P
) (5.24)
Inhibition of PP1 by activated I1 was modelled with mass-action kinetics:
vPP1 inhibition = kf[PP1][I1P]− kr[PP1 · I1] (5.25)
This treatment of cAMP-dependent signalling is loosely based on the model of
Mutalik & Venkatesh [204].
Glycogen synthase phosphorylation
We have discussed the hierarchical sequential phosphorylation of GS and the ki-
nases and phosphatases involved therein in detail in Chapter 2. We have also shown
in Chapter 3 that, even if all subunits are considered equivalent and strict sequen-
tial phosphorylation is assumed, GS can theoretically exist in 1890 kinetically distinct
states. One way in which the large number of phosphorylation states can be avoided,
is to make the additional simplifying assumption that phosphorylation and dephos-
phorylation of the same site on all the subunits of the tetramer are all-or-none, so
that if a particular site is phosphorylated, it is also simultaneously phosphorylated
on the remaining three subunits. The number of GS phosphorylation states then
decreases to 18. This assumption is similar to the assumption of infinitely coopera-
tive binding in the Hill model [87], but differs in that here it is catalysis, as opposed
to ligand binding, that is all-or-none. Unfortunately, several potentially interesting
phenomena are partially lost when this assumption is made. First, cooperativity of
phosphorylation with respect to the same site on different subunits is lost. Second,
the effect of modifiers and phosphorylation of other sites on the phosphorylation
of a particular site can only be described by an approximation that exaggerates in-
hibitory and activatory effects. To lessen the severity of these limitations we have
adopted a subtle variation of this assumption.
In order to approximate the per-subunit nature of GS phosphorylation, without
explicitly modelling all the possible intermediate phosphorylation states at a partic-
ular site, and the states that arise from combinations of intermediate states at differ-
ent sites, we modelled subunits as independent entities each able to exist in one of
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18 phosphorylation states. As would be the case for the tetramer, the conversion be-
tween the states of the monomer is catalysed by kinase and phosphatase reactions.
In the rate equation for GS the enzyme was, however, modelled as a tetramer com-
posed of subunits with identical phosphorylation states, so that the total number of
tetrameric states is also 18. The 18 tetrameric states were assumed to be present in
the same relative proportions as the 18 monomeric states. In its capacity as kinase
and phosphatase reagent, GS was therefore treated as a monomer, but in its capacity
as enzyme, it was considered a tetramer formed by the complexing of four identi-
cally modified monomers.
We have shown in Chapter 4 that kinases and phosphatases are indirectly af-
fected by the covalent and allosteric modification of their substrates if this mod-
ification results in conformational change. These effects manifest as modification
terms of either the forward or reverse maximal carrier capacity of the kinase or
phosphatase. For the kinase reaction in which an n-meric enzyme with a single
phosphorylation site per subunit is systematically phosphorylated in n steps, this
modification term for the ith step, assuming the kinase has no preference for one
conformation over another (γ = 1, see Chapter 4), takes on the form
φi =
1+ αiL
1+ αi−1L
(5.26)
where i ∈ [1, n] is the number of phosphorylated subunits before catalysis, n is the
number of subunits, and α is the factor by which each additional phosphate alters the
apparent equilibrium L between the conformational states of the substrate enzyme.
The corresponding term for the phosphatase is simply the inverse of φi. The notion
of stepwise subunit modification is strictly speaking not applicable to our simplified
treatment of GS phosphorylation. However, if phosphorylation of all n sites was
considered a simultaneous event, the modification term would be the product of
the modification terms for the individual steps. As an approximation, we therefore
included the geometric mean of the modification terms of the individual steps in the
kinase and phosphatase rate equations. The geometric mean is given by
φ = n
√
n
∏
i=1
φi (5.27)
= n
√
1+ αnL
1+ L
In terms of GS phosphorylation φ takes on the form
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φGSij =
n
√√√√√√√√√√√√√√√√√
(
1+
[UDPG]
KUDPG
+
[ATP]
K′t,ATP
)n
αnk+1L0ij
1+
[G6P]
Kt,G6P
+
[ATP]
Kt,ATP
1+
[G6P]
Kr,G6P
+
[ATP]
Kr,ATP

n
+
(
1+
[UDPG]
KUDPG
+
[ATP]
K′r,ATP
)n
(
1+
[UDPG]
KUDPG
+
[ATP]
K′t,ATP
)n
L0ij
1+
[G6P]
Kt,G6P
+
[ATP]
Kt,ATP
1+
[G6P]
Kr,G6P
+
[ATP]
Kr,ATP

n
+
(
1+
[UDPG]
KUDPG
+
[ATP]
K′r,ATP
)n
(5.28)
where k = i for N-terminal cluster phosphorylation and k = j for C-terminal phos-
phorylation.
To our knowledge, a change in the forward Vmax or Km in response to ligands of
GS has not been observed experimentally for any of the tested GS kinases. Effects on
the reverse Vmax values have not been tested due to the unfavourable equilibrium
constant. The rate equation that best describes GS kinetics, however, shows that
phosphorylation alters the equilibrium between the T and R conformations of GS,
necessitating a change to the apparent equilibrium constant of phosphorylation. In-
clusion of a modification term of the equilibrium constant of phosphorylation with-
out an accompanying change to the forward Vmax therefore results in an implicit
change to the reverse Vmax of the kinase reactions. We have therefore modelled the
GS kinase reactions with bi-substrate Michaelis-Menten equations in which only the
Keq is modified by allosteric and covalent modification of GS. Product inhibition was
considered negligible.
The rate equation for phosphorylation of site 2 by the catalytic subunit of PKA is
given by
vPKA,GS0j =
kcat[PKA]
KGS0j KATP
(
[GS0j][ATP]−
[GS2j][ADP]
φGS0j Keq
)
(
1+∑
k
[GS0k]
KGS0k
)(
1+
[ATP]
KATP
) (5.29)
for all j ∈ [0, 5, 4, 3b, 3c, 3a] and where k ∈ [0, 5, 4, 3b, 3c, 3a].
Phosphorylation of site 2 by PhKP and phosphorylation of site 2a by casein ki-
nase 1 (CK1) were modelled with rate equations of the same form as that of PKA.
Since it has been demonstrated that the forward Vmax of PP1 for the dephospho-
rylation of GS is affected by GS ligands [146], a modification term was included for
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Figure 5.8: Phosphorylation of the N-terminal cluster of GS. Both PKA and activated PhK
phosphorylate site 2, which allows subsequent phosphorylation of site 2a by CK1. Both
sites are dephosphorylated by PP1. Phosphorylation of sites 2 and 2a is independent of
C-terminal phosphorylation, of which the phosphorylation state is indicated by j. Co-
substrates and co-products are not shown.
both the Vmax and the Keq, so that no modification of the reverse Vmax is present. De-
phosphorylation of the N-terminal cluster of GS was modelled with a uni-bi Michaelis-
Menten equation in which product binding was considered negligible:
vPP1,GSij→(i−1)j =
φ−1GS(i+1)j kcat[PP1]
KGS
[GSij]− [GS(i−1)j][Pi]
φ−1GS(i+1)j Keq

(
1+∑
kl
[GSkl]
KGS
) (5.30)
for all i ∈ [2, 2a] and j ∈ [0, 5, 4, 3c, 3b, 3a], and where k ∈ [2, 2a] and l ∈ [0, 5, 4, 3c, 3b, 3a].
Phosphorylation and dephosphorylation of the N-terminal cluster of GS are de-
picted in Fig. 5.8.
The C-terminal phosphorylation cluster of GS is sequentially phosphorylated by
casein kinase 2 (CK2) and glycogen synthase kinase 3 (GSK3) and, like the N-cluster,
dephosphorylated by PP1. Phosphorylation of site 5 by CK2 was modelled with an
equation of the same form as that for PKA:
vCK2,GSi0 =
kcat[CK2]
KGSi0 KATP
(
[GSi0][ATP]− [GSi5][ADP]φGSi5Keq
)
(
1+∑
k
[GSk0]
KGSk0
)(
1+
[ATP]
KATP
) (5.31)
for all i ∈ [0, 2, 2a] and where k ∈ [0, 2, 2a]. For GSK3, on the other hand, a hyper-
bolic insulin inhibition term was included as an abbreviation of the insulin-PI3K-Akt
pathway. Stimulation of this pathway results in the phosphorylation and deactiva-
tion of GSK3. We have therefore modelled this effect as an apparent decrease in the
concentration of GSK3:
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Figure 5.9: Phosphorylation of the C-terminal cluster of GS. CK2 phosphorylates site 5 and
thus enables the sequential phosphorylation of the remaining site by GSK3. Dephosphory-
lation of all sites is catalysed by PP1. Insulin stimulation results in GSK3 inhibition. Phos-
phorylation of the C-terminal cluster is independent of phosphorylation at the N-terminal
cluster, of which the phosphorylation state is indicated by i. Co-substrates and co-products
are not shown.
vGSK3,GSij =
kcat[GSK3]
KGSij KATP
(
[GSij][ATP]−
[GSi(j+1)][ADP]
φGSi(j+1)Keq
)
(
1+∑
kl
[GSkl]
KGSkl
)(
1+
[ATP]
KATP
) × 1
1+
[Ins]
EC50Ins
(5.32)
for all i ∈ [0, 2, 2a] and j ∈ [5, 4, 3c, 3b], and where k ∈ [0, 2, 2a] and l ∈ [5, 4, 3c, 3b].
Dephosphorylation of the C-terminal cluster of GS was modelled with an equa-
tion of the same form as for the N-cluster:
vPP1:GSij→(i−1)j =
φ−1GS(i+1)j kcat[PP1]
KGSij
[GSij]− [GS(i−1)j][Pi]
φ−1GS(i+1)j Keq

(
1+∑
kl
[GSkl]
KGS
) (5.33)
for all i ∈ [0, 2, 2a] and j ∈ [5, 4, 3c, 3b, 3a], and where k ∈ [0, 2, 2a] and l ∈ [5, 4, 3c, 3b, 3a].
Phosphorylation and dephosphorylation of the C-terminal cluster of GS are depicted
in Fig. 5.9.
5.3 Parametrization
Most of the earlier research on the kinetics of enzymes involved in muscle glycogen
metabolism, and muscle metabolism in general, was conducted using rabbit muscle
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as source. For this reason and for the sake of consistency we favoured, where avail-
able, data obtained from rabbit muscle experiments. A large number of parameters
were also obtained from rat and human muscle data. For any particular enzyme,
parameters reported in the same paper, by the same group, or for the same species
were favoured over compiling parameters from various sources. Where rabbit mus-
cle data were available, but a more complete set could be obtained from another
species, the data from the other species were favoured. As needed, data from the
same tissue, but from a different species, were preferred over data from the same
species, but a different tissue, unless the same isozyme is known to be expressed
in both tissues types. Preference was given to data obtained at temperatures and
pH values close to the in vivo values (37◦C and pH 7.2), but where more complete
data sets were available, these were favoured. Overall, the guiding principles in
choosing parameter sets were quality of experimental techniques employed in de-
termining parameter values and per-enzyme consistency. Where unit conversion
was required, 1 g wet muscle weight was taken as equivalent to 0.75 mL cell water
(based on wet-to-dry weight ratio in [205]). The unit of time is minutes and the unit
of concentration is mM.
Rate constants and enzyme concentrations
The maximal forward carrying capacity of an enzyme can be expressed as
Vmax = nkcat[E]tot (5.34)
where n is the number of enzyme subunits; kcat is the first-order rate constant; and
[E]tot is the total holoenzyme concentration. For the most part, the right hand side
expression of Eq. 5.34 was used in rate equations. Values for kcat, [E]tot and Vmax
were either obtained directly from the literature, calculated from specific activities
of crude extracts and purified enzyme, estimated from specific activities relative to
known values, or combinations of these methods. The concentrations of membrane
proteins, such as the glucose transporter (GLUT), was normalized to the cytosolic
volume. See Appendix C.1 for detailed calculations. Rate constants, enzyme con-
centrations, and other parameters are listed in Tables 5.1–5.6.
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Table 5.1: Kinetic parameters for glucose uptake pathway
Parameter Value Unit Reference Source
kcat,GLUT1 72 000 min−1 [207] 3T3-L1 cells (mouse)
[GLUT1tot] 5.5 · 10−7 mM 10% of [GLUT4] [174] human muscle
KGLUT1,Glc 6.9 mM [183] human erythrocyte
kcat,GLUT4 79 000 min−1 [207] 3T3-L1 cells (mouse)
[GLUT4tot] 5.5 · 10−6 mM calculated from [208] human muscle
KGLUT4,Glc 4.6 mM [186] typical mammalian
EC50GLUT4,Ins 1.7 · 10−7 mM [209] human muscle
kcat,HK1 7 194 min−1 Table C.1 rabbit heart
[HK1] 6.1 · 10−4 mM calculated from [187] human muscle
KHK1,Glc 4.5 · 10−2 mM [196] rat muscle
KHK1,ATP 0.4 mM [196] rat muscle
KHK1,G6P 0.21 mM [196] rat muscle
KHK1,ADP 0.62 mM [196] rat muscle
Ki,HK1,G6P 2.6 · 10−2 mM [196] rat muscle
Ki,HK1,ADP 2 mM [196] rat muscle
kcat,HK2 15 065 min−1 Table C.1 recombinant, human muscle
[HK2] 9.2 · 10−5 mM calculated from [187] human muscle
KHK2,Glc 0.23 mM [196] rat muscle
KHK2,ATP 0.78 mM [196] rat muscle
KHK2,G6P 0.16 mM [196] rat muscle
KHK2,ADP 2.2 mM [196] rat muscle
Ki,HK2,G6P 2.1 · 10−2 mM [196] rat muscle
Ki,HK2,ADP 5.4 mM [196] rat muscle
Other parameters
All Michaelis constants, dissociation constants, and half-maximal effective concen-
trations were obtained directly from the literature or determined by parameter op-
timization. Equilibrium constants (Table 5.7) were taken from the literature, esti-
mated with the eQuilibrator service [36], or taken from the TECR database [206].
Equilibrium constants for protein kinase and protein phosphatase reactions were
estimated by considering the reactions serine+ATP phosphoserine+ADP and
phosphoserine+H2O serine+ Pi at pH 7.2 and ionic strength of 0.1 mM. A lim-
itation of the eQuilibrator service [36] is that it only provides equilibrium constant
values estimated for the standard conditions temperature of 25◦C.
Metabolite and other species concentrations
In a kinetic model the steady-state concentrations of variable species are completely
determined by the system parameters and, as such, it is not crucial to assign rigor-
Stellenbosch University  http://scholar.sun.ac.za
CHAPTER 5. MODELLING SKELETAL MUSCLE GLYCOGENMETABOLISM 145
Table 5.2: Kinetic parameters for the glycogen synthesis pathway
Parameter Value Unit Reference Source
Vmax,PGLM 2 078 mM min−1 [210] rabbit muscle
KPGLM,G6P 5.7 · 10−2 mM [197] rabbit muscle
KPGLM,G1P 1.05 · 10−2 mM [197] rabbit muscle
Vmax,UPP 200 min−1 9.6% of Vmax,PGLM [211] –
KUPP,G1P 0.4 mM [198] recombinant, human muscle
KUPP,UTP 0.92 mM [198] recombinant, human muscle
KUPP,UDPG 6.3 · 10−2 mM [198] recombinant, human muscle
KUPP,PPi 0.38 mM [198] recombinant, human muscle
Ki,UPP,UDPG 5.2 · 10−2 mM [198] recombinant, human muscle
Ki,UPP,UTP 0.98 mM [198] recombinant, human muscle
nGS 4 dimensionless – –
kcat,r,GS 1 004 min−1 Table C.1 rabbit muscle
total [GS] 3 · 10−3 mM [212] –
KGS,UDPG 0.72 mM Chapter 3 rat muscle
Kr,GS,G6P 6.76 · 10−2 mM Chapter 3 rat muscle
Kt,GS,G6P 0.29 mM Chapter 3 rat muscle
Kr,GS,ATP 4.94 mM Chapter 3 rat muscle
Kt,GS,ATP 2.33 mM Chapter 3 rat muscle
Kc,r,GS,ATP 15.92 mM Chapter 3 rat muscle
Kc,t,GS,ATP 3.93 mM Chapter 3 rat muscle
L0,GS00 0.25 dimensionless Chapter 3 –
L0,GS20 1.23 dimensionless Chapter 3 –
L0,GS2a0 4.98 dimensionless Chapter 3 –
L0,GS05 0.25 dimensionless Chapter 3 –
L0,GS25 1.23 dimensionless Chapter 3 –
L0,GS2a5 4.98 dimensionless Chapter 3 –
L0,GS04 0.25 dimensionless Chapter 3 –
L0,GS24 1.23 dimensionless Chapter 3 –
L0,GS2a4 4.98 dimensionless Chapter 3 –
L0,GS03c 0.25 dimensionless Chapter 3 –
L0,GS23c 1.23 dimensionless Chapter 3 –
L0,GS2a3c 4.98 dimensionless Chapter 3 –
L0,GS03b 0.67 dimensionless Chapter 3 –
L0,GS23b 3.29 dimensionless Chapter 3 –
L0,GS2a3b 13.29 dimensionless Chapter 3 –
L0,GS03a 9.31 dimensionless Chapter 3 –
L0,GS23a 45.68 dimensionless Chapter 3 –
L0,GS2a3a 184.69 dimensionless Chapter 3 –
Stellenbosch University  http://scholar.sun.ac.za
CHAPTER 5. MODELLING SKELETAL MUSCLE GLYCOGENMETABOLISM 146
Table 5.3: Kinetic parameters for the glycogen degradation pathway
Parameter Value Unit Reference
nGP 2 dimensionless –
Vmax,GP 50 mM min−1 [19]
Kr,GP,Pi 2.08 mM Table C.6
Ku,GP,Pi 4.32 mM Table C.6
Kt,GP,Pi 41.53 mM Table C.6
Kr,GP,G1P 0.67 mM Table C.6
Ku,GP,G1P 82.02 mM Table C.6
Kt,GP,G1P 27.92 mM Table C.6
Kr,GP,AMP 3.36 · 10−3 mM Table C.6
Kt,GP,AMP 0.53 mM Table C.6
Kt,GP,ATP 3.9 mM Table C.6
Kr,GP,G6P 7.42 mM Table C.6
Ku,GP,G6P 0.56 mM Table C.6
Kt,GP,G6P 0.27 mM Table C.6
Lu,GP,a 5.93 dimensionless Table C.6
Lt,GP,b 34 741 dimensionless Table C.6
Table 5.4: Kinetic parameters for the abbreviated glycolysis pathway
Parameter Value Unit Reference Source
Vmax,sink 1 · 10−2 mM min−1 assumed –
Ksink,F6P 9 · 10−3 mM [213] rabbit muscle
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Table 5.5: Kinetic parameters for the cAMP signalling pathway
Parameter Value Unit Reference Source
kcat,PKA,PhK 920 min−1 Table C.3 rabbit muscle
[PKA] 1 · 10−5 mM assumed –
KPKA,ATP 2 · 10−2 mM [214] rabbit muscle
KPKA,PhK 4 · 10−4 mM assumed in [204] –
[PhK] 2.5 · 10−3 mM [215] rabbit muscle
[PhKP] 0 mM – –
kcat,PKA,I1 84 min−1 [216] bovine heart
KPKA,I1 5 · 10−3 mM [216] bovine heart
[I1] 1.8 · 10−3 mM [217] rabbit muscle
[I1P] 0 mM – –
kcat,PP1,PhKP 110 min−1 Table C.2 rabbit muscle
KPP1,PhKP 3.7 · 10−3 mM [218] rabbit muscle
kcat,PP2A,I1P 5 min−1 assumed, based on [218, 219] rabbit muscle
[PP2A] 5 · 10−4 mM [220] –
KPP2A,I1P 7 · 10−4 mM [218] rabbit muscle
[PP1] 6 · 10−4 mM [220] –
[PP1 · I1P] 0 mM – –
Kd,PP1+I1P 1.5 · 10−6 mM [221] rabbit muscle
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Table 5.6: Kinetic parameters for GS phosphorylation
Parameter Value Unit Reference Source
kcat,PKA,GS 1 060 min−1 Table C.3 rabbit muscle
KPKA,GS 3 · 10−3 mM [139] rabbit muscle
kcat,PhKP,GS 1 200 min−1 Table C.1 rabbit muscle
KPhKP,GS 4.5 · 10−3 mM based on GP value [222, 223] rabbit muscle
KPhKP,ATP 0.5 mM [214] rabbit muscle
kcat,CK1,GS 12 min−1 Table C.1 rabbit muscle
[CK1] 4.5 · 10−4 mM Table C.4 rabbit muscle
KCK1,GS 3 · 10−3 mM [100] rabbit muscle
KCK1,ATP 1.8 · 10−2 mM [100] rabbit muscle
kcat,CK2,GS 70 min−1 Table C.1 rabbit muscle
[CK2] 1 · 10−4 mM Table C.4 rabbit muscle
KCK2,GS 1.2 · 10−2 mM [101] rabbit muscle
KCK2,ATP 1 · 10−2 mM [101] rabbit muscle
kcat,GSK3,GS 100 min−1 Table C.1 rabbit muscle
[GSK3] 7 · 10−5 mM based on [212] and Table C.4 rabbit muscle
KGSK3,GS 3.6 · 10−3 mM [101] rabbit muscle
KGSK3,ATP 2 · 10−2 mM [101] rabbit muscle
EC50GSK3,Ins 1.7 · 10−7 mM assumed same as EC50GLUT4,Ins human muscle
kcat,PP1,GS22a 115 min−1 Table C.2 rabbit muscle
kcat,PP1,GS43abc 30 min−1 Table C.2 rabbit muscle
kcat,PP1,GS5 1 min−1 Table C.2 rabbit muscle
KPP1,GS 9.4 · 10−3 mM based on GP value [224] rabbit muscle
Table 5.7: Equilibrium constants
Parameter Value Unit Reference
Keq,GLUT 1 dimensionless –
Keq,HK 2 090 dimensionless [37]
Keq,PGLM 5.62 · 10−2 dimensionless [197]
Keq,UPP 0.24 dimensionless [225]
Keq,protkin 70 000 dimensionless eQuilibrator [36]
Keq,protphos 50 000 mM eQuilibrator [36]
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Table 5.8: Metabolite and other species concentrations
Metabolite Concentration (mM) Reference Source
Glco 5 based on [226] human blood
Glci 1 · 10−3 assumed –
G6P 0.75 [19] –
G1P 5.89 · 10−2 [19] –
UTP 0.13 estimated from [227] rat muscle
PPi 1 · 10−2 assumed –
UDPG 4.3 · 10−2 [210] rat muscle
(Glc)n 112 [19] –
ATP 8.2 [19] –
ADP 1.3 · 10−2 [19] –
Pi 4.1 [19] –
Ins 4 · 10−8 based on [226] human blood
ously determined initial values to these species. Realistic values for variable species
are only relevant in terms of speeding up numeric analysis. Since the sums of con-
served moieties are not explicitly provided in the models, but are instead inferred
from the initial concentrations of species belonging to the particular moiety con-
servation cycle, it is important to provide accurate values for these species. In the
glycogen synthesis models, moiety conservation is only observed in the signalling
cascades: enzymes and their phosphorylated forms constitute moiety-conserved cy-
cles. In the glycogenolysis model of Lambeth & Kushmerick [19], several moieties
are conserved. These include the phosphate, adenylate, and creatine moieties and
the NAD/NADH cycle. Additional moiety conservation cycles arise when glycogen
synthesis and glycogen degradation are combined. Initial concentrations for several
metabolites and other species are listed in Table 5.8.
5.4 Models
Each of the subpathways described in the previous two sections can be considered
modules of glycogen metabolism. We combined these modules in various ways in
several models, each describing different aspects of glycogen metabolism. In or-
der to ensure consistency across all the models, we exploited the modular nature of
glycogen metabolism and constructed each model as a combination of all the mod-
ules relevant to the model.
Each module was described using the PySCeS [228] model description language
in combination with the Jinja2 templating meta-language (http://jinja.pocoo.org).
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PySCeS is an open-source metabolic modelling program developed in our group.
In its simplest form, a PySCeS model file is a list of reaction definitions in terms
of stoichiometries and rate equations, and definitions of parameters and variables
and their values. PySCeS uses this information to construct a system of ordinary
differential equations, which can be solved for steady-state. The steady-state infor-
mation and structural relationships in the model are then used to solve the various
coefficients of metabolic control analysis. For each model a master template file was
written that 1) defines the modules that should be included in the model, 2) lists the
fixed species, and 3) initializes the variable species pertaining to the model. These
model templates were then rendered to PySCeS model files with the Jinja2 template
engine. Although Jinja2 was designed with web development in mind, there is no
restriction on the file type that can be rendered. There are many advantages to us-
ing a template engine when dealing with multiple related models or even a single
complex model:
• parameters or variables such as initial metabolite concentrations can be man-
aged in a single file
• related module templates can inherit content from a parent template
• macros can be defined to perform frequently used tasks
• programming constructs such as for-loops and if-else-branches can be used
• data structures such as arrays are available
• mathematical expressions can be evaluated
Macros or functions are also built-in features of the PySCeS model description
language, but native PySCeS macros offer less descriptive power and introduce over-
head during model simulation. If-else-branches are also available in PySCeS but
serve a different purpose, i.e., evaluation of conditions at runtime.
We will not describe the templating scheme used in detail here, but a brief illus-
tration of how Jinja2 might be used to produce a PySCeS model file is depicted in
Fig. 5.10.
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sample.ptl sample.psc
FIX: S1 S4
{% for i in range(1,4) %}
v{{i}}:
S{{i}} = S{{i+1}}
Vmax{{i}}/Kms{{i}}*(S{{i}}-S{{i+1}}/Keq{{i}})
/(1+S{{i}}/Kms{{i}}+S{{i+1}}/Kmp{{i}})
{% endfor %}
FIX: S1 S4
v1:
S1 = S2
Vmax1/Kms1*(S1-S2/Keq1)
/(1+S1/Kms1+S2/Kmp1)
v2:
S2 = S3
Vmax2/Kms2*(S2-S3/Keq2)
/(1+S2/Kms2+S3/Kmp2)
v3:
S3 = S4
Vmax3/Kms3*(S3-S4/Keq3)
/(1+S3/Kms3+S4/Kmp3)
Figure 5.10: Excerpt from an example Jinja2 template file (sample.ptl) and the resulting
PySCeS file (sample.psc). The example demonstrates the use of for-loops to contract repet-
itive snippets. All model modules were programmed as Jinja2 template files, which were
combined in various ways in master templates and subsequently rendered with the Jinja2
templating engine as PySCeS model files.
GlySynth
The GlySynth model describes the synthesis of glycogen from external glucose. It
comprises modules describing glucose uptake, glycogen synthesis, GLUT4 traffick-
ing, the cAMP-dependent cascade (excluding PKA activation and inhibition), and
insulin signalling. Although the concentration of GLUT4 that is present in the sar-
colemma is treated as a fixed species, the activation term in the GLUT4 rate equation
describes an effective increase in [GLUT4mem]. Similarly, instead of including both
the phosphorylated and dephosphorylated forms of GSK3 in the model, the inhibi-
tion of GSK3 by insulin is described as an apparent decrease in the concentration of
GSK3. The fixed species are: Glco, ATP, ADP, UTP, PPi, UDP, glycogen, and Pi.
GlySynthExp
This model is essentially the same as GlySynth. However, instead of including an
insulin activation term in the GLUT4 rate equation, the concentration of plasma
membrane GLUT4 is set explicitly (hence ‘Exp’). Similarly, GS phosphorylation
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and dephosphorylation as regulated by cAMP and insulin are modelled explicitly
through the parameter L0, which really is a function of the concentrations of the
various GS phosphorylation states. The advantage of this model is that it allows
the function of GS phosphorylation to be investigated without concern for the sig-
nalling pathways that would bring about the phosphorylation. The fixed species
are: Glco, ATP, ADP, UTP, PPi, UDP, and glycogen. The values for L0 = 5.6 and
[GLUT4mem] = 1 × 10−6 mM were taken from the corresponding variables in
GlySynth at basal insulin concentration.
LamKus
This model is an exact implementation of the mammalian muscle glycogenolysis
model described by Lambeth & Kushmerick [19]. Since GP is present in only two
phosphorylation states, it does not include any phosphorylation cascades, but rather
describes GP phosphorylation with the parameter fGPa , the fraction of GS in the
phosphorylated form. The model was implemented as a glycogen degradation mod-
ule and a glycolysis module. As described later, the rate equation for GP was substi-
tuted with a MWC-type rate equation as a variation of the model.
GlyMetExp
We combined the GlySynthExp and LamKus models in an overall model of glycogen
metabolism. As described later, additional rate equations and modifications were
required to ensure stoichiometric consistency. The fixed species are: Glco, glycogen,
and lactate.
In the next chapter we will use the models presented here to analyse the regula-
tory design of skeletal muscle glycogen metabolism.
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Regulatory design of glycogen
metabolism
6.1 Introduction
The regulatory design of a metabolic system can be defined as the functional orga-
nization of the mechanisms that regulate it. The notion of regulation is, however,
itself in need of definition. Traditionally, discussions of regulation in metabolism are
mainly concerned with the control of flux in a system [77]. In this paradigm, enzyme
modification, whether allosteric or covalent, is immediately considered a mechanism
of flux control. In contrast, we here consider regulation as the concurrent control of
flux and metabolite concentrations in an effort to absorb environmental perturba-
tions. An investigation of the regulatory design of a metabolic system is, therefore,
one that considers how enzyme activities are modified in coordination in order to
bring about required changes in flux while maintaining metabolite concentrations
within acceptable ranges. We wish to emphasize that the notion of design, as used
here, is one that is completely void of intent and purpose.
In this chapter we analyse the models described in the previous chapter with
the aim of elucidating the regulatory design of muscle glycogen metabolism. We
begin with a brief review of the analytic frameworks that will be used in this re-
gard. We proceed to discuss the function of the allosteric and covalent regulation
of glycogen synthase (GS) in the glycogen synthesis pathway and consider the rel-
ative importance of allosteric and covalent regulation in fulfilling this function. We
also consider the function of the modification of glycogen phosphorylase (GP) in
the glycogen degradation pathway. In conclusion, we discuss the requirements of
153
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constructing a combined model of glycogen synthesis and degradation.
6.2 Analytic frameworks
Supply-demand analysis
It is sometimes desirable to step back from the detail of a complex metabolic path-
way and group reactions together in blocks linked by common intermediary me-
tabolites [229, 230]. It has been shown that such grouped metabolic systems can be
investigated with conventional metabolic control analysis (MCA). Supply-demand
analysis (SDA) is a control analytic approach in which a metabolic system is divided
into supply and demand blocks around a linking metabolite [15, 231]. The linking
metabolite is the end product of the supply block and the initial substrate of the de-
mand block. SDA around the linking metabolite is visually represented by plotting
the rate characteristics of the supply and demand blocks on the same graph [231]. A
rate characteristic is generated for each block as a log-log plot of the rate of the block
against the concentration the linking metabolite by treating the linking metabolite as
a parameter of the block. Such a rate characteristic therefore represents the variation
in flux of the isolated block with regard to changes in the linking metabolite concen-
tration. The intersection of the supply and demand rate characteristics indicates the
steady-state of the supply-demand system. Regulatory metabolites, i.e. metabolites in-
volved in feedback or feedforward loops, and branch point metabolites are generally
good choices of linking metabolite. A general method has been proposed by which
investigator bias can be removed in the process of selecting the linking metabolite
[232].
As is the case for individual enzymes, each block can be assigned a flux-control
and concentration-control coefficient and these can be expressed in terms of the
block elasticities with respect to the linking metabolite [229, 230, 233]. Block elas-
ticities, in turn, can be expressed in terms of the properties of the isolated blocks.
In particular, since the rate of a block equals the flux through the isolated block, a
block elasticity is the same as the flux-response coefficient of the particular block,
considered in isolation, with respect to the linking metabolite:
Stellenbosch University  http://scholar.sun.ac.za
CHAPTER 6. REGULATORY DESIGN OF GLYCOGENMETABOLISM 155
ε
vblocki
s = R
Ji
s (6.1)
=∑
j
C Jivjε
vj
s (6.2)
where i denotes the block in question; s is the linking metabolite; Ji is the flux within
the isolated block (i.e. with fixed s); and j is any enzyme within block i that is sensi-
tive to s.
Co-response analysis
In the introduction to MCA in Section 4.4, we have only considered the effect of
perturbations on single steady-state variables. It is, however, instructive to consider
how steady-state variables co-respond to perturbations. The co-response coefficient
quantifies the relative change in two steady-state variables y1 and y2 in response to
perturbation of a parameter p [234]:
Ωy1:y2p =
Ry1p
Ry2p
=
∑
i
Cy1vi ε
vi
p
∑
i
Cy2vi ε
vi
p
(6.3)
If only a single enzymatic step j is sensitive to p, then the expression for Ωy1:y2p
simplifies to that of the co-control coefficient:
Oy1:y2vj =
Cy1vj
Cy2vj
(6.4)
If y1 is a flux and y2 is a metabolite concentration, the co-response coefficient can
be considered a quantification of metabolite homeostasis or structural stability. A
large co-response coefficient indicates that metabolite y2 changes minimally in the
face of a large change in flux y1, given the change to parameter p.
MCA (as introduced in Section 4.4), SDA, and co-response analysis will be used
in our investigation of the regulatory design of glycogen metabolism.
6.3 Glycogen synthesis as a supply-demand system
The glycogen synthesis pathway can be considered a supply-demand system of
glucose-6-phosphate (G6P) in which glucose uptake (glucose transporter (GLUT)
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Figure 6.1: Glycogen synthesis as a supply-demand system of G6P. The glucose uptake path-
way, consisting of the GLUT and HK reactions, acts as a G6P supply process, whereas the
glycogen synthesis pathway, consisting of the PGLM, UPP, and GS reactions, functions as a
G6P demand process. G6P is an allosteric activator of GS and a competitive inhibitor of HK
with respect to ATP.
and hexokinase (HK)) functions as a supply block, and glycogen synthesis (phos-
phoglucomutase (PGLM), UDPG-pyrophosphorylase (UPP), and GS) as a demand
block (Fig. 6.1). We chose G6P as linking metabolite because it is a feedforward acti-
vator of GS and a feedback inhibitor of HK, but also because it is the metabolite that
has most often been chosen as the linking metabolite in experimental studies of GS
glycogen synthesis.
The elasticity coefficients with respect to G6P for the supply and demand blocks
are defined as
ε
supply
G6P =
∂ ln vsupply
∂ ln[G6P]
(6.5)
and
εdemandG6P =
∂ ln vdemand
∂ ln[G6P]
(6.6)
The flux-control coefficients of the supply and demand blocks can be expressed
in terms of the supply and demand elasticities as follows:
C Jsupply =
εdemandG6P
εdemandG6P − εsupplyG6P
(6.7)
C Jdemand =
−εsupplyG6P
εdemandG6P − εsupplyG6P
(6.8)
Similarly, the concentration-control coefficients are
CG6Psupply = −CG6Pdemand =
1
εdemandG6P − εsupplyG6P
(6.9)
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6.4 Homeostasis in response to change in external
glucose concentration
The glycogen synthesis model GlySynthExp contains no signalling cascades. In-
stead, the effects of the various signalling cascades are contained as explicit parame-
ters in the model. In particular, the plasma membrane glucose transporter 4 (GLUT4)
concentration is set manually to a basal level and the extent of GS phosphorylation is
varied explicitly by changing the value of L0. L0,app is, strictly speaking, a variable,
but by treating it as a parameter (designated L0), the concentrations of GS present in
the various phosphorylation states are implicitly varied, thus mimicking phosphory-
lation and dephosphorylation (see Eq. 5.12). Explicit control of the phosphorylation
state of GS, through changes to a single parameter, makes GlySynthExp an ideal
model for investigating the function of allosteric and covalent GS regulation.
Functional differentiation
A supply-demand system is said to be functionally differentiated if the absolute val-
ues of the supply and demand elasticities differ significantly, so that one block con-
trols the flux, whereas the other block determines the magnitude of concentration-
control. The degree of functional differentiation of the glycogen synthesis pathway
was investigated with supply-demand rate characteristics (Fig. 6.2). Significant func-
tional differentiation was observed between the the supply and demand blocks. In
particular,
∣∣εdemandG6P ∣∣ ∣∣∣εsupplyG6P ∣∣∣, so that flux control resided almost completely in the
supply block (C Jsupply = 0.999), whereas the demand block determined the magni-
tude of concentration-control. The values of εdemandG6P and ε
GS
G6P were in good agree-
ment and G6P may therefore be considered a regulatory metabolite of the demand
block (see [232]).
Despite the feedback inhibition of HK by G6P, the supply block was almost com-
pletely insensitive to G6P (εsupplyG6P = −0.002). This situation is explained by the very
low flux-control coefficient of HK within the supply block (Fig. 6.3A). Using Eq. 6.1,
the supply elasticity can be expressed as εsupplyG6P = C
Jsupply
HK ε
HK
G6P. A small C
Jsupply
HK value
therefore cancels the feedback inhibition of HK by G6P which is described by εHKG6P.
Although it is virtually uncontested that, within the supply block, GLUT controls
the glucose uptake flux under basal conditions, the flux-control distribution between
GLUT and HK during exercise and insulin stimulation is the topic of ongoing debate
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Figure 6.2: Supply-demand rate characteristics around G6P. G6P was treated as a clamped
metabolite and its concentration was varied in a suitable range around its steady-state con-
centration. The rates of the supply and demand blocks were calculated for each G6P concen-
tration. The intersection (red circle) of the supply and demand rates represents the steady-
state of the system. The demand block is much more sensitive to G6P than the supply block
(compare εsupplyG6P and ε
demand
G6P ). This indicates that the supply block controls the flux through
the system, whereas the demand block determines the magnitude of concentration control.
Since GLUT controls the flux within the supply block, inhibition of HK by G6P (designated
by the negative slope εHKG6P) has little effect on the sensitivity of the supply block towards G6P.
Both εPGLMG6P and ε
GS
G6P contribute significantly towards ε
demand
G6P .
[235, 236]. While we concede that an increase in GLUT activity will inevitably result
in the redistribution of flux control towards HK, it should be pointed out that com-
plete flux control of glucose uptake by HK, whether achieved by activation of GLUT
or inhibition of HK, can only be attained at the cost of GLUT operating near equilib-
rium. This point can be demonstrated visually by shifting up the vGLUT curve (blue)
in Fig. 6.3A such that εHKGlci approaches zero and HK thus gains almost all flux con-
trol (steady-state 2 in Fig. 6.3A). During insulin stimulation, the result of elevated
glycemia, it would be disadvantageous for GLUT to operate near equilibrium, as
under this condition the internal glucose concentration would rise to match the ex-
ternal concentration, which could be as high as 14 mM [12]. We are therefore of the
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Figure 6.3: Nested supply-demand rate characteristics around Glci and UDPG. The concen-
tration of G6P was clamped at its steady-state value. Red circles indicate steady-states. A)
Glci was treated as a clamped metabolite and its concentration was varied in a suitable range
around its steady-state concentration. The GLUT and HK rates were calculated for each Glci
concentration. From the values of εGLUTGlci and ε
HK
Glci
(at steady state 1) it is clear that the HK
reaction is much more sensitive to Glci than the GLUT reaction. The flux through the G6P
supply block is thus controlled by GLUT. If the GLUT rate were activated such that HK con-
trols the flux (at steady-state 2), the concentration of Glci would approach that of Glco. B)
Rate characteristics were similarly generated around UDPG. From the values of εPGLM/UPPUDPG
and εGSUDPG it is clear that the PGLM/UPP block, which is near equilibrium, is much more
sensitive to UDPG than GS. GS therefore controls the flux within the G6P demand block.
opinion that, in response to insulin stimulation, the control of glucose uptake by HK
should not be expected to increase to the point where it exceeds that of GLUT.
The demand block, on the other hand, was highly sensitive to G6P. Using Eq. 6.1,
the demand elasticity can be expressed as εdemandG6P = C
Jdemand
PGLM ε
PGLM
G6P + C
Jdemand
GS ε
GS
G6P.
Since GS had the most flux control within the demand pathway (C JdemandGS = 0.886,
Fig. 6.3B), the majority of the demand block’s sensitivity to G6P can be ascribed
to the feedforward activation of GS by G6P. However, since PGLM and UPP are
near equilibrium, the term C JdemandPGLM ε
PGLM
G6P approaches ε
GS
UDPG, which is not negligible
(Fig. 6.3B, and see Section 6.9). The large flux control of GS within the demand
block (C JdemandGS ) was not the result of GS being saturated with UDP-glucose (UDPG),
but rather resulted from PGLM/UPP being near equilibrium (Fig. 6.3B). Note that
stating that GS controls the flux within the isolated demand block is not equivalent
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to stating that GS controls the glycogen synthetic flux, which as we have seen is
controlled by the supply block (GLUT in particular).
Regulation of glycogen synthase does not alter the glycogen synthetic flux
It is often stated in the literature that GS is the rate-limiting enzyme of glycogen syn-
thesis; usually without any supporting citation (see for example [34, 51, 109, 127, 146,
169]). The contention that GS is the flux-controlling enzyme of glycogen synthesis
is presumably based on the dated perception that cooperativity and allosterism are
responsible for flux control; more so when accompanied by covalent modification.
Our results, however, showed that, although GS controls the flux within the isolated
demand block, the overall glycogen synthetic flux is controlled by glucose import.
This raises questions about the function of the regulation of GS activity.
Increasing L0 through the range of values (0.25–185) corresponding to the range
of complete GS dephosphorylation to complete phosphorylation did not result in
an increase in the flux, but instead increased the steady-state concentration of G6P
proportionally (Fig. 6.4A). The concomitant effect on the flux and steady-state G6P
concentration resulting from a change in L0 is quantified by the co-response coef-
ficient ΩJ:G6PL0 . A small co-response indicates a small change in the flux relative to
the change in steady-state G6P concentration. ΩJ:G6PL0 was virtually zero for the en-
tire range of possible L0 values (Fig. 6.4B). A deviation from zero, the result of HK
inhibition by G6P, was only observed at very high values of L0. This indicates that
phosphorylation and dephosphorylation have no effect on the glycogen synthetic
flux, but instead alter the G6P concentration. The expression for ΩJ:G6PL0 is given by
ΩJ:G6PL0 =
C Jdemandε
demand
L0
CG6Pdemandε
demand
L0
(6.10)
=
C Jdemand
CG6Pdemand
(6.11)
= ε
supply
G6P (by Eqs. 6.8 and 6.9) (6.12)
The low values of ΩJ:G6PL0 are thus a direct consequence of the insensitivity of the
supply block to G6P, which in turn is the result of the high flux-control coefficient
of GLUT. The regulation of GS by phosphorylation does therefore not appear to
function as a mechanism of flux control.
Stellenbosch University  http://scholar.sun.ac.za
CHAPTER 6. REGULATORY DESIGN OF GLYCOGENMETABOLISM 161
A
L0 = 0.25
185
∆ ln J
∆ ln [G6P]
B
10−3 10−2 10−1 100 101 102 103 104
−1
−0.5
0
0.5
1
L0
Ω
J:
G
6P
L 0
Figure 6.4: Effect of changes in L0 on the flux and steady-state G6P concentration. A) Supply-
demand rate characteristic around G6P showing the change in steady-state that results from
increasing L0 from 0.25 (corresponding to the value for completely dephosphorylated GS,
Table 5.2) to 185 (corresponding to the value for completely phosphorylated GS). No change
in the flux is observed, but a large change is seen in the G6P concentration. The supply and
demand rates are shown in blue and green. Steady-states are shown in red. B) Dependence
of ΩJ:G6PL0 on L0. Over the entire theoretical range of values for L0 (indicated by the shaded
area), ΩJ:G6PL0 is close to zero. This indicates that a change in L0 results in a much larger
change in G6P concentration than in the flux.
Similarly, increasing the ATP concentration through a physiologically relevant
range (5–8.2 mM) did not decrease the flux, but also slightly increased the G6P con-
centration (Fig. 6.5A). For each ATP value the ADP value was adjusted such that the
sum of ATP and ADP remained constant. Within the physiological range of ATP
concentrations ΩJ:G6PATP , like Ω
J:G6P
L0
, approached zero (Fig. 6.5B). A large ΩJ:G6PATP value
was observed at low ATP concentrations where ATP is limiting to and ADP inhibits
HK. The expression for ΩJ:G6PATP is somewhat more complicated because ATP is an
effector of both the supply and demand blocks:
ΩJ:G6PATP =
C Jsupplyε
supply
ATP + C
J
demandε
demand
ATP
CG6Psupplyε
supply
ATP + C
G6P
demandε
demand
ATP
(6.13)
=
εdemandG6P ε
supply
ATP − εsupplyG6P εdemandATP
ε
supply
ATP − εdemandATP
(by Eqs. 6.7, 6.8, and 6.9) (6.14)
Stellenbosch University  http://scholar.sun.ac.za
CHAPTER 6. REGULATORY DESIGN OF GLYCOGENMETABOLISM 162
A
[ATP] = 5
8.2
∆ ln J
∆ ln [G6P]
B
10−2 10−1 100
−2
−1
0
1
2
[ATP] (mM)
Ω
J:
G
6P
A
TP
Figure 6.5: Effect of changes in ATP concentration on the flux and steady-state G6P concen-
tration. A) Supply-demand rate characteristic around G6P showing the change in steady-
state that results from increasing the ATP concentration from 5 to 8.2 mM. The increase in
ATP has no effect on the flux, but leads to a small increase in G6P concentration. The supply
and demand rates are shown in blue and green. Steady-states are shown in maroon. Con-
comitant changes in ADP were made so that the total ADP and ATP concentrations remained
constant. B) Dependence of ΩJ:G6PATP on the ATP concentration. Over the complete range of
ATP concentrations between 5 and 8.2 mM (indicated by the shaded area), ΩJ:G6PATP is close to
zero. This indicates that a change in ATP concentration has essentially no effect on the flux,
but results in a change in G6P concentration.
HK is the only enzyme in the supply block that is sensitive to ATP, but since HK does
not control the glucose uptake flux, the value of εsupplyATP , like that of ε
supply
G6P , is close to
zero. It thus follows that ΩJ:G6PATP has a value close to zero. Again this low value can
be ascribed to the large flux control of GLUT within the demand block.
It is thus clear that regulation of the GS activity, within physiological limits, has
no effect on the glycogen synthetic flux, but alters the steady-state concentration of
metabolites in the pathway. This situation arises from the fact that GLUT controls
the pathway flux and, by being insensitive to its immediate product, is essentially
disconnected from and inelastic to the rest of the pathway. The only effective way to
increase the glycogen synthetic flux is to increase the rate of glucose import.
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Figure 6.6: Effect of changes in external glucose concentration on the flux and steady-state
G6P concentration. A) Supply-demand rate characteristic around G6P showing the change
in steady-state that results from increasing the external glucose concentration from eug-
lycemic (4.0) to hyperglycemic (8.0 mM) conditions. The increase in external glucose con-
centration results in a larger increase in the flux than in the steady-state G6P concentration.
The supply and demand rates are shown in blue and green. Steady-states are shown in
maroon. B) Dependence of ΩJ:G6PGlco on the external glucose concentration. The shaded area
indicates the range from euglycemic to hyperglycemic conditions.
Regulation of glycogen synthase improves glucose-6-phosphate homeostasis
The observation that L0 and the ATP concentration are able to affect the steady-state
concentration of G6P despite having no effect on the flux, suggests a role for the reg-
ulation of GS other than the regulation of flux, namely the homeostatic maintenance
of metabolite concentrations. In non-diabetics, the plasma glucose concentration can
be as low as 4 mM and increase, depending on diet, to about 8 mM after a meal [226].
Such an increase in the external glucose concentration leads to increased GLUT ac-
tivity and thus increases the glycogen synthetic flux and also the steady-state G6P
concentration. Figure 6.6A shows the increase in flux and steady-state G6P concen-
tration resulting from an increase in external glucose from 4 to 8 mM. It is clear that
the change in G6P concentration was less than the concomitant change in flux. As
before, the effect of external glucose on J and the G6P concentration can be quanti-
fied with the co-response coefficient:
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ΩJ:G6PGlco =
C Jsupplyε
supply
Glco
CG6Psupplyε
supply
Glco
(6.15)
=
C Jsupply
CG6Psupply
(6.16)
= εdemandG6P (by Eqs. 6.7 and 6.9) (6.17)
The ability of the glycogen synthesis pathway to buffer its metabolites (G6P in
particular) against large increases in the system flux therefore depends on the sen-
sitivity of the demand block to G6P. A high ΩJ:G6PGlco value was observed at basal
external glucose levels (Fig. 6.6B). As the external glucose increased, however, the
system rapidly lost its ability to buffer G6P. Let us also consider howΩJ:G6PGlco changes
with respect to L0 and the ATP concentration. Over the range of possible L0 values,
ΩJ:G6PGlco initially increased, but then decreased (Fig. 6.7). Over the same range, L0 had
no effect on the flux, but increased the G6P concentration. Note, however, that even
though there was an optimal value of L0 after which no further increase in Ω
J:G6P
Glco
was observed, the extent of GS inhibition continues to increase with L0 so that GS
would eventually gain all flux control, resulting in a decrease in flux. At very large
values of L0 the activity of GS tends to zero. It is therefore not inhibition per se that
increases ΩJ:G6PGlco , but rather the ability to bring about a significant further increase in
the fraction of GS that is in the conformation (T) that is not favoured by G6P.
ΩJ:G6PGlco also increased with increasing ATP (Fig. 6.7), but this increase was less
pronounced than the increase induced by L0. ATP had no effect on the flux, but
slightly increased the G6P concentration. Considering these weak effects of ATP in-
hibition, one may wonder why ATP inhibits both glycogen synthesis and glycogen
degradation. The latter case may be rationalized by considering that GP should be
sensitive to the energy charge of the cell (see Section 6.10), but by the same reasoning
ATP should stimulate, and not inhibit, GS. While basal muscle ATP concentrations
vary between species, the ATP concentration changes very little within muscle of a
particular species. We therefore speculate that ATP inhibition is not an active mech-
anism of GS regulation, but rather confers basal or “background” G6P sensitivity
on GS. Since the ATP concentration varies little, ATP inhibition can be considered
as a constant decrease in the affinity of GS for G6P. With regard to GP on the other
hand, small changes in the ATP concentration are amplified as large changes in AMP
Stellenbosch University  http://scholar.sun.ac.za
CHAPTER 6. REGULATORY DESIGN OF GLYCOGENMETABOLISM 165
0
1
2
3
Ω
J:
G
6P
G
lc
o
10−2
10−1
100
J
10−2 100 102 104
10−2
10−1
100
101
102
L0
[G
6P
]
10−2 10−1 100
[ATP]
Figure 6.7: Effect of covalent and allosteric modification of GS on G6P homeostasis in
response to elevated external glucose concentration. Over the physiological range of L0
(shaded area) an increase in external glucose resulted in a larger change in flux J than in G6P.
An increase in L0 generally lead to improved G6P homeostasis (as measured by Ω
J:G6P
Glco
), but
beyond a certain limit further increases in L0 weakened homeostasis. Over the range of ATP
concentrations from 5.0 to 8.2 mM (shaded area) an increase in external glucose resulted in
a larger change in J than in G6P. An increase in ATP concentration led to improved G6P ho-
meostasis (as measured by ΩJ:G6PGlco ). The external glucose concentration was 5 mM, the ATP
concentration was 8.2 mM when L0 was varied, and L0 was 5.6 when ATP was varied. Units
are in mM and minutes.
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by the enzyme adenylate kinase [77], but even in this regard it is possible that ATP
inhibition simply serves to enhance the sensitivity of GP to AMP.
Using the model GlySynthExp, we have now demonstrated that allosteric and co-
valent regulation of GS do not function to regulate the flux through the pathway, but
instead function to buffer the concentration of G6P within a narrow range in spite of
the several fold increase in system flux resulting from increased external glucose. In
particular, it was shown that this homeostasis of G6P results from the fact that both
GS phosphorylation and high ATP concentrations increase the sensitivity of the de-
mand block to G6P. A prolonged increase in external glucose concentration will,
however, result in elevated secretion of insulin by the pancreas. Insulin secretion
enhances translocation of cytosolic GLUT4 to the plasma membrane and inhibits the
phosphorylation of GS. In order to consider the function of insulin stimulation in
glycogen metabolism, a more sophisticated model that also describes GLUT4 traf-
ficking and GS phosphorylation in response to insulin is required.
6.5 Degree of GS phosphorylation as a function of
PKA and insulin
In the model GlySynth GS phosphorylation is not modelled as an explicit change
to the parameter L0 (as in GlySynthExp), but rather as the interconversion between
GS states, each of which exhibits Monod-Wyman-Changeux (MWC) kinetics, but
each with a different value for L0i. However, the total ratio of unliganded GS in
the T conformation to that in the R conformation can still be expressed as a function,
L0,app, of the various L0i values and the concentrations of GS in each phosphorylation
state. These two approaches are to a large extent equivalent, but GlySynthExp does
not allow for the possibility that ligands of GS such as G6P could also affect the
phosphorylation state of GS. Stimuli such as cyclic AMP (cAMP) (which increases
the effective cAMP-dependent protein kinase (PKA) concentration) and insulin that
affect the degree of GS phosphorylation will also affect L0,app.
The dependence of L0,app on the concentrations of PKA and insulin was investi-
gated with a parameter portrait (Fig. 6.8). As expected, the value of L0,app increased
with the concentration of PKA, indicating an increase in the degree of GS phospho-
rylation. The increase in L0,app in response to PKA occurred in two phases, with the
steepest increase near the maximal physiological concentration of PKA (∼ 0.5 µM
[237]). The effect of insulin, which inhibits the phosphorylation of GS by glycogen
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Figure 6.8: Dependence of L0,app on the concentration of PKA and insulin. PKA phosphory-
lates site 2 of GS and activates PhK which is also a site 2 kinase. In addition, PKA inhibits
PP1 which dephosphorylates all GS phosphorylation sites. Insulin inhibits GSK3 and thus
decreases the value of L0,app.
synthase kinase 3 (GSK3) and thus lowers L0,app, was most pronounced when the
PKA concentration was sufficiently high (Fig. 6.8).
The increase in L0,app resulting from an increase in the concentration of PKA is
both the consequence of increased phosphorylation at site 2 and of an increase in
the phosphorylated form of protein phosphatase inhibitor 1 (I1), which in turn in-
hibits dephosphorylation of all GS phosphorylation sites. At basal concentrations of
insulin (∼ 40 pM), a rise in [PKA] initially increased the phosphate content of site 2
(due to phosphorylation by PKA and activated PhK), but phosphorylation at site 2
was not immediately followed by significant phosphorylation at site 2a (Fig. 6.9A).
This result agrees with the finding by Nakielny et al. [109] that significant phosphory-
lation of site 2 in vivo is not accompanied by phosphorylation at site 2a, even though
phosphorylation at site 2 enhances phosphorylation at site 2a in vitro, unless PP1 is
significantly inhibited by activated I1. Based on these results, Nakielny et al. [109]
question the significance of PKA as a GS kinase, proposing a role for PKA in the
regulation of PP1 activity instead. A further increase in PKA did increase the phos-
phate content at site 2a, but since PKA does not phosphorylate site 2a, this increase
can only be ascribed to PP1 inhibition. Phosphorylation of site 2a was accompanied
by a concurrent increase in the phosphate content of all phosphorylation sites. The
initial phosphorylation of site 2 and subsequent phosphorylation of the other sites
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Figure 6.9: Dependence of GS phosphate content per site as a function of the PKA and insulin
concentrations. A) Increasing from low concentrations of PKA, site 2 is phosphorylated by
PKA and as a result of PhK activation in response to PKA. Further increasing PKA leads to
the inactivation of PP1 and thus extensive phosphorylation of all GS phosphorylation sites.
B) Increasing the insulin concentration has little effect on sites 2, 2a, and 5, but sites that are
phosphorylated by GSK3, which is inhibited by insulin, are gradually dephosphorylated in
response to insulin.
at a higher concentration of PKA explain the biphasic increase in L0,app in response
to PKA.
At very low PKA concentrations, the phosphatase activity was sufficiently high
that GS was substantially dephosphorylated at the inhibitory sites (2, 2a, 3a, 3b, see
Fig. 6.9A), whereas at high PKA concentrations, GS was almost completely phos-
phorylated at most sites. Under these conditions, a decrease in the activity of GSK3,
mimicking insulin stimulation, is not expected to activate GS markedly. In the for-
mer case GS is already activated to such an extent that insulin stimulation is with-
out effect. In the latter case, on the other hand, PP1 is inhibited to such an extent
that it cannot dephosphorylate the GSK3 sites. At a concentration of PKA that ap-
proaches the physiological maximum, however, insulin stimulation resulted in sig-
nificant dephosphorylation of the sites phosphorylated by GSK3 (sites 4, 3c, 3b, and
3a; Fig. 6.9B). The phosphate content of sites 5, 2, and 2a that are not directly affected
by GSK3 remained unchanged, as was also found by Parker et al. [238].
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6.6 Homeostasis in response to change in insulin
concentration
A euglycemic clamp is an experimental setup in which the external glucose con-
centration is kept at a constant basal concentration by infusion of glucose while the
insulin concentration may be varied [239]. Here we will consider the homeostatic
properties of glycogen synthesis in response to changes in kinase and insulin con-
centrations during a euglycemic clamp.
Using the glycogen synthesis model (GlySynthExp) in which GS phosphoryla-
tion is mimicked by an explicit change in L0, we have already shown that an increase
in L0, up to a certain point, improves homeostasis with respect to G6P in response
to changes in external glucose concentration. Using the model GlySynth, in which
the complete GS phosphorylation cascade is included, we can now investigate the
relationship between the degree of GS phosphorylation, as modulated by insulin
and PKA, and G6P homeostasis. Since an increase in PKA leads to an increase in
L0,app, inhibition of GS as a result of PKA-induced phosphorylation is also expected
to improve G6P homeostasis in response to elevated glycemia.
The effect of PKA on G6P homeostasis was investigated with parameter portraits
in which ΩJ:G6PGlco , J, [G6P], and L0,app were plotted as a function of the PKA concen-
tration (Fig. 6.10). As PKA increased, the value of ΩJ:G6PGlco initially increased in two
phases and then decreased. The overall variation in ΩJ:G6PGlco was, however, rather
modest. Even at very low concentrations of PKA more than 10% of GS was still
phosphorylated at both sites 2a and 3a and about 40% was still phosphorylated at
site 2 (Fig. 6.9), so that ΩJ:G6PGlco was maintained at the high value of 2. No change in
the flux J was observed, but G6P and L0,app increased in two phases, corresponding
to the phosphorylation of site 2 and the inactivation of PP1.
The relationship between PKA and ΩJ:G6PGlco differed from the ideal relationship
that was found between L0 and Ω
J:G6P
Glco
(Fig. 6.7) in the GlySynthExp model. This
difference is the result of at least two factors. First, in GlySynth, L0,app is a non-linear
function of [PKA]. Second, the concentration of G6P, which changes with the degree
of GS phosphorylation, can influence the degree of GS phosphorylation, which was
not allowed in GlySynthExp. In order to elucidate the relationship between PKA
andΩJ:G6PGlco , we also considered to component values that constituteΩ
J:G6P
Glco
. We have
shown that ΩJ:G6PGlco = ε
demand
G6P (Eq. 6.17). As will be discussed in Section 6.9, ε
demand
G6P
is the sum of the partial flux-response coefficients of the isolated demand block with
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Figure 6.10: Dependence of ΩJ:G6PGlco , J, G6P, and L0,app on PKA and insulin. PKA initially
increased and then decreased ΩJ:G6PGlco . PKA had no effect on the flux, J, but increased the
concentration of G6P and L0,app in two phases. Insulin steadily lowered Ω
J:G6P
Glco
with a small
change in G6P and L0,app. Insulin increased J. The insulin concentration was 40 pM when
PKA was varied, and [PKA] was 1× 10−5 mM when insulin was varied. Units are in mM
and minutes.
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respect to G6P:
εdemandG6P =
subRJdemandG6P +
allosRJdemandG6P +
kinRJdemandG6P +
phosRJdemandG6P (6.18)
These partial response coefficients were therefore also plotted as a function of [PKA]
(Fig. 6.10). subRJdemandG6P , describing the function of G6P as a substrate of the demand
block, remained near unity over the entire range of PKA concentrations. subRJdemandG6P ,
describing the function of G6P as activator of the demand block, initially increased
with PKA, but decreased again at higher PKA concentrations. The sum of kinRJdemandG6P
and phosRJdemandG6P , describing the function of G6P as GS kinase inhibitor and GS phos-
phatase activator, peaked at the PKA concentrations where the largest changes in
G6P and L0,app were observed.
In order to facilitate comparison to Fig. 6.7, the results in Fig. 6.10 were also plot-
ted against the variable L0,app (Fig. 6.11). As was found with respect to L0 in the
appropriate range in Fig. 6.7, there was an almost linear relationship between G6P
and L0,app, but the flux, J, did not vary with L0,app.
An increase in insulin, on the other hand, led to a steady decrease in ΩJ:G6PGlco
(Fig. 6.10), indicating that it weakens G6P homeostasis with respect to changes in
the external glucose concentration. Although this decrease is ultimately the result of
GS dephosphorylation (L0,app decreased as as insulin increased), it is explained by a
decrease in the sensitivity of the demand block to G6P in its capacity as PGLM sub-
strate, allosteric GS activator, GS kinase inhibitor, and GS phosphatase activator, as
measured by the decreases in the partial response coefficients subRJdemandG6P ,
allosRJdemandG6P ,
kinRJdemandG6P , and
phosRJdemandG6P . The flux J increased with insulin over the entire range,
but G6P initially decreased and then increased again at higher insulin concentra-
tions (Fig. 6.10). The overall change in G6P in response to insulin was, however,
very small compared to that in response to PKA.
These results indicate that GS phosphorylation, brought about by an increase
in the concentration of PKA, functions to improve G6P homeostasis in response to
changes in the external glucose concentration. Insulin, on the other hand, weakens
this homeostasis. However, the modest increase in G6P, in spite of the large change
in J, that resulted from insulin stimulation, suggests that insulin brings about G6P
homeostasis by means of a different mechanism in which the supply and demand
blocks are coordinately activated [13]. It is therefore instructive to also consider the
value of ΩJ:G6PIns , which quantifies the co-response of the flux and the steady-state
G6P concentration to a change in insulin concentration. ΩJ:G6PIns is expressed as
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Figure 6.11: Correlation of ΩJ:G6PGlco , J, and G6P with L0,app in response to changes in PKA and
insulin. The data in Fig. 6.10 were replotted against L0,app. Conditions were as in Fig. 6.10
.
Stellenbosch University  http://scholar.sun.ac.za
CHAPTER 6. REGULATORY DESIGN OF GLYCOGENMETABOLISM 173
ΩJ:G6PIns =
C Jsupplyε
supply
Ins + C
J
demandε
demand
Ins
CG6Psupplyε
supply
Ins + C
G6P
demandε
demand
Ins
(6.19)
=
εdemandG6P ε
supply
Ins − εsupplyG6P εdemandIns
ε
supply
Ins − εdemandIns
(by Eqs. 6.7, 6.8, and 6.9) (6.20)
=
ΩJ:G6PGlco ε
supply
Ins − εsupplyG6P εdemandIns
ε
supply
Ins − εdemandIns
(by Eq. 6.17) (6.21)
' Ω
J:G6P
Glco
ε
supply
Ins
ε
supply
Ins − εdemandIns
(since εsupplyG6P ' 0) (6.22)
The absolute value of ΩJ:G6PIns was much larger than unity for the entire range of
insulin concentrations (Fig. 6.12A). When εsupplyIns = ε
demand
Ins , then Ω
J:G6P
Ins tends to in-
finity and perfect homeostasis in response to a change in insulin is observed regard-
less of the value of ΩJ:G6PGlco . If, however, ε
supply
Ins and ε
demand
Ins differ significantly, the
contribution of ΩJ:G6PGlco to the value of Ω
J:G6P
Ins is potentially substantial. As insulin in-
creased, both εsupplyIns and ε
demand
Ins increased (Fig. 6.12B), but, as we have seen, ε
demand
G6P
decreased. εsupplyG6P remained close to zero over the entire range of insulin concentra-
tions. Initially, the demand block was activated to a lesser extent than the supply
block, but proceeded to match and then surpass activation of the supply block, be-
fore returning again to a lower insulin sensitivity. Increasing insulin from basal to
stimulated levels (indicated by shaded area in Fig. 6.12) therefore had the effect that
G6P initially decreased but then increased again (inset in Fig. 6.10).
Whether εdemandIns does indeed exceed ε
supply
Ins depends on, amongst other factors,
the concentration of PKA. At a lower PKA concentration, the activity of PP1 would
be higher and thus GS would already be in a more active state so that the demand
block is less sensitive to insulin. There is, however, experimental evidence that a
transition from a regime during which G6P decreases to a regime during which G6P
increases occurs as insulin is increased during a euglycemic clamp [240, 241], which
supports our results that in the physiological range of insulin concentrations εdemandIns
initially exceeded εsupplyIns . The transition from a basal insulin concentration to hyper-
insulinemic conditions resulted in a large change in the glycogen synthetic flux with
very little change in the concentration of G6P (Fig. 6.13). Note, however, that if the
insulin concentration is increased even further, G6P will also increase significantly.
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Figure 6.12: Homeostasis of G6P in response to insulin stimulation. Physiological normoin-
sulinemic and hyperinsulinemic concentrations are indicated with vertical lines. A) Depen-
dence of ΩJ:G6PIns on insulin concentration. The absolute value of Ω
J:G6P
Ins is larger than unity
over the entire range of insulin concentrations. This indicates that insulin stimulation results
in a much larger change in flux than in G6P concentration. B) Dependence of εsupplyG6P , ε
demand
G6P ,
ε
supply
Ins , and ε
demand
Ins on insulin concentration.
Beyond the point where glucose uptake is sensitive to insulin, no further increase in
flux or G6P concentration will occur.
Overall, these results suggest that covalent modification functions to improve
the homeostasis of G6P in response to changes in external glucose concentration by
virtue of increasing εdemandG6P . In addition, however, covalent modification (or more
precisely, the reversal of covalent modification) also facilitates G6P homeostasis in
response to changes in the insulin concentration by virtue of an increase in εdemandIns
in addition to the increase in εsupplyIns brought about by sequestration of GLUT4 to the
plasma membrane.
The present analysis is similar to that of Schafer et al. [13], in which experimen-
tally determined coefficients were employed to determine the proportional activa-
tion of the supply and demand blocks by insulin. Schafer et al. [13] calculated the
ratio εdemandIns /ε
supply
Ins (their proportional activation term pi
AB
X ) according to the ex-
pression
εdemandIns
ε
supply
Ins
=
1− εdemandG6P ΩG6P:JIns
1− εsupplyG6P ΩG6P:JIns
(6.23)
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Figure 6.13: Supply-demand rate characteristic around G6P showing the change in steady-
state that results from increasing the insulin concentration from basal (40 pM) to hyper-
glycemic (450 pM) conditions. The increase in insulin results in a much larger increase in
the flux (∆ ln J) than in the steady-state G6P concentration (∆ ln[G6P]). The supply and de-
mand rates are shown in blue and green. Steady-states are shown in maroon.
whereΩG6P:JIns is the reciprocal ofΩ
J:G6P
Ins . They used values for ε
supply
G6P and ε
demand
G6P that
were determined by Chase et al. [12] during a hyperinsulinemic clamp. Since the gly-
colytic flux is considered negligible in the treatment of Schafer et al. [13], they chose
the value of εsupplyG6P that was determined at the lowest glycolytic flux by Chase et al.
[12]. The values reported by Chase et al. [12] for this elasticity in the text (−0.185)
and Table 3 (−0.015), however, differ markedly. Unless the other values in Table
3 are also to be considered erroneous, it appears that −0.015 is the correct value.
Schafer et al. [13], however, used the value −0.185.
The plasma insulin concentrations during the hyperinsulinemic clamp were in
the order of 216–308 mU.mL−1 [12], or 1–2 µM (1 U = 5.995 nmol), which is four or-
ders of magnitude higher than physiological hyperinsulinemia (∼ 450 pM [226]).
Under these conditions glucose uptake and glycogen synthesis were completely in-
sensitive to insulin in our model (not shown). Other rat studies [240, 241] using
insulin infusion rates and durations comparable to those of Chase et al. [12] report
nanomolar plasma insulin concentrations, leading us to suspect that the micromolar
values reported by Chase et al. [12] are a misprint.
Schafer et al. [13] obtained values for ΩG6P:JIns from the slopes of the graphs of
ln[G6P] against ln J for rats fasted 6 hours and 24 hours using experimental results
from Rossetti & Hu [241]. In these experiments the insulin concentration was var-
ied in the range 250–2700 pM. Schafer et al. [13] found ΩG6P:JIns to be small (0.15–0.28)
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Table 6.1: Comparison of control analytic coefficients compiled or calculated by Schafer et al.
[13] from experimental data to our model values. Symbols used in [13] are given in parenthe-
ses. The experimental values were determined at various insulin concentrations, but mostly
under hyperinsulinemic conditions. The model values were calculated at an insulin concen-
tration of 450 pM, a typical physiological hyperinsulinemic concentration.
Coefficient Schafer et al. [13] Model value
εdemandG6P (in vivo ε
B
M) 1.9 1.89
ΩG6P:JIns (τ) 0.15–0.28 0.43
εdemandIns /ε
supply
G6P (pi
AB
X ) 0.44–0.7 0.19
and, within accuracy, independent of the insulin concentration. Our results, how-
ever, show that while the absolute value of ΩG6P:JIns is indeed small (< 1) over the
entire range of insulin concentrations, ΩG6P:JIns can also be negative (for insulin con-
centrations in which activation of glycogen synthesis exceeds activation of glucose
uptake) and zero (at the points where glycogen synthesis and glucose uptake are
stimulated in equal proportions). This discrepancy is of little consequence to the
conclusions drawn by Schafer et al. [13] regarding the function of covalent modi-
fication in G6P homeostasis, but demonstrates that, although both glucose uptake
and glycogen synthesis are activated by insulin, the proportion to which they are
activated is not independent of the insulin concentration.
Values of 0.7 (6 hour fasted rats) and 0.44 (24 hour fasted rats) were determined
for the ratio εdemandIns /ε
supply
Ins , indicating that glucose uptake is stimulated to a greater
extent than glycogen synthesis during hyperinsulinemic conditions [13]. Our results
agree with this finding, but predicts that the converse will be true at basal insulin
concentrations. This prediction is supported by the observation that the concentra-
tion of G6P initially decreases and then increases with insulin stimulation [240, 241].
Overall, our findings are in good agreement with those of Schafer et al. [13]. A com-
parison of our and their results is shown in Table 6.1. Our values were calculated
under typical physiological hyperinsulinemic conditions (450 pM).
6.7 Effect of glycolysis on the flux control of glycogen
synthesis
Up to now we have assumed that the glycolytic flux is negligible under conditions of
glycogen synthesis. In recognition that this is not always a reasonable assumption,
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Chase et al. [12] determined the control properties of glycogen synthesis experimen-
tally at various glycolytic fluxes during a hyperinsulinemic clamp. They treated
glycogen synthesis as a supply-demand system of G6P in which glucose uptake (gu)
produces G6P and glycogen synthesis (gs) consumes G6P, but with glycolysis (gly-
col) as an additional demand process (Fig. 6.14). They determined εguG6P and ε
gs
G6P
by modulating the plasma glucose concentration during a hyperinsulinemic clamp
using the expressions
ε
gu
G6P =
JguH − JguE
JguE
− [Glco]H − [Glco]E
[Glco]E
[G6P]H − [G6P]E
[G6P]E
(6.24)
and
ε
gs
G6P =
JgsH − JgsE
JgsE
[G6P]H − [G6P]E
[G6P]E
(6.25)
where J denotes the flux, E indicates euglycemic (5.5 mM) conditions, and H indi-
cates hyperglycemic (13.9 mM) conditions. εgsG6P and ε
glycol
G6P were assumed to remain
unchanged with increased Jglycol. The value of ε
glycol
G6P was taken as zero.
Chase et al. [12] proceeded to calculate the glycogen synthetic flux-control coeffi-
cients according to the equations
C Jgsgu =
1
1− ε
gu
G6P − (Jglycol/Jgu)εglycolG6P
ε
gs
G6P
− Jglycol/Jgu
(6.26)
gu G6P gs
glycol
Figure 6.14: Glycogen synthesis and glycolysis as a supply-demand system of G6P. Glucose
uptake (gu) produces G6P, whereas glycogen synthesis (gs) and glycolysis (glycol) consume
G6P.
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C Jgsgs = −C Jgsgu
ε
gu
G6P − (Jglycol/Jgu)εglycolG6P
ε
gs
G6P
(6.27)
C Jgsglycol = −C
Jgs
gu (Jglycol/Jgu) (6.28)
We reproduced the values in [12] using the model GlySynth with an additional
abbreviated glycolysis branch and by setting all fixed concentrations to the values in
[12]. The glycolysis branch included the phosphoglucose isomerase (PGI) reaction,
catalysing the conversion of G6P to fructose-6-phosphate (F6P), and an irreversible
sink reaction representing the remainder of the glycolysis pathway. The kinetics
of the sink reaction was chosen according to that of the ATPase reaction, because
ATPase controls the glycolytic flux [19]. The elasticity of glycolysis with respect to
G6P can be expressed in terms of the elasticities of individual enzymes as follows:
ε
glycol
G6P = C
Jglycol
PGI ε
PGI
G6P (6.29)
=
εsinkF6P
εsinkF6P − εPGIF6P
εPGIG6P (6.30)
= εsinkF6P (since
∣∣∣εPGIF6P∣∣∣ ∣∣∣εsinkF6P ∣∣∣ and ∣∣∣εPGIF6P∣∣∣ ' ∣∣∣εPGIG6P∣∣∣) (6.31)
' 0 (ATPase is insensitive to its immediate substrate ATP) (6.32)
While PGI is near equilibrium and C
Jglycol
PGI is thus virtually zero, the value of ε
PGI
G6P is
very large and approximately equal to the absolute value of εPGIF6P, so that ε
glycol
G6P does
not approach zero. Instead, εglycolG6P approaches ε
sink
F6P , which incidentally approaches
zero by virtue of being saturated with its substrate. We see then that although the
sink reaction is insensitive to G6P, it governs the sensitivity of the glycolysis block to
G6P. In a more realistic treatment of glycolysis, more enzymes would be present and
the expression for C
Jglycol
PGI would be more complicated. The large elasticities of PGI
would, however, still cancel and εATPaseATP would be a factor of the numerator, resulting
in a small εglycolG6P value.
We calculated all the relevant elasticities and control coefficients for a range of
glycolysis to glucose uptake flux ratios using PySCeS. To obtain the range of flux
ratios reported by Chase et al. [12], we varied Vmax,sink, the maximal forward rate
of the sink reaction, over a suitable range (Fig. 6.15). The calculated elasticities and
control coefficients are shown in Fig. 6.16 with the experimentally determined values
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Figure 6.15: Dependence of glucose uptake, glycogen synthesis, glycolysis, and G6P on the
maximal rate of the glycolytic sink reaction. Fluxes are given in mM.min−1 and the G6P
concentration is given in mM.
0.15 0.2 0.3 0.4 0.5
−0.5
0
0.5
1
1.5
2
ε
gu
G6P
ε
gs
G6P
ε
glycol
G6P
Jglycol/Jgu
0.15 0.2 0.3 0.4 0.5
−1
0
1
2
C Jgsgu
C Jgsgs
C Jgsglycol
Jglycol/Jgu
Figure 6.16: Influence of the glycolytic rate on elasticities with respect to G6P and glycogen
synthetic flux control. Dots represent experimental values from [12]. Lines represent values
calculated from our model.
from [12]. Note that we used the model value for εglycolG6P and did not follow Chase
et al. [12] in explicitly setting this value to zero.
The model results are generally in good agreement with the experimental results.
In particular, the model results show that Chase et al. [12] were justified in assum-
ing constant values for εgsG6P and ε
glycol
G6P over the range of flux ratios. Both the model
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and the experimental results also show that glucose uptake has the largest glycogen
synthetic flux control over the entire range of flux ratios. The agreement is, however,
not perfect and a few discrepancies warrant discussion. First, Chase et al. [12] found
that the absolute value of εguG6P increased with the glycolytic rate, while we found
that εguG6P remained close to zero for the entire range. Since HK is the only reaction in
the glucose uptake block that is sensitive to G6P, an increase in
∣∣εguG6P∣∣ indicates gain
of glucose uptake flux control by the HK reaction. This, in turn, can only result from
inhibition of HK by G6P, and we must conclude that the results of Chase et al. [12]
indicate that G6P increases as the glycolytic flux increases. While this result seems
contradictory, it must be recalled that glycolysis rarely increases without a concomi-
tant increase in glycogenolysis, which will replenish G6P. Our model, which does
not include glycogenolysis, however, predicts a decrease in G6P as the glycolytic
flux increases (Fig. 6.15).
It should also be noted that the coefficients in [12] were calculated from large
changes in G6P and Jgu resulting from an increase in the external glucose concentra-
tion from euglycemia to hyperglycemia. While this method should provide reason-
able approximations of the coefficients determined from infinitesimal changes, it is
not without pitfalls. At basal insulin concentrations, GLUT controls the glucose up-
take flux. Increasing the insulin concentration, however, gradually shifts flux control
to HK. Additionally increasing the external glucose concentration further shifts flux
control to HK. In the process, the glucose uptake flux becomes increasingly sensitive
to G6P. Even if the majority of flux control is still held by GLUT under hyperinsu-
linemic hyperglycemic conditions, the glucose uptake flux at hyperglycemia (JguH)
would be inhibited more than the glucose uptake flux at euglycemia (JguE), so that
(JguH− JguE)/JguE is an underestimation of the fractional change in Jgu. This has the
consequence that the ([Glco]H − [Glco]E)/[Glco]E term dominates the numerator of
Eq. 6.24 and the overall absolute value of εguG6P is larger.
We must point out that while Chase et al. [12] calculated εguG6P for various values
of the ratio Jglycol/Jgu, it is not immediately clear to us how this calculation was per-
formed, since Eq. 6.24 does not contain this ratio. We do not contest that εguG6P should
vary with this ratio (our own estimates of this value do indeed vary, albeit slightly),
but we contend that the dependence can only be obtained by experimentally chang-
ing the flux of glycolysis and determining the value at each flux. Chase et al. [12],
however, do not report physically altering or measuring the glycolytic flux.
In conclusion, our results and those of Chase et al. [12] suggest that, if glycolysis
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decreases G6P, it should be expected that the control of the glycogen synthetic flux
by glucose uptake and glycolysis should increase with the glycolytic flux, whereas,
if glycolysis increases G6P, glycogen synthesis increasingly controls its own flux as
the glycolytic flux increases.
6.8 Relative importance of allosteric and covalent
modification in glycogen synthesis
Insulin can stimulate glycogen synthesis in the absence of GS
dephosphorylation
In order to assess the relative importance of covalent and allosteric modification of
GS in response to insulin stimulation, Bouskila et al. [17] studied knock-in mice in
which the genes of the α and β isoforms of GSK3 were replaced with mutant forms
that cannot be phosphorylated. Since insulin stimulation inhibits wildtype GSK3 by
phosphorylation, GSK3 is constitutively active in the mutant mice. It was found that
insulin stimulation increased GS activity in the wildtype mice, but failed to bring
about dephosphorylation and thus activation of GS in the mutant mice (Fig. 6.17).
Insulin stimulation did, however, increase the glycogen synthesis rate to the same
extent in the wildtype and mutant mice and also increased the concentration of G6P
(Fig. 6.17). Bouskila et al. [17] interpreted these results as evidence that allosteric
regulation (through G6P-stimulation) and not covalent regulation (through inacti-
vation of GSK3) is the dominant mechanism by which insulin stimulates glycogen
synthesis.
We sought to reproduce the results of Bouskila et al. [17] with the model GlySynth
and found a good qualitative agreement between the experimental and model re-
sults (Fig. 6.17). To mimic the insensitivity of GSK3 to insulin in the mutant mice,
we removed the insulin inhibition term from all GSK3 rate equations. Bouskila et al.
[17] did not report the basal or insulin-stimulated blood insulin concentrations. We
therefore used the values (86 and 430 pM) reported in a similar study by the same
group [18]. In both the experimental and model results insulin increased the intrinsic
activity of GS in the wildtype mice, but not in the mutant mice. Despite the failure
to decrease the degree of GS phosphorylation, however, an increase in the glycogen
synthetic flux comparable to what was observed in the wildtype mice, was also ob-
served in the mutant mice in both the experimental and model results. Finally, the
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Figure 6.17: Reproduction of experimental data obtained by Bouskila et al. [17] from wild-
type (WT) mice and knock-in (GSK3α/β/S21A/S9A) mice in which GSK3 is insensitive to
insulin. The basal (-Ins) and stimulated (+Ins) insulin concentrations were not reported by
Bouskila et al. [17]; we therefore used the values from Bouskila et al. [18] instead: 86 and
430 pM. The mutation was mimicked in the model by removing the insulin inhibition terms
from the rate equations of all GSK3-catalysed reactions. The GS activity ratio is the ratio of
GS activity in the absence and presence of G6P as defined in [17]. The values from [17] were
converted to units of minutes and mM. One gram of wet muscle was considered equivalent
to 0.75 mL cell water, and one gram of dry muscle was considered equivalent to 3 mL cell
water.
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experimental and model results show that insulin stimulation leads to an increase in
the G6P concentration in both the wildtype and mutant mice.
While our results are generally in good agreement with those of Bouskila et al.
[17], our interpretation of these results differs in a few respects. We have previously
shown (see Sections 6.4 and 6.6) that, since GS does not control the glycogen syn-
thetic flux, neither allosteric nor covalent regulation of GS is expected to alter the
glycogen synthetic flux. It is therefore not surprising that the glycogen synthetic
flux is stimulated to the same extent in the wildtype and mutant mice in response
to insulin. Whether GS is dephosphorylated (as in the wildtype mice) or remains
phosphorylated (as in the mutant mice), the increase in glycogen synthetic flux in
response to insulin is the result of increased glucose uptake (resulting from an in-
crease in plasma membrane GLUT4) and not the result of increased GS activity. In-
stead, the increased GS activity in wildtype mice—resulting from increased G6P and
dephosphorylation—allows the glycogen synthetic flux to match the flux of glucose
uptake at a lower G6P concentration. In agreement with this position, our model
shows a larger increase in G6P concentration in the mutant mice over basal than in
the wildtype mice, indicating disturbed G6P homeostasis. The same result was not
observed by Bouskila et al. [17]. It is, however, possible that other pathways com-
pensate for the increase in G6P in vivo in the mutant mice. Bouskila et al. [17] also
reported a higher insulin-stimulated increase in G6P in the wildtype mice than our
model suggests. The small increase in G6P predicted by our model results from the
coordinated activation of glucose uptake and glycogen synthesis, but, as we have
discussed before, also depends on cAMP, which effectively regulates the concentra-
tion of PKA. In conclusion, we suggest that these results indicate that the regulation
of GS activity does not alter the glycogen synthetic flux and that they should not
be interpreted as evidence that dephosphorylation of GSK3 in response to insulin
stimulation is less important than allosteric activation.
Insulin fails to restore the glycogen synthetic flux in mice with
G6P-desensitized GS
To corroborate their earlier findings, Bouskila et al. [18] also studied knock-in mice in
which the gene for GS was replaced by a mutant gene (denoted R285A) of which the
product GS is insensitive to G6P, but which still exhibits normal activity in the ab-
sence of G6P. We reproduced the results of Bouskila et al. [18] with a model in which
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all G6P binding terms in the GS rate equation were removed. The -G6P/+G6P activ-
ity ratio or fractional velocity is often used as an indication of GS phosphorylation
state or intrinsic activity. These measures are, however, not applicable to the present
study, since a value of unity results for G6P-insensitive GS regardless of phosphory-
lation state. Bouskila et al. [18] therefore only report the -G6P activity.
Bouskila et al. [18] found that, while the mutant GS was insensitive to G6P, insulin
stimulation was able to increase the -G6P activity to similar levels in both wildtype
and mutant mice (Fig. 6.18). Our model results likewise showed that the intrinsic
activity of GS was similar in the wildtype and mutant mice and that insulin stimu-
lation activated GS in the mutant mice to the same extent that it activated GS in the
wildtype mice. In further agreement with Bouskila et al. [18], we also found that in
double knock-in mice—in which GS is insensitive to G6P and GSK3 is constitutively
active—insulin still resulted in an increase in glycogen synthesis. Although in our
model results this increase was very small, and possibly insignificant, we discuss a
possible mechanism behind this phenomenon in Section 6.9.
Bouskila et al. [18] reported a significantly higher basal and insulin-stimulated
G6P concentration in mutant mice compared to wildtype mice (Fig. 6.18). While we
also found an increase in mutant G6P concentration, the wildtype G6P concentra-
tions and the fold increase of the mutant over wildtype G6P concentrations were
much larger than what was found by Bouskila et al. [18]. This result is possibly ex-
plained by the fact that our model does not include pathways such as glycolysis into
which excess G6P could be channelled to compensate for the mutation, a position
supported by the observation that a 2.5-fold increase in the glycolytic flux was ob-
served in mutant mice relative to wildtype mice [18]. A side-effect of the high G6P
concentrations in our model of the mutant mice was that the glucose uptake flux was
significantly inhibited as a result of HK inhibition by G6P. Bouskila et al. [18] did not
observe a decrease in glucose uptake in the mutant mice, but concede that their di-
rect measurement of glucose uptake, as estimated by 2-deoxyglucose uptake, would
not reveal HK inhibition, because 2-deoxyglucose-6-phosphate does not inhibit HK.
A decrease in glycogen synthetic flux without a decrease in glucose uptake flux is,
however, also explained by an increase in glycolysis.
Bouskila et al. [18] interpreted these results, namely that insulin fails to restore
glycogen synthesis in mutants to wildtype levels, as further evidence that insulin
increases the glycogen synthetic flux not by dephosphorylating GS, but by the al-
losteric activation of GS by G6P. Despite the good agreement between the results of
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Figure 6.18: Reproduction of experimental data obtained by Bouskila et al. [18] from wild-
type (WT) mice and knock-in (GS/R582A) mice in which GS is insensitive to G6P. The basal
(-Ins) and stimulated (+Ins) insulin concentrations were 86 and 430 pM. The R582A mutation
was mimicked in the model by removing the G6P binding terms from the GS rate equation.
A double mutant, with both the GS/R582A and GSK3α/β/S21A/S9A mutations, was also
considered. The -G6P GS activities were normalized to the wildtype basal values. Note the
different scales of the graphs showing experimental and model G6P concentrations. The
values from [18] were converted to units of minutes and mM. One gram of wet muscle was
considered equivalent to 0.75 mL cell water. ND, not determined.
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Bouskila et al. [18] and those reported here, our interpretation of these results dif-
fers. It is intriguing that, judged by the GS activity in the absence of G6P, insulin
stimulated the dephosphorylation of GS to the same extent in wildtype and mutant
animals, but that this dephosphorylation was not sufficient to activate GS in the mu-
tant mice. This indicates that the activation arising from the dephosphorylation of
GS sites that are GSK3 substrates in response to insulin is not sufficient to overcome
the inhibition brought about by phosphorylation at other sites and by allosteric inhi-
bition. On the other hand, inhibition by phosphorylation and ATP can be overcome
by the allosteric activator G6P. This is, however, not evidence that, in response to
insulin, activation by G6P is stronger than activation by dephosphorylation of GS,
but instead indicates that the allosteric activation of GS by G6P, whether at basal or
insulin-stimulated concentrations, is critically important to the normal functioning
of glycogen synthesis. If the light bulb is removed, darkness should not be blamed
on the switch.
Change in the fraction of glycogen synthase in the R conformation
in response to insulin and external glucose
The extent to which a change in the GS activity results in a change in the pathway
flux is quantified by the flux control coefficient C JGS. Changes to the activity of GS—
whether by allosteric or covalent modification—will only have a significant effect on
the glycogen synthetic flux if C JGS has a large value. Consequently, the question of
whether insulin stimulates glycogen synthesis mostly through allosteric or mostly
through covalent activation of GS is only relevant if GS has significant control over
the glycogen synthetic flux. If, as we have argued earlier, the function of GS regu-
lation, whether allosteric or covalent, is not the control of flux, but the homeostatic
maintenance of metabolite concentrations in the face of large fluctuations in the glu-
cose uptake flux, then the answer to the question of whether allosteric or covalent
regulation contributes the most to the glycogen synthetic flux in response to insulin
can only be that neither mechanism contributes to a change in the flux.
The relative importance of allosteric and covalent GS modification in response
to insulin can also be assessed by only considering the local activity change of GS
without considering the global effect, such as a change in flux or metabolite concen-
tration, brought about by a local change in the GS activity. We thus pose the ques-
tion whether an increase—in addition to what is already observed at basal insulin
Stellenbosch University  http://scholar.sun.ac.za
CHAPTER 6. REGULATORY DESIGN OF GLYCOGENMETABOLISM 187
concentrations—in the allosteric activation of GS as a result of the insulin-stimulated
increase in G6P contributes more towards GS activation than the dephosphorylation
of GS that occurs during the transition from basal to insulin-stimulated conditions.
This question differs from that of Bouskila et al. [18] in that it is not concerned with
the glycogen synthetic flux at all, but rather with the intrinsic activity state of GS.
Another difference is that it emphasizes that the change in GS activity must be con-
sidered relative to the basal activity in wildtype mice. While this question is difficult
to address experimentally, it is readily investigated with an appropriate mathemati-
cal model.
Since we have found that the activity of GS in a particular phosphorylation state
is best described by an MWC-type rate equation in which only the R conformation is
catalytically active, the fraction of GS that is present in the R conformation provides
a measure of the intrinsic activity of the enzyme. Another aspect of the rate equation
is that both allosteric and covalent modification manifest as an apparent alteration
to the equilibrium between unliganded enzyme in the T and R conformations. This
alteration is implicit in the case of allosteric modification, but involves an explicit
change to L0 in the case of covalent modification, i.e., a different L0 value is assigned
to each phosphorylation state of GS. The fraction of GS in a particular phosphory-
lation state i that is present in the R conformation in the absence of ligands is given
by
R0i =
R0i
R0i + T0i
(6.33)
=
1
1+ L0i
(6.34)
The definition of R0i is very similar to that of the GS activity ratio which is expressed
as I/(I + D), where I and D represent the G6P-independent and G6P-dependent
activity of GS. Indeed, we showed in Chapter 3 that the activity ratio is an approx-
imation of R0. The overall fraction of GS in the R conformation, considering all
phosphorylation states, is then given by
R0 =∑
i
[GS]i
[GS]tot
R0i (6.35)
The value of R0 is independent of any allosteric modification and only reflects the
activity state as altered by covalent modification. As phosphorylation is inhibitory,
R0 increases in response to insulin stimulation which leads to the dephosphorylation
Stellenbosch University  http://scholar.sun.ac.za
CHAPTER 6. REGULATORY DESIGN OF GLYCOGENMETABOLISM 188
R¯0 R¯
0
0.1
0.2
0.3
0.4
basal HI HG
Figure 6.19: Fraction of unliganded (R0) and liganded (R) GS in the R conformation under
basal, hyperinsulinemic (HI) and hyperglycemic (GI) conditions. A change in R0 reflects
a change in covalent modification state, whereas a change in R reflects a change in both
covalent and allosteric modification state. The fold change in R0 and R in response to insulin
is approximately equal, whereas only R changes appreciably in response to elevated external
glucose.
of GS. If the effect of ligands on the fraction of GS in the R conformation is also
considered, Eq. 6.33 is transformed to
Ri =
1
1+ L0i
(
1+
[UDPG]
KUDPG
+
[ATP]
K′t,ATP
)n (
1+
[G6P]
Kt,G6P
+
[ATP]
Kt,ATP
)n
(
1+
[UDPG]
KUDPG
+
[ATP]
K′r,ATP
)n (
1+
[G6P]
Kr,G6P
+
[ATP]
Kr,ATP
)n
(6.36)
Similarly, Eq. 6.35 is transformed to
R =∑
i
[GS]i
[GS]tot
Ri (6.37)
Ligands that prefer to bind to the R conformation (activators) will increase R, whereas
ligands that prefer to bind to the T conformation (inhibitors) will decrease R.
We calculated R0 and R at basal (40 pM) and hyperinsulinemic (450 pM) condi-
tions (Fig. 6.19). R0 increased 2.64-fold from 0.14 to 0.37, whereas R increased 2.67-
fold from 0.1 to 0.27. Since R, which accounts for both allosteric and covalent modi-
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fication, increases only very slightly more than R0, which only accounts for covalent
modification, we may conclude that the major part of the resulting activation of GS
in response to insulin is due to the dephosphorylation of GS and not to allosteric
activation by G6P. We also calculated R0 and R at euglycemic (5.5 mM) and hyper-
glycemic (13 mM) conditions (Fig. 6.19). R0 increased 1.14-fold from 0.14 to 0.16,
whereas R increased 2.17-fold from 0.1 to 0.22. This indicates that, in response to
an increase in the external glucose concentration, GS activation results mostly from
activation by G6P and not from dephosphorylation of the enzyme. These results are
in agreement with experimental results showing that insulin [242], but not external
glucose [243, 244], increases the GS fractional velocity.
While we were able to reproduce the results of Bouskila et al. [17, 18] reasonably
well, we argue that those results cannot be interpreted as evidence that, in response
to insulin stimulation, allosteric modification “trumps” [245] covalent modification.
To the contrary, our analysis indicates that insulin-dependent dephosphorylation of
GS accounts for the major part of GS activation in response to insulin.
Using R0 and R to quantify the relative contributions of allosteric and covalent
modification to GS activation is, however, not without its shortcomings. If most of
the unliganded GS is already present in the R conformation, then the effect of ligands
that also favour the R conformation is less than what would be observed if most of
the unliganded GS was in the T conformation. Our values for R0 were, however, well
below 0.5 and the importance of allosteric modification would only be marginally
underestimated. Another shortcoming is that while a change in R0 reflects a change
in the covalent state of GS, it is also true that G6P can alter the phosphorylation state
of GS by virtue of PP1 activation. This is evident in the change in R0 that results from
an increase in external glucose. This insulin-independent change in R0 is, however,
much smaller than the change in R and we therefore do not expect it to significantly
affect the change in R0 resulting from an increase in insulin.
These results agree well with our earlier findings that the value of ΩJ:G6PGlco is com-
pletely determined by the value of εdemandG6P , whereas Ω
J:G6P
Ins is only influenced by
εdemandG6P when the absolute values of ε
supply
Ins and ε
demand
Ins differ significantly. That
is, activation of the demand block (glycogen synthesis) by G6P is essential for the
homeostatic maintenance of G6P in response to the increased flux resulting from
elevated external glucose. In response to insulin, on the other hand, the mecha-
nism by which G6P is maintained in a narrow range involves the coordinate acti-
vation of glucose uptake and glycogen synthesis. The situation is, however, more
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complex, because G6P is also able to stimulate net dephosphorylation of GS in an
insulin-independent mechanism. The result is that εdemandG6P is not a pure indication
of allosteric activation, and εdemandIns is not a pure indication of covalent activation.
The relative importance of allosteric and covalent modification can also be inves-
tigated with MCA. In this framework, the effect of insulin on R can be quantified
with the response coefficient RRIns, which is expressed as
RRIns = C
R
GLUTε
GLUT
Ins +∑
i
CRGSK3iε
GSK3i
Ins (6.38)
where i denotes a particular GSK3-catalysed reaction. CRGLUT and C
R
GSK3i
can be ex-
pressed in terms of conventional concentration-control coefficients and hence also in
terms of elasticities. One would then proceed to separate all the terms that describe
allosteric modification from those that describe covalent modification, provided that
this distinction can be clearly made, in order to quantify the contributions of these
two mechanisms toward a change in R. The resulting expression is, however, so
complicated that we will not attempt this analysis here. RRGlco could similarly be
employed to investigate the relative contributions of allosteric and covalent modifi-
cation to a change in R in response to an increase in external glucose concentration.
6.9 The mechanisms by which glucose-6-phosphate
stimulates glycogen synthesis
In Section 6.4 we saw that εdemandG6P , the elasticity of the glycogen synthesis block to
G6P, is an important determinant of the extent to which the concentration of G6P
is maintained in a narrow range in the face of large increases in the flux resulting
from elevated external glucose concentrations. In Chapter 2 we reviewed five mech-
anisms by which G6P stimulates glycogen synthesis. Four of these mechanisms were
included in our model of glycogen synthesis (GlySynth):
• G6P is a precursor of UDPG and can thus be considered the substrate of the
demand (glycogen synthesis) block
• G6P is an allosteric activator of GS
• G6P is a substrate-specific inhibitor of GS kinases
• G6P is a substrate-specific activator of GS phosphatases
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In this section we consider the contribution of each of these mechanisms towards the
value of εdemandG6P .
Since εdemandG6P is a block elasticity it can be expressed in terms of the elasticities of
individual enzymes in the block with respect to G6P, each scaled by the flux-control
coefficient of the particular enzyme within the block. Stated otherwise, εdemandG6P is the
flux-response coefficient of the isolated block with respect to G6P:
εdemandG6P = R
Jdemand
G6P (6.39)
= C JdemandPGLM ε
PGLM
G6P + C
Jdemand
GS ε
GS
G6P +∑
i
C Jdemandkini ε
kini
G6P +∑
j
C Jdemandphosj ε
phosj
G6P (6.40)
where kini is any GS kinase reaction and phosj is any GS phosphatase reaction. If
we define these partial response coefficients:
subRJdemandG6P = C
Jdemand
PGLM ε
PGLM
G6P (6.41)
allosRJdemandG6P = C
Jdemand
GS ε
GS
G6P (6.42)
kinRJdemandG6P =∑
i
C Jdemandkini ε
kini
G6P (6.43)
phosRJdemandG6P =∑
j
C Jdemandphosj ε
phosj
G6P (6.44)
then Eq. 6.39 can be rewritten as
εdemandG6P =
subRJdemandG6P +
allosRJdemandG6P +
kinRJdemandG6P +
phosRJdemandG6P (6.45)
The contribution of each of the four terms in Eq. 6.45 as a function of G6P concentra-
tion is shown in Fig. 6.20.
Contribution of G6P as substrate precursor
The contribution of G6P as substrate precursor of GS to the value of εdemandG6P is quanti-
fied by subRJdemandG6P . In order to express
subRJdemandG6P completely in terms of elasticities of
the demand block, it is necessary to find an expression for C JdemandPGLM . In addition to the
glycogen synthesis pathway, the demand block also contains the pathway describing
the interconversion between all the GS phosphorylation states. If no intermediates
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Figure 6.20: The relative contributions of four mechanisms by which G6P activates glycogen
synthesis. The values of subRJdemandG6P ,
allosRJdemandG6P ,
kinRJdemandG6P , and
phosRJdemandG6P were calculated for
a range of G6P values by considering the glycogen synthesis pathway, together with the GS
phosphorylation module, in isolation from the rest of the system. In all cases kinRJdemandG6P was
negligible. A) εdemandG6P (black line) as the sum of the (stacked) partial response coefficients. B)
Fractional contribution of the partial response coefficients to εdemandG6P .
in the glycogen synthesis pathway affect the rates of the kinases and phosphatases
that catalyse the interconversion of GS, then C JdemandPGLM could be expressed in terms
of elasticities by considering the glycogen synthesis pathway in isolation from the
interconversion pathway:
C JdemandPGLM =
εUPPG1Pε
GS
UDPG
εPGLMG1P ε
UPP
UDPG − εPGLMG1P εGSUDPG + εUPPG1PεGSUDPG
(6.46)
In reality UDPG affects both the kinase and phosphatase reactions by virtue of be-
ing a GS ligand. Although UDPG binds with equal affinities to both the T and R
conformations of GS, and should therefore not result in a conformational change
that would affect the kinase and phosphatase reactions, competition for the catalytic
binding site by ATP offsets the balance so that binding of UDPG does result in a
slight conformational change. While Eq. 6.46 then only provides an approximation
of the real value of C JdemandPGLM , we will nevertheless use this expression in what follows.
The expression of subRJdemandG6P in terms of elasticities is then given by
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subRJdemandG6P '
εUPPG1Pε
GS
UDPG
εPGLMG1P ε
UPP
UDPG − εPGLMG1P εGSUDPG + εUPPG1PεGSUDPG
· εPGLMG6P (6.47)
Since both PGLM and UPP are near equilibrium, it follows that
∣∣εPGLMG6P ∣∣ ' ∣∣εPGLMG1P ∣∣,∣∣εUPPG1P∣∣ ' ∣∣εUPPUDPG∣∣, and that the value of εGSUDPG is much smaller than εPGLMG6P and εUPPG1P
in absolute terms. Equation 6.47 then simplifies to
subRJdemandG6P ' εGSUDPG (6.48)
The high activities of PGLM and UPP essentially keep the concentrations of G6P and
UDPG in a fixed ratio, so that a small percentage change in G6P results in an equal
percentage change in UDPG. The relative effect of G6P as substrate precursor of
GS is therefore identical to that of the real GS substrate. At low G6P concentrations
subRJdemandG6P is the sole contributor to ε
demand
G6P and has a value close to unity (Fig. 6.20A).
As G6P further increases, the UDPG concentration enters the range in which slight
UDPG binding cooperativity is observed, so that subRJdemandG6P increases to just above 1.
Finally, at very high G6P concentrations, the UDPG concentration becomes saturat-
ing to GS with the result that subRJdemandG6P approaches zero. Note that if we modelled
GS as a reversible reaction, subRJdemandG6P would approach infinity, not unity, at very low
G6P concentrations where the GS reaction is near equilibrium.
Contribution of G6P as allosteric activator
The contribution of G6P as allosteric activator of GS to the value of εdemandG6P is quanti-
fied by allosRJdemandG6P = C
Jdemand
GS ε
GS
G6P. Following the same reasoning as above, the value
of C JdemandGS can be approximated by considering glycogen synthesis as a pathway
that is isolated from the GS interconversion pathway. The expression for C JdemandGS
then reads
C JdemandGS =
εPGLMG1P ε
UPP
UDPG
εPGLMG1P ε
UPP
UDPG − εPGLMG1P εGSUDPG + εUPPG1PεGSUDPG
(6.49)
Considering that PGLM and UPP operate near equilibrium, Eq. 6.49 simplifies to
C JdemandGS ' 1 (6.50)
and Eq. 6.42 simplifies to
allosRJdemandG6P ' εGSG6P (6.51)
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The condition C JdemandGS ' 1 could also be achieved if GS were saturated with its
substrate UDPG, i.e., if εGSUDPG ' 0 held. If this were the case, one would expect
G6P to activate GS by increasing the maximal rate of catalysis and not the affinity of
UDPG, as discussed by Hofmeyr et al. [16] and in Chapter 4. However, since UDPG
is not saturating in our model, no such restriction is placed on the mechanism by
which G6P activates GS. Indeed, the rate equation that we have found to provide the
best description of GS kinetics mandates that G6P activates GS both by increasing the
rate constant (by favouring the catalytically active conformation) and by increasing
the affinity for UDPG (by favouring the conformation in which ATP competition
with UDPG is the weakest).
εGSG6P itself can be expressed as a sum of weighted elasticities: the elasticity of each
phosphorylation state of GS to G6P contributes to εGSG6P in proportion to the fraction
that catalysis by the particular phosphorylation state contributes toward the overall
GS rate (Appendix A.2):
εGSG6P =∑
i
vGSi
vGS
ε
GSi
G6P (6.52)
where
ε
GSi
G6P =
n
(
1+
[UDPG]
KUDPG
+
[ATP]
K′t,ATP
)n
L0i
 1+
[G6P]
Kt,G6P
+
[ATP]
Kt,ATP
1+
[G6P]
Kr,G6P
+
[ATP]
Kr,ATP

n 
[G6P]
Kr,G6P
1+
[G6P]
Kr,G6P
+
[ATP]
Kr,ATP
−
[G6P]
Kt,G6P
1+
[G6P]
Kt,G6P
+
[ATP]
Kt,ATP

(
1+
[UDPG]
KUDPG
+
[ATP]
K′t,ATP
)n
L0i
 1+
[G6P]
Kt,G6P
+
[ATP]
Kt,ATP
1+
[G6P]
Kr,G6P
+
[ATP]
Kr,ATP

n
+
(
1+
[UDPG]
KUDPG
+
[ATP]
K′r,ATP
)n (6.53)
The theoretical maximum value of εGSiG6P is n = 4, which is achieved if the enzyme
is present only in the T conformation (L0i → ∞) and if G6P is saturating (Kr,G6P 
[G6P]), but does not bind to the T conformation (Kt,G6P → ∞). These conditions are
not met for any of the GS phosphorylation states and therefore εGSiG6P and thus ε
GS
G6P
are smaller than 4 for all i.
Rubin & Changeux [161] have shown that the slope of the graph of fractional
saturation against ligand concentration is maximized when L =
√
Knt /Knr . Since the
effects of ligand binding and covalent modification both manifest as changes in Lapp
(which is proportional to L0,app but takes ligand concentrations into account), it is in-
structive to consider the value of Lapp that will result in a maximum ε
GSi
G6P value. The
present situation, however, differs from the one considered by Rubin & Changeux
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[161] in that we are interested in the relationship between vGS, which is proportional
to the fractional saturation of GS with UDPG (as opposed to G6P) and G6P. Never-
theless, from the fitted values of Kt,G6P and Kr,G6P the value of Lapp that maximizes
εGSG6P is calculated as 18.4. ATP inhibits GS both by preferentially binding to the T
conformation and by competing with G6P for the allosteric site. Since competition
of ATP with G6P results in an apparent change to Kt,G6P and Kr,G6P, the value of Lapp
that results in a maximal value of εGSG6P depends on the ATP concentration. Other
ligands will also alter the optimal Lapp value.
The values of L0i range between 0.25 for the dephosphorylated enzyme and 185
for the completely phosphorylated enzyme. While phosphorylation will continue to
inhibit GS beyond Lapp values of about 18.4, depending on the concentrations of GS
ligands, this inhibition will not be accompanied by a further increase in εGSG6P. In fact,
a steady decrease in εGSG6P is expected. Similarly, inhibition by ATP will increase ε
GS
G6P
only as long as Lapp remains below 18.4. In summary then, the value of εGSG6P is the
result of the cooperative binding of G6P to GS, the degree of which is enhanced by
ATP and phosphorylation, but only up to a point.
At very low concentrations G6P is not able to activate GS and allosRJdemandG6P does not
contribute to εdemandG6P (Fig. 6.20). As G6P increases to within the range between Kr,G6P
and Kt,G6P, allosR
Jdemand
G6P increases and passes through its maximal value. Further in-
creases in G6P cause GS to become saturated with G6P, so that allosRJdemandG6P decreases
asymptotically to zero again.
Contribution of G6P as kinase inhibitor and phosphatase activator
The contribution of G6P as GS kinase inhibitor and GS phosphatase activator to the
value of εdemandG6P is quantified by
kinRJdemandG6P and
phosRJdemandG6P . While it is possible to
express these two partial elasticities in terms of elasticities of individual enzymes in
the demand block, the resulting expressions are too complicated to be workable. It
is, however, reasonable to assume that the same conditions identified for the simpler
system considered in Chapter 4 will also maximize kinRJdemandG6P and
phosRJdemandG6P . These
conditions, as applied to GS modification, are
1. GS must control the flux within the isolated glycogen synthesis pathway
2. UDPG must bind equally well to the T and R conformations of GS
3. the various phosphorylation states of GS must exhibit different kinetics
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4. the GS kinases and phosphatase must exhibit zero-order sensitivity to GS as
substrate
We have already seen that the first condition is satisfied by virtue of PGLM and
UPP operating near equilibrium. The second condition is not met, because although
UDPG binds equally well to the T and R conformations in the absence of ATP, com-
petition with ATP at the catalytic site alters the apparent affinity of GS for UDPG
to such an extent that, in the presence of ATP, UDPG binds preferentially to the R
conformation. It must, however, be recalled that we fitted the kinetic parameters for
GS to experimental data that were obtained under conditions (low pH) were ATP
inhibition is very pronounced [39, 67]. At any rate, judging by the mild UDPG co-
operativity observed, the violation of the second condition is not significant.
While not all the GS phosphorylation states exhibit the same kinetics, the kinetics
of some states are not altered by phosphorylation. Conversion between GS states
with identical kinetics will not contribute to kinRJdemandG6P and
phosRJdemandG6P . The third
condition is thus only partially satisfied.
Finally, for a number of reasons, the fourth condition is also not met. The Michaelis
constants for the phosphatase and kinase reactions are rather high (in the order
of the concentrations of the various GS states) and thus neither the kinase nor the
phosphatase reactions are near saturation. For the phosphatase reactions, the high
Michaelis constants are possibly explained by the fact that glycogen is generally
omitted in assays. Since both GS and PP1 are in association with glycogen in vivo
which results in an apparent increase in GS concentration, the kinetics determined
in the absence of glycogen would overestimate the Michaelis constant. Moreover,
GS in phosphorylation states that do not affect the kinetics of the enzyme compete
with GS in states that do, which further increases the apparent Michaelis constants.
More extensive kinetic data are required to assess whether this condition is met in
vivo.
Although most of the conditions that would maximize kinRJdemandG6P and
phosRJdemandG6P
are not satisfied, phosRJdemandG6P still contributes to the value of ε
demand
G6P , albeit to an extent
well below the theoretical maximum of infinity. The relationship between phosRJdemandG6P
and G6P follow a similar profile as that of the relationship between allosRJdemandG6P and
G6P: initially the values are very small but then peak between Kr,G6P and Kt,G6P, only
to decrease to zero again (Fig. 6.20). Note, however, that the peaks of kinRJdemandG6P , if
present, and phosRJdemandG6P will generally not coincide with each other or with the peak
of allosRJdemandG6P . Also note that the contribution of
kinRJdemandG6P to ε
demand
G6P is negligible.
Stellenbosch University  http://scholar.sun.ac.za
CHAPTER 6. REGULATORY DESIGN OF GLYCOGENMETABOLISM 197
This results from the fact that we only included modification terms that alter the Keq
(and the reverse Vmax by implication) of kinase reactions. Since the kinase reactions
are practically irreversible, the modification terms have almost no effect on the ki-
nase reaction rates. While it is reasonable to expect that G6P also affects the forward
Vmax values of GS kinases in vivo, we found no direct evidence from the limited data
available in the literature that would suggest that modification terms that alter the
forward Vmax must also be included in kinase reactions. We are, however, to our
knowledge, the first to propose a theory that would suggest that such modification
terms should be looked for in the first place.
Since PKA and insulin affect L0,app, it is expected that the values of allosR
Jdemand
G6P ,
kinRJdemandG6P , and
phosRJdemandG6P will be influenced by PKA and insulin. Here we will con-
sider the relationships between PKA and insulin, and phosRJdemandG6P . Over a physiolog-
ically relevant range of PKA concentrations (as would be observed in response to
adrenergic stimulation and the subsequent increase in cellular cAMP), two peak ar-
eas are observed for phosRJdemandG6P (Fig. 6.21A). The first (at a lower [PKA]) corresponds
to the phosphorylation of site 2 by PKA (compare Fig. 6.9), whereas the second corre-
sponds to the phosphorylation of the remaining GS phosphorylation sites resulting
from inhibition of PP1 by PKA. The value of phosRJdemandG6P decreases as the insulin con-
centration increases (Fig. 6.21B), because GS is already substantially dephosphory-
lated under these conditions and further stimulation of net dephosphorylation does
not significantly alter the rate of the GS reaction.
Discussion
Chase et al. [12] determined the value of εGSG6P in vivo and in vitro experimentally
under hyperinsulinemic conditions and found a large discrepancy between these
values (1.9 and 0.79). In reality, however, the in vivo and in vitro values of Chase
et al. [12] correspond to our εdemandG6P and ε
GS
G6P. Since the value of ε
GS
UDPG is about 1,
Schafer et al. [13] were correct in suggesting that the discrepancy can be resolved by
also considering the contribution of G6P as substrate precursor of GS. The remaining
difference (about 0.1) is probably not significant within error. However, here we have
shown that the contribution of phosRJdemandG6P to ε
demand
G6P is indeed in the order of 0.1 and
could therefore explain this remaining discrepancy. The significant contribution of
subRJdemandG6P to ε
demand
G6P could also explain why Bouskila et al. [18] observed an increase
in the glycogen synthetic flux in response to insulin in the double knock-in mice in
which GS is insensitive to G6P and GSK3 is insensitive to insulin, a possibility also
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Figure 6.21: Dependence of phosRJdemandG6P on the PKA and insulin concentrations. Two peak
areas, corresponding to the phosphorylation of site 2 and the inhibition of PP1 (which results
in the phosphorylation of all sites) are observed when PKA is varied. phosRJdemandG6P decreases
as insulin increases from a basal to hyperinsulinemic concentration.
considered by them.
The relevance (or even presence) of kinRJdemandG6P and
phosRJdemandG6P in vivo is not estab-
lished. While modification of GS kinases and phosphatases by G6P is an established
phenomenon in vitro, to our knowledge, we are the first to provide quantification
of these effects in a detailed model. In Chapter 4 we have shown from first prin-
ciples, given that GS is a MWC-type equation, that the inclusion of these effects is
necessary to satisfy thermodynamic constraints. The theory developed in Chapter 4
is supported by a wealth of experimental data. Unfortunately, the experimental data
were obtained from experiments in vitro, are mostly qualitative, and in many cases
the exact phosphorylation state of the enzyme used in assays is unknown. We have
only included terms that modify the forward Vmax for kinase and phosphatase reac-
tions where it has been shown experimentally that G6P influences the Vmax. In all
other cases we have only included these terms for the Keq to satisfy the thermody-
namic constraints. Due to the large Keq values of kinase and phosphatase reactions,
terms that modify the Keq are practically without effect on the activity of the kinases
and phosphatases. While the effects quantified by kinRJdemandG6P and
phosRJdemandG6P have
not been observed in vivo, it would be surprising, given the theoretical considera-
tions and in vitro data, if these effects are not present in vivo.
As we have seen, the values of kinRJdemandG6P and
phosRJdemandG6P are small in comparison
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to subRJdemandG6P and
allosRJdemandG6P . The question then arises as to what function kinase
inhibition and phosphatase activation by G6P fulfil that is not already fulfilled by
allosteric activation of GS. We have already discussed the possibility that kinRJdemandG6P
and phosRJdemandG6P are underestimated in our model, but even if this is the case the
value of εdemandG6P determined by Chase et al. [12] indicates that the underestimation
cannot be very large. A very large εdemandG6P value would result in switch-like behav-
iour in response to G6P. While switch-like behaviour is desirable in many systems,
the possibility must be considered that glycogen synthesis could have evolved to
repress this behaviour. This possibility must be considered with regard to the sites
phosphorylated by casein kinase 2 (CK2) and GSK3 in particular. GS states that are
phosphorylated to various extents at this cluster will all serve as PP1 substrates, but
only the dephosphorylation of sites 3a and 3b would be enhanced by G6P. The other
sites in this cluster will serve as competitive inhibitors in the dephosphorylation of
sites 3a and 3b and their presence will therefore diminish the value of phosRJdemandG6P .
Similarly, GS that is not phosphorylated at sites 4 and 3c will diminish the inhibi-
tion by G6P of phosphorylation at sites 3b and 3a by GSK3. It appears therefore that
multisite phosphorylation could act as a mechanism that minimizes kinRJdemandG6P and
phosRJdemandG6P . More substantive conclusions can, however, only be drawn when more
detailed experimental data are available.
6.10 Energy charge homeostasis in response to ATP
demand
Up to this point we have only considered the regulation of glycogen synthesis. In
many respects the regulation of glycogen synthesis and glycogen degradation is re-
ciprocal: G6P activates GS, but inhibits GP; phosphorylation generally inhibits GS,
but activates GP. Since we have established that the regulation of glycogen synthesis
involves the maintenance of G6P homeostasis in response to elevated external glu-
cose and insulin—and not the control of the glycogen synthetic flux—it is of interest
to also consider the function of the regulation of glycogen degradation. For this
purpose we employed an implementation of the mathematical model (LamKus) of
mammalian skeletal muscle glycogenolysis by Lambeth & Kushmerick [19]. Since it
was first published, this model has been extended to also take into account the effect
of pH on kinetic parameters and reaction equilibria [202]. We will, however, only be
Stellenbosch University  http://scholar.sun.ac.za
CHAPTER 6. REGULATORY DESIGN OF GLYCOGENMETABOLISM 200
concerned with the original model.
With regard to the rate equation and kinetics for GP, Lambeth & Kushmerick
[19] chose to only include activation of the dephosphorylated enzyme by AMP, but
omitted inhibition by ATP and G6P. Considering the possibility that the modifiers
omitted by Lambeth & Kushmerick [19] could play important roles in the regula-
tion of glycogen degradation, we developed an alternative GP rate equation that
includes these modifiers. In developing this rate equation, we followed the same ba-
sic strategy as Walcott & Lehman [201], but with the important difference that G6P
inhibition was included and that, similar to our treatment of GS, the kinetics of both
phosphorylation states of GP were simultaneously fitted to experimental data. See
Appendix C.2 for more details. The developed rate equation is a MWC-type equa-
tion in which phosphorylation alters the equilibria between the T, R, and U confor-
mations. Only the R conformation is catalytically active. We substituted the GP rate
equation in the model of Lambeth & Kushmerick [19] with this equation (GP MWC).
We also considered a form of the equation that excludes G6P inhibition for purposes
of comparison (GP G6P-insensitive).
The presence of a feedback inhibition loop in which G6P inhibits GP leaves little
doubt that G6P could be considered, as in glycogen synthesis, to be a regulatory
metabolite of glycogen degradation. Unfortunately, glycogen degradation cannot
be treated as a simple supply-demand system of G6P, because G6P is involved in a
phosphate moiety-conserved cycle, which prevents the system from being divided
into functionally differentiated blocks unambiguously. At any rate, it is much more
likely that the regulation of glycogen degradation is primarily concerned with the
maintenance of the cellular energy charge than with the homeostasis of G6P.
Energy charge, ψ, is a secondary system variable and has been defined by Atkin-
son [246] as:
ψ =
2[ATP] + [ADP]
2([ATP] + [ADP] + [AMP])
(6.54)
In what follows we will be mainly concerned with the energy charge and ignore
most glycolytic intermediates.
In order to assess the impact on the steady-state of replacing the rate equation
of GP, we compared the steady-states of the adapted models to the original model
of Lambeth & Kushmerick [19] (Fig. 6.22). No change in any of the fluxes was ob-
served. The differences between metabolite concentrations were, for the most part,
very small and in all cases the values from the adapted and original models were
Stellenbosch University  http://scholar.sun.ac.za
CHAPTER 6. REGULATORY DESIGN OF GLYCOGENMETABOLISM 201
within the same order of magnitude. The absence of any difference in flux values
is already an indication that alteration to the kinetics of GP, whether in the form of
a different rate equation or in the form of allosteric and covalent modification, has
little effect on the glycogen degradation flux.
We also considered the effects of varying the parameters kATPase, the first-order
rate constant of the ATPase reaction, and fGPa , the fraction of GP that is present
in the phosphorylated form, on the ATPase flux, JATPase, and on the energy charge
(Fig. 6.23). As expected, since the ATPase reaction has almost complete control of
the ATPase flux (C JATPaseATPase = 0.99) [19], JATPase increased linearly with kATPase in all
three the models considered. On the other hand, increasing fGPa from 0.001 to 1 had
virtually no effect on the ATPase flux (or any other flux in the system, not shown) in
any of the models.
From the graphs on the right in Fig. 6.23, it is clear that an increased ATPase flux
resulted in a decrease in energy charge. This decrease could, however, be reversed
by an increase in the fraction of GP that is present in the active conformation. Overall
these results indicate that the regulation of GP by phosphorylation does not function
to regulate the flux of glycogen degradation, but instead enables the system to match
the demand for ATP in such a way that the energy charge of the cell is maintained
within a narrow range.
The extent to which the energy charge is buffered in the face of large changes in
the demand for ATP is described by the co-response coefficient
ΩJATPase:ψkATPase =
C JATPaseATPaseε
ATPase
kATPase
CψATPaseε
ATPase
kATPase
(6.55)
=
C JATPaseATPase
CψATPase
(6.56)
The value of C JATPaseATPase is readily obtainable by standard MCA methodology. Since
ψ is really a function of steady-state variables, CψATPase can be expressed in terms of
conventional concentration-control coefficients. An expression for the control coeffi-
cient of ψ with respect to an arbitrary enzymatic step v is derived as follows. Taking
the natural logarithm on the right and left hand sides of Eq. 6.54 yields
lnψ = ln(2[ATP] + [ADP])− ln(2[ATP] + 2[ADP] + 2[AMP]) (6.57)
From the definition of Cψv we have
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Figure 6.22: Correlation of fluxes and steady-state concentrations of the original (LamKus)
and adapted Lambeth & Kushmerick [19] models. The model designated ‘GP MWC’ is iden-
tical to the original model with the exception that the rate equation for GP was replaced by
a MWC-type equation that describes ATP and G6P inhibition in addition to AMP activa-
tion. The model designated ‘GP G6P-insensitive’ is identical to GP MWC with the exception
that G6P inhibition was omitted from the rate equation. Note that all fluxes were integer
multiples of the flux through GP. Red lines represent the function y = x.
Stellenbosch University  http://scholar.sun.ac.za
CHAPTER 6. REGULATORY DESIGN OF GLYCOGENMETABOLISM 203
La
m
K
us
10−3
10−2
10−1
10010−1
100
100
101
102
JATPase
10−3
10−2
10−1
100
10−1
100
10−0.06
10−0.04
10−0.02
100
Energy charge (ψ)
G
P
M
W
C
10−3
10−2
10−1
10010−1
100
100
101
102
10−3
10−2
10−1
100
10−1
100
10−0.06
10−0.04
10−0.02
100
G
P
G
6P
-i
ns
en
si
ti
ve
10−3
10−2
10−1
10010−1
100
100
101
102
fGP
a
kATPase
10−3
10−2
10−1
100
10−1
100
10−0.06
10−0.04
10−0.02
100
fGPa
kATPase
Figure 6.23: ATPase flux (JATPase) and energy charge (ψ) as functions of GP fractional phos-
phorylation ( fGPa) and ATP demand (kATPase). LamKus, the original model by Lambeth &
Kushmerick [19]; GP MWC, the original model with a replaced GP rate equation that de-
scribes ATP and G6P inhibition in addition to AMP activation; GP G6P-insensitive, the same
as GP MWC but without any G6P binding terms in the GP rate equation.
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Cψv =
∂ lnψ
∂ ln v
(6.58)
=
∂
∂ ln v
[
ln(2[ATP] + [ADP])− ln(2[ATP] + 2[ADP] + 2[AMP])
]
(6.59)
=
2[ATP]
∂ ln[ATP]
∂ ln v
+ [ADP]
∂ ln[ADP]
∂ ln v
2[ATP] + [ADP]
−
2[ATP]
∂ ln[ATP]
∂ ln v
+ 2[ADP]
∂ ln[ADP]
∂ ln v
+ 2[AMP]
∂ ln[AMP]
∂ ln v
2[ATP] + 2[ADP] + 2[AMP]
(6.60)
=
2[ATP]CATPv + [ADP]CADPv
2[ATP] + [ADP]
− [ATP]C
ATP
v + [ADP]CADPv + [AMP]CAMPv
[ATP] + [ADP] + [AMP]
(6.61)
Finally, we substitute v for vATPase to obtain an expression for C
ψ
ATPase.
We calculated ΩJATPase:ψkATPase for a range of kATPase and fGPa values (Fig. 6.24). In all
cases the absolute value of ΩJATPase:ψkATPase was well above unity. This indicates that a
change in ATPase activity results in a much larger change in the ATPase flux than
in the energy charge. In other words, the energy charge is homeostatically buffered
despite changing energy demands. The best homeostasis of energy charge was ob-
served when there was a low ATP demand and the majority of GP was present in
the dephosphorylated state. Note that ΩJATPase:ψkATPase is negative, since the energy charge
decreases with ATP demand.
Although, we varied kATPase and fGPa independently, these parameters are sub-
ject to coordinated regulation in vivo. During muscle contraction, calcium ions stim-
ulate both PhK (which activates GP and thus increases fGPa) and myosin (modelled
as an increase in kATPase). The situation is therefore very similar to the coordinated
activation of glucose uptake and glycogen synthesis by insulin, and, in analogy, we
speculate that the coordinated regulation of ATPase and GP functions to increase the
flux in response to ATP demand, by increasing kATPase, while maintaining the energy
charge within a narrow range, by increasing fGPa .
It has been found in numerous experiments in vitro that, in addition to allosteric
modification, the ligands of GP also promote its covalent modification. It is well-
established that AMP inhibits PP1 in the reaction with phosphorylated GP as sub-
strate [167, 247, 248]. The effect of ATP is less clear, because our results suggests
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Figure 6.24: Co-response of ATPase flux (JATPase) and energy charge (ψ) to ATP demand
(kATPase) as a function of GP fractional phosphorylation ( fGPa) and ATP demand. LamKus,
the original model by Lambeth & Kushmerick [19]; GP MWC, the original model with a
replaced GP rate equation that describes ATP and G6P inhibition in addition to AMP activa-
tion; GP G6P-insensitive, the same as GP MWC but without any G6P binding terms in the
GP rate equation.
Stellenbosch University  http://scholar.sun.ac.za
CHAPTER 6. REGULATORY DESIGN OF GLYCOGENMETABOLISM 206
that, in addition to being a PhK substrate, it should also be a non-competitive in-
hibitor with GP as substrate. G6P, on the other hand, inhibits PhK and activates PP1
[166, 168, 222, 249]. These experimental results are in agreement with our finding
that ligands of MWC-enzymes of which covalent modification results in a change in
the equilibrium between conformations of the enzyme will affect the rates of cova-
lent modification (see Section 4.3). While the effects of GP ligands on its covalent
modification have not been studied in detail, it seems reasonable to speculate that
a decrease in energy charge (decrease in ATP, increase in AMP) will of its own—
independent of GP activation by calcium or cAMP—stimulate net phosphorylation
of GP and thus act as a mechanism that increases the energy charge.
Any differences between the results obtained from the original model of Lam-
beth & Kushmerick [19] and the models with the adapted GP rate equations seem
to be primarily quantitative and not qualitative. The differences are most apparent
when energy charge is shown as a function of kATPase and fGPa (Fig. 6.24). In the
models with MWC-type GP rate equations, the restoration of energy charge by fGPa
was more pronounced than in the original model, but it should be noted that the
decrease in energy charge in the original model in response to increases ATP de-
mand was also much less pronounced. It is unlikely that ATP inhibition and G6P
inhibition in the ‘GP MWC’ and ‘GP G6P-insensitive’ models are the primary fac-
tors contributing to these quantitative differences, because the ATP concentration
changes very little and there is only a slight difference between the graphs of the
‘GP MWC’ and ‘GP G6P-insensitive’ models. The differences are most likely due to
inherent differences between the Hill and MWC models. In particular, the degree of
binding cooperativity is constant in the Hill model, but variable in the MWC model.
The role of the feedback loop in which G6P inhibits GP is unclear from the present
results.
Several other mechanisms in glycogenolysis probably play more significant roles
in the homeostasis of energy charge. These mechanisms include the amplification
of the sensitivity to changes in the ATP/ADP ratio by adenylate kinase perceived as
a large change in AMP [77], the supplementation of ATP from phosphocreatine by
creatine kinase, and the regulation of phosphofructokinase by AMP and ATP. Our
emphasis on the covalent modification of GP results only from the fact that GP is
often considered the rate-limiting enzyme of glycogenolysis (see for example [250–
252]), with the implication that its covalent regulation should function to regulate the
glycogenolytic flux. Here we have demonstrated instead that the covalent regulation
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of GP is involved in the homeostasis of energy charge.
6.11 Combining glycogen synthesis and degradation
The natural next step is to combine the models of glycogen synthesis and glycogen
degradation in an overall model of glycogen metabolism. In order to build such
an overall model, several problems need to be addressed. First, it is necessary to
formulate a description of glycogen concentration that accounts for the fact that not
all glucose residues in the glycogen molecule are accessible to enzymes such as GS
and GP. Second, additional enzymatic steps must be included to ensure that the
system’s stoichiometry is consistent.
Glycogen concentration
Glycogen is usually quantified as either the total residual glucose concentration or
as the non-reducing end concentration. The former is readily determined experi-
mentally, but it is the latter that is relevant in terms of enzymatic catalysis. Here
we will show that the structural properties of the glycogen molecule allow one to
approximate the non-reducing end concentration in terms of the glycogenin concen-
tration and the total residual glucose concentration. As discussed earlier, glycogen
synthesis is initiated by the enzyme glycogenin, which remains covalently bound to
the glycogen molecule. Glycogen is synthesized by the linear elongation of glucose
chains by means of α(1 → 4) glycosidic bonds and by the introduction of branches
initiated by means of α(1→ 6) glycosidic bonds. Glycogen chains are on average 13
residues long, and each chain branches twice on average.
If, as a simplification, it is assumed that all glycogen chains have the same length
and degree of branching, the total number of chains CT and the total number of
glucose residues GT per glycogen molecule can be expressed as follows [2]:
CT =
1− CAr
1− r (6.62)
and
GT = CTgc (6.63)
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where CA is the number of chains in the outermost tier of branching, r = 2 is the
degree of branching, and gc = 13 is the number of glucose residues per glycogen
chain. Substituting Eq. 6.62 into Eq. 6.63 yields
GT =
1− CAr
1− r gc (6.64)
which can be rewritten with CA on the left hand side:
CA =
GT(r− 1) + gc
gcr
(6.65)
The number of outermost chains for n molecules of glycogen is then given by
CA =
n
∑
i
CAi (6.66)
=
n
∑
i
GTi(r− 1) + gc
gcr
(6.67)
=
∑ni GTi(r− 1) + ngc
gcr
(6.68)
=
GT(r− 1) + ngc
gcr
(6.69)
where the index i denotes a particular glycogen molecule. The amounts in Eq. 6.69
are readily transformed to concentrations to yield
[NRE] =
[Glcres](r− 1) + [GN]gc
gcr
(6.70)
=
[Glcres] + 13[GN]
26
(6.71)
where [NRE] is the total non-reducing end concentration, [Glcres] is the total residual
glucose concentration, and [GN] is the concentration of glycogenin. Note that the
number of glycogen molecules, n, is equal to the number of glycogenin molecules.
The reaction stoichiometries for GS and GP would then be given by
UDPG UDP+Glcres (6.72)
Pi +Glcres  G1P (6.73)
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so that the model differential equations describe the change in residual glucose, but
only the non-reducing end concentration is used within rate equations. Glycogen is
thus effectively treated as a pool of glucose of which only a fraction, which can be
calculated with knowledge of the structure of glycogen, can take part in enzymatic
reactions.
This treatment is, however, not without shortcomings. First, not all non-reducing
ends function as both substrates and products for GS and GP. The present treatment
does not allow substrate non-reducing ends to be distinguished from product non-
reducing ends. But, for sufficiently large glycogen molecules, substrate and product
non-reducing ends overlap to such an extent that all non-reducing ends may be con-
sidered both substrates and products. Neglecting the difference between substrate
and product non-reducing ends, however, results in further problems. It has the
implication that GS is only sensitive to the ratio of UDPG and UDP, and that GP is
only sensitive to the ratio of glucose-1-phosphate (G1P) and phosphate. Glycogen
synthesis is therefore completely decoupled from glycogen degradation and glyco-
gen will either accumulate or be depleted; no steady-state can be reached. This is
of course not only a modelling problem but is potentially also a problem for the cell
itself. It is therefore to be expected that glycogen sensitivity is conferred on GS and
GP by mechanisms other than glycogen simply functioning as a reagent. Indeed, it
is well-established that glycogen content regulates GS activity in a phosphorylation-
dependent manner [138, 253]. A role in this regard has been suggested for AMP-
activated protein kinase (AMPK) [254], a GS kinase that is able to sense glycogen
branch points. Whether a similar mechanism also facilitates the sensitivity of GP to
glycogen remains to be seen.
Second, Eq. 6.70 predicts a non-zero non-reducing end concentration in the ab-
sence of residual glucose. With regard to glycogen synthesis, this anomaly is indeed
required to facilitate de novo glycogen synthesis. It does, however, allow glycogen
degradation to continue even in the absence of residual glucose and thus could re-
sult in a negative residual glucose concentration. Third, it enforces no upper limit
on the size of glycogen granules, whereas in reality steric constraints limit granules
to 12 tiers (levels of branching). Finally, the roles of branching enzyme, debranching
enzyme, and, to a certain extent, glycogenin are ignored. Until it becomes possible to
address these problems, the issue of glycogen concentration can be side-stepped by
treating the non-reducing end concentration as a clamped value in the model. The
irony of this solution is of course that such a model of glycogen metabolism does not
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actually describe the metabolism of glycogen.
Stoichiometric considerations
In the models of glycogen synthesis so far considered ATP and ADP are treated as
clamped species. In a single cycle from external glucose to elongated glycogen, 3
phosphate moieties enter the system as a molecule of ATP, of which 2 leave again
as an ADP. Three phosphate moieties also enter as UTP, whereas two leave as PPi
and another two as UDP. There is thus no gain or loss of phosphate moieties in the
system:
3 −2 +3 −2 −2 = 0
ATP ADP UTP PPi UDP
(6.74)
When the glycogen synthesis model is combined with the model of glycogenoly-
sis, ATP and ADP, however, become variable species. The conservation of phosphate
moieties is then given by:
3 −2 −2 = −1
UTP PPi UDP
(6.75)
which reveals that the phosphate moiety drains from the system. Treating also PPi
as a variable species and adding an inorganic diphosphatase (PPase) reaction that
breaks PPi down to two molecules of Pi yields
3 −2 = 1
UTP UDP
(6.76)
so that now the phosphate moiety accumulates in the system. It is therefore also nec-
essary to treat UTP and UDP as variable species and to add a reaction that converts
UDP back to UTP at the cost of ATP.
A combined model of glycogen synthesis and glycogen degradation
Keeping the above considerations in mind, we proceeded to construct a model (Gly-
MetExp) of glycogen metabolism by combining the model GlySynthExp with the
model of glycogenolysis by Lambeth & Kushmerick [19]. We treated glycogen as a
fixed metabolite. In addition to the reactions already present in these models we also
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Table 6.2: Kinetic parameters for PPase and NDPK
Parameter Value Unit Reference Source
Vmax,PPase 30 mM min−1 Table C.4 rabbit muscle
KPPase:PPi 5.1 · 10−3 mM [255] rabbit muscle
KPPase:ATP 0.3 mM [255] rabbit muscle
KPPase:Pi 1 mM based on value from [113] –
Keq,PPase 2,460 mM TECR database [206] –
Vmax,NDPK 440 mM min−1 Table C.4 bovine heart
KNDPK,UDP 7 · 10−2 mM based on value with ADP as substrate [256] rat liver
KNDPK,ATP 0.5 mM [256] rat liver
KNDPK,UTP 0.7 mM assumed –
KNDPK,ADP 0.14 mM [256] rat liver
Keq,NDPK 1 – eQuilibrator [36] –
added the PPase and nucleoside diphosphokinase (NDPK) reactions. PPase cataly-
ses the reaction PPi  2Pi. We modelled the reaction with a uni-bi Michaelis-Menten
rate equation containing an additional ATP inhibition term:
vPPase =
Vmax
KPPi
(
[PPi]− [Pi]
2
Keq
)
[PPi]
KPPi
+
[ATP]
KATP
+
(
1+
[Pi]
KPi
)2 (6.77)
NDPK catalyses, amongst others, the reaction UDP+ATP UTP+ADP. We mod-
elled this reaction with a random-order bi-bi Michaelis-Menten equation:
vNDPK =
Vmax
KUDPKATP
(
[UDP][ATP]− [UTP][ADP]
Keq
)
(
1+
[UDP]
KUDP
+
[UTP]
KUTP
)(
1+
[ATP]
KATP
+
[ADP]
KADP
) (6.78)
The kinetic parameter values for the PPase and NDPK reactions are listed in Ta-
ble 6.2.
Steady-state analysis of the model, however, revealed that, even under resting
conditions, the glycolytic flux (JPGI = 2.43× 10−1 mM min−1) was almost three times
larger than the glucose uptake flux (JGLUT = 9.06× 10−2 mM min−1). Accordingly,
GS had a large flux-control coefficient for the glycogen synthetic flux (C JGSGS = 0.89).
If glycogen were not treated as a fixed species, this high glycolytic flux would result
in complete glycogen depletion. The glycolytic flux could be reduced by decreasing
the first-order rate constant of the ATPase reaction (a parameter that was assigned
an arbitrary value by Lambeth & Kushmerick [19]), but with the side-effect that the
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concentration of G6P decreased to values where its activatory effect on GS was no
longer able to overcome inhibition by ATP and phosphorylation. Decreasing the
rate constant for lactate export very slightly increased G6P again, but at the cost of
lactate accumulation. We also replaced the mass-action rate equations for the lactate
export and ATPase reactions with irreversible Michaelis-Menten equations so as not
to force unit elasticities on these reactions. These modifications did not improve the
situation.
While it is possible that appropriate parameter adjustments will yield a model
that is in qualitative agreement with in vivo glycogen metabolism, the merit of such
an approach is questionable unless great care it taken to only use parameter values
that fall within experimentally determined ranges. Since construction of a detailed
model of glycogen degradation is not within the scope of the present research, we
did not pursue this avenue further. Future attempts will have to ensure that the
same modelling approach and philosophy is followed in constructing the glycogen
synthesis and degradation modules.
Stellenbosch University  http://scholar.sun.ac.za
Chapter 7
Discussion
7.1 Glycogen metabolism as a molecular economy
The inner workings of the cell have been described in terms of a molecular economy
of supply and demand [15, 257]. In this analogy between human economies and cel-
lular processes, biosynthesis can be compared to a factory in which a certain product
is manufactured for consumption by the public. A typical cellular example of such a
factory is the biosynthesis of amino acids for consumption by the process of protein
synthesis. Just as uncontrolled manufacturing without regard for consumer demand
results in overrun or shortage in human economies, usually with financial loss, so
any cellular biosynthetic process that is not controlled by the demand for its product
would be detrimental to the proper functioning of the cell.
If biosynthesis is a factory, muscle glycogen metabolism is a warehouse or, per-
haps more appropriately, a granary. One may view glycogen metabolism as a supply-
demand system of glycogen in which glycogen synthesis and degradation are the
supply and demand processes. However, while glycogen is consumed during ex-
ercise, it is not primarily exercise that immediately drives glycogen synthesis. Nor
is it feeding that drives exercise. It is therefore more instructive to view glycogen
synthesis and degradation as processes that can themselves be divided into supply
and demand systems. In keeping with our analogy, the process in which glycogen
is synthesized is comparable to the storage of harvested animal feed in the granary.
It is clear that the rate at which feed is stored should be determined by the harvest
and that there really is no immediate demand, so to speak, by the granary for feed.
In glycogen synthesis one therefore expects glucose uptake to control the flux of
glycogen synthesis. Glycogen degradation, on the other hand, can be compared to
213
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feeding farm animals from the granary. Here it is clear that the rate at which feed
is removed from the granary should be determined by the dietary requirements of
the animals and not by the supply of feed in the granary. With regard to glycogen
degradation, one would therefore expect the rate of glycogenolysis to be controlled
by the demand for energy and not by the supply of glycogen.
We see then that glycogen synthesis should be expected to be a supply-driven
process, whereas glycogen degradation should be expected to be a demand-driven.
While it is reasonable to expect that the demand process controls the flux in a biosyn-
thetic pathway, it may well be that the supply controls the flux in other pathways. In
both glycogen synthesis and degradation it is interesting to note that allosteric and
covalent regulation does not affect the activities of the flux controlling processes. We
may then ask why the activities of enzymes that do not affect the flux are regulated.
7.2 Regulation of glycogen metabolism
Using detailed mathematical models of glycogen synthesis, we have shown first that
the basal levels of glycogen synthase (GS) phosphorylation and ATP inhibition in
conjunction with the feedforward activation of GS by glucose-6-phosphate (G6P)
impart G6P sensitivity on the demand block that greatly surpasses that of the supply
block (Section 6.4). We have also shown that this high G6P sensitivity of the demand
block allows it to match any increases in the flux of the supply block, which would
typically result from elevated glycemia, with only minimal increases in G6P. This
suggests that the allosteric and covalent regulation of GS functions to maintain G6P
homeostasis despite large increases in the blood glucose concentration after meals.
Note that changes in the external glucose concentration do not lead to changes in the
GS degree of phosphorylation. The basal phosphorylation state of GS is therefore
sufficient to ensure G6P homeostasis.
With regard to insulin stimulation, on the other hand, we have shown that GS
phosphorylation is not involved in increasing the sensitivity of the demand block to
G6P (Section 6.6). On the contrary, insulin stimulation results in the dephosphoryla-
tion of GS and therefore weakens G6P homeostasis with respect to increases in exter-
nal glucose. Insulin stimulation achieves G6P homeostasis via an entirely different
mechanism, namely, the coordinated activation of glucose uptake and glycogen syn-
thesis. These results do not only agree with but also elaborate on the findings of
Schafer et al. [13] in that a wide range of insulin concentrations is considered.
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Using the existing model of glycogenolysis by Lambeth & Kushmerick [19], we
have also shown that the covalent regulation of glycogen phosphorylase (GP) is not
involved in flux control, but rather functions to maintain the energy charge of the
cell within narrow limits despite large changes in the cell’s energy demand (Sec-
tion 6.10). While we have not explicitly considered the function of allosteric regula-
tion of GP, GP phosphorylation affects the apparent affinities of GP for its various
allosteric modifiers, so that we may assume similar functions for allosteric and cova-
lent regulation of GP. Note that we do not claim that energy charge homeostasis is
the sole function of the regulation of GP, or even that GP regulation is the most im-
portant cellular mechanism that enhances energy charge homeostasis. The function
of GP regulation is, however, certainly not the flux control of glycogenolysis.
While it appears that the function of GS regulation is the homeostasis of G6P and
the function of GP regulation is the homeostasis of energy charge, the function of the
regulation of enzyme activities is by no means limited to homeostatic maintenance.
Flux-controlling enzymes are often regulated, so that changes in the activity of these
enzymes will result in changes to the flux. Indeed, in the coordinated regulation of
glucose uptake and glycogen synthesis by insulin stimulation, the activities of both
the flux-controlling enzyme, glucose transporter 4 (GLUT4), and the “regulated” en-
zyme GS, are simultaneously increased. It may be that such coordinated regulation
is far more common than is currently recognized and may even be a requirement for
effective flux regulation [258]. We have argued that coordinated regulation is also
at work in glycogen degradation during exercise. Here too the flux-controlling en-
zyme, ATPase, as well as the “regulated” enzyme, GP, are activated in response to
calcium.
7.3 Relative importance of allosteric and covalent
modification of glycogen synthase
The presence of both allosteric and covalent regulation in glycogen metabolism has
led to questions regarding the relative importance of these mechanisms. Hofmeyr &
Cornish-Bowden [15] have pointed out that a mechanism’s “regulatory performance
should always be measured in terms of a specified function.” In judging the relative
importance of allosteric and covalent modification, one must therefore first identify
its function and also ascertain that both mechanisms indeed have the same function.
We have argued that in glycogen synthesis both allosteric and covalent regulation
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function to maintain the homeostasis of G6P. There is, however, some indication
that these mechanisms do not perform this function in response to the same stim-
uli. We have shown that the increase in intrinsic GS activity in response to elevated
glycemia, measured as the fraction of enzyme in the active R conformation, is almost
entirely the result of allosteric activation by G6P. On the other hand, the increase in
intrinsic GS activity in response to elevated insulin is almost entirely the result of net
dephosphorylation of GS. In a certain sense then, the question of whether allosteric
or covalent modification is the most important mechanism of G6P homeostasis be-
comes irrelevant.
The question of whether allosteric or covalent modification is most important
may also be posed in a different way: which mechanism contributes most to the
basal activity state of GS? It is well-established that sufficiently high concentrations
of G6P are able to completely reverse inhibition of GS by phosphorylation. In agree-
ment with this, Bouskila et al. [18] have found that insulin is unable to restore the
basal activity of GS that has been desensitized to G6P. In other words, dephosphory-
lation of the GS sites that are phosphorylated by glycogen synthase kinase 3 (GSK3)
does not overcome the inhibition of GS caused by phosphorylation at the remaining
sites and the additional inhibition by ATP. Bouskila et al. [18] have interpreted these
results as evidence that allosteric, and not covalent, regulation of GS is the most
important mechanism by which insulin stimulates GS activity. We agree that G6P
activation is an essential component of the basal GS activity, but argue that the re-
sults of Bouskila et al. [18] give no indication of the relative contributions of allosteric
and covalent activation beyond the basal state.
7.4 Qualitative equivalence of allosteric and covalent
regulation
Covalent enzyme modification is often considered to be fundamentally different
from allosteric modification. The various covalent forms of enzymes such as GS
and GP are often studied separately. This probably results from the fact that, while
terms for allosteric modification can be incorporated into initial velocity equations,
the same cannot be done for covalent modification. Instead, separate rate equations
are required for each covalent form of an enzyme. In a very real sense covalent mod-
ification is, however, also a form of allosteric modification in that the covalent bond
is usually formed at a site other than the catalytic site. Despite this agreement, the
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model of cooperativity and allosterism identified as providing the best description
of allosteric modification for a particular enzyme is often disregarded when cova-
lent modification is considered. A carte blanche is given to covalent modification to
alter any kinetic parameter without consideration for an underlying kinetic model
or mechanism by which such alteration is explained.
We have conducted a comprehensive review of GS kinetics and regulation and
concluded that the interaction between the allosteric and covalent modification of
GS behaves in a qualitatively identical manner to what is expected for the interac-
tion between two classic heterotropic Monod-Wyman-Changeux (MWC)-type effec-
tors (Chapter 2). This led us to propose a unified view of allosteric and covalent
regulation of GS in which only the equilibrium between between the T and R con-
formation may be altered. In this unified view there is no need to determine the
full set of kinetic parameters for the rate equations of all phosphorylation states of
GS. The only requirement is that L0, the T/R equilibrium, should be determined for
each phosphorylation state. However, for many states L0 can be estimated from the
values of “component” states. This model allowed us to develop which is to our
knowledge the first kinetic treatment of GS that is able to account for both allosteric
and covalent regulation (Chapter 3). The same model, but with an additional con-
formation, was also used to obtain a rate equation for GP that describes its allosteric
modification by all the major effectors as well as its covalent modification.
To be sure, we are not advocating the position that covalent modification will be
qualitatively identical to allosteric modification for all enzymes. Nor do we argue
that covalent modification can always be described as bringing about a conforma-
tional change. As but one example, phosphorylation of isocitrate dehydrogenase
does not involve any conformational change, but instead prevents substrate binding
by obstructing the catalytic site [259]. This type of covalent modification cannot be
described with the MWC model. With regard to GS there are many phosphorylation
sites that do not affect the enzyme’s activity. These sites can, however, be accounted
for in the MWC model by simply considering phosphorylation at each of these sites
as multiplying L0 with a factor of one.
Since activation of GS by G6P and inhibition of GS by phosphorylation stabi-
lize opposing conformations of the enzyme, they also reverse each other’s effect on
the activity of GS. This reversal is not only the result of conformational change, but
also results because phosphorylation promotes a state in which G6P associates less
readily with GS and G6P promotes a state that is more readily dephosphorylated.
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Phosphorylation favours the T conformation, which is inactive, but also decreases
the affinity of GS for G6P and may even cause G6P to dissociate. G6P, on the other
hand, favours the R conformation, countering the effect of phosphorylation. Be-
cause phosphate is covalently bound, however, G6P is not able to directly cause the
phosphate group to dissociate from GS. G6P nevertheless promotes net dephospho-
rylation of GS by kinase inhibition and phosphatase activation. Such interaction
between allosteric and covalent regulation has been observed experimentally for GS
(see for example [139, 146]) and GP (see for example [260]). An explanation in terms
of an underlying mechanism has to our knowledge not been proposed before.
Covalent modification of an enzyme is itself catalysed by enzymes. Activation
or inhibition of these covalent interconversion enzymes by allosteric modifiers of
the substrate enzyme should therefore manifest as apparent changes to their kinetic
parameters. From thermodynamic considerations, we have shown that apparent
changes in both the rate constants and Michaelis constants can result from such al-
losteric modification (Section 4.3). Changes in the rate constant result entirely from
the fact that covalent modification alters the T/R equilibrium of the substrate en-
zyme. The factor by which rate constants are modified is therefore determined by
the kinetics of the substrate protein and not by the kinetics of the covalent intercon-
version enzymes. Changes in the Michaelis constants, on the other hand, are specific
to the interconversion enzymes and are not governed by the substrate enzyme’s ki-
netics. The substrate and product Michaelis constants are modified by the same
factor. If covalent modification does not alter the T/R equilibrium of the substrate
enzyme, then changes are observed in neither the rate constants nor the Michaelis
constants. Note that these effects on the kinetics of the interconversion enzymes are
independent of their kinetic mechanism. Indeed, it may be that the interconversion
enzymes are themselves MWC-type enzymes.
The regulation of muscle glycogen synthesis therefore involves a feedforward
activation loop in which G6P activates GS, but also a complex phosphorylation cas-
cade in which all GS ligands are also indirect ligands of the interconversion enzymes.
Hofmeyr et al. [16] considered the conditions that would allow feedforward loops to
function optimally. Small & Fell [164], on the other hand, considered the conditions
that would allow covalent modification cascades to elicit an optimal response in re-
sponse to external effectors. The situation in glycogen metabolism differs from these
analyses in that the feedforward activator is also the effector that regulates the cova-
lent modification of GS. We analysed the conditions that would maximize the flux
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response to an allosteric modifier in a minimal feedforward system in which the
allosteric enzyme is also regulated by a monocyclic cascade (Section 4.4). Broadly
speaking, our results indicated that one would expect the feedforward activation of
the regulated enzyme to be dominated by a catalytic and not a specific component,
and that the enzymes catalysing the covalent modification of the regulated enzyme
should be saturated with their protein substrates.
Is glucose-6-phosphate really a specific activator?
The GS rate equation and parameters that we identified as providing the best de-
scription of experimental data incidentally show that G6P is a catalytic activator of
GS. There is, however, also a slight specific component which results from the com-
petition of ATP with the UDP-glucose (UDPG) substrate. Since, however, GS is not
saturated with its substrate and because the enzyme that precedes it operates close
to equilibrium, the strict requirement for catalytic activation may be relaxed. The
strong catalytic component predicted by our results and the absence of specific ac-
tivation in the absence of ATP is, however, at variance with the standard view of
GS kinetics which holds that phosphorylation decreases the UDPG affinity, whereas
G6P increases it. This discrepancy could be explained by considering that the experi-
mental data that we used for GS parameter optimization were determined at a lower
pH (6.6) than what is usually used (7.8). High pH values suppress ATP inhibition in
GS assays [67]. Piras et al. [39, 67] found significant differences in GS kinetics when
comparing data obtained at low and high pH values. Another possible explanation
is that GS kinetic parameters are routinely determined from linear transformations
of initial velocity data even though GS is a cooperative enzyme. Walcott & Lehman
[201] have shown that this practice, when applied to GP kinetics, portrays ATP as
a competitive inhibitor with respect to AMP, whereas non-linear regression, which
allows for fitting sigmoidal curves, suggests that ATP is also a non-competitive in-
hibitor and that the non-competitive component is in fact the dominant component.
Similar artefacts are to be expected for GS kinetics when cast in a Michaelis-Menten
mould.
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7.5 Modelling glycogen metabolism
The model of glycogen synthesis, GlySynth, in which the interconversion between
GS phosphorylation states is described with the appropriate kinase and phosphatase
reactions, as well as the combined model of glycogen metabolism that incorporates
the existing model by Lambeth & Kushmerick [19], contains a substantial number
of parameters that were obtained from the literature. Considering the accumula-
tion of experimental error in the determined kinetic parameters, this large num-
ber of parameters poses a threat to the validity of the models. We have neverthe-
less shown that in many respects the models’ predicted behaviour is qualitatively
in agreement with experimentally observed behaviour. It should be noted that the
GlySynth model consists of two modules that are not connected by mass flow: the
main pathway and the GS interconversion pathway. While the interconversion path-
way is sensitive to G6P and UDPG from the main pathway, the main pathway is only
sensitive to the concentrations of GS in its various states as determined by the inter-
conversion pathway. In effect, therefore, the only “parameter” of the main pathway
that is determined by the interconversion pathway is the equilibrium between the
T and R conformations of GS. Any error in the interconversion pathway is there-
fore propagated to the main pathway as an error in a single parameter, unless one is
specifically interested in the concentrations of GS in its various states.
Existing models of muscle metabolism that include glycogen synthesis are for the
most part based on the model by Cabrera et al. [261]. This model has been extended
to incorporate many additional aspects of muscle metabolism, such as insulin sig-
nalling and compartmentation. Some of the more recent extensions are those by
Dash et al. [262] and Li et al. [263]. While this model includes a GS reaction, its focus
is not on glycogen metabolism. It treats the GS reaction as the combined reactions
of GS and UDPG-pyrophosphorylase (UPP). The GS reaction is modelled with a
hyperbolic Michaelis-Menten type rate equation that does not include the G6P feed-
forward activation loop. No description of GS phosphorylation is present, although
insulin stimulation terms have been incorporated in some versions. The model also
treats glycogen as a pool of glucose in which all residues, as opposed to only non-
reducing residues, are visible to enzymes.
We have demonstrated the usefulness of the models that we have constructed
in shedding light on the regulatory design of muscle glycogen metabolism. It is
essential to understand the regulation of muscle glycogen metabolism by endocrine
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and other signals in order to fully comprehend the pathology of insulin resistance
and diabetes mellitus type 2. Insulin resistance is, however, a whole-body syndrome
involving the systemic malfunctioning of insulin-dependent metabolism in various
tissues. There is thus a need to integrate models of insulin-dependent metabolism
from various tissues. Such models have been constructed [264, 265], but are mostly
phenomenological, contain only abbreviated descriptions of glycogen metabolism,
or only include glucose uptake.
While we appreciate the merits of phenomenological modelling, we argue that
great care must be taken to ensure that important regulatory features of a pathway
are not obscured by disregard for the underlying mechanisms. In many cases mech-
anism does matter. It may be of little consequence, for instance, whether a bi-bi
reaction is modelled with a ping-pong or random order rate equation [266], but it
has been demonstrated that the seemingly inconsequential difference between cat-
alytic and specific activation can have important implications for the effectiveness
of regulatory mechanisms such as feedback and feedforward loops [16]. An unin-
formed modelling choice could lead to the inclusion of such regulatory mechanisms
that turn out to perform no function at all. Incidentally, careful consideration of the
mechanism of GS cooperativity was instrumental both in understanding the reg-
ulatory design of glycogen synthesis and in the identification of novel regulatory
aspects. Nevertheless, even very detailed mechanistic models are of little use if they
are parametrized with parameter sets of poor quality. There is a pressing need for
high-quality muscle enzyme kinetic data. It is essential that research in muscle me-
tabolism does not neglect enzyme kinetics in favour of semi-quantitative studies.
Much can be learned from a good model in less time than from experimentation.
7.6 Future research
Many aspects of muscle glycogen metabolism remain unaddressed by the present
research. In future research the model of glycogen synthesis can be extended to
also describe the phosphorylation of GS by AMP-activated protein kinase (AMPK),
an enzyme that is able to sense the glycogen concentration as well as the energy
charge in the cell [252]. We have also disregarded the targeting of protein phos-
phatase 1 (PP1) to various subcellular pools and the role of phosphorylation in this
regard [1, 31]. Additionally, it would be of interest to construct a combined model
of glycogen synthesis and degradation in which glycogen itself is a variable species.
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It would also be instructive to validate the unified view of allosteric and covalent
GS regulation experimentally. Finally, kinetic parameters for the interconversion be-
tween GS phosphorylation states and for the main pathway should be determined
under conditions that would prevail in vivo.
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Miscellaneous derivations
A.1 Expression of the sum of MWC-type rate
equations as a single term
Consider the irreversible two-state MWC rate equation:
v = e
nkcat,r (1+ σr)
n−1 + nkcat,t (1+ σt)n−1 L0
(1+ σr)
n + (1+ σt)
n L0
(A.1)
Let
numr = nkcat,r (1+ σr)
n−1 (A.2)
numt = nkcat,t (1+ σt)
n−1 L0 (A.3)
denr = (1+ σr)
n (A.4)
dent = (1+ σt)
n L0 (A.5)
then
v = e
numr + numtL0
denr + dentL0
(A.6)
With appropriate definitions, any two-state MWC rate equation, including re-
versible forms, can be written in this form. Consider now the sum of rates v = ∑i vi,
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where each rate vi is of the form of Eq. A.6, but in which only the parameter L0
depends on i (each enzyme concentration ei is a variable):
v =∑
i
ei
numr + numtL0i
denr + dentL0i
(A.7)
Multiplication of the numerator and denominator with ∑i ei yields
v =
(∑i ei)
(
∑i ei
numr + numtL0i
denr + dentL0i
)
∑i ei
(A.8)
Further multiplying each sum term in the denominator with
denr + dentL0i
denr + dentL0i
gives
v =
(∑i ei)
(
∑i ei
numr + numtL0i
denr + dentL0i
)
∑i ei
denr + dentL0i
denr + dentL0i
(A.9)
The fractions in the numerator and denominator can be separated so that
v =
(∑i ei)∑i
(
ei
numr
denr + dentL0i
+ ei
numtL0i
denr + dentL0i
)
∑i
(
ei
denr
denr + dentL0i
+ ei
dentL0i
denr + dentL0i
) (A.10)
=
(∑i ei)
(
∑i ei
numr
denr + dentL0i
+∑i ei
numtL0i
denr + dentL0i
)
∑i ei
denr
denr + dentL0i
+∑i ei
dentL0i
denr + dentL0i
(A.11)
Extracting terms that are independent on i from the sums yields
v =
(∑i ei)
(
numr ∑i ei
1
denr + dentL0i
+ numt ∑i ei
L0i
denr + dentL0i
)
denr ∑i ei
1
denr + dentL0i
+ dent ∑i ei
L0i
denr + dentL0i
(A.12)
Finally, division of the numerator and denominator by ∑i ei
1
denr + dentL0i
gives
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v =
(∑i ei)
numr + numt∑i ei
L0i
denr + dentL0i
∑i ei
1
denr + dentL0i

denr + dent
∑i ei
L0i
denr + dentL0i
∑i ei
1
denr + dentL0i
(A.13)
If we then define
L0,app =
∑i ei
L0i
denr + dentL0i
∑i ei
1
denr + dentL0i
(A.14)
and
e =∑
i
ei (A.15)
Eq. A.13 is rewritten as
v = e
numr + numtL0,app
denr + dentL0,app
(A.16)
Note also that, since ei = r(denr + dentL0i) and ti = L0iri, it follows that
L0,app =
∑i ti
∑i ri
(A.17)
A.2 Expression of the overall elasticity of a sum of
rates in terms of elasticities of individual rates
Let v be the sum of rates catalysed by isoforms or different covalent states of a par-
ticular enzyme:
v =∑
i
vi (A.18)
The elasticity of the rate v towards an arbitrary ligand X is then given by
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εvx =
∂ ln v
∂ ln x
(A.19)
=
x
v
· ∂v
∂x
(A.20)
=
x
v
· ∂
∂x
[
∑
i
vi
]
(A.21)
=
x
v
·∑
i
∂vi
∂x
(A.22)
=
x
v
·∑
i
vi
x
· ∂ ln vi
∂ ln x
(A.23)
= ∑
i
vi
v
· ∂ ln vi
∂ ln x
(A.24)
= ∑
i
vi
v
· εvix (A.25)
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Appendix B
Control analysis of two-module
system in which allosteric and
covalent modification interact
B.1 Control analysis
The control matrix C of a system with arbitrary complexity can be expressed in terms
of the matrix formulation
C = E−1 (B.1)
where C is the matrix of control-coefficients with respect to independent fluxes and
species, and E is a matrix containing structural properties and elasticities. Hofmeyr
& Westerhoff [162] have shown that, if a system comprises modules that are not
connected by mass flow, Eq. B.1 becomes
G = E−1 (B.2)
The use of G-notation indicates that the control matrix contains global or integral
control coefficients. The internal structure of G is the same as that of C, but for a
system of two modules the rows and columns of G and E can be rearranged to allow
the following partitioning: [
G11 G
1
2
G21 G
2
2
]
=
[
E11 E
1
2
E21 E
2
2
]−1
(B.3)
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X
1
S 2 P
A
E20 E21
B
εvAs
εvBs
εv2e20 ε
v2
e21
Figure B.1: Feedforward activation mechanism in which the regulated enzyme is inhibited
by covalent modification. Pathway precursor and allosteric modifier X activates enzyme 2,
an MWC-type enzyme that is inhibited by covalent modification. Since covalent modifica-
tion favours the T conformations and allosteric modification favours the R conformation,
modifier X promotes net reversal of covalent modification by inhibiting enzyme A, which
catalyses forward covalent modification, and activating enzyme B, which catalyses reverse
covalent modification. Enzymes A and B are also influenced by substrate S, if S binds with
different affinities to the T and R conformations of enzyme 2. The reaction network consists
of two modules not connected by mass flow: the main pathway converting X to P with flux
J1, and the pathway that catalyses the interconversion between covalent states of enzyme 2
with flux JA. Internal elasticities are indicated with dashed arrows.
where Gij is the control matrix of the variables in modules i with respect to the steps
in module j; and
Eij =
{ [Ki −εiiLi] if i = j[
0 −εijLj
]
if i 6= j (B.4)
where Ki and Li are the scaled kernel and link matrices obtained from the reduced
stoichiometric matrix.
Let us now apply this treatment to the system in Fig. B.1. Let L be the linear
pathway from X to P, and C the cyclical pathway from E20 to E21.
In module L either J1 or J2 can be chosen as the independent flux. We choose J1,
so that [
J1
J2
]
=
[
1
1
] [
J1
]
(B.5)
The kernel matrix for module L is then given by
KL =
[
1
1
]
(B.6)
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and since no branching is present, KL = KL. As there is no moiety conservation in
module L, it also follows that LL = LL = [1], where L is the link matrix. Finally the
elasticity matrix for module L is given by
εLL =
[
εv1s
εv2s
]
(B.7)
We choose JA as the independent flux in module C. As for module L,KC = KC =
[1 1]T. Since E20 and E21 constitute a moiety-conserved cycle,
de20
dt = − de21dt , so that[
de20
dt
de21
dt
]
=
[
1
−1
] [
de20
dt
]
(B.8)
The link matrix for module C is then LC = [1 − 1]T, and the scaled link matrix
is the matrix product
LC =
[
1
e20
1
e21
]
LC
[
e20
]
=
[
1
−e20
e21
]
(B.9)
Finally the elasticity matrix for module C is given by
εCC =
[
εvAe20 ε
vA
e21
εvBe20 ε
vB
e21
]
(B.10)
Similarly
εLC =
[
εv1e20 ε
v1
e21
εv2e20 ε
v2
e21
]
=
[
0 0
εv2e20 ε
v2
e21
]
(B.11)
and
εCL =
[
εvAs
εvBs
]
(B.12)
Note that εv1e20 and ε
v1
e21 are zero, as the intermediates in module C only affect enzyme
2 in module L. Also, since S is a ligand of enzyme 2, it potentially affects the inter-
conversion between covalent forms of enzyme 2, so that εvAs and ε
vB
s are potentially
non-zero.
The expressions for the partitioned E matrices are then
ELL =
[
KL −εLLLL
]
(B.13)
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ELC =
[
0 −εLCLC
]
(B.14)
ECL =
[
0 −εCLLL
]
(B.15)
and
ECC =
[
KC −εCCLC
]
(B.16)
The control matrix G is then

G J1v1 G
J1
v2 G
J1
vA G
J1
vB
Gsv1 G
s
v2 G
s
vA G
s
vB
G JAv1 G
JA
v2 G
JA
vA G
JA
vB
Ge20v1 G
e20
v2 G
e20
vA G
e20
vB
 =
[
KL −εLLLL 0 −εLCLC
0 −εCLLL KC −εCCLC
]−1
(B.17)
=

1 −εv1s 0 0
1 −εv2s 0 −∗εv2e20
0 −εvAs 1 −∗εvAe20
0 −εvBs 1 −∗εvBe20

−1
(B.18)
=

εv2s (
∗εvBe20 − ∗εvAe20)− ∗εv2e20(εvBs − εvAs ) −εv1s (∗εvBe20 − ∗εvAe20) −εv1s ∗εv2e20 εv1s ∗εv2e20
∗εvBe20 − ∗εvAe20 ∗εvAe20 − ∗εvBe20 −∗εv2e20 ∗εv2e20
∗εvBe20ε
vA
s − ∗εvAe20εvBs ∗εvAe20εvBs − ∗εvBe20εvAs ∗εvBe20(εv2s − εv1s )− ∗εv2e20εvBs ∗εv2e20εvAs − ∗εvAe20(εv2s − εv1s )
εvAs − εvBs εvBs − εvAs εv2s − εv1s εv1s − εv2s

1
(εv2s − εv1s )(∗εvBe20 − ∗εvAe20)− ∗εv2e20(εvBs − εvAs )
(B.19)
where ∗εv2e20 = ε
v2
e20 − εv2e21 e20e21 , ∗ε
vA
e20 = ε
vA
e20 − εvAe21 e20e21 , and ∗ε
vB
e20 = ε
vB
e20 − εvBe21 e20e21 are “effective”
elasticities [230].
We can also solve for the control matrices of the two modules independently,
yielding intramodule control coefficients:
[
C J1v1 C
J1
v2
Csv1 C
s
v2
]
=
[
KL −εLLLL
]−1
(B.20)
=

εv2s
εv2s − εv1s
−εv1s
εv2s − εv1s
1
εv2s − εv1s
−1
εv2s − εv1s
 (B.21)
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and
[
C JAvA C
JA
vB
Ce20vA C
e20
vB
]
=
[
KC −εCCLC
]−1
(B.22)
=

∗εvBe20
∗εvBe20 − ∗εvAe20
−∗εvAe20
∗εvBe20 − ∗εvAe20
1
∗εvBe20 − ∗εvAe20
−1
∗εvBe20 − ∗εvAe20
 (B.23)
B.2 Elasticity expressions
The elasticity expressions derived in this section all pertain to the reactions in Fig. B.1.
Elasticities with respect to S
The elasticity of v1 with respect to S is given by
εv1s =
− s/x
Keq1
1− s/x
Keq1
− σ1
1+ ξ1 + σ1
(B.24)
where ξ1 =
x
K1x
and σ1 =
s
K1s
. The absolute value of εv1s increases from zero to
unity as s increases from zero to saturation and then suddenly increases to infinity
as equilibrium is approached.
∣∣εv1s ∣∣ therefore has a maximum value near equilibrium.
The elasticity of v2 with respect to S is given by
εv2s =∑
i
v2i
v2
ε
v2i
s (B.25)
where
ε
v2i
s = 1− csσ2α
iL(1+ cxξ2) + σ2(1+ ξ2)
(1+ csσ2)αiL(1+ cxξ2) + (1+ σ2)(1+ ξ2)
(B.26)
where ck is the factor by which the rate constant for the T conformation differs from
that of the R conformation; σ2 = s/Kr2s and cs = Kr2s/Kt2s; ξ2 = x/Kr2x and
cx = Kr2x/Kt2x; Kr2s, Kt2s, Kr2x, and Kt2x are the intrinsic dissociation constants with
respect to S and X for the T and R conformations; α is the factor by which covalent
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modification alters L; L is the allosteric constant; and i ∈ [0, 1]. |εv2is | → 0 in the limit
σ2 → ∞:
lim
σ2→∞
ε
v2i
s = 1− csα
iL(1+ cxξ2) + (1+ ξ2)
csαiL(1+ cxξ2) + (1+ ξ2)
(B.27)
= 0 (B.28)
The expressions for εvAs and ε
vA
s are given by
εvAs =
[
φ′num
φnum
− φ
′
den
φden
]1−
e21c/(e20c′)
φKeqA
1− e21c/(e20c
′)
φKeqA
 (B.29)
and
εvBs =
[
φ′den
φden
− φ
′
num
φnum
]1−
e20g/e21
φ−1KeqB
1− e20g/e21
φ−1KeqB
 (B.30)
where
φ′num = csσ2αL(1+ cxξ2) + σ2(1+ ξ2) (B.31)
φnum = (1+ csσ2)(1+ cxξ2)αL + (1+ σ2)(1+ ξ2) (B.32)
φ′den = csσ2(1+ cxξ2)L + σ2(1+ ξ2) (B.33)
φden = (1+ csσ2)(1+ cxξ2)L + (1+ σ2)(1+ ξ2) (B.34)
If reactions A and B operate far from equilibrium
εvBs + ε
vA
s =
[
φ′den
φden
− φ
′
num
φnum
]
+
[
φ′num
φnum
− φ
′
den
φden
]
= 0 (B.35)
If enzyme 2 is saturated with S, or if cs = 1, then ε
vA
s = ε
vB
s = 0.
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Elasticities with respect to X
The elasticity of v1 with respect to X is given by
εv1x =
1
1− x/s
Keq1
− ξ1
1+ ξ1 + σ1
(B.36)
The elasticity of v2 with respect to X is given by
εv2x =∑
i
v2i
v2
ε
v2i
x (B.37)
where
ε
v2i
x =
ckcsαiLcxξ2 + ξ2
ckcsαiL(1+ cxξ2) + (1+ ξ2)
− (1+ csσ2)α
iLcxξ2 + (1+ σ2)ξ2
(1+ csσ2)αiL(1+ cxξ2) + (1+ σ2)(1+ ξ2)
(B.38)
When enzyme 2 is saturated with S, εv2ix is given by
lim
σ2→∞
ε
v2i
x =
ckcsαiLcxξ2 + ξ2
ckcsαiL(1+ cxξ2) + (1+ ξ2)
− csα
iLcxξ2 + ξ2
csαiL(1+ cxξ2) + (1+ ξ2)
(B.39)
which if ck = 1 or if cs  1αi L equals zero.
The elasticities of vA and vB with respect to X are given by
εvAx =
[
φ′num
φnum
− φ
′
den
φden
]1−
e21c/(e20c′)
φKeqA
1− e21c/(e20c
′)
φKeqA
 (B.40)
and
εvBx =
[
φ′den
φden
− φ
′
num
φnum
]1−
e20g/e21
φ−1KeqB
1− e20g/e21
φ−1KeqB
 (B.41)
where
φ′num = (1+ csσ2)cxξ2αiL + (1+ σ2)ξ2 (B.42)
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φnum = (1+ csσ2)(1+ cxξ2)αiL + (1+ σ2)(1+ ξ2) (B.43)
φ′den = (1+ csσ2)cxξ2L + (1+ σ2)ξ2 (B.44)
φden = (1+ csσ2)(1+ cxξ2)L + (1+ σ2)(1+ ξ2) (B.45)
If enzyme 2 is saturated with S, then
[
φ′num
φnum
− φ
′
den
φden
]
=
[
φ′num
φnum
− φ
′
den
φden
]
= 0, so that
εvAx = ε
vB
x = 0. If enzymes A and B operate far from equilibrium, then ε
vA
x = −εvBx .
Elasticities with respect to e2
The expression for εv2e20 is given by
εv2e20 =
v20
v2
εv20e20 +
v21
v2
εv21e20 (B.46)
=
v20
v2
(since εv20e20 = 1, and ε
v21
e20 = 0) (B.47)
Similarly, εv2e21 =
v21
v2
. It follows that
εv2e20 − εv2e21 ·
e20
e21
=
v20 − v21 · e20e21
v2
(B.48)
=
ckk2e20csσ2L
(
1+ cxξ2
1+ ξ2
)
+ k2e20σ2
(1+ csσ2) L
(
1+ cxξ2
1+ ξ2
)
+ (1+ σ2)
−
ckk2e20csσ2αiL
(
1+ cxξ2
1+ ξ2
)
+ k2e20σ2
(1+ csσ2) αiL
(
1+ cxξ2
1+ ξ2
)
+ (1+ σ2)
v2
(B.49)
or if S saturates enzyme 2:
εv2e20 − εv2e21 ·
e20
e21
=
ckk2e20csL
(
1+ cxξ2
1+ ξ2
)
+ k2e20
csL
(
1+ cxξ2
1+ ξ2
)
+ 1
−
ckk2e20csαL
(
1+ cxξ2
1+ ξ2
)
+ k2e20
csαL
(
1+ cxξ2
1+ ξ2
)
+ 1
v2
(B.50)
= 0 (if cs  1
αL
) (B.51)
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The expression for εvAe20 is given by
εvAe20 =
1
1− e21c/(e20c
′)
φKeqA
− σA1
1+ σA1 + piA1
(B.52)
= 1− σA1
1+ σA1
(assuming piA1 → 0 and KeqA → ∞) (B.53)
Similarly, εvBe21 is given by
εvBe21 = 1−
σB1
1+ σB1
(B.54)
The expression for εvAe21 is given by
εvAe21 =
− e21c/(e20c
′)
φKeqA
1− e21c/(e20c
′)
φKeqA
− piA1
1+ σA1 + piA1
(B.55)
= 0 (assuming piA1 → 0 and KeqA → ∞) (B.56)
Similarly, εvBe20 is given by
εvBe20 = 0 (B.57)
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Appendix C
Model parametrization
C.1 Calculation of rate constants, enzyme
concentrations, and maximal velocities
Calculation of kcat and Vmax from specific activity
If the mass of total protein per volume is known, Vmax can be calculated directly
from the specific activity (usually product formation per time per mass protein) of
crude cell extracts according to the equation [210]:
Vmax = crude specific activity× protein per cell volume (C.1)
From the Vmax, if the subunit composition is known, either kcat or [E]tot can be cal-
culated if the other is known. If the holoenzyme molecular mass is known, nkcat
can be calculated from the specific activity of cell extracts purified to homogeneity
according to the equation
nkcat = purified specific activity× holoenzyme molecular mass (C.2)
Alternatively
kcat = purified specific activity× subunit molecular mass (C.3)
Multimeric enzymes that exhibit no cooperativity may be treated as monomeric
enzymes (n = 1), so that the calculated kcat is really an apparent value.
236
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Table C.1: Rate constants calculated from specific activities of purified enzymes. Molecular
masses were obtained from the UniProt database [267], or from the given reference. See text
for calculation details.
Specific Holoenzyme
activity molecular kcat
Enzyme (mol/g/min) n mass (g/mol) (min−1) Substrate Ref. Source
CK1 3.1 · 10−4 1 37 567 11.65 casein [268] rabbit muscle
CK2 4.91 · 10−4 1 140 116 68.8 GS [214] rabbit muscle
GS 1.2 · 10−2 4 334 580 1 004.58 UDPG [41] rabbit muscle
GSK3 2.2 · 10−3 1 46 744 102.84 GS [269] rabbit muscle
HK1 7.02 · 10−2 1 102 486 7 194.52 Glc [270] rabbit heart
HK2 0.15 1 102 486 15 065.44 Glc [193] human, recombinant
PhKP 3.8 · 10−3 1 318 000 1 208.4 GS [271] rabbit muscle
Table C.2: Rate constants for dephosphorylation of various PP1 substrates. The activities of
PP1 with various substrates relative to the activity with PhKP as substrate are converted to
activities relative to the activity with GPa as substrate. Values for kcat for each substrate can
then be calculated from kcat,PP1,GPa. The value of kcat,PP1,GPa is 30 mM/min [272].
Relative PhKP Relative GPa
dephosphorylation dephosphorylation
PP1 substrate activity [273] activity kcat
PhKP 1 3.7 111.11
GPa 0.27 1 –
GS22a 1.03 3.81 114.44
GS43abc 0.28 1.04 31.11
GS5 1 · 10−2 3.7 · 10−2 1.11
Table C.3: Rate constants for phosphorylation of various PKA substrates. The activities of
PKA with various substrates relative to the activity with PhK as substrate are converted to
activities relative to the activity with histone as substrate. Values for kcat for each substrate
can then be calculated from kcat,PKA,histone. The value of kcat,PKA,histone is 291 mM/min [237].
Relative PhK Relative histone
phosphorylation phosphorylation Average
activity [57] activity relative
PKA substrate 1 2 1 2 activity kcat
histone 0.18 0.16 1 1 1 –
PhK 1 1 2.98 3.32 3.15 917.76
GS 1.12 1.18 3.34 3.93 3.63 1 057.63
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Table C.4: Maximal velocities calculated from specific activities of crude enzyme extracts.
The total protein per cell volume for mammalian muscle was taken as 260 mg/mL (based on
rat muscle value) [210]. See text for calculation details.
Specific
activity Vmax [E]tot
Enzyme (µmol/min/mg) (mM/min) (mM) Substrate Ref. Source
CK1 2 · 10−5 0.0052 4.47 · 10−4 casein [268] rabbit muscle
CK2 2.7 · 10−5 0.00702 1.02 · 10−4 GS [214] rabbit muscle
GSK3 3 · 10−5 0.0078 7.58 · 10−5 GS [269] rabbit muscle
PPase 0.11 27.3 – PPi [255] rabbit muscle
NDPK 1.7 442 – – [256] bovine heart
Table C.5: Experimental data used during parameter optimization
Phosphorylation state Reaction direction Ligand dependence Reference
GPa forward Pi vs. AMP [274]
GPa reverse glucose-1-phosphate (G1P) vs. G6P [275]
GPb forward Pi vs. ATP [276]
GPb reverse G1P vs. G6P [277]
GPb reverse AMP vs. G6P [277]
C.2 Glycogen phosphorylase rate equation and
parameter optimization
A rate equation for GP was recently proposed by Walcott & Lehman [201]. Their
equation, however, only describes the kinetics of the dephosphorylated enzyme,
GPb. They also did not consider inhibition of GP by G6P. Since we are interested
in a rate equation for both GP phosphorylation states that is also able to describe
inhibition by G6P, a new rate equation was developed.
Experimental data
As far as possible we used only experimental data that were obtained under the
same conditions and preferably in the same lab. Data points were obtained by digi-
tizing graphs from the PDF versions of published articles. The data sources are listed
in Table C.5.
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Algorithm and software
The parameter optimization was carried out using a combination of Python pro-
gramming language modules: NumPy and SciPy for numeric procedures, and LMfit-
py, a wrapper around the SciPy implementation of the Levenberg-Marquardt algo-
rithm with added support for constraints. IPython was used as an interactive shell
for Python. IPython’s built-in support for parallel computing was used to speed
up optimizations. To increase the likelihood of finding a global minimum, the op-
timization was repeated 1000 times with random initial parameter values for each
iteration.
Rate equation and feature selection
Guided by the observation that GP ligands also influence the rate of the kinase and
phosphatase that catalyse the covalent modification of GP, we chose an MWC-type
rate equation similar to that of Walcott & Lehman [201], but in which phosphoryla-
tion and dephosphorylation are considered to only affect the equilibria between the
various GP conformations. Like Walcott & Lehman [201] we used a MWC equation
with three conformations (R, T, and U) of which only the R conformation is catalyti-
cally active.
The GP literature suggests that AMP, ATP, and G6P all bind to the activation site,
but that G6P is inhibitory and that ATP, although activatory, binds with a weak affin-
ity to this site. AMP and ATP also both bind to the nucleoside site, where they result
in inhibition, but AMP binds only with a weak affinity and is not a physiological
inhibitor of GP. We could not obtain a rich enough data set from the literature that
would allow parameters that describe the binding of ATP to the activation site and
the binding of AMP to the inhibition site to be optimized. These features were thus
omitted from the onset. In addition, glycogen was considered saturating and was
thus also omitted. The number of subunits were taken as two. Separate Vmax values
were fitted for data from different source and for the reverse and forward reactions.
The initial rate equation, which was further simplified during a process of feature
selection, is given by
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vGP =∑
i
Vmax,rn
[Pi]
Kr,Pi
(
1+
[Pi]
Kr,Pi
+
[G1P]
Kr,G1P
)n−1 (
1+
[AMP]
Kr,AMP
+
[G6P]
Kr,G6P
)n (
1+
[ATP]
Kr,ATP
)n
(
1+
[Pi]
Kr,Pi
+
[G1P]
Kr,G1P
)n (
1+
[AMP]
Kr,AMP
+
[G6P]
Kr,G6P
)n (
1+
[ATP]
Kr,ATP
)n
+ Lt,i
(
1+
[Pi]
Kt,Pi
+
[G1P]
Kt,G1P
)n (
1+
[AMP]
Kt,AMP
+
[G6P]
Kt,G6P
)n (
1+
[ATP]
Kt,ATP
)n
+ Lu,i
(
1+
[Pi]
Ku,Pi
+
[G1P]
Ku,G1P
)n (
1+
[AMP]
Ku,AMP
+
[G6P]
Ku,G6P
)n (
1+
[ATP]
Ku,ATP
)n
(C.4)
A preliminary optimization revealed that the T conformation was negligible for GPa
and that the U conformation was negligible for GPb. We therefore set Lt,a = 0 and
Lu,b = 0. So that Eq. C.4 simplifies to
vGP =
kcat,r[GP]an
[Pi]
Kr,Pi
(
1+
[Pi]
Kr,Pi
+
[G1P]
Kr,G1P
)n−1
(
1+
[Pi]
Kr,Pi
+
[G1P]
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(C.5)
However, since, none of our data sets contained ATP binding data for GPa, binding
of ATP to the U conformation had to be considered negligible, so that
vGP =
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Table C.6: Optimized parameters for the best-fit equation (Eq. C.7).
Parameter Value Error Unit
R2 0.9991 – –
R¯2 0.999 – –
Vmax,a,reverse 31.446 0.917 µmol.min−1mg−1
Vmax,a,forward 257.71 1.348 U.mg−1
Vmax,b,reverse,AMP 26.778 0.592 µmol.min
−1mg−1
Vmax,b,reverse,G1P 38.181 1.005 µmol.min
−1mg−1
Kr,GP:G6P 7.4174 2.73 mM
Ku,GP:G6P 0.5551 0.12 mM
Kt,GP:G6P 0.2685 4.853 · 10−2 mM
Kr,GP:AMP 3.3581 · 10−3 3.958 · 10−3 mM
Kt,GP:AMP 0.525 0.283 mM
Kt,GP:ATP 3.8991 22.627 mM
Kr,GP:G1P 0.6671 8.345 · 10−2 mM
Ku,GP:G1P 82.016 53.359 mM
Kt,GP:G1P 27.923 9.316 mM
Kr,GP:Pi 2.0821 4.402 · 10−2 mM
Ku,GP,Pi 4.3177 0.177 mM
Kt,GP,Pi 41.532 547.57 mM
Lu,GP,a 5.9348 0.405 dimensionless
Lt,GP,a 0 0 dimensionless
Lu,GP,b 0 0 dimensionless
Lt,GP,b 34,741 72,931 dimensionless
We further found that neither Ku,AMP nor Kr,ATP affected the goodness of fit what-
soever. Equation C.6 thus simplifies to
vGP =
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(C.7)
The parameters that provided the best fit (Fig. C.1) to Eq. C.7 are listed in Ta-
ble C.6.
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Figure C.1: Comparison of experimental data points to the rates calculated from the best-fit
equation (Eq. C.7).
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